id	sid	tid	token	lemma	pos
ajlm-2381	1	1	abstract	abstract	ADJ
ajlm-2381	1	2	introduction	introduction	NOUN
ajlm-2381	1	3	methods	method	NOUN
ajlm-2381	1	4	conclusion	conclusion	VERB
ajlm-2381	1	5	acknowledgements	acknowledgement	NOUN
ajlm-2381	1	6	references	reference	NOUN
ajlm-2381	1	7	about	about	ADP
ajlm-2381	1	8	the	the	DET
ajlm-2381	1	9	author(s	author(s	NOUN
ajlm-2381	1	10	)	)	PUNCT
ajlm-2381	1	11	ethan	ethan	PROPN
ajlm-2381	1	12	j.	j.	PROPN
ajlm-2381	1	13	gantana	gantana	PROPN
ajlm-2381	1	14	department	department	PROPN
ajlm-2381	1	15	of	of	ADP
ajlm-2381	1	16	pathology	pathology	PROPN
ajlm-2381	1	17	,	,	PUNCT
ajlm-2381	1	18	faculty	faculty	NOUN
ajlm-2381	1	19	of	of	ADP
ajlm-2381	1	20	medicine	medicine	NOUN
ajlm-2381	1	21	and	and	CCONJ
ajlm-2381	1	22	health	health	NOUN
ajlm-2381	1	23	sciences	sciences	PROPN
ajlm-2381	1	24	,	,	PUNCT
ajlm-2381	1	25	stellenbosch	stellenbosch	PROPN
ajlm-2381	1	26	university	university	PROPN
ajlm-2381	1	27	,	,	PUNCT
ajlm-2381	1	28	cape	cape	NOUN
ajlm-2381	1	29	town	town	NOUN
ajlm-2381	1	30	,	,	PUNCT
ajlm-2381	1	31	south	south	PROPN
ajlm-2381	1	32	africa	africa	PROPN
ajlm-2381	1	33	department	department	PROPN
ajlm-2381	1	34	of	of	ADP
ajlm-2381	1	35	haematology	haematology	PROPN
ajlm-2381	1	36	,	,	PUNCT
ajlm-2381	1	37	national	national	PROPN
ajlm-2381	1	38	health	health	PROPN
ajlm-2381	1	39	laboratory	laboratory	PROPN
ajlm-2381	1	40	service	service	PROPN
ajlm-2381	1	41	,	,	PUNCT
ajlm-2381	1	42	cape	cape	NOUN
ajlm-2381	1	43	town	town	NOUN
ajlm-2381	1	44	,	,	PUNCT
ajlm-2381	1	45	south	south	PROPN
ajlm-2381	1	46	africa	africa	PROPN
ajlm-2381	1	47	ernest	ernest	PROPN
ajlm-2381	1	48	musekwa	musekwa	PROPN
ajlm-2381	1	49	department	department	PROPN
ajlm-2381	1	50	of	of	ADP
ajlm-2381	1	51	pathology	pathology	PROPN
ajlm-2381	1	52	,	,	PUNCT
ajlm-2381	1	53	faculty	faculty	NOUN
ajlm-2381	1	54	of	of	ADP
ajlm-2381	1	55	medicine	medicine	NOUN
ajlm-2381	1	56	and	and	CCONJ
ajlm-2381	1	57	health	health	NOUN
ajlm-2381	1	58	sciences	sciences	PROPN
ajlm-2381	1	59	,	,	PUNCT
ajlm-2381	1	60	stellenbosch	stellenbosch	PROPN
ajlm-2381	1	61	university	university	PROPN
ajlm-2381	1	62	,	,	PUNCT
ajlm-2381	1	63	cape	cape	NOUN
ajlm-2381	1	64	town	town	NOUN
ajlm-2381	1	65	,	,	PUNCT
ajlm-2381	1	66	south	south	PROPN
ajlm-2381	1	67	africa	africa	PROPN
ajlm-2381	1	68	department	department	PROPN
ajlm-2381	1	69	of	of	ADP
ajlm-2381	1	70	haematology	haematology	PROPN
ajlm-2381	1	71	,	,	PUNCT
ajlm-2381	1	72	national	national	PROPN
ajlm-2381	1	73	health	health	PROPN
ajlm-2381	1	74	laboratory	laboratory	PROPN
ajlm-2381	1	75	service	service	PROPN
ajlm-2381	1	76	,	,	PUNCT
ajlm-2381	1	77	cape	cape	NOUN
ajlm-2381	1	78	town	town	NOUN
ajlm-2381	1	79	,	,	PUNCT
ajlm-2381	1	80	south	south	PROPN
ajlm-2381	1	81	africa	africa	PROPN
ajlm-2381	1	82	zivanai	zivanai	PROPN
ajlm-2381	1	83	c.	c.	PROPN
ajlm-2381	1	84	chapanduka	chapanduka	PROPN
ajlm-2381	1	85	department	department	PROPN
ajlm-2381	1	86	of	of	ADP
ajlm-2381	1	87	pathology	pathology	PROPN
ajlm-2381	1	88	,	,	PUNCT
ajlm-2381	1	89	faculty	faculty	NOUN
ajlm-2381	1	90	of	of	ADP
ajlm-2381	1	91	medicine	medicine	NOUN
ajlm-2381	1	92	and	and	CCONJ
ajlm-2381	1	93	health	health	NOUN
ajlm-2381	1	94	sciences	sciences	PROPN
ajlm-2381	1	95	,	,	PUNCT
ajlm-2381	1	96	stellenbosch	stellenbosch	PROPN
ajlm-2381	1	97	university	university	PROPN
ajlm-2381	1	98	,	,	PUNCT
ajlm-2381	1	99	cape	cape	NOUN
ajlm-2381	1	100	town	town	NOUN
ajlm-2381	1	101	,	,	PUNCT
ajlm-2381	1	102	south	south	PROPN
ajlm-2381	1	103	africa	africa	PROPN
ajlm-2381	1	104	department	department	PROPN
ajlm-2381	1	105	of	of	ADP
ajlm-2381	1	106	haematology	haematology	PROPN
ajlm-2381	1	107	,	,	PUNCT
ajlm-2381	1	108	national	national	PROPN
ajlm-2381	1	109	health	health	PROPN
ajlm-2381	1	110	laboratory	laboratory	PROPN
ajlm-2381	1	111	service	service	PROPN
ajlm-2381	1	112	,	,	PUNCT
ajlm-2381	1	113	cape	cape	NOUN
ajlm-2381	1	114	town	town	NOUN
ajlm-2381	1	115	,	,	PUNCT
ajlm-2381	1	116	south	south	PROPN
ajlm-2381	1	117	africa	africa	PROPN
ajlm-2381	1	118	citation	citation	PROPN
ajlm-2381	1	119	gantana	gantana	PROPN
ajlm-2381	1	120	ej	ej	PROPN
ajlm-2381	1	121	,	,	PUNCT
ajlm-2381	1	122	musekwa	musekwa	NOUN
ajlm-2381	1	123	e	e	PROPN
ajlm-2381	1	124	,	,	PUNCT
ajlm-2381	1	125	chapanduka	chapanduka	PROPN
ajlm-2381	1	126	zc	zc	NOUN
ajlm-2381	1	127	.	.	PUNCT
ajlm-2381	1	128	advances	advance	NOUN
ajlm-2381	1	129	in	in	ADP
ajlm-2381	1	130	estimating	estimate	VERB
ajlm-2381	1	131	plasma	plasma	NOUN
ajlm-2381	1	132	cells	cell	NOUN
ajlm-2381	1	133	in	in	ADP
ajlm-2381	1	134	bone	bone	NOUN
ajlm-2381	1	135	marrow	marrow	NOUN
ajlm-2381	1	136	:	:	PUNCT
ajlm-2381	1	137	a	a	DET
ajlm-2381	1	138	comprehensive	comprehensive	ADJ
ajlm-2381	1	139	method	method	NOUN
ajlm-2381	1	140	review	review	NOUN
ajlm-2381	1	141	.	.	PUNCT
ajlm-2381	2	1	afr	afr	PROPN
ajlm-2381	2	2	j	j	PROPN
ajlm-2381	2	3	lab	lab	PROPN
ajlm-2381	2	4	med	me	VERB
ajlm-2381	2	5	.	.	PUNCT
ajlm-2381	3	1	2024;13(1	2024;13(1	NUM
ajlm-2381	3	2	)	)	PUNCT
ajlm-2381	3	3	,	,	PUNCT
ajlm-2381	3	4	a2381	a2381	VERB
ajlm-2381	3	5	.	.	PUNCT
ajlm-2381	4	1	https://doi.org/10.4102/ajlm.v13i1.2381	https://doi.org/10.4102/ajlm.v13i1.2381	PRON
ajlm-2381	4	2	note	note	VERB
ajlm-2381	4	3	:	:	PUNCT
ajlm-2381	4	4	special	special	ADJ
ajlm-2381	4	5	collection	collection	NOUN
ajlm-2381	4	6	:	:	PUNCT
ajlm-2381	4	7	transforming	transform	VERB
ajlm-2381	4	8	african	african	ADJ
ajlm-2381	4	9	lds	ld	NOUN
ajlm-2381	4	10	with	with	ADP
ajlm-2381	4	11	dt	dt	PROPN
ajlm-2381	4	12	and	and	CCONJ
ajlm-2381	4	13	ai	ai	VERB
ajlm-2381	4	14	.	.	PROPN
ajlm-2381	4	15	review	review	NOUN
ajlm-2381	4	16	article	article	NOUN
ajlm-2381	4	17	advances	advance	VERB
ajlm-2381	4	18	in	in	ADP
ajlm-2381	4	19	estimating	estimate	VERB
ajlm-2381	4	20	plasma	plasma	NOUN
ajlm-2381	4	21	cells	cell	NOUN
ajlm-2381	4	22	in	in	ADP
ajlm-2381	4	23	bone	bone	NOUN
ajlm-2381	4	24	marrow	marrow	NOUN
ajlm-2381	4	25	:	:	PUNCT
ajlm-2381	4	26	a	a	DET
ajlm-2381	4	27	comprehensive	comprehensive	ADJ
ajlm-2381	4	28	method	method	NOUN
ajlm-2381	4	29	review	review	NOUN
ajlm-2381	4	30	ethan	ethan	PROPN
ajlm-2381	4	31	j.	j.	PROPN
ajlm-2381	4	32	gantana	gantana	PROPN
ajlm-2381	4	33	,	,	PUNCT
ajlm-2381	4	34	ernest	ernest	PROPN
ajlm-2381	4	35	musekwa	musekwa	PROPN
ajlm-2381	4	36	,	,	PUNCT
ajlm-2381	4	37	zivanai	zivanai	PROPN
ajlm-2381	4	38	c.	c.	PROPN
ajlm-2381	4	39	chapanduka	chapanduka	PROPN
ajlm-2381	4	40	received	receive	VERB
ajlm-2381	4	41	:	:	PUNCT
ajlm-2381	4	42	30	30	NUM
ajlm-2381	4	43	nov	nov	NOUN
ajlm-2381	4	44	.	.	PROPN
ajlm-2381	4	45	2023	2023	NUM
ajlm-2381	4	46	;	;	PUNCT
ajlm-2381	4	47	accepted	accept	VERB
ajlm-2381	4	48	:	:	PUNCT
ajlm-2381	4	49	25	25	NUM
ajlm-2381	4	50	mar	mar	PROPN
ajlm-2381	4	51	.	.	PROPN
ajlm-2381	4	52	2024	2024	NUM
ajlm-2381	4	53	;	;	PUNCT
ajlm-2381	4	54	published	publish	VERB
ajlm-2381	4	55	:	:	PUNCT
ajlm-2381	4	56	11	11	NUM
ajlm-2381	4	57	july	july	PROPN
ajlm-2381	4	58	2024	2024	NUM
ajlm-2381	4	59	copyright	copyright	NOUN
ajlm-2381	4	60	:	:	PUNCT
ajlm-2381	4	61	©	©	PROPN
ajlm-2381	4	62	2024	2024	NUM
ajlm-2381	4	63	.	.	PUNCT
ajlm-2381	5	1	the	the	DET
ajlm-2381	5	2	author(s	author(s	PROPN
ajlm-2381	5	3	)	)	PUNCT
ajlm-2381	5	4	.	.	PUNCT
ajlm-2381	6	1	licensee	licensee	NOUN
ajlm-2381	6	2	:	:	PUNCT
ajlm-2381	6	3	aosis	aosis	NOUN
ajlm-2381	6	4	.	.	PUNCT
ajlm-2381	7	1	this	this	PRON
ajlm-2381	7	2	is	be	AUX
ajlm-2381	7	3	an	an	DET
ajlm-2381	7	4	open	open	ADJ
ajlm-2381	7	5	access	access	NOUN
ajlm-2381	7	6	article	article	NOUN
ajlm-2381	7	7	distributed	distribute	VERB
ajlm-2381	7	8	under	under	ADP
ajlm-2381	7	9	the	the	DET
ajlm-2381	7	10	terms	term	NOUN
ajlm-2381	7	11	of	of	ADP
ajlm-2381	7	12	the	the	DET
ajlm-2381	7	13	creative	creative	ADJ
ajlm-2381	7	14	commons	common	NOUN
ajlm-2381	7	15	attribution	attribution	NOUN
ajlm-2381	7	16	license	license	NOUN
ajlm-2381	7	17	,	,	PUNCT
ajlm-2381	7	18	which	which	PRON
ajlm-2381	7	19	permits	permit	VERB
ajlm-2381	7	20	unrestricted	unrestricted	ADJ
ajlm-2381	7	21	use	use	NOUN
ajlm-2381	7	22	,	,	PUNCT
ajlm-2381	7	23	distribution	distribution	NOUN
ajlm-2381	7	24	,	,	PUNCT
ajlm-2381	7	25	and	and	CCONJ
ajlm-2381	7	26	reproduction	reproduction	NOUN
ajlm-2381	7	27	in	in	ADP
ajlm-2381	7	28	any	any	DET
ajlm-2381	7	29	medium	medium	NOUN
ajlm-2381	7	30	,	,	PUNCT
ajlm-2381	7	31	provided	provide	VERB
ajlm-2381	7	32	the	the	DET
ajlm-2381	7	33	original	original	ADJ
ajlm-2381	7	34	work	work	NOUN
ajlm-2381	7	35	is	be	AUX
ajlm-2381	7	36	properly	properly	ADV
ajlm-2381	7	37	cited	cite	VERB
ajlm-2381	7	38	.	.	PUNCT
ajlm-2381	8	1	abstract	abstract	VERB
ajlm-2381	8	2	the	the	DET
ajlm-2381	8	3	quantitation	quantitation	NOUN
ajlm-2381	8	4	of	of	ADP
ajlm-2381	8	5	plasma	plasma	NOUN
ajlm-2381	8	6	cells	cell	NOUN
ajlm-2381	8	7	in	in	ADP
ajlm-2381	8	8	bone	bone	NOUN
ajlm-2381	8	9	marrow	marrow	NOUN
ajlm-2381	8	10	(	(	PUNCT
ajlm-2381	8	11	bm	bm	PROPN
ajlm-2381	8	12	)	)	PUNCT
ajlm-2381	8	13	is	be	AUX
ajlm-2381	8	14	crucial	crucial	ADJ
ajlm-2381	8	15	for	for	ADP
ajlm-2381	8	16	diagnosing	diagnose	VERB
ajlm-2381	8	17	and	and	CCONJ
ajlm-2381	8	18	classifying	classify	VERB
ajlm-2381	8	19	plasma	plasma	NOUN
ajlm-2381	8	20	cell	cell	NOUN
ajlm-2381	8	21	neoplasms	neoplasm	NOUN
ajlm-2381	8	22	.	.	PUNCT
ajlm-2381	9	1	various	various	ADJ
ajlm-2381	9	2	methods	method	NOUN
ajlm-2381	9	3	,	,	PUNCT
ajlm-2381	9	4	including	include	VERB
ajlm-2381	9	5	romanowsky	romanowsky	NOUN
ajlm-2381	9	6	-	-	PUNCT
ajlm-2381	9	7	stained	stain	VERB
ajlm-2381	9	8	bm	bm	PROPN
ajlm-2381	9	9	aspirates	aspirates	PROPN
ajlm-2381	9	10	(	(	PUNCT
ajlm-2381	9	11	bma	bma	PROPN
ajlm-2381	9	12	)	)	PUNCT
ajlm-2381	9	13	,	,	PUNCT
ajlm-2381	9	14	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	9	15	,	,	PUNCT
ajlm-2381	9	16	flow	flow	NOUN
ajlm-2381	9	17	cytometry	cytometry	NOUN
ajlm-2381	9	18	,	,	PUNCT
ajlm-2381	9	19	and	and	CCONJ
ajlm-2381	9	20	radiological	radiological	ADJ
ajlm-2381	9	21	imaging	imaging	NOUN
ajlm-2381	9	22	,	,	PUNCT
ajlm-2381	9	23	have	have	AUX
ajlm-2381	9	24	been	be	AUX
ajlm-2381	9	25	explored	explore	VERB
ajlm-2381	9	26	.	.	PUNCT
ajlm-2381	10	1	however	however	ADV
ajlm-2381	10	2	,	,	PUNCT
ajlm-2381	10	3	challenges	challenge	NOUN
ajlm-2381	10	4	such	such	ADJ
ajlm-2381	10	5	as	as	ADP
ajlm-2381	10	6	patchy	patchy	ADJ
ajlm-2381	10	7	infiltration	infiltration	NOUN
ajlm-2381	10	8	and	and	CCONJ
ajlm-2381	10	9	sample	sample	NOUN
ajlm-2381	10	10	haemodilution	haemodilution	NOUN
ajlm-2381	10	11	can	can	AUX
ajlm-2381	10	12	impact	impact	VERB
ajlm-2381	10	13	the	the	DET
ajlm-2381	10	14	reliability	reliability	NOUN
ajlm-2381	10	15	of	of	ADP
ajlm-2381	10	16	bm	bm	PROPN
ajlm-2381	10	17	plasma	plasma	NOUN
ajlm-2381	10	18	cell	cell	NOUN
ajlm-2381	10	19	percentage	percentage	NOUN
ajlm-2381	10	20	estimates	estimate	NOUN
ajlm-2381	10	21	.	.	PUNCT
ajlm-2381	11	1	bone	bone	NOUN
ajlm-2381	11	2	marrow	marrow	NOUN
ajlm-2381	11	3	plasma	plasma	NOUN
ajlm-2381	11	4	cell	cell	NOUN
ajlm-2381	11	5	percentage	percentage	NOUN
ajlm-2381	11	6	varies	vary	VERB
ajlm-2381	11	7	across	across	ADP
ajlm-2381	11	8	methods	method	NOUN
ajlm-2381	11	9	,	,	PUNCT
ajlm-2381	11	10	with	with	ADP
ajlm-2381	11	11	immunohistochemically	immunohistochemically	ADV
ajlm-2381	11	12	stained	stain	VERB
ajlm-2381	11	13	biopsies	biopsy	NOUN
ajlm-2381	11	14	consistently	consistently	ADV
ajlm-2381	11	15	yielding	yield	VERB
ajlm-2381	11	16	higher	high	ADJ
ajlm-2381	11	17	values	value	NOUN
ajlm-2381	11	18	than	than	ADP
ajlm-2381	11	19	romanowsky	romanowsky	NOUN
ajlm-2381	11	20	-	-	PUNCT
ajlm-2381	11	21	stained	stain	VERB
ajlm-2381	11	22	bma	bma	NOUN
ajlm-2381	11	23	or	or	CCONJ
ajlm-2381	11	24	flow	flow	VERB
ajlm-2381	11	25	cytometry	cytometry	NOUN
ajlm-2381	11	26	alone	alone	ADV
ajlm-2381	11	27	.	.	PUNCT
ajlm-2381	12	1	cd138	cd138	NOUN
ajlm-2381	12	2	or	or	CCONJ
ajlm-2381	12	3	mum1	mum1	PROPN
ajlm-2381	12	4	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	12	5	and	and	CCONJ
ajlm-2381	12	6	artificial	artificial	ADJ
ajlm-2381	12	7	intelligence	intelligence	NOUN
ajlm-2381	12	8	image	image	NOUN
ajlm-2381	12	9	analysis	analysis	NOUN
ajlm-2381	12	10	on	on	ADP
ajlm-2381	12	11	whole	whole	ADJ
ajlm-2381	12	12	-	-	PUNCT
ajlm-2381	12	13	slide	slide	NOUN
ajlm-2381	12	14	images	image	NOUN
ajlm-2381	12	15	are	be	AUX
ajlm-2381	12	16	emerging	emerge	VERB
ajlm-2381	12	17	as	as	ADP
ajlm-2381	12	18	promising	promising	ADJ
ajlm-2381	12	19	tools	tool	NOUN
ajlm-2381	12	20	for	for	ADP
ajlm-2381	12	21	accurate	accurate	ADJ
ajlm-2381	12	22	plasma	plasma	NOUN
ajlm-2381	12	23	cell	cell	NOUN
ajlm-2381	12	24	identification	identification	NOUN
ajlm-2381	12	25	and	and	CCONJ
ajlm-2381	12	26	quantification	quantification	NOUN
ajlm-2381	12	27	.	.	PUNCT
ajlm-2381	13	1	radiological	radiological	ADJ
ajlm-2381	13	2	imaging	imaging	NOUN
ajlm-2381	13	3	,	,	PUNCT
ajlm-2381	13	4	particularly	particularly	ADV
ajlm-2381	13	5	with	with	ADP
ajlm-2381	13	6	advanced	advanced	ADJ
ajlm-2381	13	7	technologies	technology	NOUN
ajlm-2381	13	8	like	like	ADP
ajlm-2381	13	9	dual	dual	ADJ
ajlm-2381	13	10	-	-	PUNCT
ajlm-2381	13	11	energy	energy	NOUN
ajlm-2381	13	12	computed	compute	VERB
ajlm-2381	13	13	tomography	tomography	NOUN
ajlm-2381	13	14	and	and	CCONJ
ajlm-2381	13	15	radiomics	radiomic	NOUN
ajlm-2381	13	16	,	,	PUNCT
ajlm-2381	13	17	shows	show	VERB
ajlm-2381	13	18	potential	potential	NOUN
ajlm-2381	13	19	for	for	ADP
ajlm-2381	13	20	multiple	multiple	ADJ
ajlm-2381	13	21	myeloma	myeloma	NOUN
ajlm-2381	13	22	diagnosis	diagnosis	NOUN
ajlm-2381	13	23	,	,	PUNCT
ajlm-2381	13	24	although	although	SCONJ
ajlm-2381	13	25	standardisation	standardisation	NOUN
ajlm-2381	13	26	remains	remain	VERB
ajlm-2381	13	27	a	a	DET
ajlm-2381	13	28	challenge	challenge	NOUN
ajlm-2381	13	29	.	.	PUNCT
ajlm-2381	14	1	molecular	molecular	ADJ
ajlm-2381	14	2	techniques	technique	NOUN
ajlm-2381	14	3	,	,	PUNCT
ajlm-2381	14	4	such	such	ADJ
ajlm-2381	14	5	as	as	ADP
ajlm-2381	14	6	allele	allele	NOUN
ajlm-2381	14	7	-	-	PUNCT
ajlm-2381	14	8	specific	specific	ADJ
ajlm-2381	14	9	oligonucleotide	oligonucleotide	NOUN
ajlm-2381	14	10	quantitative	quantitative	ADJ
ajlm-2381	14	11	polymerase	polymerase	NOUN
ajlm-2381	14	12	chain	chain	NOUN
ajlm-2381	14	13	reaction	reaction	NOUN
ajlm-2381	14	14	and	and	CCONJ
ajlm-2381	14	15	next	next	ADJ
ajlm-2381	14	16	-	-	PUNCT
ajlm-2381	14	17	generation	generation	NOUN
ajlm-2381	14	18	sequencing	sequencing	NOUN
ajlm-2381	14	19	,	,	PUNCT
ajlm-2381	14	20	offer	offer	VERB
ajlm-2381	14	21	insights	insight	NOUN
ajlm-2381	14	22	into	into	ADP
ajlm-2381	14	23	clonality	clonality	NOUN
ajlm-2381	14	24	and	and	CCONJ
ajlm-2381	14	25	measurable	measurable	ADJ
ajlm-2381	14	26	residual	residual	ADJ
ajlm-2381	14	27	disease	disease	NOUN
ajlm-2381	14	28	.	.	PUNCT
ajlm-2381	15	1	while	while	SCONJ
ajlm-2381	15	2	no	no	DET
ajlm-2381	15	3	consensus	consensus	NOUN
ajlm-2381	15	4	exists	exist	VERB
ajlm-2381	15	5	on	on	ADP
ajlm-2381	15	6	a	a	DET
ajlm-2381	15	7	gold	gold	ADJ
ajlm-2381	15	8	standard	standard	ADJ
ajlm-2381	15	9	method	method	NOUN
ajlm-2381	15	10	for	for	ADP
ajlm-2381	15	11	bm	bm	PROPN
ajlm-2381	15	12	plasma	plasma	NOUN
ajlm-2381	15	13	cell	cell	NOUN
ajlm-2381	15	14	quantitation	quantitation	NOUN
ajlm-2381	15	15	,	,	PUNCT
ajlm-2381	15	16	cd138	cd138	NOUN
ajlm-2381	15	17	-	-	PUNCT
ajlm-2381	15	18	stained	stain	VERB
ajlm-2381	15	19	biopsies	biopsy	NOUN
ajlm-2381	15	20	are	be	AUX
ajlm-2381	15	21	favoured	favour	VERB
ajlm-2381	15	22	for	for	ADP
ajlm-2381	15	23	accurate	accurate	ADJ
ajlm-2381	15	24	estimation	estimation	NOUN
ajlm-2381	15	25	and	and	CCONJ
ajlm-2381	15	26	play	play	VERB
ajlm-2381	15	27	a	a	DET
ajlm-2381	15	28	pivotal	pivotal	ADJ
ajlm-2381	15	29	role	role	NOUN
ajlm-2381	15	30	in	in	ADP
ajlm-2381	15	31	diagnosing	diagnose	VERB
ajlm-2381	15	32	and	and	CCONJ
ajlm-2381	15	33	assessing	assess	VERB
ajlm-2381	15	34	multiple	multiple	ADJ
ajlm-2381	15	35	myeloma	myeloma	NOUN
ajlm-2381	15	36	treatment	treatment	NOUN
ajlm-2381	15	37	responses	response	NOUN
ajlm-2381	15	38	.	.	PUNCT
ajlm-2381	16	1	combining	combine	VERB
ajlm-2381	16	2	multiple	multiple	ADJ
ajlm-2381	16	3	methods	method	NOUN
ajlm-2381	16	4	,	,	PUNCT
ajlm-2381	16	5	such	such	ADJ
ajlm-2381	16	6	as	as	ADP
ajlm-2381	16	7	bma	bma	PROPN
ajlm-2381	16	8	,	,	PUNCT
ajlm-2381	16	9	bm	bm	PROPN
ajlm-2381	16	10	biopsy	biopsy	PROPN
ajlm-2381	16	11	,	,	PUNCT
ajlm-2381	16	12	and	and	CCONJ
ajlm-2381	16	13	flow	flow	NOUN
ajlm-2381	16	14	cytometry	cytometry	NOUN
ajlm-2381	16	15	,	,	PUNCT
ajlm-2381	16	16	enhances	enhance	VERB
ajlm-2381	16	17	accuracy	accuracy	NOUN
ajlm-2381	16	18	of	of	ADP
ajlm-2381	16	19	diagnosis	diagnosis	NOUN
ajlm-2381	16	20	and	and	CCONJ
ajlm-2381	16	21	classification	classification	NOUN
ajlm-2381	16	22	of	of	ADP
ajlm-2381	16	23	plasma	plasma	NOUN
ajlm-2381	16	24	cell	cell	NOUN
ajlm-2381	16	25	neoplasms	neoplasm	NOUN
ajlm-2381	16	26	.	.	PUNCT
ajlm-2381	17	1	the	the	DET
ajlm-2381	17	2	quest	quest	NOUN
ajlm-2381	17	3	for	for	ADP
ajlm-2381	17	4	a	a	DET
ajlm-2381	17	5	gold	gold	ADJ
ajlm-2381	17	6	standard	standard	NOUN
ajlm-2381	17	7	requires	require	VERB
ajlm-2381	17	8	ongoing	ongoing	ADJ
ajlm-2381	17	9	research	research	NOUN
ajlm-2381	17	10	and	and	CCONJ
ajlm-2381	17	11	collaboration	collaboration	NOUN
ajlm-2381	17	12	to	to	PART
ajlm-2381	17	13	refine	refine	VERB
ajlm-2381	17	14	existing	exist	VERB
ajlm-2381	17	15	methods	method	NOUN
ajlm-2381	17	16	.	.	PUNCT
ajlm-2381	18	1	furthermore	furthermore	ADV
ajlm-2381	18	2	,	,	PUNCT
ajlm-2381	18	3	the	the	DET
ajlm-2381	18	4	rise	rise	NOUN
ajlm-2381	18	5	of	of	ADP
ajlm-2381	18	6	digital	digital	ADJ
ajlm-2381	18	7	pathology	pathology	NOUN
ajlm-2381	18	8	is	be	AUX
ajlm-2381	18	9	anticipated	anticipate	VERB
ajlm-2381	18	10	to	to	PART
ajlm-2381	18	11	reshape	reshape	VERB
ajlm-2381	18	12	laboratory	laboratory	NOUN
ajlm-2381	18	13	medicine	medicine	NOUN
ajlm-2381	18	14	and	and	CCONJ
ajlm-2381	18	15	the	the	DET
ajlm-2381	18	16	role	role	NOUN
ajlm-2381	18	17	of	of	ADP
ajlm-2381	18	18	pathologists	pathologist	NOUN
ajlm-2381	18	19	in	in	ADP
ajlm-2381	18	20	the	the	DET
ajlm-2381	18	21	digital	digital	ADJ
ajlm-2381	18	22	era	era	NOUN
ajlm-2381	18	23	.	.	PUNCT
ajlm-2381	19	1	what	what	PRON
ajlm-2381	19	2	this	this	DET
ajlm-2381	19	3	study	study	NOUN
ajlm-2381	19	4	adds	add	VERB
ajlm-2381	19	5	:	:	PUNCT
ajlm-2381	19	6	this	this	DET
ajlm-2381	19	7	article	article	NOUN
ajlm-2381	19	8	adds	add	VERB
ajlm-2381	19	9	a	a	DET
ajlm-2381	19	10	comprehensive	comprehensive	ADJ
ajlm-2381	19	11	review	review	NOUN
ajlm-2381	19	12	and	and	CCONJ
ajlm-2381	19	13	comparison	comparison	NOUN
ajlm-2381	19	14	of	of	ADP
ajlm-2381	19	15	different	different	ADJ
ajlm-2381	19	16	methods	method	NOUN
ajlm-2381	19	17	for	for	ADP
ajlm-2381	19	18	plasma	plasma	NOUN
ajlm-2381	19	19	cell	cell	NOUN
ajlm-2381	19	20	estimation	estimation	NOUN
ajlm-2381	19	21	in	in	ADP
ajlm-2381	19	22	the	the	DET
ajlm-2381	19	23	bone	bone	NOUN
ajlm-2381	19	24	marrow	marrow	NOUN
ajlm-2381	19	25	,	,	PUNCT
ajlm-2381	19	26	highlighting	highlight	VERB
ajlm-2381	19	27	their	their	PRON
ajlm-2381	19	28	strengths	strength	NOUN
ajlm-2381	19	29	and	and	CCONJ
ajlm-2381	19	30	limitations	limitation	NOUN
ajlm-2381	19	31	.	.	PUNCT
ajlm-2381	20	1	the	the	DET
ajlm-2381	20	2	goal	goal	NOUN
ajlm-2381	20	3	is	be	AUX
ajlm-2381	20	4	to	to	PART
ajlm-2381	20	5	contribute	contribute	VERB
ajlm-2381	20	6	valuable	valuable	ADJ
ajlm-2381	20	7	insights	insight	NOUN
ajlm-2381	20	8	that	that	PRON
ajlm-2381	20	9	can	can	AUX
ajlm-2381	20	10	guide	guide	VERB
ajlm-2381	20	11	the	the	DET
ajlm-2381	20	12	selection	selection	NOUN
ajlm-2381	20	13	of	of	ADP
ajlm-2381	20	14	optimal	optimal	ADJ
ajlm-2381	20	15	techniques	technique	NOUN
ajlm-2381	20	16	for	for	ADP
ajlm-2381	20	17	accurate	accurate	ADJ
ajlm-2381	20	18	plasma	plasma	NOUN
ajlm-2381	20	19	cell	cell	NOUN
ajlm-2381	20	20	estimation	estimation	NOUN
ajlm-2381	20	21	.	.	PUNCT
ajlm-2381	21	1	keywords	keyword	NOUN
ajlm-2381	21	2	:	:	PUNCT
ajlm-2381	21	3	plasma	plasma	NOUN
ajlm-2381	21	4	cell	cell	NOUN
ajlm-2381	21	5	neoplasms	neoplasm	NOUN
ajlm-2381	21	6	;	;	PUNCT
ajlm-2381	21	7	multiple	multiple	ADJ
ajlm-2381	21	8	myeloma	myeloma	NOUN
ajlm-2381	21	9	;	;	PUNCT
ajlm-2381	21	10	digital	digital	ADJ
ajlm-2381	21	11	pathology	pathology	NOUN
ajlm-2381	21	12	;	;	PUNCT
ajlm-2381	21	13	artificial	artificial	ADJ
ajlm-2381	21	14	intelligence	intelligence	NOUN
ajlm-2381	21	15	;	;	PUNCT
ajlm-2381	21	16	haematology	haematology	NOUN
ajlm-2381	21	17	;	;	PUNCT
ajlm-2381	21	18	pathology	pathology	NOUN
ajlm-2381	21	19	.	.	PUNCT
ajlm-2381	22	1	introduction	introduction	NOUN
ajlm-2381	22	2	plasma	plasma	NOUN
ajlm-2381	22	3	cell	cell	NOUN
ajlm-2381	22	4	neoplasms	neoplasm	NOUN
ajlm-2381	22	5	encompass	encompass	VERB
ajlm-2381	22	6	a	a	DET
ajlm-2381	22	7	wide	wide	ADJ
ajlm-2381	22	8	variety	variety	NOUN
ajlm-2381	22	9	of	of	ADP
ajlm-2381	22	10	disorders	disorder	NOUN
ajlm-2381	22	11	that	that	PRON
ajlm-2381	22	12	result	result	VERB
ajlm-2381	22	13	from	from	ADP
ajlm-2381	22	14	the	the	DET
ajlm-2381	22	15	clonal	clonal	ADJ
ajlm-2381	22	16	expansion	expansion	NOUN
ajlm-2381	22	17	of	of	ADP
ajlm-2381	22	18	terminally	terminally	ADV
ajlm-2381	22	19	differentiated	differentiate	VERB
ajlm-2381	22	20	b	b	NOUN
ajlm-2381	22	21	cells	cell	NOUN
ajlm-2381	22	22	(	(	PUNCT
ajlm-2381	22	23	plasma	plasma	NOUN
ajlm-2381	22	24	cells	cell	NOUN
ajlm-2381	22	25	)	)	PUNCT
ajlm-2381	22	26	,	,	PUNCT
ajlm-2381	22	27	typically	typically	ADV
ajlm-2381	22	28	secreting	secrete	VERB
ajlm-2381	22	29	a	a	DET
ajlm-2381	22	30	single	single	ADJ
ajlm-2381	22	31	homogeneous	homogeneous	ADJ
ajlm-2381	22	32	monoclonal	monoclonal	NOUN
ajlm-2381	22	33	immunoglobulin.1	immunoglobulin.1	NOUN
ajlm-2381	22	34	the	the	DET
ajlm-2381	22	35	differentiation	differentiation	NOUN
ajlm-2381	22	36	between	between	ADP
ajlm-2381	22	37	some	some	PRON
ajlm-2381	22	38	of	of	ADP
ajlm-2381	22	39	these	these	DET
ajlm-2381	22	40	disorders	disorder	NOUN
ajlm-2381	22	41	and	and	CCONJ
ajlm-2381	22	42	the	the	DET
ajlm-2381	22	43	monitoring	monitoring	NOUN
ajlm-2381	22	44	of	of	ADP
ajlm-2381	22	45	plasma	plasma	NOUN
ajlm-2381	22	46	cell	cell	NOUN
ajlm-2381	22	47	(	(	PUNCT
ajlm-2381	22	48	pc	pc	NOUN
ajlm-2381	22	49	)	)	PUNCT
ajlm-2381	22	50	neoplasms	neoplasm	NOUN
ajlm-2381	22	51	depends	depend	VERB
ajlm-2381	22	52	on	on	ADP
ajlm-2381	22	53	the	the	DET
ajlm-2381	22	54	quantitation	quantitation	NOUN
ajlm-2381	22	55	of	of	ADP
ajlm-2381	22	56	clonal	clonal	ADJ
ajlm-2381	22	57	pc	pc	NOUN
ajlm-2381	22	58	in	in	ADP
ajlm-2381	22	59	the	the	DET
ajlm-2381	22	60	bone	bone	NOUN
ajlm-2381	22	61	marrow	marrow	NOUN
ajlm-2381	22	62	(	(	PUNCT
ajlm-2381	22	63	bm	bm	PROPN
ajlm-2381	22	64	)	)	PUNCT
ajlm-2381	22	65	and	and	CCONJ
ajlm-2381	22	66	the	the	DET
ajlm-2381	22	67	use	use	NOUN
ajlm-2381	22	68	of	of	ADP
ajlm-2381	22	69	biochemical	biochemical	ADJ
ajlm-2381	22	70	and	and	CCONJ
ajlm-2381	22	71	haematological	haematological	ADJ
ajlm-2381	22	72	parameters	parameter	NOUN
ajlm-2381	22	73	and	and	CCONJ
ajlm-2381	22	74	imaging	imaging	NOUN
ajlm-2381	22	75	techniques.1,2,3,4	techniques.1,2,3,4	ADJ
ajlm-2381	22	76	quantitation	quantitation	NOUN
ajlm-2381	22	77	of	of	ADP
ajlm-2381	22	78	pc	pc	NOUN
ajlm-2381	22	79	in	in	ADP
ajlm-2381	22	80	bm	bm	PROPN
ajlm-2381	22	81	samples	sample	NOUN
ajlm-2381	22	82	has	have	AUX
ajlm-2381	22	83	historically	historically	ADV
ajlm-2381	22	84	relied	rely	VERB
ajlm-2381	22	85	on	on	ADP
ajlm-2381	22	86	manual	manual	ADJ
ajlm-2381	22	87	methods	method	NOUN
ajlm-2381	22	88	such	such	ADJ
ajlm-2381	22	89	as	as	ADP
ajlm-2381	22	90	microscopy	microscopy	NOUN
ajlm-2381	22	91	-	-	PUNCT
ajlm-2381	22	92	based	base	VERB
ajlm-2381	22	93	cell	cell	NOUN
ajlm-2381	22	94	counting	counting	NOUN
ajlm-2381	22	95	on	on	ADP
ajlm-2381	22	96	bm	bm	PROPN
ajlm-2381	22	97	aspirates	aspirates	PROPN
ajlm-2381	22	98	and	and	CCONJ
ajlm-2381	22	99	immunohistochemically	immunohistochemically	ADV
ajlm-2381	22	100	stained	stain	VERB
ajlm-2381	22	101	trephine	trephine	NOUN
ajlm-2381	22	102	biopsies	biopsy	NOUN
ajlm-2381	22	103	.	.	PUNCT
ajlm-2381	23	1	the	the	DET
ajlm-2381	23	2	surface	surface	NOUN
ajlm-2381	23	3	marker	marker	NOUN
ajlm-2381	23	4	cd138	cd138	NOUN
ajlm-2381	23	5	is	be	AUX
ajlm-2381	23	6	sensitive	sensitive	ADJ
ajlm-2381	23	7	and	and	CCONJ
ajlm-2381	23	8	specific	specific	ADJ
ajlm-2381	23	9	for	for	ADP
ajlm-2381	23	10	pc	pc	NOUN
ajlm-2381	23	11	,	,	PUNCT
ajlm-2381	23	12	thus	thus	ADV
ajlm-2381	23	13	cd138	cd138	PROPN
ajlm-2381	23	14	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	23	15	is	be	AUX
ajlm-2381	23	16	commonly	commonly	ADV
ajlm-2381	23	17	used	use	VERB
ajlm-2381	23	18	for	for	ADP
ajlm-2381	23	19	estimating	estimate	VERB
ajlm-2381	23	20	pc	pc	NOUN
ajlm-2381	23	21	in	in	ADP
ajlm-2381	23	22	bm	bm	PROPN
ajlm-2381	23	23	biopsies	biopsy	NOUN
ajlm-2381	23	24	.	.	PUNCT
ajlm-2381	24	1	this	this	DET
ajlm-2381	24	2	practice	practice	NOUN
ajlm-2381	24	3	is	be	AUX
ajlm-2381	24	4	supported	support	VERB
ajlm-2381	24	5	by	by	ADP
ajlm-2381	24	6	the	the	DET
ajlm-2381	24	7	world	world	NOUN
ajlm-2381	24	8	health	health	NOUN
ajlm-2381	24	9	organization.1,5,6	organization.1,5,6	VERB
ajlm-2381	24	10	however	however	ADV
ajlm-2381	24	11	,	,	PUNCT
ajlm-2381	24	12	various	various	ADJ
ajlm-2381	24	13	alternative	alternative	ADJ
ajlm-2381	24	14	approaches	approach	NOUN
ajlm-2381	24	15	have	have	AUX
ajlm-2381	24	16	emerged	emerge	VERB
ajlm-2381	24	17	,	,	PUNCT
ajlm-2381	24	18	each	each	PRON
ajlm-2381	24	19	with	with	ADP
ajlm-2381	24	20	their	their	PRON
ajlm-2381	24	21	strengths	strength	NOUN
ajlm-2381	24	22	and	and	CCONJ
ajlm-2381	24	23	limitations	limitation	NOUN
ajlm-2381	24	24	.	.	PUNCT
ajlm-2381	25	1	as	as	SCONJ
ajlm-2381	25	2	the	the	DET
ajlm-2381	25	3	field	field	NOUN
ajlm-2381	25	4	continues	continue	VERB
ajlm-2381	25	5	to	to	PART
ajlm-2381	25	6	evolve	evolve	VERB
ajlm-2381	25	7	,	,	PUNCT
ajlm-2381	25	8	it	it	PRON
ajlm-2381	25	9	is	be	AUX
ajlm-2381	25	10	essential	essential	ADJ
ajlm-2381	25	11	to	to	PART
ajlm-2381	25	12	critically	critically	ADV
ajlm-2381	25	13	review	review	VERB
ajlm-2381	25	14	and	and	CCONJ
ajlm-2381	25	15	evaluate	evaluate	VERB
ajlm-2381	25	16	the	the	DET
ajlm-2381	25	17	available	available	ADJ
ajlm-2381	25	18	methods	method	NOUN
ajlm-2381	25	19	for	for	ADP
ajlm-2381	25	20	estimating	estimate	VERB
ajlm-2381	25	21	pc	pc	NOUN
ajlm-2381	25	22	in	in	ADP
ajlm-2381	25	23	bm	bm	PROPN
ajlm-2381	25	24	.	.	PUNCT
ajlm-2381	26	1	currently	currently	ADV
ajlm-2381	26	2	,	,	PUNCT
ajlm-2381	26	3	there	there	PRON
ajlm-2381	26	4	is	be	VERB
ajlm-2381	26	5	no	no	DET
ajlm-2381	26	6	acceptable	acceptable	ADJ
ajlm-2381	26	7	reference	reference	NOUN
ajlm-2381	26	8	method	method	NOUN
ajlm-2381	26	9	for	for	ADP
ajlm-2381	26	10	estimating	estimate	VERB
ajlm-2381	26	11	pc	pc	NOUN
ajlm-2381	26	12	in	in	ADP
ajlm-2381	26	13	bm	bm	PROPN
ajlm-2381	26	14	,	,	PUNCT
ajlm-2381	26	15	although	although	SCONJ
ajlm-2381	26	16	many	many	ADJ
ajlm-2381	26	17	methods	method	NOUN
ajlm-2381	26	18	have	have	AUX
ajlm-2381	26	19	been	be	AUX
ajlm-2381	26	20	developed	develop	VERB
ajlm-2381	26	21	and	and	CCONJ
ajlm-2381	26	22	evaluated	evaluate	VERB
ajlm-2381	26	23	for	for	ADP
ajlm-2381	26	24	accuracy	accuracy	NOUN
ajlm-2381	26	25	and	and	CCONJ
ajlm-2381	26	26	reproducibility	reproducibility	NOUN
ajlm-2381	26	27	.	.	PUNCT
ajlm-2381	27	1	this	this	DET
ajlm-2381	27	2	method	method	NOUN
ajlm-2381	27	3	review	review	NOUN
ajlm-2381	27	4	aims	aim	VERB
ajlm-2381	27	5	to	to	PART
ajlm-2381	27	6	comprehensively	comprehensively	ADV
ajlm-2381	27	7	evaluate	evaluate	VERB
ajlm-2381	27	8	existing	exist	VERB
ajlm-2381	27	9	techniques	technique	NOUN
ajlm-2381	27	10	for	for	ADP
ajlm-2381	27	11	the	the	DET
ajlm-2381	27	12	quantitation	quantitation	NOUN
ajlm-2381	27	13	of	of	ADP
ajlm-2381	27	14	pc	pc	NOUN
ajlm-2381	27	15	in	in	ADP
ajlm-2381	27	16	bm	bm	PROPN
ajlm-2381	27	17	samples	sample	NOUN
ajlm-2381	27	18	.	.	PUNCT
ajlm-2381	28	1	by	by	ADP
ajlm-2381	28	2	examining	examine	VERB
ajlm-2381	28	3	the	the	DET
ajlm-2381	28	4	principles	principle	NOUN
ajlm-2381	28	5	,	,	PUNCT
ajlm-2381	28	6	procedures	procedure	NOUN
ajlm-2381	28	7	,	,	PUNCT
ajlm-2381	28	8	advantages	advantage	NOUN
ajlm-2381	28	9	,	,	PUNCT
ajlm-2381	28	10	and	and	CCONJ
ajlm-2381	28	11	challenges	challenge	NOUN
ajlm-2381	28	12	associated	associate	VERB
ajlm-2381	28	13	with	with	ADP
ajlm-2381	28	14	the	the	DET
ajlm-2381	28	15	various	various	ADJ
ajlm-2381	28	16	methods	method	NOUN
ajlm-2381	28	17	,	,	PUNCT
ajlm-2381	28	18	we	we	PRON
ajlm-2381	28	19	aim	aim	VERB
ajlm-2381	28	20	to	to	PART
ajlm-2381	28	21	provide	provide	VERB
ajlm-2381	28	22	a	a	DET
ajlm-2381	28	23	comprehensive	comprehensive	ADJ
ajlm-2381	28	24	understanding	understanding	NOUN
ajlm-2381	28	25	of	of	ADP
ajlm-2381	28	26	the	the	DET
ajlm-2381	28	27	options	option	NOUN
ajlm-2381	28	28	available	available	ADJ
ajlm-2381	28	29	to	to	ADP
ajlm-2381	28	30	clinicians	clinician	NOUN
ajlm-2381	28	31	,	,	PUNCT
ajlm-2381	28	32	researchers	researcher	NOUN
ajlm-2381	28	33	,	,	PUNCT
ajlm-2381	28	34	pathologists	pathologist	NOUN
ajlm-2381	28	35	,	,	PUNCT
ajlm-2381	28	36	and	and	CCONJ
ajlm-2381	28	37	haematologists	haematologist	NOUN
ajlm-2381	28	38	.	.	PUNCT
ajlm-2381	29	1	in	in	ADP
ajlm-2381	29	2	this	this	DET
ajlm-2381	29	3	review	review	NOUN
ajlm-2381	29	4	the	the	DET
ajlm-2381	29	5	authors	author	NOUN
ajlm-2381	29	6	examine	examine	VERB
ajlm-2381	29	7	the	the	DET
ajlm-2381	29	8	factors	factor	NOUN
ajlm-2381	29	9	that	that	PRON
ajlm-2381	29	10	affect	affect	VERB
ajlm-2381	29	11	the	the	DET
ajlm-2381	29	12	reliability	reliability	NOUN
ajlm-2381	29	13	of	of	ADP
ajlm-2381	29	14	plasma	plasma	NOUN
ajlm-2381	29	15	cell	cell	NOUN
ajlm-2381	29	16	estimation	estimation	NOUN
ajlm-2381	29	17	and	and	CCONJ
ajlm-2381	29	18	share	share	NOUN
ajlm-2381	29	19	thoughts	thought	NOUN
ajlm-2381	29	20	on	on	ADP
ajlm-2381	29	21	the	the	DET
ajlm-2381	29	22	promising	promising	ADJ
ajlm-2381	29	23	role	role	NOUN
ajlm-2381	29	24	of	of	ADP
ajlm-2381	29	25	new	new	ADJ
ajlm-2381	29	26	technologies	technology	NOUN
ajlm-2381	29	27	.	.	PUNCT
ajlm-2381	30	1	in	in	ADP
ajlm-2381	30	2	addition	addition	NOUN
ajlm-2381	30	3	,	,	PUNCT
ajlm-2381	30	4	the	the	DET
ajlm-2381	30	5	challenges	challenge	NOUN
ajlm-2381	30	6	of	of	ADP
ajlm-2381	30	7	standardisation	standardisation	NOUN
ajlm-2381	30	8	,	,	PUNCT
ajlm-2381	30	9	clinical	clinical	ADJ
ajlm-2381	30	10	relevance	relevance	NOUN
ajlm-2381	30	11	and	and	CCONJ
ajlm-2381	30	12	future	future	ADJ
ajlm-2381	30	13	directions	direction	NOUN
ajlm-2381	30	14	will	will	AUX
ajlm-2381	30	15	stimulate	stimulate	VERB
ajlm-2381	30	16	discussion	discussion	NOUN
ajlm-2381	30	17	and	and	CCONJ
ajlm-2381	30	18	encourage	encourage	VERB
ajlm-2381	30	19	collaboration	collaboration	NOUN
ajlm-2381	30	20	in	in	ADP
ajlm-2381	30	21	this	this	DET
ajlm-2381	30	22	field	field	NOUN
ajlm-2381	30	23	.	.	PUNCT
ajlm-2381	31	1	we	we	PRON
ajlm-2381	31	2	hope	hope	VERB
ajlm-2381	31	3	to	to	PART
ajlm-2381	31	4	contribute	contribute	VERB
ajlm-2381	31	5	to	to	ADP
ajlm-2381	31	6	the	the	DET
ajlm-2381	31	7	refinement	refinement	NOUN
ajlm-2381	31	8	of	of	ADP
ajlm-2381	31	9	pc	pc	NOUN
ajlm-2381	31	10	estimation	estimation	NOUN
ajlm-2381	31	11	methods	method	NOUN
ajlm-2381	31	12	and	and	CCONJ
ajlm-2381	31	13	their	their	PRON
ajlm-2381	31	14	integration	integration	NOUN
ajlm-2381	31	15	into	into	ADP
ajlm-2381	31	16	routine	routine	ADJ
ajlm-2381	31	17	clinical	clinical	ADJ
ajlm-2381	31	18	practice	practice	NOUN
ajlm-2381	31	19	.	.	PUNCT
ajlm-2381	32	1	methods	method	NOUN
ajlm-2381	32	2	based	base	VERB
ajlm-2381	32	3	on	on	ADP
ajlm-2381	32	4	the	the	DET
ajlm-2381	32	5	recommendations	recommendation	NOUN
ajlm-2381	32	6	by	by	ADP
ajlm-2381	32	7	levac	levac	NOUN
ajlm-2381	32	8	et	et	PROPN
ajlm-2381	32	9	al	al	PROPN
ajlm-2381	32	10	.	.	PROPN
ajlm-2381	32	11	,	,	PUNCT
ajlm-2381	32	12	colquhoun	colquhoun	PRON
ajlm-2381	32	13	et	et	PROPN
ajlm-2381	32	14	al	al	PROPN
ajlm-2381	32	15	.	.	PROPN
ajlm-2381	33	1	and	and	CCONJ
ajlm-2381	33	2	the	the	DET
ajlm-2381	33	3	methods	method	NOUN
ajlm-2381	33	4	of	of	ADP
ajlm-2381	33	5	arksey	arksey	NOUN
ajlm-2381	33	6	and	and	CCONJ
ajlm-2381	33	7	o’malley	o’malley	PROPN
ajlm-2381	33	8	,	,	PUNCT
ajlm-2381	33	9	we	we	PRON
ajlm-2381	33	10	conducted	conduct	VERB
ajlm-2381	33	11	a	a	DET
ajlm-2381	33	12	literature	literature	NOUN
ajlm-2381	33	13	search	search	NOUN
ajlm-2381	33	14	for	for	ADP
ajlm-2381	33	15	a	a	DET
ajlm-2381	33	16	narrative	narrative	NOUN
ajlm-2381	33	17	(	(	PUNCT
ajlm-2381	33	18	scoping	scoping	NOUN
ajlm-2381	33	19	)	)	PUNCT
ajlm-2381	33	20	review	review	NOUN
ajlm-2381	33	21	article.7,8,9	article.7,8,9	ADP
ajlm-2381	34	1	the	the	DET
ajlm-2381	34	2	four	four	NUM
ajlm-2381	34	3	main	main	ADJ
ajlm-2381	34	4	electronic	electronic	ADJ
ajlm-2381	34	5	databases	database	NOUN
ajlm-2381	34	6	(	(	PUNCT
ajlm-2381	34	7	pubmed	pubmed	PROPN
ajlm-2381	34	8	,	,	PUNCT
ajlm-2381	34	9	google	google	PROPN
ajlm-2381	34	10	scholar	scholar	NOUN
ajlm-2381	34	11	,	,	PUNCT
ajlm-2381	34	12	cochrane	cochrane	NOUN
ajlm-2381	34	13	library	library	NOUN
ajlm-2381	34	14	and	and	CCONJ
ajlm-2381	34	15	mendeley	mendeley	NOUN
ajlm-2381	34	16	)	)	PUNCT
ajlm-2381	34	17	were	be	AUX
ajlm-2381	34	18	searched	search	VERB
ajlm-2381	34	19	to	to	PART
ajlm-2381	34	20	map	map	VERB
ajlm-2381	34	21	the	the	DET
ajlm-2381	34	22	existing	exist	VERB
ajlm-2381	34	23	landscape	landscape	NOUN
ajlm-2381	34	24	of	of	ADP
ajlm-2381	34	25	methods	method	NOUN
ajlm-2381	34	26	for	for	ADP
ajlm-2381	34	27	estimating	estimate	VERB
ajlm-2381	34	28	bone	bone	NOUN
ajlm-2381	34	29	marrow	marrow	NOUN
ajlm-2381	34	30	plasma	plasma	NOUN
ajlm-2381	34	31	cell	cell	NOUN
ajlm-2381	34	32	percentage	percentage	NOUN
ajlm-2381	34	33	(	(	PUNCT
ajlm-2381	34	34	bmpc%	bmpc%	NUM
ajlm-2381	34	35	)	)	PUNCT
ajlm-2381	34	36	,	,	PUNCT
ajlm-2381	34	37	and	and	CCONJ
ajlm-2381	34	38	to	to	PART
ajlm-2381	34	39	compare	compare	VERB
ajlm-2381	34	40	and	and	CCONJ
ajlm-2381	34	41	summarise	summarise	VERB
ajlm-2381	34	42	these	these	DET
ajlm-2381	34	43	methods	method	NOUN
ajlm-2381	34	44	to	to	PART
ajlm-2381	34	45	provide	provide	VERB
ajlm-2381	34	46	suggestions	suggestion	NOUN
ajlm-2381	34	47	for	for	ADP
ajlm-2381	34	48	the	the	DET
ajlm-2381	34	49	use	use	NOUN
ajlm-2381	34	50	and	and	CCONJ
ajlm-2381	34	51	further	further	ADJ
ajlm-2381	34	52	development	development	NOUN
ajlm-2381	34	53	of	of	ADP
ajlm-2381	34	54	appropriate	appropriate	ADJ
ajlm-2381	34	55	and	and	CCONJ
ajlm-2381	34	56	cost	cost	NOUN
ajlm-2381	34	57	-	-	PUNCT
ajlm-2381	34	58	effective	effective	ADJ
ajlm-2381	34	59	methods	method	NOUN
ajlm-2381	34	60	for	for	ADP
ajlm-2381	34	61	estimating	estimate	VERB
ajlm-2381	34	62	bmpc%	bmpc%	ADV
ajlm-2381	34	63	,	,	PUNCT
ajlm-2381	34	64	particularly	particularly	ADV
ajlm-2381	34	65	in	in	ADP
ajlm-2381	34	66	resource	resource	NOUN
ajlm-2381	34	67	-	-	PUNCT
ajlm-2381	34	68	limited	limit	VERB
ajlm-2381	34	69	settings	setting	NOUN
ajlm-2381	34	70	.	.	PUNCT
ajlm-2381	35	1	a	a	DET
ajlm-2381	35	2	summary	summary	NOUN
ajlm-2381	35	3	table	table	NOUN
ajlm-2381	35	4	(	(	PUNCT
ajlm-2381	35	5	table	table	NOUN
ajlm-2381	35	6	1	1	NUM
ajlm-2381	35	7	)	)	PUNCT
ajlm-2381	35	8	was	be	AUX
ajlm-2381	35	9	created	create	VERB
ajlm-2381	35	10	to	to	PART
ajlm-2381	35	11	summarise	summarise	VERB
ajlm-2381	35	12	the	the	DET
ajlm-2381	35	13	data	datum	NOUN
ajlm-2381	35	14	from	from	ADP
ajlm-2381	35	15	the	the	DET
ajlm-2381	35	16	literature	literature	NOUN
ajlm-2381	35	17	review	review	NOUN
ajlm-2381	35	18	and	and	CCONJ
ajlm-2381	35	19	to	to	PART
ajlm-2381	35	20	present	present	VERB
ajlm-2381	35	21	the	the	DET
ajlm-2381	35	22	different	different	ADJ
ajlm-2381	35	23	methods	method	NOUN
ajlm-2381	35	24	,	,	PUNCT
ajlm-2381	35	25	as	as	ADV
ajlm-2381	35	26	well	well	ADV
ajlm-2381	35	27	as	as	ADP
ajlm-2381	35	28	their	their	PRON
ajlm-2381	35	29	advantages	advantage	NOUN
ajlm-2381	35	30	and	and	CCONJ
ajlm-2381	35	31	disadvantages	disadvantage	NOUN
ajlm-2381	35	32	,	,	PUNCT
ajlm-2381	35	33	in	in	ADP
ajlm-2381	35	34	a	a	DET
ajlm-2381	35	35	clear	clear	ADJ
ajlm-2381	35	36	format	format	NOUN
ajlm-2381	35	37	.	.	PUNCT
ajlm-2381	36	1	the	the	DET
ajlm-2381	36	2	search	search	NOUN
ajlm-2381	36	3	was	be	AUX
ajlm-2381	36	4	conducted	conduct	VERB
ajlm-2381	36	5	from	from	ADP
ajlm-2381	36	6	inception	inception	NOUN
ajlm-2381	36	7	to	to	ADP
ajlm-2381	36	8	31	31	NUM
ajlm-2381	36	9	november	november	PROPN
ajlm-2381	36	10	2023	2023	NUM
ajlm-2381	36	11	to	to	PART
ajlm-2381	36	12	find	find	VERB
ajlm-2381	36	13	relevant	relevant	ADJ
ajlm-2381	36	14	articles	article	NOUN
ajlm-2381	36	15	published	publish	VERB
ajlm-2381	36	16	in	in	ADP
ajlm-2381	36	17	peer	peer	NOUN
ajlm-2381	36	18	-	-	PUNCT
ajlm-2381	36	19	reviewed	review	VERB
ajlm-2381	36	20	journals	journal	NOUN
ajlm-2381	36	21	.	.	PUNCT
ajlm-2381	37	1	the	the	DET
ajlm-2381	37	2	search	search	NOUN
ajlm-2381	37	3	strategy	strategy	NOUN
ajlm-2381	37	4	consisted	consist	VERB
ajlm-2381	37	5	of	of	ADP
ajlm-2381	37	6	a	a	DET
ajlm-2381	37	7	combination	combination	NOUN
ajlm-2381	37	8	of	of	ADP
ajlm-2381	37	9	keywords	keyword	NOUN
ajlm-2381	37	10	and	and	CCONJ
ajlm-2381	37	11	medical	medical	ADJ
ajlm-2381	37	12	subject	subject	NOUN
ajlm-2381	37	13	heading	head	VERB
ajlm-2381	37	14	terms	term	NOUN
ajlm-2381	37	15	related	relate	VERB
ajlm-2381	37	16	to	to	ADP
ajlm-2381	37	17	the	the	DET
ajlm-2381	37	18	topic	topic	NOUN
ajlm-2381	37	19	of	of	ADP
ajlm-2381	37	20	interest	interest	NOUN
ajlm-2381	37	21	,	,	PUNCT
ajlm-2381	37	22	such	such	ADJ
ajlm-2381	37	23	as	as	ADP
ajlm-2381	37	24	‘	'	PUNCT
ajlm-2381	37	25	multiple	multiple	ADJ
ajlm-2381	37	26	myeloma	myeloma	NOUN
ajlm-2381	37	27	’	'	PUNCT
ajlm-2381	37	28	,	,	PUNCT
ajlm-2381	37	29	‘	'	PUNCT
ajlm-2381	37	30	bone	bone	NOUN
ajlm-2381	37	31	marrow	marrow	NOUN
ajlm-2381	37	32	plasma	plasma	NOUN
ajlm-2381	37	33	cells	cell	NOUN
ajlm-2381	37	34	’	'	PUNCT
ajlm-2381	37	35	,	,	PUNCT
ajlm-2381	37	36	‘	'	PUNCT
ajlm-2381	37	37	plasma	plasma	NOUN
ajlm-2381	37	38	cell	cell	NOUN
ajlm-2381	37	39	estimation	estimation	NOUN
ajlm-2381	37	40	’	'	PUNCT
ajlm-2381	37	41	,	,	PUNCT
ajlm-2381	37	42	etc	etc	X
ajlm-2381	37	43	.	.	X
ajlm-2381	37	44	articles	article	NOUN
ajlm-2381	37	45	that	that	PRON
ajlm-2381	37	46	were	be	AUX
ajlm-2381	37	47	irrelevant	irrelevant	ADJ
ajlm-2381	37	48	,	,	PUNCT
ajlm-2381	37	49	did	do	AUX
ajlm-2381	37	50	not	not	PART
ajlm-2381	37	51	contain	contain	VERB
ajlm-2381	37	52	a	a	DET
ajlm-2381	37	53	methods	method	NOUN
ajlm-2381	37	54	section	section	NOUN
ajlm-2381	37	55	,	,	PUNCT
ajlm-2381	37	56	and	and	CCONJ
ajlm-2381	37	57	were	be	AUX
ajlm-2381	37	58	not	not	PART
ajlm-2381	37	59	written	write	VERB
ajlm-2381	37	60	in	in	ADP
ajlm-2381	37	61	english	english	PROPN
ajlm-2381	37	62	were	be	AUX
ajlm-2381	37	63	excluded	exclude	VERB
ajlm-2381	37	64	.	.	PUNCT
ajlm-2381	38	1	all	all	DET
ajlm-2381	38	2	relevant	relevant	ADJ
ajlm-2381	38	3	articles	article	NOUN
ajlm-2381	38	4	,	,	PUNCT
ajlm-2381	38	5	literature	literature	NOUN
ajlm-2381	38	6	sources	source	NOUN
ajlm-2381	38	7	and	and	CCONJ
ajlm-2381	38	8	citations	citation	NOUN
ajlm-2381	38	9	were	be	AUX
ajlm-2381	38	10	included	include	VERB
ajlm-2381	38	11	in	in	ADP
ajlm-2381	38	12	the	the	DET
ajlm-2381	38	13	reference	reference	NOUN
ajlm-2381	38	14	list	list	NOUN
ajlm-2381	38	15	and	and	CCONJ
ajlm-2381	38	16	duplicates	duplicate	NOUN
ajlm-2381	38	17	were	be	AUX
ajlm-2381	38	18	removed	remove	VERB
ajlm-2381	38	19	.	.	PUNCT
ajlm-2381	39	1	table	table	NOUN
ajlm-2381	39	2	1	1	NUM
ajlm-2381	39	3	:	:	PUNCT
ajlm-2381	39	4	 	 	SPACE
ajlm-2381	39	5	summary	summary	NOUN
ajlm-2381	39	6	of	of	ADP
ajlm-2381	39	7	various	various	ADJ
ajlm-2381	39	8	methods	method	NOUN
ajlm-2381	39	9	used	use	VERB
ajlm-2381	39	10	for	for	ADP
ajlm-2381	39	11	the	the	DET
ajlm-2381	39	12	estimation	estimation	NOUN
ajlm-2381	39	13	of	of	ADP
ajlm-2381	39	14	bone	bone	NOUN
ajlm-2381	39	15	marrow	marrow	NOUN
ajlm-2381	39	16	plasma	plasma	NOUN
ajlm-2381	39	17	cell	cell	NOUN
ajlm-2381	39	18	percentages	percentage	NOUN
ajlm-2381	39	19	,	,	PUNCT
ajlm-2381	39	20	highlighting	highlight	VERB
ajlm-2381	39	21	their	their	PRON
ajlm-2381	39	22	advantages	advantage	NOUN
ajlm-2381	39	23	and	and	CCONJ
ajlm-2381	39	24	disadvantages	disadvantage	NOUN
ajlm-2381	39	25	.	.	PUNCT
ajlm-2381	40	1	pre	pre	ADJ
ajlm-2381	40	2	-	-	ADJ
ajlm-2381	40	3	analytical	analytical	ADJ
ajlm-2381	40	4	factors	factor	NOUN
ajlm-2381	40	5	affecting	affect	VERB
ajlm-2381	40	6	plasma	plasma	NOUN
ajlm-2381	40	7	cell	cell	NOUN
ajlm-2381	40	8	estimation	estimation	NOUN
ajlm-2381	40	9	bone	bone	NOUN
ajlm-2381	40	10	marrow	marrow	NOUN
ajlm-2381	40	11	aspiration	aspiration	NOUN
ajlm-2381	40	12	and	and	CCONJ
ajlm-2381	40	13	processing	processing	NOUN
ajlm-2381	40	14	for	for	ADP
ajlm-2381	40	15	accurate	accurate	ADJ
ajlm-2381	40	16	visualisation	visualisation	NOUN
ajlm-2381	40	17	the	the	DET
ajlm-2381	40	18	first	first	ADJ
ajlm-2381	40	19	millilitre	millilitre	NOUN
ajlm-2381	40	20	of	of	ADP
ajlm-2381	40	21	aspirated	aspirated	ADJ
ajlm-2381	40	22	bm	bm	PROPN
ajlm-2381	40	23	represents	represent	VERB
ajlm-2381	40	24	pure	pure	ADJ
ajlm-2381	40	25	bm	bm	PROPN
ajlm-2381	40	26	elements	element	NOUN
ajlm-2381	40	27	.	.	PUNCT
ajlm-2381	41	1	the	the	DET
ajlm-2381	41	2	subsequent	subsequent	ADJ
ajlm-2381	41	3	sampling	sampling	NOUN
ajlm-2381	41	4	becomes	becomes	AUX
ajlm-2381	41	5	significantly	significantly	ADV
ajlm-2381	41	6	blood	blood	NOUN
ajlm-2381	41	7	diluted	dilute	VERB
ajlm-2381	41	8	(	(	PUNCT
ajlm-2381	41	9	haemodilution).10,11	haemodilution).10,11	NOUN
ajlm-2381	41	10	ancillary	ancillary	ADJ
ajlm-2381	41	11	testing	testing	NOUN
ajlm-2381	41	12	including	include	VERB
ajlm-2381	41	13	flow	flow	NOUN
ajlm-2381	41	14	cytometry	cytometry	NOUN
ajlm-2381	41	15	and	and	CCONJ
ajlm-2381	41	16	cytogenetics	cytogenetic	NOUN
ajlm-2381	41	17	require	require	VERB
ajlm-2381	41	18	additional	additional	ADJ
ajlm-2381	41	19	drawing	drawing	NOUN
ajlm-2381	41	20	of	of	ADP
ajlm-2381	41	21	bm	bm	PROPN
ajlm-2381	41	22	aspirate	aspirate	PROPN
ajlm-2381	41	23	(	(	PUNCT
ajlm-2381	41	24	bma	bma	PROPN
ajlm-2381	41	25	)	)	PUNCT
ajlm-2381	41	26	.	.	PUNCT
ajlm-2381	42	1	the	the	DET
ajlm-2381	42	2	first	first	ADJ
ajlm-2381	42	3	and	and	CCONJ
ajlm-2381	42	4	second	second	ADJ
ajlm-2381	42	5	draw	draw	NOUN
ajlm-2381	42	6	of	of	ADP
ajlm-2381	42	7	bma	bma	PROPN
ajlm-2381	42	8	yield	yield	PROPN
ajlm-2381	42	9	discrepant	discrepant	NOUN
ajlm-2381	42	10	results	result	NOUN
ajlm-2381	42	11	,	,	PUNCT
ajlm-2381	42	12	with	with	ADP
ajlm-2381	42	13	the	the	DET
ajlm-2381	42	14	second	second	ADJ
ajlm-2381	42	15	draw	draw	NOUN
ajlm-2381	42	16	of	of	ADP
ajlm-2381	42	17	bma	bma	PROPN
ajlm-2381	42	18	smears	smear	NOUN
ajlm-2381	42	19	significantly	significantly	ADV
ajlm-2381	42	20	underrepresenting	underrepresente	VERB
ajlm-2381	42	21	the	the	DET
ajlm-2381	42	22	pc	pc	NOUN
ajlm-2381	42	23	count	count	NOUN
ajlm-2381	42	24	.	.	PUNCT
ajlm-2381	43	1	this	this	PRON
ajlm-2381	43	2	remains	remain	VERB
ajlm-2381	43	3	important	important	ADJ
ajlm-2381	43	4	in	in	ADP
ajlm-2381	43	5	the	the	DET
ajlm-2381	43	6	evaluation	evaluation	NOUN
ajlm-2381	43	7	of	of	ADP
ajlm-2381	43	8	newly	newly	ADV
ajlm-2381	43	9	diagnosed	diagnose	VERB
ajlm-2381	43	10	multiple	multiple	ADJ
ajlm-2381	43	11	myeloma	myeloma	NOUN
ajlm-2381	43	12	(	(	PUNCT
ajlm-2381	43	13	mm	mm	NOUN
ajlm-2381	43	14	)	)	PUNCT
ajlm-2381	43	15	patients.12	patients.12	PROPN
ajlm-2381	43	16	bone	bone	NOUN
ajlm-2381	43	17	marrow	marrow	NOUN
ajlm-2381	43	18	aspirate	aspirate	NOUN
ajlm-2381	43	19	smears	smear	NOUN
ajlm-2381	43	20	are	be	AUX
ajlm-2381	43	21	considered	consider	VERB
ajlm-2381	43	22	the	the	DET
ajlm-2381	43	23	least	least	ADV
ajlm-2381	43	24	manipulated	manipulate	VERB
ajlm-2381	43	25	sample	sample	NOUN
ajlm-2381	43	26	.	.	PUNCT
ajlm-2381	44	1	therefore	therefore	ADV
ajlm-2381	44	2	,	,	PUNCT
ajlm-2381	44	3	the	the	DET
ajlm-2381	44	4	numeric	numeric	ADJ
ajlm-2381	44	5	discrepancy	discrepancy	NOUN
ajlm-2381	44	6	between	between	ADP
ajlm-2381	44	7	the	the	DET
ajlm-2381	44	8	morphological	morphological	ADJ
ajlm-2381	44	9	assessment	assessment	NOUN
ajlm-2381	44	10	and	and	CCONJ
ajlm-2381	44	11	the	the	DET
ajlm-2381	44	12	flow	flow	NOUN
ajlm-2381	44	13	cytometric	cytometric	ADJ
ajlm-2381	44	14	assessment	assessment	NOUN
ajlm-2381	44	15	can	can	AUX
ajlm-2381	44	16	not	not	PART
ajlm-2381	44	17	be	be	AUX
ajlm-2381	44	18	attributed	attribute	VERB
ajlm-2381	44	19	solely	solely	ADV
ajlm-2381	44	20	to	to	ADP
ajlm-2381	44	21	technical	technical	ADJ
ajlm-2381	44	22	or	or	CCONJ
ajlm-2381	44	23	methodological	methodological	ADJ
ajlm-2381	44	24	deficiencies	deficiency	NOUN
ajlm-2381	44	25	.	.	PUNCT
ajlm-2381	45	1	note	note	VERB
ajlm-2381	45	2	that	that	SCONJ
ajlm-2381	45	3	the	the	DET
ajlm-2381	45	4	same	same	ADJ
ajlm-2381	45	5	degree	degree	NOUN
ajlm-2381	45	6	of	of	ADP
ajlm-2381	45	7	discrepancy	discrepancy	NOUN
ajlm-2381	45	8	is	be	AUX
ajlm-2381	45	9	not	not	PART
ajlm-2381	45	10	seen	see	VERB
ajlm-2381	45	11	with	with	ADP
ajlm-2381	45	12	other	other	ADJ
ajlm-2381	45	13	haematological	haematological	ADJ
ajlm-2381	45	14	malignancies	malignancy	NOUN
ajlm-2381	45	15	such	such	ADJ
ajlm-2381	45	16	as	as	ADP
ajlm-2381	45	17	acute	acute	ADJ
ajlm-2381	45	18	myeloid	myeloid	NOUN
ajlm-2381	45	19	leukaemia.13	leukaemia.13	PROPN
ajlm-2381	45	20	bone	bone	PROPN
ajlm-2381	45	21	marrow	marrow	PROPN
ajlm-2381	45	22	aspirate	aspirate	NOUN
ajlm-2381	45	23	smears	smear	NOUN
ajlm-2381	45	24	are	be	AUX
ajlm-2381	45	25	usually	usually	ADV
ajlm-2381	45	26	stained	stain	VERB
ajlm-2381	45	27	with	with	ADP
ajlm-2381	45	28	romanowsky	romanowsky	NOUN
ajlm-2381	45	29	-	-	PUNCT
ajlm-2381	45	30	type	type	NOUN
ajlm-2381	45	31	stains	stain	NOUN
ajlm-2381	45	32	,	,	PUNCT
ajlm-2381	45	33	which	which	PRON
ajlm-2381	45	34	are	be	AUX
ajlm-2381	45	35	used	use	VERB
ajlm-2381	45	36	either	either	CCONJ
ajlm-2381	45	37	in	in	ADP
ajlm-2381	45	38	combination	combination	NOUN
ajlm-2381	45	39	or	or	CCONJ
ajlm-2381	45	40	individually	individually	ADV
ajlm-2381	45	41	.	.	PUNCT
ajlm-2381	46	1	the	the	DET
ajlm-2381	46	2	staining	staining	NOUN
ajlm-2381	46	3	of	of	ADP
ajlm-2381	46	4	bm	bm	PROPN
ajlm-2381	46	5	films	film	NOUN
ajlm-2381	46	6	may	may	AUX
ajlm-2381	46	7	be	be	AUX
ajlm-2381	46	8	adversely	adversely	ADV
ajlm-2381	46	9	affected	affect	VERB
ajlm-2381	46	10	by	by	ADP
ajlm-2381	46	11	any	any	PRON
ajlm-2381	46	12	of	of	ADP
ajlm-2381	46	13	the	the	DET
ajlm-2381	46	14	pre	pre	ADJ
ajlm-2381	46	15	-	-	ADJ
ajlm-2381	46	16	analytical	analytical	ADJ
ajlm-2381	46	17	processes.11	processes.11	ADJ
ajlm-2381	46	18	plasma	plasma	NOUN
ajlm-2381	46	19	cells	cell	NOUN
ajlm-2381	46	20	on	on	ADP
ajlm-2381	46	21	romanowsky	romanowsky	NOUN
ajlm-2381	46	22	-	-	PUNCT
ajlm-2381	46	23	stained	stain	VERB
ajlm-2381	46	24	bma	bma	NOUN
ajlm-2381	46	25	are	be	AUX
ajlm-2381	46	26	recognised	recognise	VERB
ajlm-2381	46	27	by	by	ADP
ajlm-2381	46	28	their	their	PRON
ajlm-2381	46	29	distinctive	distinctive	ADJ
ajlm-2381	46	30	nuclear	nuclear	ADJ
ajlm-2381	46	31	and	and	CCONJ
ajlm-2381	46	32	cytoplasmic	cytoplasmic	ADJ
ajlm-2381	46	33	features.14	features.14	PROPN
ajlm-2381	46	34	bone	bone	NOUN
ajlm-2381	46	35	marrow	marrow	PROPN
ajlm-2381	46	36	trephine	trephine	PROPN
ajlm-2381	46	37	biopsy	biopsy	PROPN
ajlm-2381	46	38	specimens	specimen	NOUN
ajlm-2381	46	39	and	and	CCONJ
ajlm-2381	46	40	selection	selection	NOUN
ajlm-2381	46	41	of	of	ADP
ajlm-2381	46	42	appropriate	appropriate	ADJ
ajlm-2381	46	43	antibodies	antibody	NOUN
ajlm-2381	46	44	the	the	DET
ajlm-2381	46	45	common	common	ADJ
ajlm-2381	46	46	problem	problem	NOUN
ajlm-2381	46	47	with	with	ADP
ajlm-2381	46	48	myeloma	myeloma	PROPN
ajlm-2381	46	49	trephine	trephine	PROPN
ajlm-2381	46	50	samples	sample	NOUN
ajlm-2381	46	51	is	be	AUX
ajlm-2381	46	52	inadequate	inadequate	ADJ
ajlm-2381	46	53	or	or	CCONJ
ajlm-2381	46	54	fragmented	fragmented	ADJ
ajlm-2381	46	55	cores	core	NOUN
ajlm-2381	46	56	.	.	PUNCT
ajlm-2381	47	1	the	the	DET
ajlm-2381	47	2	biopsy	biopsy	NOUN
ajlm-2381	47	3	may	may	AUX
ajlm-2381	47	4	be	be	AUX
ajlm-2381	47	5	inadequate	inadequate	ADJ
ajlm-2381	47	6	if	if	SCONJ
ajlm-2381	47	7	the	the	DET
ajlm-2381	47	8	same	same	ADJ
ajlm-2381	47	9	bone	bone	NOUN
ajlm-2381	47	10	puncture	puncture	NOUN
ajlm-2381	47	11	site	site	NOUN
ajlm-2381	47	12	is	be	AUX
ajlm-2381	47	13	used	use	VERB
ajlm-2381	47	14	for	for	ADP
ajlm-2381	47	15	aspiration	aspiration	NOUN
ajlm-2381	47	16	and	and	CCONJ
ajlm-2381	47	17	biopsy.15	biopsy.15	PROPN
ajlm-2381	47	18	multiple	multiple	ADJ
ajlm-2381	47	19	myeloma	myeloma	PROPN
ajlm-2381	47	20	trephine	trephine	PROPN
ajlm-2381	47	21	biopsy	biopsy	NOUN
ajlm-2381	47	22	should	should	AUX
ajlm-2381	47	23	ideally	ideally	ADV
ajlm-2381	47	24	contain	contain	VERB
ajlm-2381	47	25	five	five	NUM
ajlm-2381	47	26	to	to	PART
ajlm-2381	47	27	six	six	NUM
ajlm-2381	47	28	intertrabecular	intertrabecular	ADJ
ajlm-2381	47	29	spaces	space	NOUN
ajlm-2381	47	30	that	that	PRON
ajlm-2381	47	31	provide	provide	VERB
ajlm-2381	47	32	a	a	DET
ajlm-2381	47	33	reasonable	reasonable	ADJ
ajlm-2381	47	34	probability	probability	NOUN
ajlm-2381	47	35	of	of	ADP
ajlm-2381	47	36	detecting	detect	VERB
ajlm-2381	47	37	focal	focal	ADJ
ajlm-2381	47	38	bm	bm	PROPN
ajlm-2381	47	39	lesions.14	lesions.14	PROPN
ajlm-2381	47	40	bone	bone	PROPN
ajlm-2381	47	41	marrow	marrow	PROPN
ajlm-2381	47	42	trephine	trephine	PROPN
ajlm-2381	47	43	biopsy	biopsy	PROPN
ajlm-2381	47	44	specimens	specimen	NOUN
ajlm-2381	47	45	are	be	AUX
ajlm-2381	47	46	usually	usually	ADV
ajlm-2381	47	47	fixed	fix	VERB
ajlm-2381	47	48	in	in	ADP
ajlm-2381	47	49	formalin	formalin	NOUN
ajlm-2381	47	50	,	,	PUNCT
ajlm-2381	47	51	embedded	embed	VERB
ajlm-2381	47	52	in	in	ADP
ajlm-2381	47	53	paraffin	paraffin	NOUN
ajlm-2381	47	54	,	,	PUNCT
ajlm-2381	47	55	and	and	CCONJ
ajlm-2381	47	56	stained	stain	VERB
ajlm-2381	47	57	with	with	ADP
ajlm-2381	47	58	haematoxylin	haematoxylin	NOUN
ajlm-2381	47	59	and	and	CCONJ
ajlm-2381	47	60	eosin.11	eosin.11	VERB
ajlm-2381	47	61	identifying	identify	VERB
ajlm-2381	47	62	plasma	plasma	NOUN
ajlm-2381	47	63	cells	cell	NOUN
ajlm-2381	47	64	on	on	ADP
ajlm-2381	47	65	haematoxylin	haematoxylin	NOUN
ajlm-2381	47	66	and	and	CCONJ
ajlm-2381	47	67	eosin	eosin	NOUN
ajlm-2381	47	68	preparations	preparation	NOUN
ajlm-2381	47	69	is	be	AUX
ajlm-2381	47	70	relatively	relatively	ADV
ajlm-2381	47	71	easy	easy	ADJ
ajlm-2381	47	72	for	for	ADP
ajlm-2381	47	73	the	the	DET
ajlm-2381	47	74	experienced	experienced	ADJ
ajlm-2381	47	75	microscopist	microscopist	NOUN
ajlm-2381	47	76	.	.	PUNCT
ajlm-2381	48	1	however	however	ADV
ajlm-2381	48	2	,	,	PUNCT
ajlm-2381	48	3	pc	pc	NOUN
ajlm-2381	48	4	are	be	AUX
ajlm-2381	48	5	more	more	ADV
ajlm-2381	48	6	easily	easily	ADV
ajlm-2381	48	7	distinguished	distinguish	VERB
ajlm-2381	48	8	from	from	ADP
ajlm-2381	48	9	other	other	ADJ
ajlm-2381	48	10	nucleated	nucleated	ADJ
ajlm-2381	48	11	cells	cell	NOUN
ajlm-2381	48	12	by	by	ADP
ajlm-2381	48	13	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	48	14	using	use	VERB
ajlm-2381	48	15	antibodies	antibody	NOUN
ajlm-2381	48	16	targeting	target	VERB
ajlm-2381	48	17	antigens	antigen	NOUN
ajlm-2381	48	18	such	such	ADJ
ajlm-2381	48	19	as	as	ADP
ajlm-2381	48	20	cd138	cd138	PROPN
ajlm-2381	48	21	or	or	CCONJ
ajlm-2381	48	22	mum1	mum1	PROPN
ajlm-2381	48	23	.	.	PUNCT
ajlm-2381	49	1	these	these	DET
ajlm-2381	49	2	antibodies	antibody	NOUN
ajlm-2381	49	3	are	be	AUX
ajlm-2381	49	4	specific	specific	ADJ
ajlm-2381	49	5	to	to	PART
ajlm-2381	49	6	pc	pc	VERB
ajlm-2381	49	7	in	in	ADP
ajlm-2381	49	8	the	the	DET
ajlm-2381	49	9	bm	bm	PROPN
ajlm-2381	49	10	;	;	PUNCT
ajlm-2381	49	11	however	however	ADV
ajlm-2381	49	12	,	,	PUNCT
ajlm-2381	49	13	soft	soft	ADJ
ajlm-2381	49	14	tissue	tissue	NOUN
ajlm-2381	49	15	tumours	tumour	NOUN
ajlm-2381	49	16	such	such	ADJ
ajlm-2381	49	17	as	as	ADP
ajlm-2381	49	18	melanoma	melanoma	NOUN
ajlm-2381	49	19	,	,	PUNCT
ajlm-2381	49	20	osteosarcoma	osteosarcoma	ADJ
ajlm-2381	49	21	and	and	CCONJ
ajlm-2381	49	22	osteoblastoma	osteoblastoma	NOUN
ajlm-2381	49	23	may	may	AUX
ajlm-2381	49	24	also	also	ADV
ajlm-2381	49	25	stain	stain	VERB
ajlm-2381	49	26	positive	positive	ADJ
ajlm-2381	49	27	for	for	ADP
ajlm-2381	49	28	cd138	cd138	PROPN
ajlm-2381	49	29	on	on	ADP
ajlm-2381	49	30	immunohistochemistry.5,16	immunohistochemistry.5,16	PROPN
ajlm-2381	49	31	sections	section	NOUN
ajlm-2381	49	32	of	of	ADP
ajlm-2381	49	33	clotted	clotted	PROPN
ajlm-2381	49	34	bma	bma	PROPN
ajlm-2381	49	35	may	may	AUX
ajlm-2381	49	36	be	be	AUX
ajlm-2381	49	37	used	use	VERB
ajlm-2381	49	38	in	in	ADP
ajlm-2381	49	39	cases	case	NOUN
ajlm-2381	49	40	where	where	SCONJ
ajlm-2381	49	41	it	it	PRON
ajlm-2381	49	42	is	be	AUX
ajlm-2381	49	43	difficult	difficult	ADJ
ajlm-2381	49	44	to	to	PART
ajlm-2381	49	45	obtain	obtain	VERB
ajlm-2381	49	46	a	a	DET
ajlm-2381	49	47	trephine	trephine	ADJ
ajlm-2381	49	48	biopsy	biopsy	NOUN
ajlm-2381	49	49	.	.	PUNCT
ajlm-2381	50	1	the	the	DET
ajlm-2381	50	2	bma	bma	PROPN
ajlm-2381	50	3	is	be	AUX
ajlm-2381	50	4	allowed	allow	VERB
ajlm-2381	50	5	to	to	PART
ajlm-2381	50	6	clot	clot	VERB
ajlm-2381	50	7	in	in	ADP
ajlm-2381	50	8	a	a	DET
ajlm-2381	50	9	syringe	syringe	NOUN
ajlm-2381	50	10	.	.	PUNCT
ajlm-2381	51	1	the	the	DET
ajlm-2381	51	2	clot	clot	NOUN
ajlm-2381	51	3	is	be	AUX
ajlm-2381	51	4	then	then	ADV
ajlm-2381	51	5	carefully	carefully	ADV
ajlm-2381	51	6	removed	remove	VERB
ajlm-2381	51	7	,	,	PUNCT
ajlm-2381	51	8	placed	place	VERB
ajlm-2381	51	9	in	in	ADP
ajlm-2381	51	10	a	a	DET
ajlm-2381	51	11	fixative	fixative	NOUN
ajlm-2381	51	12	such	such	ADJ
ajlm-2381	51	13	as	as	ADP
ajlm-2381	51	14	formalin	formalin	NOUN
ajlm-2381	51	15	,	,	PUNCT
ajlm-2381	51	16	and	and	CCONJ
ajlm-2381	51	17	processed	process	VERB
ajlm-2381	51	18	in	in	ADP
ajlm-2381	51	19	the	the	DET
ajlm-2381	51	20	same	same	ADJ
ajlm-2381	51	21	way	way	NOUN
ajlm-2381	51	22	as	as	ADP
ajlm-2381	51	23	a	a	DET
ajlm-2381	51	24	trephine	trephine	ADJ
ajlm-2381	51	25	biopsy	biopsy	NOUN
ajlm-2381	51	26	,	,	PUNCT
ajlm-2381	51	27	except	except	SCONJ
ajlm-2381	51	28	that	that	SCONJ
ajlm-2381	51	29	no	no	DET
ajlm-2381	51	30	decalcification	decalcification	NOUN
ajlm-2381	51	31	is	be	AUX
ajlm-2381	51	32	required.11	required.11	ADJ
ajlm-2381	51	33	current	current	ADJ
ajlm-2381	51	34	methods	method	NOUN
ajlm-2381	51	35	for	for	ADP
ajlm-2381	51	36	estimating	estimate	VERB
ajlm-2381	51	37	plasma	plasma	NOUN
ajlm-2381	51	38	cells	cell	NOUN
ajlm-2381	51	39	in	in	ADP
ajlm-2381	51	40	bone	bone	NOUN
ajlm-2381	51	41	marrow	marrow	NOUN
ajlm-2381	51	42	manual	manual	ADJ
ajlm-2381	51	43	cell	cell	NOUN
ajlm-2381	51	44	counting	counting	NOUN
ajlm-2381	51	45	on	on	ADP
ajlm-2381	51	46	bone	bone	NOUN
ajlm-2381	51	47	marrow	marrow	NOUN
ajlm-2381	51	48	aspirate	aspirate	NOUN
ajlm-2381	51	49	smears	smear	VERB
ajlm-2381	51	50	cellular	cellular	ADJ
ajlm-2381	51	51	trails	trail	NOUN
ajlm-2381	51	52	of	of	ADP
ajlm-2381	51	53	romanowsky	romanowsky	NOUN
ajlm-2381	51	54	-	-	PUNCT
ajlm-2381	51	55	stained	stain	VERB
ajlm-2381	51	56	bm	bm	PROPN
ajlm-2381	51	57	aspirates	aspirate	NOUN
ajlm-2381	51	58	are	be	AUX
ajlm-2381	51	59	used	use	VERB
ajlm-2381	51	60	for	for	ADP
ajlm-2381	51	61	differential	differential	ADJ
ajlm-2381	51	62	counts	count	NOUN
ajlm-2381	51	63	under	under	ADP
ajlm-2381	51	64	the	the	DET
ajlm-2381	51	65	light	light	ADJ
ajlm-2381	51	66	microscope	microscope	NOUN
ajlm-2381	51	67	,	,	PUNCT
ajlm-2381	51	68	but	but	CCONJ
ajlm-2381	51	69	can	can	AUX
ajlm-2381	51	70	be	be	AUX
ajlm-2381	51	71	misleading	misleading	ADJ
ajlm-2381	51	72	if	if	SCONJ
ajlm-2381	51	73	pc	pc	NOUN
ajlm-2381	51	74	do	do	AUX
ajlm-2381	51	75	not	not	PART
ajlm-2381	51	76	‘	'	PUNCT
ajlm-2381	51	77	fall	fall	VERB
ajlm-2381	51	78	out	out	ADP
ajlm-2381	51	79	’	'	PUNCT
ajlm-2381	51	80	from	from	ADP
ajlm-2381	51	81	the	the	DET
ajlm-2381	51	82	bm	bm	PROPN
ajlm-2381	51	83	particles	particle	NOUN
ajlm-2381	51	84	or	or	CCONJ
ajlm-2381	51	85	are	be	AUX
ajlm-2381	51	86	not	not	PART
ajlm-2381	51	87	aspirated	aspirate	VERB
ajlm-2381	51	88	due	due	ADP
ajlm-2381	51	89	to	to	ADP
ajlm-2381	51	90	the	the	DET
ajlm-2381	51	91	patchy	patchy	ADJ
ajlm-2381	51	92	nature	nature	NOUN
ajlm-2381	51	93	of	of	ADP
ajlm-2381	51	94	mm	mm	PROPN
ajlm-2381	51	95	.	.	PUNCT
ajlm-2381	52	1	plasma	plasma	NOUN
ajlm-2381	52	2	cell	cell	NOUN
ajlm-2381	52	3	are	be	AUX
ajlm-2381	52	4	counted	count	VERB
ajlm-2381	52	5	as	as	ADP
ajlm-2381	52	6	a	a	DET
ajlm-2381	52	7	proportion	proportion	NOUN
ajlm-2381	52	8	of	of	ADP
ajlm-2381	52	9	all	all	DET
ajlm-2381	52	10	other	other	ADJ
ajlm-2381	52	11	nucleated	nucleated	ADJ
ajlm-2381	52	12	haematopoietic	haematopoietic	ADJ
ajlm-2381	52	13	cells	cell	NOUN
ajlm-2381	52	14	in	in	ADP
ajlm-2381	52	15	a	a	DET
ajlm-2381	52	16	200–500	200–500	NUM
ajlm-2381	52	17	cell	cell	NOUN
ajlm-2381	52	18	differential	differential	NOUN
ajlm-2381	52	19	to	to	PART
ajlm-2381	52	20	estimate	estimate	VERB
ajlm-2381	52	21	the	the	DET
ajlm-2381	52	22	percentage	percentage	NOUN
ajlm-2381	52	23	of	of	ADP
ajlm-2381	52	24	pc	pc	NOUN
ajlm-2381	52	25	in	in	ADP
ajlm-2381	52	26	the	the	DET
ajlm-2381	52	27	bm.11	bm.11	ADJ
ajlm-2381	52	28	bone	bone	NOUN
ajlm-2381	52	29	marrow	marrow	NOUN
ajlm-2381	52	30	aspirate	aspirate	NOUN
ajlm-2381	52	31	smears	smear	NOUN
ajlm-2381	52	32	often	often	ADV
ajlm-2381	52	33	underestimate	underestimate	VERB
ajlm-2381	52	34	the	the	DET
ajlm-2381	52	35	percentage	percentage	NOUN
ajlm-2381	52	36	of	of	ADP
ajlm-2381	52	37	pc	pc	NOUN
ajlm-2381	52	38	compared	compare	VERB
ajlm-2381	52	39	to	to	ADP
ajlm-2381	52	40	bm	bm	PROPN
ajlm-2381	52	41	biopsies	biopsy	NOUN
ajlm-2381	52	42	,	,	PUNCT
ajlm-2381	52	43	leading	lead	VERB
ajlm-2381	52	44	to	to	ADP
ajlm-2381	52	45	a	a	DET
ajlm-2381	52	46	lack	lack	NOUN
ajlm-2381	52	47	of	of	ADP
ajlm-2381	52	48	consensus	consensus	NOUN
ajlm-2381	52	49	on	on	ADP
ajlm-2381	52	50	the	the	DET
ajlm-2381	52	51	appropriateness	appropriateness	NOUN
ajlm-2381	52	52	of	of	ADP
ajlm-2381	52	53	smears	smear	NOUN
ajlm-2381	52	54	for	for	ADP
ajlm-2381	52	55	determining	determine	VERB
ajlm-2381	52	56	the	the	DET
ajlm-2381	52	57	percentage	percentage	NOUN
ajlm-2381	52	58	of	of	ADP
ajlm-2381	52	59	pc	pc	NOUN
ajlm-2381	52	60	in	in	ADP
ajlm-2381	52	61	bm.17,18,19,20,21,22,23	bm.17,18,19,20,21,22,23	NOUN
ajlm-2381	52	62	in	in	ADP
ajlm-2381	52	63	a	a	DET
ajlm-2381	52	64	study	study	NOUN
ajlm-2381	52	65	conducted	conduct	VERB
ajlm-2381	52	66	in	in	ADP
ajlm-2381	52	67	the	the	DET
ajlm-2381	52	68	united	united	PROPN
ajlm-2381	52	69	states	states	PROPN
ajlm-2381	52	70	in	in	ADP
ajlm-2381	52	71	2007	2007	NUM
ajlm-2381	52	72	,	,	PUNCT
ajlm-2381	52	73	al	al	PROPN
ajlm-2381	52	74	-	-	PUNCT
ajlm-2381	52	75	quran	quran	PROPN
ajlm-2381	52	76	et	et	PROPN
ajlm-2381	52	77	al	al	PROPN
ajlm-2381	52	78	.	.	PROPN
ajlm-2381	52	79	evaluated	evaluate	VERB
ajlm-2381	52	80	cd138	cd138	NOUN
ajlm-2381	52	81	-	-	PUNCT
ajlm-2381	52	82	stained	stain	VERB
ajlm-2381	52	83	bm	bm	NOUN
ajlm-2381	52	84	specimens	specimen	NOUN
ajlm-2381	52	85	and	and	CCONJ
ajlm-2381	52	86	showed	show	VERB
ajlm-2381	52	87	poor	poor	ADJ
ajlm-2381	52	88	intraobserver	intraobserver	ADJ
ajlm-2381	52	89	concordance	concordance	NOUN
ajlm-2381	52	90	with	with	ADP
ajlm-2381	52	91	an	an	DET
ajlm-2381	52	92	intraclass	intraclass	NOUN
ajlm-2381	52	93	correlation	correlation	NOUN
ajlm-2381	52	94	coefficient	coefficient	NOUN
ajlm-2381	52	95	of	of	ADP
ajlm-2381	52	96	0.55	0.55	NUM
ajlm-2381	52	97	for	for	ADP
ajlm-2381	52	98	one	one	NUM
ajlm-2381	52	99	observer	observer	NOUN
ajlm-2381	52	100	and	and	CCONJ
ajlm-2381	52	101	an	an	DET
ajlm-2381	52	102	intraclass	intraclass	NOUN
ajlm-2381	52	103	correlation	correlation	NOUN
ajlm-2381	52	104	coefficient	coefficient	NOUN
ajlm-2381	52	105	of	of	ADP
ajlm-2381	52	106	0.47	0.47	NUM
ajlm-2381	52	107	for	for	ADP
ajlm-2381	52	108	another	another	PRON
ajlm-2381	52	109	between	between	ADP
ajlm-2381	52	110	pc	pc	NOUN
ajlm-2381	52	111	quantitation	quantitation	NOUN
ajlm-2381	52	112	on	on	ADP
ajlm-2381	52	113	bm	bm	PROPN
ajlm-2381	52	114	aspirate	aspirate	PROPN
ajlm-2381	52	115	smears	smear	NOUN
ajlm-2381	52	116	and	and	CCONJ
ajlm-2381	52	117	cd138	cd138	PROPN
ajlm-2381	52	118	immunohistochemistry.19	immunohistochemistry.19	PROPN
ajlm-2381	52	119	smith	smith	PROPN
ajlm-2381	52	120	and	and	CCONJ
ajlm-2381	52	121	elnawawi	elnawawi	NOUN
ajlm-2381	52	122	,	,	PUNCT
ajlm-2381	52	123	in	in	ADP
ajlm-2381	52	124	a	a	DET
ajlm-2381	52	125	study	study	NOUN
ajlm-2381	52	126	conducted	conduct	VERB
ajlm-2381	52	127	in	in	ADP
ajlm-2381	52	128	the	the	DET
ajlm-2381	52	129	united	united	PROPN
ajlm-2381	52	130	states	states	PROPN
ajlm-2381	52	131	in	in	ADP
ajlm-2381	52	132	2008	2008	NUM
ajlm-2381	52	133	,	,	PUNCT
ajlm-2381	52	134	found	find	VERB
ajlm-2381	52	135	that	that	SCONJ
ajlm-2381	52	136	aspirate	aspirate	NOUN
ajlm-2381	52	137	smear	smear	NOUN
ajlm-2381	52	138	pc	pc	NOUN
ajlm-2381	52	139	counts	count	NOUN
ajlm-2381	52	140	were	be	AUX
ajlm-2381	52	141	considerably	considerably	ADV
ajlm-2381	52	142	lower	low	ADJ
ajlm-2381	52	143	(	(	PUNCT
ajlm-2381	52	144	mean	mean	NOUN
ajlm-2381	52	145	10.6	10.6	NUM
ajlm-2381	52	146	;	;	PUNCT
ajlm-2381	52	147	standard	standard	ADJ
ajlm-2381	52	148	deviation	deviation	NOUN
ajlm-2381	52	149	[	[	X
ajlm-2381	52	150	s.d	s.d	PROPN
ajlm-2381	52	151	.	.	PROPN
ajlm-2381	52	152	]	]	PUNCT
ajlm-2381	52	153	±	±	NUM
ajlm-2381	52	154	13.1	13.1	NUM
ajlm-2381	52	155	)	)	PUNCT
ajlm-2381	52	156	than	than	ADP
ajlm-2381	52	157	the	the	DET
ajlm-2381	52	158	counts	count	NOUN
ajlm-2381	52	159	by	by	ADP
ajlm-2381	52	160	other	other	ADJ
ajlm-2381	52	161	methods	method	NOUN
ajlm-2381	52	162	such	such	ADJ
ajlm-2381	52	163	as	as	ADP
ajlm-2381	52	164	overview	overview	NOUN
ajlm-2381	52	165	estimates	estimate	NOUN
ajlm-2381	52	166	(	(	PUNCT
ajlm-2381	52	167	mean	mean	NOUN
ajlm-2381	52	168	19.2	19.2	NUM
ajlm-2381	52	169	;	;	PUNCT
ajlm-2381	52	170	s.d	s.d	PROPN
ajlm-2381	52	171	.	.	PROPN
ajlm-2381	52	172	±	±	PROPN
ajlm-2381	52	173	20.4	20.4	NUM
ajlm-2381	52	174	)	)	PUNCT
ajlm-2381	52	175	and	and	CCONJ
ajlm-2381	52	176	manual	manual	ADJ
ajlm-2381	52	177	counts	count	NOUN
ajlm-2381	52	178	on	on	ADP
ajlm-2381	52	179	cd138	cd138	PROPN
ajlm-2381	52	180	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	52	181	(	(	PUNCT
ajlm-2381	52	182	mean	mean	NOUN
ajlm-2381	52	183	23.1	23.1	NUM
ajlm-2381	52	184	;	;	PUNCT
ajlm-2381	52	185	s.d	s.d	PROPN
ajlm-2381	52	186	.	.	PROPN
ajlm-2381	52	187	±	±	PROPN
ajlm-2381	52	188	17.7	17.7	NUM
ajlm-2381	52	189	)	)	PUNCT
ajlm-2381	52	190	,	,	PUNCT
ajlm-2381	52	191	and	and	CCONJ
ajlm-2381	52	192	attributed	attribute	VERB
ajlm-2381	52	193	this	this	PRON
ajlm-2381	52	194	to	to	ADP
ajlm-2381	52	195	an	an	DET
ajlm-2381	52	196	under	under	NOUN
ajlm-2381	52	197	-	-	PUNCT
ajlm-2381	52	198	representation	representation	NOUN
ajlm-2381	52	199	of	of	ADP
ajlm-2381	52	200	pc	pc	NOUN
ajlm-2381	52	201	in	in	ADP
ajlm-2381	52	202	aspirate	aspirate	NOUN
ajlm-2381	52	203	smears.18	smears.18	PROPN
ajlm-2381	52	204	despite	despite	SCONJ
ajlm-2381	52	205	this	this	DET
ajlm-2381	52	206	percentage	percentage	NOUN
ajlm-2381	52	207	discrepancy	discrepancy	NOUN
ajlm-2381	52	208	,	,	PUNCT
ajlm-2381	52	209	one	one	NUM
ajlm-2381	52	210	study	study	NOUN
ajlm-2381	52	211	found	find	VERB
ajlm-2381	52	212	a	a	DET
ajlm-2381	52	213	significant	significant	ADJ
ajlm-2381	52	214	linear	linear	ADJ
ajlm-2381	52	215	correlation	correlation	NOUN
ajlm-2381	52	216	between	between	ADP
ajlm-2381	52	217	bmpc%	bmpc%	PUNCT
ajlm-2381	52	218	in	in	ADP
ajlm-2381	52	219	aspirate	aspirate	NOUN
ajlm-2381	52	220	enumeration	enumeration	NOUN
ajlm-2381	52	221	and	and	CCONJ
ajlm-2381	52	222	cd138	cd138	PROPN
ajlm-2381	52	223	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	52	224	(	(	PUNCT
ajlm-2381	52	225	r	r	NOUN
ajlm-2381	52	226	=	=	SYM
ajlm-2381	52	227	0.71	0.71	NUM
ajlm-2381	52	228	[	[	X
ajlm-2381	52	229	pearson	pearson	NOUN
ajlm-2381	52	230	correlation	correlation	NOUN
ajlm-2381	52	231	coefficient	coefficient	NOUN
ajlm-2381	52	232	]	]	X
ajlm-2381	52	233	)	)	PUNCT
ajlm-2381	52	234	,	,	PUNCT
ajlm-2381	52	235	which	which	PRON
ajlm-2381	52	236	suggests	suggest	VERB
ajlm-2381	52	237	the	the	DET
ajlm-2381	52	238	possibility	possibility	NOUN
ajlm-2381	52	239	of	of	ADP
ajlm-2381	52	240	extrapolating	extrapolate	VERB
ajlm-2381	52	241	the	the	DET
ajlm-2381	52	242	true	true	ADJ
ajlm-2381	52	243	bmpc%	bmpc%	PUNCT
ajlm-2381	52	244	from	from	ADP
ajlm-2381	52	245	the	the	DET
ajlm-2381	52	246	manual	manual	ADJ
ajlm-2381	52	247	count	count	NOUN
ajlm-2381	52	248	on	on	ADP
ajlm-2381	52	249	bma	bma	PROPN
ajlm-2381	52	250	smears.23	smears.23	VERB
ajlm-2381	52	251	morphological	morphological	ADJ
ajlm-2381	52	252	assessment	assessment	NOUN
ajlm-2381	52	253	of	of	ADP
ajlm-2381	52	254	bma	bma	PROPN
ajlm-2381	52	255	smears	smear	NOUN
ajlm-2381	52	256	has	have	VERB
ajlm-2381	52	257	limitations	limitation	NOUN
ajlm-2381	52	258	,	,	PUNCT
ajlm-2381	52	259	including	include	VERB
ajlm-2381	52	260	the	the	DET
ajlm-2381	52	261	assessment	assessment	NOUN
ajlm-2381	52	262	of	of	ADP
ajlm-2381	52	263	tumour	tumour	NOUN
ajlm-2381	52	264	burden	burden	NOUN
ajlm-2381	52	265	and	and	CCONJ
ajlm-2381	52	266	the	the	DET
ajlm-2381	52	267	determination	determination	NOUN
ajlm-2381	52	268	of	of	ADP
ajlm-2381	52	269	pc	pc	NOUN
ajlm-2381	52	270	clonality	clonality	NOUN
ajlm-2381	52	271	.	.	PUNCT
ajlm-2381	53	1	it	it	PRON
ajlm-2381	53	2	is	be	AUX
ajlm-2381	53	3	therefore	therefore	ADV
ajlm-2381	53	4	best	well	ADV
ajlm-2381	53	5	used	use	VERB
ajlm-2381	53	6	in	in	ADP
ajlm-2381	53	7	combination	combination	NOUN
ajlm-2381	53	8	with	with	ADP
ajlm-2381	53	9	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	53	10	and	and	CCONJ
ajlm-2381	53	11	with	with	ADP
ajlm-2381	53	12	or	or	CCONJ
ajlm-2381	53	13	without	without	ADP
ajlm-2381	53	14	multiparameter	multiparameter	NOUN
ajlm-2381	53	15	flow	flow	NOUN
ajlm-2381	53	16	cytometry	cytometry	NOUN
ajlm-2381	53	17	(	(	PUNCT
ajlm-2381	53	18	mfc	mfc	PROPN
ajlm-2381	53	19	)	)	PUNCT
ajlm-2381	53	20	when	when	SCONJ
ajlm-2381	53	21	detection	detection	NOUN
ajlm-2381	53	22	of	of	ADP
ajlm-2381	53	23	clonality	clonality	NOUN
ajlm-2381	53	24	with	with	ADP
ajlm-2381	53	25	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	53	26	is	be	AUX
ajlm-2381	53	27	difficult	difficult	ADJ
ajlm-2381	53	28	,	,	PUNCT
ajlm-2381	53	29	especially	especially	ADV
ajlm-2381	53	30	in	in	ADP
ajlm-2381	53	31	the	the	DET
ajlm-2381	53	32	context	context	NOUN
ajlm-2381	53	33	of	of	ADP
ajlm-2381	53	34	post	post	ADJ
ajlm-2381	53	35	-	-	ADJ
ajlm-2381	53	36	therapeutic	therapeutic	ADJ
ajlm-2381	53	37	hypocellular	hypocellular	ADJ
ajlm-2381	53	38	bm	bm	NOUN
ajlm-2381	53	39	samples	sample	NOUN
ajlm-2381	53	40	or	or	CCONJ
ajlm-2381	53	41	a	a	DET
ajlm-2381	53	42	low	low	ADJ
ajlm-2381	53	43	tumour	tumour	NOUN
ajlm-2381	53	44	burden.1,3,4,14,24	burden.1,3,4,14,24	NOUN
ajlm-2381	53	45	the	the	DET
ajlm-2381	53	46	world	world	PROPN
ajlm-2381	53	47	health	health	NOUN
ajlm-2381	53	48	organization	organization	NOUN
ajlm-2381	53	49	allows	allow	VERB
ajlm-2381	53	50	the	the	PRON
ajlm-2381	53	51	bmpc%	bmpc%	PUNCT
ajlm-2381	53	52	to	to	PART
ajlm-2381	53	53	be	be	AUX
ajlm-2381	53	54	determined	determine	VERB
ajlm-2381	53	55	either	either	CCONJ
ajlm-2381	53	56	by	by	ADP
ajlm-2381	53	57	manual	manual	ADJ
ajlm-2381	53	58	counting	counting	NOUN
ajlm-2381	53	59	of	of	ADP
ajlm-2381	53	60	the	the	DET
ajlm-2381	53	61	aspirate	aspirate	NOUN
ajlm-2381	53	62	or	or	CCONJ
ajlm-2381	53	63	by	by	ADP
ajlm-2381	53	64	cd138	cd138	PROPN
ajlm-2381	53	65	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	53	66	.	.	PUNCT
ajlm-2381	54	1	it	it	PRON
ajlm-2381	54	2	is	be	AUX
ajlm-2381	54	3	recommended	recommend	VERB
ajlm-2381	54	4	to	to	PART
ajlm-2381	54	5	consider	consider	VERB
ajlm-2381	54	6	the	the	DET
ajlm-2381	54	7	highest	high	ADJ
ajlm-2381	54	8	pc	pc	NOUN
ajlm-2381	54	9	percentage	percentage	NOUN
ajlm-2381	54	10	of	of	ADP
ajlm-2381	54	11	aspirate	aspirate	NOUN
ajlm-2381	54	12	or	or	CCONJ
ajlm-2381	54	13	trephine	trephine	NOUN
ajlm-2381	54	14	if	if	SCONJ
ajlm-2381	54	15	there	there	PRON
ajlm-2381	54	16	is	be	VERB
ajlm-2381	54	17	a	a	DET
ajlm-2381	54	18	discrepancy	discrepancy	NOUN
ajlm-2381	54	19	between	between	ADP
ajlm-2381	54	20	the	the	DET
ajlm-2381	54	21	two	two	NUM
ajlm-2381	54	22	methods.1,3	methods.1,3	PROPN
ajlm-2381	54	23	multiparameter	multiparameter	NOUN
ajlm-2381	54	24	flow	flow	NOUN
ajlm-2381	54	25	cytometry	cytometry	NOUN
ajlm-2381	54	26	on	on	ADP
ajlm-2381	54	27	bone	bone	NOUN
ajlm-2381	54	28	marrow	marrow	NOUN
ajlm-2381	54	29	aspirate	aspirate	NOUN
ajlm-2381	54	30	specimens	specimen	VERB
ajlm-2381	54	31	the	the	DET
ajlm-2381	54	32	literature	literature	NOUN
ajlm-2381	54	33	supports	support	VERB
ajlm-2381	54	34	the	the	DET
ajlm-2381	54	35	use	use	NOUN
ajlm-2381	54	36	of	of	ADP
ajlm-2381	54	37	mfc	mfc	PROPN
ajlm-2381	54	38	in	in	ADP
ajlm-2381	54	39	the	the	DET
ajlm-2381	54	40	diagnosis	diagnosis	NOUN
ajlm-2381	54	41	and	and	CCONJ
ajlm-2381	54	42	follow	follow	VERB
ajlm-2381	54	43	-	-	PUNCT
ajlm-2381	54	44	up	up	NOUN
ajlm-2381	54	45	of	of	ADP
ajlm-2381	54	46	mm	mm	NOUN
ajlm-2381	54	47	,	,	PUNCT
ajlm-2381	54	48	particularly	particularly	ADV
ajlm-2381	54	49	regarding	regard	VERB
ajlm-2381	54	50	establishing	establish	VERB
ajlm-2381	54	51	the	the	DET
ajlm-2381	54	52	clonal	clonal	ADJ
ajlm-2381	54	53	nature	nature	NOUN
ajlm-2381	54	54	of	of	ADP
ajlm-2381	54	55	the	the	DET
ajlm-2381	54	56	pc.25,26,27	pc.25,26,27	NOUN
ajlm-2381	54	57	multiparameter	multiparameter	NOUN
ajlm-2381	54	58	flow	flow	NOUN
ajlm-2381	54	59	cytometry	cytometry	NOUN
ajlm-2381	54	60	has	have	AUX
ajlm-2381	54	61	been	be	AUX
ajlm-2381	54	62	shown	show	VERB
ajlm-2381	54	63	to	to	PART
ajlm-2381	54	64	provide	provide	VERB
ajlm-2381	54	65	more	more	ADJ
ajlm-2381	54	66	prognostic	prognostic	ADJ
ajlm-2381	54	67	information	information	NOUN
ajlm-2381	54	68	for	for	ADP
ajlm-2381	54	69	overall	overall	ADJ
ajlm-2381	54	70	survival	survival	NOUN
ajlm-2381	54	71	than	than	ADP
ajlm-2381	54	72	morphological	morphological	ADJ
ajlm-2381	54	73	assessment	assessment	NOUN
ajlm-2381	54	74	in	in	ADP
ajlm-2381	54	75	patients	patient	NOUN
ajlm-2381	54	76	with	with	ADP
ajlm-2381	54	77	mm.25	mm.25	PROPN
ajlm-2381	54	78	the	the	DET
ajlm-2381	54	79	use	use	NOUN
ajlm-2381	54	80	of	of	ADP
ajlm-2381	54	81	mfc	mfc	PROPN
ajlm-2381	54	82	to	to	PART
ajlm-2381	54	83	quantify	quantify	VERB
ajlm-2381	54	84	pc	pc	NOUN
ajlm-2381	54	85	in	in	ADP
ajlm-2381	54	86	bm	bm	PROPN
ajlm-2381	54	87	is	be	AUX
ajlm-2381	54	88	more	more	ADV
ajlm-2381	54	89	controversial	controversial	ADJ
ajlm-2381	54	90	.	.	PUNCT
ajlm-2381	55	1	it	it	PRON
ajlm-2381	55	2	has	have	AUX
ajlm-2381	55	3	been	be	AUX
ajlm-2381	55	4	shown	show	VERB
ajlm-2381	55	5	that	that	SCONJ
ajlm-2381	55	6	the	the	DET
ajlm-2381	55	7	percentage	percentage	NOUN
ajlm-2381	55	8	yield	yield	NOUN
ajlm-2381	55	9	of	of	ADP
ajlm-2381	55	10	pc	pc	NOUN
ajlm-2381	55	11	is	be	AUX
ajlm-2381	55	12	consistently	consistently	ADV
ajlm-2381	55	13	lower	low	ADJ
ajlm-2381	55	14	with	with	ADP
ajlm-2381	55	15	flow	flow	NOUN
ajlm-2381	55	16	cytometric	cytometric	ADJ
ajlm-2381	55	17	methods	method	NOUN
ajlm-2381	55	18	than	than	ADP
ajlm-2381	55	19	with	with	ADP
ajlm-2381	55	20	morphological	morphological	ADJ
ajlm-2381	55	21	assessment	assessment	NOUN
ajlm-2381	55	22	of	of	ADP
ajlm-2381	55	23	smears	smear	NOUN
ajlm-2381	55	24	from	from	ADP
ajlm-2381	55	25	bma.12,13,22,25,27,28,29	bma.12,13,22,25,27,28,29	NOUN
ajlm-2381	55	26	this	this	DET
ajlm-2381	55	27	discrepancy	discrepancy	NOUN
ajlm-2381	55	28	is	be	AUX
ajlm-2381	55	29	thought	think	VERB
ajlm-2381	55	30	to	to	PART
ajlm-2381	55	31	be	be	AUX
ajlm-2381	55	32	because	because	SCONJ
ajlm-2381	55	33	of	of	ADP
ajlm-2381	55	34	pc	pc	NOUN
ajlm-2381	55	35	fragility	fragility	NOUN
ajlm-2381	55	36	,	,	PUNCT
ajlm-2381	55	37	differences	difference	NOUN
ajlm-2381	55	38	in	in	ADP
ajlm-2381	55	39	sample	sample	NOUN
ajlm-2381	55	40	quality	quality	NOUN
ajlm-2381	55	41	,	,	PUNCT
ajlm-2381	55	42	dilution	dilution	NOUN
ajlm-2381	55	43	with	with	ADP
ajlm-2381	55	44	peripheral	peripheral	ADJ
ajlm-2381	55	45	blood	blood	NOUN
ajlm-2381	55	46	(	(	PUNCT
ajlm-2381	55	47	haemodilution	haemodilution	NOUN
ajlm-2381	55	48	)	)	PUNCT
ajlm-2381	55	49	or	or	CCONJ
ajlm-2381	55	50	clotted	clot	VERB
ajlm-2381	55	51	specimens	specimen	NOUN
ajlm-2381	55	52	and	and	CCONJ
ajlm-2381	55	53	cellular	cellular	ADJ
ajlm-2381	55	54	processing	processing	NOUN
ajlm-2381	55	55	techniques	technique	NOUN
ajlm-2381	55	56	used	use	VERB
ajlm-2381	55	57	in	in	ADP
ajlm-2381	55	58	flow	flow	NOUN
ajlm-2381	55	59	cytometry	cytometry	NOUN
ajlm-2381	55	60	that	that	PRON
ajlm-2381	55	61	reduce	reduce	VERB
ajlm-2381	55	62	the	the	DET
ajlm-2381	55	63	pc	pc	NOUN
ajlm-2381	55	64	count	count	NOUN
ajlm-2381	55	65	.	.	PUNCT
ajlm-2381	56	1	in	in	ADP
ajlm-2381	56	2	contrast	contrast	NOUN
ajlm-2381	56	3	to	to	ADP
ajlm-2381	56	4	this	this	PRON
ajlm-2381	56	5	,	,	PUNCT
ajlm-2381	56	6	a	a	DET
ajlm-2381	56	7	2017	2017	NUM
ajlm-2381	56	8	study	study	NOUN
ajlm-2381	56	9	by	by	ADP
ajlm-2381	56	10	matsue	matsue	NOUN
ajlm-2381	56	11	et	et	PROPN
ajlm-2381	56	12	al	al	PROPN
ajlm-2381	56	13	.	.	PROPN
ajlm-2381	57	1	in	in	ADP
ajlm-2381	57	2	japan	japan	PROPN
ajlm-2381	57	3	showed	show	VERB
ajlm-2381	57	4	that	that	SCONJ
ajlm-2381	57	5	the	the	DET
ajlm-2381	57	6	bmpc%	bmpc%	PUNCT
ajlm-2381	57	7	on	on	ADP
ajlm-2381	57	8	aspirate	aspirate	NOUN
ajlm-2381	57	9	smear	smear	NOUN
ajlm-2381	57	10	counts	count	NOUN
ajlm-2381	57	11	correlated	correlate	VERB
ajlm-2381	57	12	with	with	ADP
ajlm-2381	57	13	flow	flow	NOUN
ajlm-2381	57	14	cytometry	cytometry	NOUN
ajlm-2381	57	15	(	(	PUNCT
ajlm-2381	57	16	r	r	NOUN
ajlm-2381	57	17	=	=	NOUN
ajlm-2381	57	18	0.93	0.93	NUM
ajlm-2381	57	19	)	)	PUNCT
ajlm-2381	57	20	,	,	PUNCT
ajlm-2381	57	21	but	but	CCONJ
ajlm-2381	57	22	bma	bma	PROPN
ajlm-2381	57	23	smear	smear	NOUN
ajlm-2381	57	24	and	and	CCONJ
ajlm-2381	57	25	flow	flow	NOUN
ajlm-2381	57	26	cytometry	cytometry	NOUN
ajlm-2381	57	27	significantly	significantly	ADV
ajlm-2381	57	28	underestimated	underestimate	VERB
ajlm-2381	57	29	the	the	DET
ajlm-2381	57	30	pc	pc	NOUN
ajlm-2381	57	31	percentage	percentage	NOUN
ajlm-2381	57	32	compared	compare	VERB
ajlm-2381	57	33	to	to	ADP
ajlm-2381	57	34	bm	bm	PROPN
ajlm-2381	57	35	biopsy	biopsy	PROPN
ajlm-2381	57	36	or	or	CCONJ
ajlm-2381	57	37	clot	clot	NOUN
ajlm-2381	57	38	stained	stain	VERB
ajlm-2381	57	39	with	with	ADP
ajlm-2381	57	40	cd138	cd138	PROPN
ajlm-2381	57	41	immunohistochemistry.30	immunohistochemistry.30	NOUN
ajlm-2381	57	42	another	another	DET
ajlm-2381	57	43	study	study	NOUN
ajlm-2381	57	44	showed	show	VERB
ajlm-2381	57	45	that	that	SCONJ
ajlm-2381	57	46	even	even	ADV
ajlm-2381	57	47	though	though	SCONJ
ajlm-2381	57	48	a	a	DET
ajlm-2381	57	49	discrepancy	discrepancy	NOUN
ajlm-2381	57	50	was	be	AUX
ajlm-2381	57	51	seen	see	VERB
ajlm-2381	57	52	with	with	ADP
ajlm-2381	57	53	morphological	morphological	ADJ
ajlm-2381	57	54	enumeration	enumeration	NOUN
ajlm-2381	57	55	average	average	NOUN
ajlm-2381	57	56	(	(	PUNCT
ajlm-2381	57	57	60	60	NUM
ajlm-2381	57	58	%	%	NOUN
ajlm-2381	57	59	)	)	PUNCT
ajlm-2381	57	60	in	in	ADP
ajlm-2381	57	61	mm	mm	PROPN
ajlm-2381	57	62	patients	patient	NOUN
ajlm-2381	57	63	compared	compare	VERB
ajlm-2381	57	64	to	to	PART
ajlm-2381	57	65	flow	flow	VERB
ajlm-2381	57	66	cytometry	cytometry	NOUN
ajlm-2381	57	67	(	(	PUNCT
ajlm-2381	57	68	20	20	NUM
ajlm-2381	57	69	%	%	NOUN
ajlm-2381	57	70	)	)	PUNCT
ajlm-2381	57	71	,	,	PUNCT
ajlm-2381	57	72	this	this	DET
ajlm-2381	57	73	discrepancy	discrepancy	NOUN
ajlm-2381	57	74	was	be	AUX
ajlm-2381	57	75	not	not	PART
ajlm-2381	57	76	found	find	VERB
ajlm-2381	57	77	between	between	ADP
ajlm-2381	57	78	morphological	morphological	ADJ
ajlm-2381	57	79	and	and	CCONJ
ajlm-2381	57	80	flow	flow	VERB
ajlm-2381	57	81	cytometry	cytometry	NOUN
ajlm-2381	57	82	assessment	assessment	NOUN
ajlm-2381	57	83	in	in	ADP
ajlm-2381	57	84	acute	acute	ADJ
ajlm-2381	57	85	myeloid	myeloid	NOUN
ajlm-2381	57	86	leukaemia	leukaemia	NOUN
ajlm-2381	57	87	samples.13	samples.13	NOUN
ajlm-2381	57	88	based	base	VERB
ajlm-2381	57	89	on	on	ADP
ajlm-2381	57	90	these	these	DET
ajlm-2381	57	91	findings	finding	NOUN
ajlm-2381	57	92	,	,	PUNCT
ajlm-2381	57	93	the	the	DET
ajlm-2381	57	94	discrepancy	discrepancy	NOUN
ajlm-2381	57	95	regarding	regard	VERB
ajlm-2381	57	96	mm	mm	PROPN
ajlm-2381	57	97	can	can	AUX
ajlm-2381	57	98	not	not	PART
ajlm-2381	57	99	be	be	AUX
ajlm-2381	57	100	attributed	attribute	VERB
ajlm-2381	57	101	solely	solely	ADV
ajlm-2381	57	102	to	to	ADP
ajlm-2381	57	103	technical	technical	ADJ
ajlm-2381	57	104	or	or	CCONJ
ajlm-2381	57	105	methodological	methodological	ADJ
ajlm-2381	57	106	problems	problem	NOUN
ajlm-2381	57	107	.	.	PUNCT
ajlm-2381	58	1	it	it	PRON
ajlm-2381	58	2	may	may	AUX
ajlm-2381	58	3	stem	stem	VERB
ajlm-2381	58	4	from	from	ADP
ajlm-2381	58	5	unique	unique	ADJ
ajlm-2381	58	6	interaction	interaction	NOUN
ajlm-2381	58	7	between	between	ADP
ajlm-2381	58	8	malignant	malignant	ADJ
ajlm-2381	58	9	pc	pc	NOUN
ajlm-2381	58	10	and	and	CCONJ
ajlm-2381	58	11	the	the	DET
ajlm-2381	58	12	bm	bm	PROPN
ajlm-2381	58	13	niche	niche	NOUN
ajlm-2381	58	14	they	they	PRON
ajlm-2381	58	15	occupy	occupy	VERB
ajlm-2381	58	16	,	,	PUNCT
ajlm-2381	58	17	including	include	VERB
ajlm-2381	58	18	bone	bone	NOUN
ajlm-2381	58	19	surfaces	surface	NOUN
ajlm-2381	58	20	,	,	PUNCT
ajlm-2381	58	21	basement	basement	NOUN
ajlm-2381	58	22	membranes	membrane	NOUN
ajlm-2381	58	23	,	,	PUNCT
ajlm-2381	58	24	and	and	CCONJ
ajlm-2381	58	25	lipid	lipid	NOUN
ajlm-2381	58	26	-	-	PUNCT
ajlm-2381	58	27	enriched	enrich	VERB
ajlm-2381	58	28	spicules.13	spicules.13	NOUN
ajlm-2381	58	29	furthermore	furthermore	ADV
ajlm-2381	58	30	,	,	PUNCT
ajlm-2381	58	31	patchy	patchy	ADJ
ajlm-2381	58	32	marrow	marrow	PROPN
ajlm-2381	58	33	infiltration	infiltration	NOUN
ajlm-2381	58	34	,	,	PUNCT
ajlm-2381	58	35	hypoplastic	hypoplastic	ADJ
ajlm-2381	58	36	or	or	CCONJ
ajlm-2381	58	37	fibrotic	fibrotic	ADJ
ajlm-2381	58	38	marrows	marrow	NOUN
ajlm-2381	58	39	may	may	AUX
ajlm-2381	58	40	cause	cause	VERB
ajlm-2381	58	41	the	the	DET
ajlm-2381	58	42	underestimation	underestimation	NOUN
ajlm-2381	58	43	of	of	ADP
ajlm-2381	58	44	pc	pc	NOUN
ajlm-2381	58	45	percentages	percentage	NOUN
ajlm-2381	58	46	.	.	PUNCT
ajlm-2381	59	1	with	with	ADP
ajlm-2381	59	2	the	the	DET
ajlm-2381	59	3	concern	concern	NOUN
ajlm-2381	59	4	of	of	ADP
ajlm-2381	59	5	the	the	DET
ajlm-2381	59	6	significant	significant	ADJ
ajlm-2381	59	7	discrepancy	discrepancy	NOUN
ajlm-2381	59	8	between	between	ADP
ajlm-2381	59	9	morphological	morphological	ADJ
ajlm-2381	59	10	assessment	assessment	NOUN
ajlm-2381	59	11	and	and	CCONJ
ajlm-2381	59	12	flow	flow	VERB
ajlm-2381	59	13	cytometry	cytometry	NOUN
ajlm-2381	59	14	pc	pc	NOUN
ajlm-2381	59	15	percentage	percentage	NOUN
ajlm-2381	59	16	estimation	estimation	NOUN
ajlm-2381	59	17	,	,	PUNCT
ajlm-2381	59	18	frebet	frebet	NOUN
ajlm-2381	59	19	et	et	PROPN
ajlm-2381	59	20	al	al	PROPN
ajlm-2381	59	21	.	.	PROPN
ajlm-2381	59	22	,	,	PUNCT
ajlm-2381	59	23	in	in	ADP
ajlm-2381	59	24	a	a	DET
ajlm-2381	59	25	study	study	NOUN
ajlm-2381	59	26	in	in	ADP
ajlm-2381	59	27	france	france	PROPN
ajlm-2381	59	28	in	in	ADP
ajlm-2381	59	29	2011	2011	NUM
ajlm-2381	59	30	,	,	PUNCT
ajlm-2381	59	31	developed	develop	VERB
ajlm-2381	59	32	an	an	DET
ajlm-2381	59	33	mfc	mfc	PROPN
ajlm-2381	59	34	protocol	protocol	NOUN
ajlm-2381	59	35	that	that	PRON
ajlm-2381	59	36	uses	use	VERB
ajlm-2381	59	37	specific	specific	ADJ
ajlm-2381	59	38	antibody	antibody	NOUN
ajlm-2381	59	39	combinations	combination	NOUN
ajlm-2381	59	40	to	to	PART
ajlm-2381	59	41	include	include	VERB
ajlm-2381	59	42	pc	pc	NOUN
ajlm-2381	59	43	(	(	PUNCT
ajlm-2381	59	44	cd138+/cd38	cd138+/cd38	NOUN
ajlm-2381	59	45	+	+	NOUN
ajlm-2381	59	46	)	)	PUNCT
ajlm-2381	59	47	and	and	CCONJ
ajlm-2381	59	48	haematopoietic	haematopoietic	ADJ
ajlm-2381	59	49	precursors	precursor	NOUN
ajlm-2381	59	50	(	(	PUNCT
ajlm-2381	59	51	cd45+/cd117+/cd34	cd45+/cd117+/cd34	NOUN
ajlm-2381	59	52	+	+	NOUN
ajlm-2381	59	53	)	)	PUNCT
ajlm-2381	59	54	,	,	PUNCT
ajlm-2381	59	55	and	and	CCONJ
ajlm-2381	59	56	exclude	exclude	VERB
ajlm-2381	59	57	erythroblasts	erythroblast	NOUN
ajlm-2381	59	58	and	and	CCONJ
ajlm-2381	59	59	debris	debris	NOUN
ajlm-2381	59	60	(	(	PUNCT
ajlm-2381	59	61	cd36+/cd45	cd36+/cd45	NOUN
ajlm-2381	59	62	–	–	PUNCT
ajlm-2381	59	63	)	)	PUNCT
ajlm-2381	59	64	,	,	PUNCT
ajlm-2381	59	65	to	to	PART
ajlm-2381	59	66	calculate	calculate	VERB
ajlm-2381	59	67	a	a	DET
ajlm-2381	59	68	plasma	plasma	NOUN
ajlm-2381	59	69	cell	cell	NOUN
ajlm-2381	59	70	:	:	PUNCT
ajlm-2381	59	71	precursor	precursor	NOUN
ajlm-2381	59	72	ratio.29	ratio.29	NOUN
ajlm-2381	59	73	a	a	DET
ajlm-2381	59	74	plasma	plasma	NOUN
ajlm-2381	59	75	cell	cell	NOUN
ajlm-2381	59	76	:	:	PUNCT
ajlm-2381	59	77	precursor	precursor	NOUN
ajlm-2381	59	78	ratio	ratio	NOUN
ajlm-2381	59	79	threshold	threshold	NOUN
ajlm-2381	59	80	of	of	ADP
ajlm-2381	59	81	2	2	NUM
ajlm-2381	59	82	was	be	AUX
ajlm-2381	59	83	validated	validate	VERB
ajlm-2381	59	84	as	as	ADP
ajlm-2381	59	85	a	a	DET
ajlm-2381	59	86	discriminative	discriminative	NOUN
ajlm-2381	59	87	tool	tool	NOUN
ajlm-2381	59	88	to	to	PART
ajlm-2381	59	89	differentiate	differentiate	VERB
ajlm-2381	59	90	between	between	ADP
ajlm-2381	59	91	monoclonal	monoclonal	NOUN
ajlm-2381	59	92	gammopathy	gammopathy	ADJ
ajlm-2381	59	93	of	of	ADP
ajlm-2381	59	94	undetermined	undetermined	ADJ
ajlm-2381	59	95	significance	significance	NOUN
ajlm-2381	59	96	and	and	CCONJ
ajlm-2381	59	97	smouldering	smoulder	VERB
ajlm-2381	59	98	mm	mm	PROPN
ajlm-2381	59	99	with	with	ADP
ajlm-2381	59	100	high	high	ADJ
ajlm-2381	59	101	specificity	specificity	NOUN
ajlm-2381	59	102	(	(	PUNCT
ajlm-2381	59	103	84	84	NUM
ajlm-2381	59	104	%	%	NOUN
ajlm-2381	59	105	)	)	PUNCT
ajlm-2381	59	106	and	and	CCONJ
ajlm-2381	59	107	sensitivity	sensitivity	NOUN
ajlm-2381	59	108	(	(	PUNCT
ajlm-2381	59	109	81%).29	81%).29	NUM
ajlm-2381	59	110	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	59	111	on	on	ADP
ajlm-2381	59	112	bone	bone	NOUN
ajlm-2381	59	113	marrow	marrow	PROPN
ajlm-2381	59	114	biopsy	biopsy	PROPN
ajlm-2381	59	115	trephine	trephine	PROPN
ajlm-2381	59	116	specimens	specimen	NOUN
ajlm-2381	59	117	cd138	cd138	PROPN
ajlm-2381	59	118	(	(	PUNCT
ajlm-2381	59	119	syndecan-1	syndecan-1	PROPN
ajlm-2381	59	120	)	)	PUNCT
ajlm-2381	59	121	is	be	AUX
ajlm-2381	59	122	a	a	DET
ajlm-2381	59	123	cell	cell	NOUN
ajlm-2381	59	124	surface	surface	NOUN
ajlm-2381	59	125	,	,	PUNCT
ajlm-2381	59	126	sulphate	sulphate	NOUN
ajlm-2381	59	127	-	-	PUNCT
ajlm-2381	59	128	rich	rich	ADJ
ajlm-2381	59	129	proteoglycan	proteoglycan	ADJ
ajlm-2381	59	130	adhesion	adhesion	NOUN
ajlm-2381	59	131	molecule	molecule	NOUN
ajlm-2381	59	132	which	which	PRON
ajlm-2381	59	133	is	be	AUX
ajlm-2381	59	134	expressed	express	VERB
ajlm-2381	59	135	in	in	ADP
ajlm-2381	59	136	the	the	DET
ajlm-2381	59	137	late	late	ADJ
ajlm-2381	59	138	stages	stage	NOUN
ajlm-2381	59	139	of	of	ADP
ajlm-2381	59	140	b	b	NOUN
ajlm-2381	59	141	-	-	PUNCT
ajlm-2381	59	142	cell	cell	NOUN
ajlm-2381	59	143	differentiation	differentiation	NOUN
ajlm-2381	59	144	and	and	CCONJ
ajlm-2381	59	145	on	on	ADP
ajlm-2381	59	146	pc	pc	NOUN
ajlm-2381	59	147	.	.	PUNCT
ajlm-2381	60	1	cd138	cd138	NOUN
ajlm-2381	60	2	is	be	AUX
ajlm-2381	60	3	a	a	DET
ajlm-2381	60	4	highly	highly	ADV
ajlm-2381	60	5	sensitive	sensitive	ADJ
ajlm-2381	60	6	and	and	CCONJ
ajlm-2381	60	7	specific	specific	ADJ
ajlm-2381	60	8	marker	marker	NOUN
ajlm-2381	60	9	for	for	ADP
ajlm-2381	60	10	bmpcs	bmpc	NOUN
ajlm-2381	60	11	,	,	PUNCT
ajlm-2381	60	12	making	make	VERB
ajlm-2381	60	13	it	it	PRON
ajlm-2381	60	14	useful	useful	ADJ
ajlm-2381	60	15	in	in	ADP
ajlm-2381	60	16	identification	identification	NOUN
ajlm-2381	60	17	and	and	CCONJ
ajlm-2381	60	18	enumeration	enumeration	NOUN
ajlm-2381	60	19	of	of	ADP
ajlm-2381	60	20	bmpc.5,6	bmpc.5,6	NOUN
ajlm-2381	60	21	cd138	cd138	PROPN
ajlm-2381	60	22	staining	stain	VERB
ajlm-2381	60	23	has	have	VERB
ajlm-2381	60	24	the	the	DET
ajlm-2381	60	25	advantage	advantage	NOUN
ajlm-2381	60	26	of	of	ADP
ajlm-2381	60	27	improved	improved	ADJ
ajlm-2381	60	28	pc	pc	NOUN
ajlm-2381	60	29	identification	identification	NOUN
ajlm-2381	60	30	compared	compare	VERB
ajlm-2381	60	31	to	to	ADP
ajlm-2381	60	32	haematoxylin	haematoxylin	NOUN
ajlm-2381	60	33	and	and	CCONJ
ajlm-2381	60	34	eosin	eosin	NOUN
ajlm-2381	60	35	-	-	PUNCT
ajlm-2381	60	36	stained	stain	VERB
ajlm-2381	60	37	sections	section	NOUN
ajlm-2381	60	38	.	.	PUNCT
ajlm-2381	61	1	the	the	DET
ajlm-2381	61	2	estimation	estimation	NOUN
ajlm-2381	61	3	of	of	ADP
ajlm-2381	61	4	pc	pc	NOUN
ajlm-2381	61	5	in	in	ADP
ajlm-2381	61	6	bm	bm	PROPN
ajlm-2381	61	7	biopsies	biopsy	NOUN
ajlm-2381	61	8	using	use	VERB
ajlm-2381	61	9	cd138	cd138	PROPN
ajlm-2381	61	10	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	61	11	,	,	PUNCT
ajlm-2381	61	12	as	as	SCONJ
ajlm-2381	61	13	suggested	suggest	VERB
ajlm-2381	61	14	by	by	ADP
ajlm-2381	61	15	the	the	DET
ajlm-2381	61	16	world	world	PROPN
ajlm-2381	61	17	health	health	PROPN
ajlm-2381	61	18	organization	organization	NOUN
ajlm-2381	61	19	,	,	PUNCT
ajlm-2381	61	20	is	be	AUX
ajlm-2381	61	21	generally	generally	ADV
ajlm-2381	61	22	performed	perform	VERB
ajlm-2381	61	23	using	use	VERB
ajlm-2381	61	24	a	a	DET
ajlm-2381	61	25	semi	semi	ADJ
ajlm-2381	61	26	-	-	ADJ
ajlm-2381	61	27	quantitative	quantitative	ADJ
ajlm-2381	61	28	overview	overview	NOUN
ajlm-2381	61	29	estimation	estimation	NOUN
ajlm-2381	61	30	method.1	method.1	NOUN
ajlm-2381	61	31	in	in	ADP
ajlm-2381	61	32	their	their	PRON
ajlm-2381	61	33	2008	2008	NUM
ajlm-2381	61	34	study	study	NOUN
ajlm-2381	61	35	,	,	PUNCT
ajlm-2381	61	36	smith	smith	PROPN
ajlm-2381	61	37	and	and	CCONJ
ajlm-2381	61	38	elnawawi	elnawawi	PROPN
ajlm-2381	61	39	proposed	propose	VERB
ajlm-2381	61	40	an	an	DET
ajlm-2381	61	41	alternative	alternative	NOUN
ajlm-2381	61	42	to	to	PART
ajlm-2381	61	43	overview	overview	VERB
ajlm-2381	61	44	estimation	estimation	NOUN
ajlm-2381	61	45	by	by	ADP
ajlm-2381	61	46	performing	perform	VERB
ajlm-2381	61	47	a	a	DET
ajlm-2381	61	48	manual	manual	ADJ
ajlm-2381	61	49	count	count	NOUN
ajlm-2381	61	50	on	on	ADP
ajlm-2381	61	51	a	a	DET
ajlm-2381	61	52	single	single	ADJ
ajlm-2381	61	53	selected	select	VERB
ajlm-2381	61	54	field	field	NOUN
ajlm-2381	61	55	of	of	ADP
ajlm-2381	61	56	view	view	NOUN
ajlm-2381	61	57	at	at	ADP
ajlm-2381	61	58	high	high	ADJ
ajlm-2381	61	59	magnification	magnification	NOUN
ajlm-2381	61	60	(	(	PUNCT
ajlm-2381	61	61	40x	40x	NOUN
ajlm-2381	61	62	objective	objective	NOUN
ajlm-2381	61	63	)	)	PUNCT
ajlm-2381	61	64	.	.	PUNCT
ajlm-2381	62	1	the	the	DET
ajlm-2381	62	2	manual	manual	ADJ
ajlm-2381	62	3	count	count	NOUN
ajlm-2381	62	4	(	(	PUNCT
ajlm-2381	62	5	mean	mean	NOUN
ajlm-2381	62	6	23.1	23.1	NUM
ajlm-2381	62	7	;	;	PUNCT
ajlm-2381	62	8	s.d	s.d	PROPN
ajlm-2381	62	9	.	.	PROPN
ajlm-2381	62	10	±	±	PROPN
ajlm-2381	62	11	17.7	17.7	NUM
ajlm-2381	62	12	)	)	PUNCT
ajlm-2381	62	13	correlated	correlate	VERB
ajlm-2381	62	14	better	well	ADV
ajlm-2381	62	15	with	with	ADP
ajlm-2381	62	16	computer	computer	NOUN
ajlm-2381	62	17	-	-	PUNCT
ajlm-2381	62	18	assisted	assist	VERB
ajlm-2381	62	19	image	image	NOUN
ajlm-2381	62	20	cytometry	cytometry	NOUN
ajlm-2381	62	21	(	(	PUNCT
ajlm-2381	62	22	mean	mean	NOUN
ajlm-2381	62	23	21.4	21.4	NUM
ajlm-2381	62	24	;	;	PUNCT
ajlm-2381	62	25	±	±	NUM
ajlm-2381	62	26	10.7	10.7	NUM
ajlm-2381	62	27	s.d	s.d	PROPN
ajlm-2381	62	28	.	.	PUNCT
ajlm-2381	62	29	)	)	PUNCT
ajlm-2381	63	1	than	than	SCONJ
ajlm-2381	63	2	the	the	DET
ajlm-2381	63	3	overview	overview	NOUN
ajlm-2381	63	4	estimates	estimate	NOUN
ajlm-2381	63	5	(	(	PUNCT
ajlm-2381	63	6	mean	mean	NOUN
ajlm-2381	63	7	19.2	19.2	NUM
ajlm-2381	63	8	;	;	PUNCT
ajlm-2381	63	9	s.d	s.d	PROPN
ajlm-2381	63	10	.	.	PROPN
ajlm-2381	63	11	±	±	PROPN
ajlm-2381	63	12	20.4	20.4	NUM
ajlm-2381	63	13	)	)	PUNCT
ajlm-2381	63	14	,	,	PUNCT
ajlm-2381	63	15	on	on	ADP
ajlm-2381	63	16	44	44	NUM
ajlm-2381	63	17	cd138	cd138	NOUN
ajlm-2381	63	18	-	-	PUNCT
ajlm-2381	63	19	stained	stain	VERB
ajlm-2381	63	20	core	core	NOUN
ajlm-2381	63	21	biopsy	biopsy	NOUN
ajlm-2381	63	22	specimens.18	specimens.18	PROPN
ajlm-2381	63	23	importantly	importantly	ADV
ajlm-2381	63	24	,	,	PUNCT
ajlm-2381	63	25	the	the	DET
ajlm-2381	63	26	s.d	s.d	PROPN
ajlm-2381	63	27	.	.	PROPN
ajlm-2381	63	28	of	of	ADP
ajlm-2381	63	29	selected	select	VERB
ajlm-2381	63	30	field	field	NOUN
ajlm-2381	63	31	counts	count	NOUN
ajlm-2381	63	32	in	in	ADP
ajlm-2381	63	33	this	this	DET
ajlm-2381	63	34	study	study	NOUN
ajlm-2381	63	35	and	and	CCONJ
ajlm-2381	63	36	the	the	DET
ajlm-2381	63	37	overview	overview	NOUN
ajlm-2381	63	38	estimation	estimation	NOUN
ajlm-2381	63	39	are	be	AUX
ajlm-2381	63	40	high	high	ADJ
ajlm-2381	63	41	,	,	PUNCT
ajlm-2381	63	42	and	and	CCONJ
ajlm-2381	63	43	may	may	AUX
ajlm-2381	63	44	be	be	AUX
ajlm-2381	63	45	clinically	clinically	ADV
ajlm-2381	63	46	relevant	relevant	ADJ
ajlm-2381	63	47	for	for	ADP
ajlm-2381	63	48	the	the	DET
ajlm-2381	63	49	diagnosis	diagnosis	NOUN
ajlm-2381	63	50	and	and	CCONJ
ajlm-2381	63	51	evaluation	evaluation	NOUN
ajlm-2381	63	52	of	of	ADP
ajlm-2381	63	53	treatment	treatment	NOUN
ajlm-2381	63	54	response	response	NOUN
ajlm-2381	63	55	of	of	ADP
ajlm-2381	63	56	pc	pc	NOUN
ajlm-2381	63	57	neoplasms	neoplasm	NOUN
ajlm-2381	63	58	.	.	PUNCT
ajlm-2381	64	1	a	a	DET
ajlm-2381	64	2	single	single	ADJ
ajlm-2381	64	3	area	area	NOUN
ajlm-2381	64	4	was	be	AUX
ajlm-2381	64	5	selected	select	VERB
ajlm-2381	64	6	for	for	ADP
ajlm-2381	64	7	the	the	DET
ajlm-2381	64	8	manual	manual	ADJ
ajlm-2381	64	9	counting	counting	NOUN
ajlm-2381	64	10	method	method	NOUN
ajlm-2381	64	11	of	of	ADP
ajlm-2381	64	12	pc	pc	NOUN
ajlm-2381	64	13	estimation	estimation	NOUN
ajlm-2381	64	14	,	,	PUNCT
ajlm-2381	64	15	even	even	ADV
ajlm-2381	64	16	though	though	SCONJ
ajlm-2381	64	17	mm	mm	PROPN
ajlm-2381	64	18	is	be	AUX
ajlm-2381	64	19	a	a	DET
ajlm-2381	64	20	patchy	patchy	ADJ
ajlm-2381	64	21	disease	disease	NOUN
ajlm-2381	64	22	and	and	CCONJ
ajlm-2381	64	23	shows	show	VERB
ajlm-2381	64	24	considerable	considerable	ADJ
ajlm-2381	64	25	variation	variation	NOUN
ajlm-2381	64	26	in	in	ADP
ajlm-2381	64	27	bm	bm	PROPN
ajlm-2381	64	28	infiltration	infiltration	NOUN
ajlm-2381	64	29	.	.	PUNCT
ajlm-2381	65	1	in	in	ADP
ajlm-2381	65	2	their	their	PRON
ajlm-2381	65	3	2017	2017	NUM
ajlm-2381	65	4	study	study	NOUN
ajlm-2381	65	5	in	in	ADP
ajlm-2381	65	6	japan	japan	PROPN
ajlm-2381	65	7	,	,	PUNCT
ajlm-2381	65	8	matsue	matsue	VERB
ajlm-2381	65	9	et	et	PROPN
ajlm-2381	65	10	al	al	PROPN
ajlm-2381	65	11	.	.	PROPN
ajlm-2381	65	12	counted	count	VERB
ajlm-2381	65	13	more	more	ADJ
ajlm-2381	65	14	cells	cell	NOUN
ajlm-2381	65	15	(	(	PUNCT
ajlm-2381	65	16	500–2500	500–2500	NUM
ajlm-2381	65	17	)	)	PUNCT
ajlm-2381	65	18	in	in	ADP
ajlm-2381	65	19	2–5	2–5	PROPN
ajlm-2381	65	20	representative	representative	ADJ
ajlm-2381	65	21	microscopic	microscopic	ADJ
ajlm-2381	65	22	fields	field	NOUN
ajlm-2381	65	23	at	at	ADP
ajlm-2381	65	24	low	low	ADJ
ajlm-2381	65	25	magnification	magnification	NOUN
ajlm-2381	65	26	in	in	ADP
ajlm-2381	65	27	cd138	cd138	NOUN
ajlm-2381	65	28	-	-	PUNCT
ajlm-2381	65	29	stained	stain	VERB
ajlm-2381	65	30	bm	bm	NOUN
ajlm-2381	65	31	clot	clot	NOUN
ajlm-2381	65	32	and	and	CCONJ
ajlm-2381	65	33	biopsy	biopsy	NOUN
ajlm-2381	65	34	sections	section	NOUN
ajlm-2381	65	35	.	.	PUNCT
ajlm-2381	66	1	they	they	PRON
ajlm-2381	66	2	showed	show	VERB
ajlm-2381	66	3	significant	significant	ADJ
ajlm-2381	66	4	correlation	correlation	NOUN
ajlm-2381	66	5	between	between	ADP
ajlm-2381	66	6	the	the	DET
ajlm-2381	66	7	marrow	marrow	NOUN
ajlm-2381	66	8	clot	clot	NOUN
ajlm-2381	66	9	and	and	CCONJ
ajlm-2381	66	10	biopsy	biopsy	NOUN
ajlm-2381	66	11	sections	section	NOUN
ajlm-2381	66	12	(	(	PUNCT
ajlm-2381	66	13	r	r	NOUN
ajlm-2381	66	14	=	=	NOUN
ajlm-2381	66	15	0.96	0.96	NUM
ajlm-2381	66	16	)	)	PUNCT
ajlm-2381	66	17	;	;	PUNCT
ajlm-2381	66	18	however	however	ADV
ajlm-2381	66	19	,	,	PUNCT
ajlm-2381	66	20	quantification	quantification	NOUN
ajlm-2381	66	21	by	by	ADP
ajlm-2381	66	22	bma	bma	PROPN
ajlm-2381	66	23	smear	smear	PROPN
ajlm-2381	66	24	(	(	PUNCT
ajlm-2381	66	25	bmpc%	bmpc%	CCONJ
ajlm-2381	66	26	=	=	SYM
ajlm-2381	66	27	3.7	3.7	NUM
ajlm-2381	67	1	[	[	PUNCT
ajlm-2381	67	2	interquartile	interquartile	ADJ
ajlm-2381	67	3	range	range	NOUN
ajlm-2381	67	4	{	{	PUNCT
ajlm-2381	67	5	iqr	iqr	NOUN
ajlm-2381	67	6	}	}	PUNCT
ajlm-2381	67	7	:	:	PUNCT
ajlm-2381	67	8	1.2–10	1.2–10	NUM
ajlm-2381	67	9	]	]	PUNCT
ajlm-2381	67	10	)	)	PUNCT
ajlm-2381	67	11	and	and	CCONJ
ajlm-2381	67	12	flow	flow	NOUN
ajlm-2381	67	13	cytometry	cytometry	NOUN
ajlm-2381	67	14	(	(	PUNCT
ajlm-2381	67	15	odds	odd	NOUN
ajlm-2381	67	16	ratio	ratio	NOUN
ajlm-2381	67	17	=	=	SYM
ajlm-2381	67	18	2.4	2.4	NUM
ajlm-2381	67	19	[	[	X
ajlm-2381	67	20	iqr	iqr	NOUN
ajlm-2381	67	21	:	:	PUNCT
ajlm-2381	67	22	0.8–6.2	0.8–6.2	NOUN
ajlm-2381	67	23	]	]	X
ajlm-2381	67	24	)	)	PUNCT
ajlm-2381	67	25	underestimated	underestimate	VERB
ajlm-2381	67	26	pc	pc	NOUN
ajlm-2381	67	27	percentage	percentage	NOUN
ajlm-2381	67	28	compared	compare	VERB
ajlm-2381	67	29	to	to	ADP
ajlm-2381	67	30	bm	bm	PROPN
ajlm-2381	67	31	biopsy	biopsy	PROPN
ajlm-2381	67	32	(	(	PUNCT
ajlm-2381	67	33	odds	odd	NOUN
ajlm-2381	67	34	ratio	ratio	NOUN
ajlm-2381	67	35	=	=	SYM
ajlm-2381	67	36	13.3	13.3	NUM
ajlm-2381	67	37	[	[	NOUN
ajlm-2381	67	38	iqr	iqr	NOUN
ajlm-2381	67	39	:	:	PUNCT
ajlm-2381	67	40	6.7–36.2	6.7–36.2	NOUN
ajlm-2381	67	41	]	]	PUNCT
ajlm-2381	67	42	)	)	PUNCT
ajlm-2381	67	43	and	and	CCONJ
ajlm-2381	67	44	bma	bma	PROPN
ajlm-2381	67	45	clot	clot	NOUN
ajlm-2381	67	46	(	(	PUNCT
ajlm-2381	67	47	odds	odd	NOUN
ajlm-2381	67	48	ratio	ratio	NOUN
ajlm-2381	67	49	=	=	SYM
ajlm-2381	67	50	12.8	12.8	NUM
ajlm-2381	67	51	[	[	NOUN
ajlm-2381	67	52	iqr	iqr	NOUN
ajlm-2381	67	53	:	:	PUNCT
ajlm-2381	67	54	6.8–31.9]).30	6.8–31.9]).30	NUM
ajlm-2381	67	55	samples	sample	VERB
ajlm-2381	67	56	with	with	ADP
ajlm-2381	67	57	a	a	DET
ajlm-2381	67	58	nodular	nodular	ADJ
ajlm-2381	67	59	or	or	CCONJ
ajlm-2381	67	60	diffuse	diffuse	ADJ
ajlm-2381	67	61	pattern	pattern	NOUN
ajlm-2381	67	62	of	of	ADP
ajlm-2381	67	63	the	the	DET
ajlm-2381	67	64	pc	pc	NOUN
ajlm-2381	67	65	and	and	CCONJ
ajlm-2381	67	66	cells	cell	NOUN
ajlm-2381	67	67	with	with	ADP
ajlm-2381	67	68	golgi	golgi	NOUN
ajlm-2381	67	69	staining	stain	VERB
ajlm-2381	67	70	or	or	CCONJ
ajlm-2381	67	71	non	non	ADJ
ajlm-2381	67	72	-	-	ADJ
ajlm-2381	67	73	specific	specific	ADJ
ajlm-2381	67	74	cytoplasmic	cytoplasmic	ADJ
ajlm-2381	67	75	staining	stain	VERB
ajlm-2381	67	76	were	be	AUX
ajlm-2381	67	77	excluded	exclude	VERB
ajlm-2381	67	78	from	from	ADP
ajlm-2381	67	79	the	the	DET
ajlm-2381	67	80	study	study	NOUN
ajlm-2381	67	81	.	.	PUNCT
ajlm-2381	68	1	in	in	ADP
ajlm-2381	68	2	their	their	PRON
ajlm-2381	68	3	2023	2023	NUM
ajlm-2381	68	4	publication	publication	NOUN
ajlm-2381	68	5	in	in	ADP
ajlm-2381	68	6	south	south	PROPN
ajlm-2381	68	7	africa	africa	PROPN
ajlm-2381	68	8	,	,	PUNCT
ajlm-2381	68	9	gantana	gantana	PROPN
ajlm-2381	68	10	et	et	PROPN
ajlm-2381	68	11	al	al	PROPN
ajlm-2381	68	12	.	.	PROPN
ajlm-2381	68	13	evaluated	evaluate	VERB
ajlm-2381	68	14	a	a	DET
ajlm-2381	68	15	counting	counting	NOUN
ajlm-2381	68	16	method	method	NOUN
ajlm-2381	68	17	in	in	ADP
ajlm-2381	68	18	which	which	PRON
ajlm-2381	68	19	reviewers	reviewer	NOUN
ajlm-2381	68	20	selected	select	VERB
ajlm-2381	68	21	three	three	NUM
ajlm-2381	68	22	representative	representative	ADJ
ajlm-2381	68	23	biopsy	biopsy	NOUN
ajlm-2381	68	24	areas	area	NOUN
ajlm-2381	68	25	with	with	ADP
ajlm-2381	68	26	low	low	ADJ
ajlm-2381	68	27	,	,	PUNCT
ajlm-2381	68	28	intermediate	intermediate	ADJ
ajlm-2381	68	29	,	,	PUNCT
ajlm-2381	68	30	and	and	CCONJ
ajlm-2381	68	31	high	high	ADJ
ajlm-2381	68	32	pc	pc	NOUN
ajlm-2381	68	33	densities	density	NOUN
ajlm-2381	68	34	,	,	PUNCT
ajlm-2381	68	35	followed	follow	VERB
ajlm-2381	68	36	by	by	ADP
ajlm-2381	68	37	a	a	DET
ajlm-2381	68	38	manual	manual	ADJ
ajlm-2381	68	39	count	count	NOUN
ajlm-2381	68	40	in	in	ADP
ajlm-2381	68	41	each	each	PRON
ajlm-2381	68	42	of	of	ADP
ajlm-2381	68	43	these	these	DET
ajlm-2381	68	44	areas	area	NOUN
ajlm-2381	68	45	and	and	CCONJ
ajlm-2381	68	46	averaging	average	VERB
ajlm-2381	68	47	the	the	DET
ajlm-2381	68	48	bmpc%	bmpc%	PUNCT
ajlm-2381	68	49	for	for	ADP
ajlm-2381	68	50	each	each	DET
ajlm-2381	68	51	sample	sample	NOUN
ajlm-2381	68	52	.	.	PUNCT
ajlm-2381	69	1	this	this	DET
ajlm-2381	69	2	study	study	NOUN
ajlm-2381	69	3	showed	show	VERB
ajlm-2381	69	4	superior	superior	ADJ
ajlm-2381	69	5	interobserver	interobserver	ADJ
ajlm-2381	69	6	concordance	concordance	NOUN
ajlm-2381	69	7	with	with	ADP
ajlm-2381	69	8	the	the	DET
ajlm-2381	69	9	manual	manual	ADJ
ajlm-2381	69	10	counting	counting	NOUN
ajlm-2381	69	11	method	method	NOUN
ajlm-2381	69	12	at	at	ADP
ajlm-2381	69	13	low	low	ADJ
ajlm-2381	69	14	pc	pc	NOUN
ajlm-2381	69	15	tumour	tumour	NOUN
ajlm-2381	69	16	burden	burden	NOUN
ajlm-2381	69	17	compared	compare	VERB
ajlm-2381	69	18	to	to	ADP
ajlm-2381	69	19	an	an	DET
ajlm-2381	69	20	overview	overview	NOUN
ajlm-2381	69	21	estimation	estimation	NOUN
ajlm-2381	69	22	method	method	NOUN
ajlm-2381	69	23	(	(	PUNCT
ajlm-2381	69	24	intraclass	intraclass	NOUN
ajlm-2381	69	25	correlation	correlation	NOUN
ajlm-2381	69	26	coefficient	coefficient	NOUN
ajlm-2381	69	27	=	=	PUNCT
ajlm-2381	69	28	0.105).31	0.105).31	NUM
ajlm-2381	70	1	many	many	ADJ
ajlm-2381	70	2	studies	study	NOUN
ajlm-2381	70	3	show	show	VERB
ajlm-2381	70	4	significantly	significantly	ADV
ajlm-2381	70	5	higher	high	ADJ
ajlm-2381	70	6	numbers	number	NOUN
ajlm-2381	70	7	of	of	ADP
ajlm-2381	70	8	bmpc%	bmpc%	PUNCT
ajlm-2381	70	9	on	on	ADP
ajlm-2381	70	10	cd138	cd138	NOUN
ajlm-2381	70	11	-	-	PUNCT
ajlm-2381	70	12	stained	stain	VERB
ajlm-2381	70	13	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	70	14	biopsies	biopsy	NOUN
ajlm-2381	70	15	compared	compare	VERB
ajlm-2381	70	16	to	to	ADP
ajlm-2381	70	17	bma.12,18,19,21	bma.12,18,19,21	NOUN
ajlm-2381	70	18	suggested	suggest	VERB
ajlm-2381	70	19	reasons	reason	NOUN
ajlm-2381	70	20	for	for	ADP
ajlm-2381	70	21	this	this	DET
ajlm-2381	70	22	discrepancy	discrepancy	NOUN
ajlm-2381	70	23	are	be	AUX
ajlm-2381	70	24	the	the	DET
ajlm-2381	70	25	patchy	patchy	ADJ
ajlm-2381	70	26	nature	nature	NOUN
ajlm-2381	70	27	of	of	ADP
ajlm-2381	70	28	mm	mm	PROPN
ajlm-2381	70	29	,	,	PUNCT
ajlm-2381	70	30	haemodilute	haemodilute	PROPN
ajlm-2381	70	31	bma	bma	PROPN
ajlm-2381	70	32	,	,	PUNCT
ajlm-2381	70	33	and	and	CCONJ
ajlm-2381	70	34	poor	poor	ADJ
ajlm-2381	70	35	sample	sample	NOUN
ajlm-2381	70	36	quality	quality	NOUN
ajlm-2381	70	37	.	.	PUNCT
ajlm-2381	71	1	for	for	ADP
ajlm-2381	71	2	these	these	DET
ajlm-2381	71	3	reasons	reason	NOUN
ajlm-2381	71	4	,	,	PUNCT
ajlm-2381	71	5	cd138	cd138	PROPN
ajlm-2381	71	6	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	71	7	is	be	AUX
ajlm-2381	71	8	regarded	regard	VERB
ajlm-2381	71	9	as	as	ADP
ajlm-2381	71	10	the	the	DET
ajlm-2381	71	11	most	most	ADV
ajlm-2381	71	12	sensitive	sensitive	ADJ
ajlm-2381	71	13	method	method	NOUN
ajlm-2381	71	14	for	for	ADP
ajlm-2381	71	15	pc	pc	NOUN
ajlm-2381	71	16	estimation	estimation	NOUN
ajlm-2381	71	17	.	.	PUNCT
ajlm-2381	72	1	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	72	2	determination	determination	NOUN
ajlm-2381	72	3	of	of	ADP
ajlm-2381	72	4	pc	pc	NOUN
ajlm-2381	72	5	percentage	percentage	NOUN
ajlm-2381	72	6	is	be	AUX
ajlm-2381	72	7	valuable	valuable	ADJ
ajlm-2381	72	8	for	for	ADP
ajlm-2381	72	9	diagnosis	diagnosis	NOUN
ajlm-2381	72	10	and	and	CCONJ
ajlm-2381	72	11	monitoring	monitor	VERB
ajlm-2381	72	12	treatment	treatment	NOUN
ajlm-2381	72	13	response	response	NOUN
ajlm-2381	72	14	,	,	PUNCT
ajlm-2381	72	15	notably	notably	ADV
ajlm-2381	72	16	the	the	DET
ajlm-2381	72	17	complete	complete	ADJ
ajlm-2381	72	18	and	and	CCONJ
ajlm-2381	72	19	stringent	stringent	ADJ
ajlm-2381	72	20	complete	complete	ADJ
ajlm-2381	72	21	response	response	NOUN
ajlm-2381	72	22	criteria	criterion	NOUN
ajlm-2381	72	23	as	as	SCONJ
ajlm-2381	72	24	defined	define	VERB
ajlm-2381	72	25	by	by	ADP
ajlm-2381	72	26	the	the	DET
ajlm-2381	72	27	international	international	ADJ
ajlm-2381	72	28	myeloma	myeloma	PROPN
ajlm-2381	72	29	working	working	NOUN
ajlm-2381	72	30	group	group	NOUN
ajlm-2381	72	31	(	(	PUNCT
ajlm-2381	72	32	imwg).3	imwg).3	ADV
ajlm-2381	72	33	furthermore	furthermore	ADV
ajlm-2381	72	34	,	,	PUNCT
ajlm-2381	72	35	bm	bm	PROPN
ajlm-2381	72	36	trephine	trephine	PROPN
ajlm-2381	72	37	pc	pc	NOUN
ajlm-2381	72	38	percentages	percentage	NOUN
ajlm-2381	72	39	have	have	AUX
ajlm-2381	72	40	shown	show	VERB
ajlm-2381	72	41	to	to	PART
ajlm-2381	72	42	correlate	correlate	VERB
ajlm-2381	72	43	with	with	ADP
ajlm-2381	72	44	corresponding	corresponding	ADJ
ajlm-2381	72	45	end	end	NOUN
ajlm-2381	72	46	organ	organ	NOUN
ajlm-2381	72	47	disorders	disorder	NOUN
ajlm-2381	72	48	,	,	PUNCT
ajlm-2381	72	49	quantitative	quantitative	ADJ
ajlm-2381	72	50	fluorescence	fluorescence	NOUN
ajlm-2381	72	51	in	in	ADP
ajlm-2381	72	52	situ	situ	ADJ
ajlm-2381	72	53	hybridisation	hybridisation	NOUN
ajlm-2381	72	54	results	result	NOUN
ajlm-2381	72	55	,	,	PUNCT
ajlm-2381	72	56	and	and	CCONJ
ajlm-2381	72	57	overall	overall	ADJ
ajlm-2381	72	58	survival	survival	NOUN
ajlm-2381	72	59	in	in	ADP
ajlm-2381	72	60	patients	patient	NOUN
ajlm-2381	72	61	with	with	ADP
ajlm-2381	72	62	a	a	DET
ajlm-2381	72	63	low	low	ADJ
ajlm-2381	72	64	bma	bma	PROPN
ajlm-2381	72	65	pc	pc	NOUN
ajlm-2381	72	66	percentage.24	percentage.24	NOUN
ajlm-2381	72	67	molecular	molecular	ADJ
ajlm-2381	72	68	techniques	technique	NOUN
ajlm-2381	72	69	molecular	molecular	ADJ
ajlm-2381	72	70	techniques	technique	NOUN
ajlm-2381	72	71	are	be	AUX
ajlm-2381	72	72	based	base	VERB
ajlm-2381	72	73	on	on	ADP
ajlm-2381	72	74	the	the	DET
ajlm-2381	72	75	amplification	amplification	NOUN
ajlm-2381	72	76	of	of	ADP
ajlm-2381	72	77	unique	unique	ADJ
ajlm-2381	72	78	variable	variable	NOUN
ajlm-2381	72	79	,	,	PUNCT
ajlm-2381	72	80	diversity	diversity	NOUN
ajlm-2381	72	81	,	,	PUNCT
ajlm-2381	72	82	joining	join	VERB
ajlm-2381	72	83	rearrangements	rearrangement	NOUN
ajlm-2381	72	84	of	of	ADP
ajlm-2381	72	85	the	the	DET
ajlm-2381	72	86	immunoglobulin	immunoglobulin	NOUN
ajlm-2381	72	87	heavy	heavy	ADJ
ajlm-2381	72	88	chain	chain	NOUN
ajlm-2381	72	89	variable	variable	NOUN
ajlm-2381	72	90	(	(	PUNCT
ajlm-2381	72	91	ighv	ighv	NOUN
ajlm-2381	72	92	)	)	PUNCT
ajlm-2381	72	93	gene	gene	NOUN
ajlm-2381	72	94	on	on	ADP
ajlm-2381	72	95	chromosome	chromosome	NOUN
ajlm-2381	72	96	14	14	NUM
ajlm-2381	72	97	,	,	PUNCT
ajlm-2381	72	98	which	which	PRON
ajlm-2381	72	99	are	be	AUX
ajlm-2381	72	100	specific	specific	ADJ
ajlm-2381	72	101	for	for	ADP
ajlm-2381	72	102	each	each	DET
ajlm-2381	72	103	pc	pc	NOUN
ajlm-2381	72	104	clone	clone	NOUN
ajlm-2381	72	105	and	and	CCONJ
ajlm-2381	72	106	can	can	AUX
ajlm-2381	72	107	be	be	AUX
ajlm-2381	72	108	used	use	VERB
ajlm-2381	72	109	for	for	ADP
ajlm-2381	72	110	identification	identification	NOUN
ajlm-2381	72	111	by	by	ADP
ajlm-2381	72	112	amplification	amplification	NOUN
ajlm-2381	72	113	of	of	ADP
ajlm-2381	72	114	the	the	DET
ajlm-2381	72	115	variable	variable	ADJ
ajlm-2381	72	116	,	,	PUNCT
ajlm-2381	72	117	diversity	diversity	NOUN
ajlm-2381	72	118	,	,	PUNCT
ajlm-2381	72	119	joining	join	VERB
ajlm-2381	72	120	sequence	sequence	NOUN
ajlm-2381	72	121	.	.	PUNCT
ajlm-2381	73	1	the	the	DET
ajlm-2381	73	2	light	light	ADJ
ajlm-2381	73	3	chain	chain	NOUN
ajlm-2381	73	4	genes	gene	NOUN
ajlm-2381	73	5	lack	lack	VERB
ajlm-2381	73	6	the	the	DET
ajlm-2381	73	7	d	d	NOUN
ajlm-2381	73	8	segment	segment	NOUN
ajlm-2381	73	9	,	,	PUNCT
ajlm-2381	73	10	which	which	PRON
ajlm-2381	73	11	reduces	reduce	VERB
ajlm-2381	73	12	the	the	DET
ajlm-2381	73	13	sensitivity	sensitivity	NOUN
ajlm-2381	73	14	of	of	ADP
ajlm-2381	73	15	detecting	detect	VERB
ajlm-2381	73	16	the	the	DET
ajlm-2381	73	17	pc	pc	NOUN
ajlm-2381	73	18	clone.32	clone.32	VERB
ajlm-2381	73	19	patient	patient	NOUN
ajlm-2381	73	20	-	-	PUNCT
ajlm-2381	73	21	specific	specific	ADJ
ajlm-2381	73	22	ighv	ighv	NOUN
ajlm-2381	73	23	gene	gene	NOUN
ajlm-2381	73	24	rearrangements	rearrangement	NOUN
ajlm-2381	73	25	are	be	AUX
ajlm-2381	73	26	amplified	amplify	VERB
ajlm-2381	73	27	and	and	CCONJ
ajlm-2381	73	28	sequenced	sequence	VERB
ajlm-2381	73	29	from	from	ADP
ajlm-2381	73	30	ighv	ighv	NOUN
ajlm-2381	73	31	gene	gene	NOUN
ajlm-2381	73	32	-	-	PUNCT
ajlm-2381	73	33	specific	specific	ADJ
ajlm-2381	73	34	complementary	complementary	ADJ
ajlm-2381	73	35	dna	dna	NOUN
ajlm-2381	73	36	to	to	PART
ajlm-2381	73	37	determine	determine	VERB
ajlm-2381	73	38	the	the	DET
ajlm-2381	73	39	clone	clone	NOUN
ajlm-2381	73	40	-	-	PUNCT
ajlm-2381	73	41	specific	specific	ADJ
ajlm-2381	73	42	variable	variable	ADJ
ajlm-2381	73	43	gene	gene	NOUN
ajlm-2381	73	44	sequence.32,33	sequence.32,33	NOUN
ajlm-2381	73	45	this	this	PRON
ajlm-2381	73	46	should	should	AUX
ajlm-2381	73	47	be	be	AUX
ajlm-2381	73	48	done	do	VERB
ajlm-2381	73	49	at	at	ADP
ajlm-2381	73	50	diagnosis	diagnosis	NOUN
ajlm-2381	73	51	,	,	PUNCT
ajlm-2381	73	52	to	to	PART
ajlm-2381	73	53	design	design	VERB
ajlm-2381	73	54	primers	primer	NOUN
ajlm-2381	73	55	for	for	ADP
ajlm-2381	73	56	real	real	ADJ
ajlm-2381	73	57	-	-	PUNCT
ajlm-2381	73	58	time	time	NOUN
ajlm-2381	73	59	polymerase	polymerase	NOUN
ajlm-2381	73	60	chain	chain	NOUN
ajlm-2381	73	61	reaction	reaction	NOUN
ajlm-2381	73	62	(	(	PUNCT
ajlm-2381	73	63	pcr	pcr	NOUN
ajlm-2381	73	64	)	)	PUNCT
ajlm-2381	73	65	quantification	quantification	NOUN
ajlm-2381	73	66	for	for	ADP
ajlm-2381	73	67	determination	determination	NOUN
ajlm-2381	73	68	of	of	ADP
ajlm-2381	73	69	the	the	DET
ajlm-2381	73	70	level	level	NOUN
ajlm-2381	73	71	of	of	ADP
ajlm-2381	73	72	tumour	tumour	NOUN
ajlm-2381	73	73	contamination	contamination	NOUN
ajlm-2381	73	74	in	in	ADP
ajlm-2381	73	75	a	a	DET
ajlm-2381	73	76	sample	sample	NOUN
ajlm-2381	73	77	after	after	ADP
ajlm-2381	73	78	chemoimmunotherapy	chemoimmunotherapy	NOUN
ajlm-2381	73	79	and	and	CCONJ
ajlm-2381	73	80	stem	stem	NOUN
ajlm-2381	73	81	-	-	PUNCT
ajlm-2381	73	82	cell	cell	NOUN
ajlm-2381	73	83	transplants	transplant	NOUN
ajlm-2381	73	84	to	to	PART
ajlm-2381	73	85	be	be	AUX
ajlm-2381	73	86	used	use	VERB
ajlm-2381	73	87	for	for	ADP
ajlm-2381	73	88	follow	follow	VERB
ajlm-2381	73	89	-	-	PUNCT
ajlm-2381	73	90	up	up	ADP
ajlm-2381	73	91	monitoring	monitoring	NOUN
ajlm-2381	73	92	.	.	PUNCT
ajlm-2381	74	1	the	the	DET
ajlm-2381	74	2	sense	sense	NOUN
ajlm-2381	74	3	primers	primer	NOUN
ajlm-2381	74	4	are	be	AUX
ajlm-2381	74	5	usually	usually	ADV
ajlm-2381	74	6	derived	derive	VERB
ajlm-2381	74	7	from	from	ADP
ajlm-2381	74	8	the	the	DET
ajlm-2381	74	9	second	second	ADJ
ajlm-2381	74	10	complementarity	complementarity	NOUN
ajlm-2381	74	11	-	-	PUNCT
ajlm-2381	74	12	determining	determine	VERB
ajlm-2381	74	13	region	region	NOUN
ajlm-2381	74	14	and	and	CCONJ
ajlm-2381	74	15	the	the	DET
ajlm-2381	74	16	antisense	antisense	NOUN
ajlm-2381	74	17	primer	primer	NOUN
ajlm-2381	74	18	from	from	ADP
ajlm-2381	74	19	the	the	DET
ajlm-2381	74	20	highly	highly	ADV
ajlm-2381	74	21	hypervariable	hypervariable	ADJ
ajlm-2381	74	22	third	third	ADJ
ajlm-2381	74	23	complementarity	complementarity	NOUN
ajlm-2381	74	24	-	-	PUNCT
ajlm-2381	74	25	determining	determine	VERB
ajlm-2381	74	26	region	region	NOUN
ajlm-2381	74	27	in	in	ADP
ajlm-2381	74	28	the	the	DET
ajlm-2381	74	29	ighv	ighv	NOUN
ajlm-2381	74	30	gene	gene	NOUN
ajlm-2381	74	31	to	to	PART
ajlm-2381	74	32	be	be	AUX
ajlm-2381	74	33	used	use	VERB
ajlm-2381	74	34	for	for	ADP
ajlm-2381	74	35	the	the	DET
ajlm-2381	74	36	amplification	amplification	NOUN
ajlm-2381	74	37	of	of	ADP
ajlm-2381	74	38	the	the	DET
ajlm-2381	74	39	sequence	sequence	NOUN
ajlm-2381	74	40	of	of	ADP
ajlm-2381	74	41	interest	interest	NOUN
ajlm-2381	74	42	during	during	ADP
ajlm-2381	74	43	follow	follow	NOUN
ajlm-2381	74	44	-	-	PUNCT
ajlm-2381	74	45	up.34,35,36	up.34,35,36	NOUN
ajlm-2381	74	46	molecular	molecular	ADJ
ajlm-2381	74	47	techniques	technique	NOUN
ajlm-2381	74	48	such	such	ADJ
ajlm-2381	74	49	as	as	ADP
ajlm-2381	74	50	allele	allele	NOUN
ajlm-2381	74	51	-	-	PUNCT
ajlm-2381	74	52	specific	specific	ADJ
ajlm-2381	74	53	oligonucleotide	oligonucleotide	NOUN
ajlm-2381	74	54	quantitative	quantitative	ADJ
ajlm-2381	74	55	pcr	pcr	PROPN
ajlm-2381	74	56	(	(	PUNCT
ajlm-2381	74	57	aso	aso	NOUN
ajlm-2381	74	58	-	-	PUNCT
ajlm-2381	74	59	qpcr	qpcr	ADV
ajlm-2381	74	60	)	)	PUNCT
ajlm-2381	74	61	and	and	CCONJ
ajlm-2381	74	62	next	next	ADJ
ajlm-2381	74	63	-	-	PUNCT
ajlm-2381	74	64	generation	generation	NOUN
ajlm-2381	74	65	sequencing	sequencing	NOUN
ajlm-2381	74	66	(	(	PUNCT
ajlm-2381	74	67	ngs	ng	NOUN
ajlm-2381	74	68	)	)	PUNCT
ajlm-2381	74	69	are	be	AUX
ajlm-2381	74	70	used	use	VERB
ajlm-2381	74	71	during	during	ADP
ajlm-2381	74	72	follow	follow	NOUN
ajlm-2381	74	73	-	-	PUNCT
ajlm-2381	74	74	up	up	NOUN
ajlm-2381	74	75	for	for	ADP
ajlm-2381	74	76	the	the	DET
ajlm-2381	74	77	quantification	quantification	NOUN
ajlm-2381	74	78	of	of	ADP
ajlm-2381	74	79	clonal	clonal	ADJ
ajlm-2381	74	80	plasma	plasma	NOUN
ajlm-2381	74	81	cells	cell	NOUN
ajlm-2381	74	82	to	to	PART
ajlm-2381	74	83	evaluate	evaluate	VERB
ajlm-2381	74	84	treatment	treatment	NOUN
ajlm-2381	74	85	response	response	NOUN
ajlm-2381	74	86	and	and	CCONJ
ajlm-2381	74	87	detect	detect	VERB
ajlm-2381	74	88	measurable	measurable	ADJ
ajlm-2381	74	89	residual	residual	ADJ
ajlm-2381	74	90	disease	disease	NOUN
ajlm-2381	74	91	(	(	PUNCT
ajlm-2381	74	92	mrd	mrd	PROPN
ajlm-2381	74	93	)	)	PUNCT
ajlm-2381	74	94	rather	rather	ADV
ajlm-2381	74	95	than	than	ADP
ajlm-2381	74	96	quantification	quantification	NOUN
ajlm-2381	74	97	at	at	ADP
ajlm-2381	74	98	diagnosis.4	diagnosis.4	PROPN
ajlm-2381	74	99	the	the	DET
ajlm-2381	74	100	use	use	NOUN
ajlm-2381	74	101	of	of	ADP
ajlm-2381	74	102	aso	aso	NOUN
ajlm-2381	74	103	-	-	PUNCT
ajlm-2381	74	104	qpcr	qpcr	ADV
ajlm-2381	74	105	for	for	ADP
ajlm-2381	74	106	the	the	DET
ajlm-2381	74	107	detection	detection	NOUN
ajlm-2381	74	108	of	of	ADP
ajlm-2381	74	109	these	these	DET
ajlm-2381	74	110	specific	specific	ADJ
ajlm-2381	74	111	variable	variable	NOUN
ajlm-2381	74	112	,	,	PUNCT
ajlm-2381	74	113	diversity	diversity	NOUN
ajlm-2381	74	114	,	,	PUNCT
ajlm-2381	74	115	joining	join	VERB
ajlm-2381	74	116	sequences	sequence	NOUN
ajlm-2381	74	117	correlates	correlate	VERB
ajlm-2381	74	118	well	well	ADV
ajlm-2381	74	119	with	with	ADP
ajlm-2381	74	120	mfc	mfc	PROPN
ajlm-2381	74	121	in	in	ADP
ajlm-2381	74	122	mrd	mrd	PROPN
ajlm-2381	74	123	quantitation	quantitation	NOUN
ajlm-2381	74	124	(	(	PUNCT
ajlm-2381	74	125	r	r	NOUN
ajlm-2381	74	126	=	=	SYM
ajlm-2381	74	127	0.881	0.881	NUM
ajlm-2381	74	128	,	,	PUNCT
ajlm-2381	74	129	p	p	X
ajlm-2381	74	130	<	<	X
ajlm-2381	74	131	0.001	0.001	NUM
ajlm-2381	74	132	)	)	PUNCT
ajlm-2381	74	133	,	,	PUNCT
ajlm-2381	74	134	but	but	CCONJ
ajlm-2381	74	135	its	its	PRON
ajlm-2381	74	136	application	application	NOUN
ajlm-2381	74	137	was	be	AUX
ajlm-2381	74	138	limited	limit	VERB
ajlm-2381	74	139	to	to	ADP
ajlm-2381	74	140	42	42	NUM
ajlm-2381	74	141	%	%	NOUN
ajlm-2381	74	142	of	of	ADP
ajlm-2381	74	143	cases	case	NOUN
ajlm-2381	74	144	in	in	ADP
ajlm-2381	74	145	the	the	DET
ajlm-2381	74	146	study	study	NOUN
ajlm-2381	74	147	due	due	ADP
ajlm-2381	74	148	to	to	ADP
ajlm-2381	74	149	lack	lack	NOUN
ajlm-2381	74	150	of	of	ADP
ajlm-2381	74	151	clonality	clonality	NOUN
ajlm-2381	74	152	detection	detection	NOUN
ajlm-2381	74	153	,	,	PUNCT
ajlm-2381	74	154	unsuccessful	unsuccessful	ADJ
ajlm-2381	74	155	sequencing	sequencing	NOUN
ajlm-2381	74	156	and	and	CCONJ
ajlm-2381	74	157	suboptimal	suboptimal	ADJ
ajlm-2381	74	158	aso	aso	NOUN
ajlm-2381	74	159	performance.37	performance.37	PROPN
ajlm-2381	74	160	this	this	PRON
ajlm-2381	74	161	complicates	complicate	VERB
ajlm-2381	74	162	the	the	DET
ajlm-2381	74	163	practicality	practicality	NOUN
ajlm-2381	74	164	of	of	ADP
ajlm-2381	74	165	using	use	VERB
ajlm-2381	74	166	only	only	ADV
ajlm-2381	74	167	molecular	molecular	ADJ
ajlm-2381	74	168	techniques	technique	NOUN
ajlm-2381	74	169	for	for	ADP
ajlm-2381	74	170	this	this	DET
ajlm-2381	74	171	indication	indication	NOUN
ajlm-2381	74	172	.	.	PUNCT
ajlm-2381	75	1	radiological	radiological	ADJ
ajlm-2381	75	2	imaging	imaging	NOUN
ajlm-2381	75	3	techniques	technique	NOUN
ajlm-2381	75	4	radiological	radiological	ADJ
ajlm-2381	75	5	imaging	imaging	NOUN
ajlm-2381	75	6	plays	play	VERB
ajlm-2381	75	7	a	a	DET
ajlm-2381	75	8	significant	significant	ADJ
ajlm-2381	75	9	role	role	NOUN
ajlm-2381	75	10	in	in	ADP
ajlm-2381	75	11	the	the	DET
ajlm-2381	75	12	diagnosis	diagnosis	NOUN
ajlm-2381	75	13	and	and	CCONJ
ajlm-2381	75	14	management	management	NOUN
ajlm-2381	75	15	of	of	ADP
ajlm-2381	75	16	mm	mm	PROPN
ajlm-2381	75	17	as	as	SCONJ
ajlm-2381	75	18	approximately	approximately	ADV
ajlm-2381	75	19	90	90	NUM
ajlm-2381	75	20	%	%	NOUN
ajlm-2381	75	21	of	of	ADP
ajlm-2381	75	22	mm	mm	PROPN
ajlm-2381	75	23	patients	patient	NOUN
ajlm-2381	75	24	develop	develop	VERB
ajlm-2381	75	25	bone	bone	NOUN
ajlm-2381	75	26	disease.38	disease.38	PROPN
ajlm-2381	75	27	radiological	radiological	ADJ
ajlm-2381	75	28	imaging	imaging	NOUN
ajlm-2381	75	29	may	may	AUX
ajlm-2381	75	30	suggest	suggest	VERB
ajlm-2381	75	31	diagnosis	diagnosis	NOUN
ajlm-2381	75	32	,	,	PUNCT
ajlm-2381	75	33	assess	assess	VERB
ajlm-2381	75	34	possible	possible	ADJ
ajlm-2381	75	35	bone	bone	NOUN
ajlm-2381	75	36	complications	complication	NOUN
ajlm-2381	75	37	,	,	PUNCT
ajlm-2381	75	38	and	and	CCONJ
ajlm-2381	75	39	determine	determine	VERB
ajlm-2381	75	40	response	response	NOUN
ajlm-2381	75	41	to	to	ADP
ajlm-2381	75	42	treatment	treatment	NOUN
ajlm-2381	75	43	or	or	CCONJ
ajlm-2381	75	44	disease	disease	NOUN
ajlm-2381	75	45	progression.1,4,39	progression.1,4,39	NOUN
ajlm-2381	75	46	radiographic	radiographic	ADJ
ajlm-2381	75	47	examination	examination	NOUN
ajlm-2381	75	48	(	(	PUNCT
ajlm-2381	75	49	skeletal	skeletal	ADJ
ajlm-2381	75	50	survey	survey	NOUN
ajlm-2381	75	51	)	)	PUNCT
ajlm-2381	75	52	to	to	PART
ajlm-2381	75	53	identify	identify	VERB
ajlm-2381	75	54	lytic	lytic	ADJ
ajlm-2381	75	55	bone	bone	NOUN
ajlm-2381	75	56	lesions	lesion	NOUN
ajlm-2381	75	57	has	have	AUX
ajlm-2381	75	58	been	be	AUX
ajlm-2381	75	59	replaced	replace	VERB
ajlm-2381	75	60	by	by	ADP
ajlm-2381	75	61	more	more	ADV
ajlm-2381	75	62	sensitive	sensitive	ADJ
ajlm-2381	75	63	alternatives	alternative	NOUN
ajlm-2381	75	64	such	such	ADJ
ajlm-2381	75	65	as	as	ADP
ajlm-2381	75	66	whole	whole	ADJ
ajlm-2381	75	67	body	body	NOUN
ajlm-2381	75	68	,	,	PUNCT
ajlm-2381	75	69	low	low	ADJ
ajlm-2381	75	70	-	-	PUNCT
ajlm-2381	75	71	dose	dose	NOUN
ajlm-2381	75	72	computed	compute	VERB
ajlm-2381	75	73	tomography	tomography	NOUN
ajlm-2381	75	74	(	(	PUNCT
ajlm-2381	75	75	ct	ct	PROPN
ajlm-2381	75	76	)	)	PUNCT
ajlm-2381	75	77	,	,	PUNCT
ajlm-2381	75	78	18f	18f	PROPN
ajlm-2381	75	79	fluorodeoxyglucose	fluorodeoxyglucose	PROPN
ajlm-2381	75	80	(	(	PUNCT
ajlm-2381	75	81	18f	18f	PROPN
ajlm-2381	75	82	-	-	PUNCT
ajlm-2381	75	83	fdg	fdg	VERB
ajlm-2381	75	84	)	)	PUNCT
ajlm-2381	75	85	positron	positron	NOUN
ajlm-2381	75	86	emission	emission	NOUN
ajlm-2381	75	87	tomography	tomography	NOUN
ajlm-2381	75	88	/	/	SYM
ajlm-2381	75	89	ct	ct	PROPN
ajlm-2381	75	90	(	(	PUNCT
ajlm-2381	75	91	pet	pet	PROPN
ajlm-2381	75	92	/	/	SYM
ajlm-2381	75	93	ct	ct	NOUN
ajlm-2381	75	94	)	)	PUNCT
ajlm-2381	75	95	scanning	scanning	NOUN
ajlm-2381	75	96	,	,	PUNCT
ajlm-2381	75	97	and	and	CCONJ
ajlm-2381	75	98	magnetic	magnetic	ADJ
ajlm-2381	75	99	resonance	resonance	NOUN
ajlm-2381	75	100	imaging	imaging	NOUN
ajlm-2381	75	101	(	(	PUNCT
ajlm-2381	75	102	mri	mri	NOUN
ajlm-2381	75	103	)	)	PUNCT
ajlm-2381	75	104	.	.	PUNCT
ajlm-2381	76	1	in	in	ADP
ajlm-2381	76	2	under	under	ADV
ajlm-2381	76	3	-	-	PUNCT
ajlm-2381	76	4	resourced	resource	VERB
ajlm-2381	76	5	countries	country	NOUN
ajlm-2381	76	6	,	,	PUNCT
ajlm-2381	76	7	skeletal	skeletal	ADJ
ajlm-2381	76	8	surveys	survey	NOUN
ajlm-2381	76	9	are	be	AUX
ajlm-2381	76	10	still	still	ADV
ajlm-2381	76	11	widely	widely	ADV
ajlm-2381	76	12	used	use	VERB
ajlm-2381	76	13	due	due	ADP
ajlm-2381	76	14	to	to	ADP
ajlm-2381	76	15	the	the	DET
ajlm-2381	76	16	lack	lack	NOUN
ajlm-2381	76	17	of	of	ADP
ajlm-2381	76	18	availability	availability	NOUN
ajlm-2381	76	19	of	of	ADP
ajlm-2381	76	20	superior	superior	ADJ
ajlm-2381	76	21	modalities	modality	NOUN
ajlm-2381	76	22	especially	especially	ADV
ajlm-2381	76	23	for	for	ADP
ajlm-2381	76	24	detection	detection	NOUN
ajlm-2381	76	25	of	of	ADP
ajlm-2381	76	26	osteolytic	osteolytic	ADJ
ajlm-2381	76	27	lesions	lesion	NOUN
ajlm-2381	76	28	in	in	ADP
ajlm-2381	76	29	the	the	DET
ajlm-2381	76	30	spine	spine	NOUN
ajlm-2381	76	31	and	and	CCONJ
ajlm-2381	76	32	pelvis.40,41,42,43,44	pelvis.40,41,42,43,44	NOUN
ajlm-2381	76	33	positron	positron	NOUN
ajlm-2381	76	34	emission	emission	NOUN
ajlm-2381	76	35	tomography	tomography	NOUN
ajlm-2381	76	36	/	/	SYM
ajlm-2381	76	37	ct	ct	PROPN
ajlm-2381	76	38	and	and	CCONJ
ajlm-2381	76	39	mri	mri	NOUN
ajlm-2381	76	40	can	can	AUX
ajlm-2381	76	41	be	be	AUX
ajlm-2381	76	42	used	use	VERB
ajlm-2381	76	43	to	to	PART
ajlm-2381	76	44	assess	assess	VERB
ajlm-2381	76	45	tumour	tumour	NOUN
ajlm-2381	76	46	burden	burden	NOUN
ajlm-2381	76	47	and	and	CCONJ
ajlm-2381	76	48	disease	disease	NOUN
ajlm-2381	77	1	activity.45,46	activity.45,46	PROPN
ajlm-2381	77	2	positron	positron	PROPN
ajlm-2381	77	3	emission	emission	PROPN
ajlm-2381	77	4	tomography	tomography	NOUN
ajlm-2381	77	5	/	/	SYM
ajlm-2381	77	6	ct	ct	PROPN
ajlm-2381	77	7	uses	use	VERB
ajlm-2381	77	8	a	a	DET
ajlm-2381	77	9	surrogate	surrogate	ADJ
ajlm-2381	77	10	measure	measure	NOUN
ajlm-2381	77	11	of	of	ADP
ajlm-2381	77	12	intracellular	intracellular	ADJ
ajlm-2381	77	13	glucose	glucose	NOUN
ajlm-2381	77	14	metabolism	metabolism	NOUN
ajlm-2381	77	15	to	to	PART
ajlm-2381	77	16	distinguish	distinguish	VERB
ajlm-2381	77	17	between	between	ADP
ajlm-2381	77	18	metabolically	metabolically	ADV
ajlm-2381	77	19	active	active	ADJ
ajlm-2381	77	20	and	and	CCONJ
ajlm-2381	77	21	inactive	inactive	ADJ
ajlm-2381	77	22	sites	site	NOUN
ajlm-2381	77	23	of	of	ADP
ajlm-2381	77	24	proliferating	proliferate	VERB
ajlm-2381	77	25	cells	cell	NOUN
ajlm-2381	77	26	,	,	PUNCT
ajlm-2381	77	27	while	while	SCONJ
ajlm-2381	77	28	mri	mri	NOUN
ajlm-2381	77	29	examines	examine	VERB
ajlm-2381	77	30	the	the	DET
ajlm-2381	77	31	water	water	NOUN
ajlm-2381	77	32	and	and	CCONJ
ajlm-2381	77	33	fat	fat	ADJ
ajlm-2381	77	34	composition	composition	NOUN
ajlm-2381	77	35	of	of	ADP
ajlm-2381	77	36	tissues.47	tissues.47	PROPN
ajlm-2381	77	37	magnetic	magnetic	ADJ
ajlm-2381	77	38	resonance	resonance	NOUN
ajlm-2381	77	39	imaging	imaging	NOUN
ajlm-2381	77	40	is	be	AUX
ajlm-2381	77	41	therefore	therefore	ADV
ajlm-2381	77	42	more	more	ADV
ajlm-2381	77	43	sensitive	sensitive	ADJ
ajlm-2381	77	44	for	for	ADP
ajlm-2381	77	45	the	the	DET
ajlm-2381	77	46	detection	detection	NOUN
ajlm-2381	77	47	of	of	ADP
ajlm-2381	77	48	diffuse	diffuse	PROPN
ajlm-2381	77	49	infiltration	infiltration	NOUN
ajlm-2381	77	50	and	and	CCONJ
ajlm-2381	77	51	pet	pet	NOUN
ajlm-2381	77	52	/	/	SYM
ajlm-2381	77	53	ct	ct	PROPN
ajlm-2381	77	54	is	be	AUX
ajlm-2381	77	55	better	well	ADJ
ajlm-2381	77	56	for	for	ADP
ajlm-2381	77	57	the	the	DET
ajlm-2381	77	58	assessment	assessment	NOUN
ajlm-2381	77	59	of	of	ADP
ajlm-2381	77	60	focal	focal	ADJ
ajlm-2381	77	61	lesions	lesion	NOUN
ajlm-2381	77	62	,	,	PUNCT
ajlm-2381	77	63	especially	especially	ADV
ajlm-2381	77	64	when	when	SCONJ
ajlm-2381	77	65	these	these	DET
ajlm-2381	77	66	lesions	lesion	NOUN
ajlm-2381	77	67	are	be	AUX
ajlm-2381	77	68	outside	outside	ADP
ajlm-2381	77	69	the	the	DET
ajlm-2381	77	70	field	field	NOUN
ajlm-2381	77	71	of	of	ADP
ajlm-2381	77	72	view	view	NOUN
ajlm-2381	77	73	of	of	ADP
ajlm-2381	77	74	mri.44	mri.44	NOUN
ajlm-2381	77	75	the	the	DET
ajlm-2381	77	76	patchy	patchy	ADJ
ajlm-2381	77	77	and	and	CCONJ
ajlm-2381	77	78	focal	focal	ADJ
ajlm-2381	77	79	nature	nature	NOUN
ajlm-2381	77	80	of	of	ADP
ajlm-2381	77	81	mm	mm	PROPN
ajlm-2381	77	82	infiltration	infiltration	NOUN
ajlm-2381	77	83	means	mean	VERB
ajlm-2381	77	84	that	that	SCONJ
ajlm-2381	77	85	disease	disease	NOUN
ajlm-2381	77	86	burden	burden	NOUN
ajlm-2381	77	87	measured	measure	VERB
ajlm-2381	77	88	on	on	ADP
ajlm-2381	77	89	a	a	DET
ajlm-2381	77	90	random	random	ADJ
ajlm-2381	77	91	bm	bm	PROPN
ajlm-2381	77	92	biopsy	biopsy	NOUN
ajlm-2381	77	93	may	may	AUX
ajlm-2381	77	94	not	not	PART
ajlm-2381	77	95	be	be	AUX
ajlm-2381	77	96	representative	representative	ADJ
ajlm-2381	77	97	.	.	PUNCT
ajlm-2381	78	1	furthermore	furthermore	ADV
ajlm-2381	78	2	,	,	PUNCT
ajlm-2381	78	3	seven	seven	NUM
ajlm-2381	78	4	focal	focal	ADJ
ajlm-2381	78	5	lesions	lesion	NOUN
ajlm-2381	78	6	on	on	ADP
ajlm-2381	78	7	spinal	spinal	ADJ
ajlm-2381	78	8	mri	mri	NOUN
ajlm-2381	78	9	and	and	CCONJ
ajlm-2381	78	10	more	more	ADJ
ajlm-2381	78	11	than	than	ADP
ajlm-2381	78	12	three	three	NUM
ajlm-2381	78	13	lesions	lesion	NOUN
ajlm-2381	78	14	and	and	CCONJ
ajlm-2381	78	15	extramedullary	extramedullary	ADJ
ajlm-2381	78	16	disease	disease	NOUN
ajlm-2381	78	17	on	on	ADP
ajlm-2381	78	18	pet	pet	NOUN
ajlm-2381	78	19	/	/	SYM
ajlm-2381	78	20	ct	ct	PROPN
ajlm-2381	78	21	have	have	AUX
ajlm-2381	78	22	been	be	AUX
ajlm-2381	78	23	shown	show	VERB
ajlm-2381	78	24	to	to	PART
ajlm-2381	78	25	be	be	AUX
ajlm-2381	78	26	prognostically	prognostically	ADV
ajlm-2381	78	27	significant	significant	ADJ
ajlm-2381	78	28	,	,	PUNCT
ajlm-2381	78	29	and	and	CCONJ
ajlm-2381	78	30	it	it	PRON
ajlm-2381	78	31	is	be	AUX
ajlm-2381	78	32	therefore	therefore	ADV
ajlm-2381	78	33	recommended	recommend	VERB
ajlm-2381	78	34	that	that	SCONJ
ajlm-2381	78	35	the	the	DET
ajlm-2381	78	36	absolute	absolute	ADJ
ajlm-2381	78	37	number	number	NOUN
ajlm-2381	78	38	of	of	ADP
ajlm-2381	78	39	focal	focal	ADJ
ajlm-2381	78	40	lesions	lesion	NOUN
ajlm-2381	78	41	should	should	AUX
ajlm-2381	78	42	be	be	AUX
ajlm-2381	78	43	reported.39,47,48,49,50	reported.39,47,48,49,50	PRON
ajlm-2381	78	44	a	a	DET
ajlm-2381	78	45	south	south	ADJ
ajlm-2381	78	46	african	african	ADJ
ajlm-2381	78	47	study	study	NOUN
ajlm-2381	78	48	in	in	ADP
ajlm-2381	78	49	patients	patient	NOUN
ajlm-2381	78	50	at	at	ADP
ajlm-2381	78	51	a	a	DET
ajlm-2381	78	52	tertiary	tertiary	ADJ
ajlm-2381	78	53	hospital	hospital	NOUN
ajlm-2381	78	54	showed	show	VERB
ajlm-2381	78	55	good	good	ADJ
ajlm-2381	78	56	concordance	concordance	NOUN
ajlm-2381	78	57	between	between	ADP
ajlm-2381	78	58	representative	representative	PROPN
ajlm-2381	78	59	bm	bm	PROPN
ajlm-2381	78	60	biopsy	biopsy	PROPN
ajlm-2381	78	61	samples	sample	NOUN
ajlm-2381	78	62	and	and	CCONJ
ajlm-2381	78	63	18f	18f	NUM
ajlm-2381	78	64	-	-	PUNCT
ajlm-2381	78	65	fdg	fdg	PROPN
ajlm-2381	78	66	pet	pet	PROPN
ajlm-2381	78	67	/	/	SYM
ajlm-2381	78	68	ct	ct	PROPN
ajlm-2381	78	69	image	image	NOUN
ajlm-2381	78	70	analysis	analysis	NOUN
ajlm-2381	78	71	.	.	PUNCT
ajlm-2381	79	1	however	however	ADV
ajlm-2381	79	2	,	,	PUNCT
ajlm-2381	79	3	this	this	PRON
ajlm-2381	79	4	did	do	AUX
ajlm-2381	79	5	not	not	PART
ajlm-2381	79	6	reliably	reliably	ADV
ajlm-2381	79	7	predict	predict	VERB
ajlm-2381	79	8	pc	pc	NOUN
ajlm-2381	79	9	infiltration	infiltration	NOUN
ajlm-2381	79	10	of	of	ADP
ajlm-2381	79	11	<	<	X
ajlm-2381	79	12	10	10	NUM
ajlm-2381	79	13	%	%	NOUN
ajlm-2381	79	14	or	or	CCONJ
ajlm-2381	79	15	diffuse	diffuse	VERB
ajlm-2381	79	16	non	non	ADJ
ajlm-2381	79	17	-	-	ADJ
ajlm-2381	79	18	hypermetabolic	hypermetabolic	ADJ
ajlm-2381	79	19	marrow	marrow	PROPN
ajlm-2381	79	20	involvement	involvement	NOUN
ajlm-2381	79	21	on	on	ADP
ajlm-2381	79	22	imaging.51	imaging.51	NOUN
ajlm-2381	79	23	this	this	DET
ajlm-2381	79	24	study	study	NOUN
ajlm-2381	79	25	further	far	ADV
ajlm-2381	79	26	emphasised	emphasise	VERB
ajlm-2381	79	27	the	the	DET
ajlm-2381	79	28	patchy	patchy	ADJ
ajlm-2381	79	29	nature	nature	NOUN
ajlm-2381	79	30	of	of	ADP
ajlm-2381	79	31	the	the	DET
ajlm-2381	79	32	disease	disease	NOUN
ajlm-2381	79	33	where	where	SCONJ
ajlm-2381	79	34	patients	patient	NOUN
ajlm-2381	79	35	with	with	ADP
ajlm-2381	79	36	irregular	irregular	ADJ
ajlm-2381	79	37	bm	bm	PROPN
ajlm-2381	79	38	infiltration	infiltration	NOUN
ajlm-2381	79	39	may	may	AUX
ajlm-2381	79	40	result	result	VERB
ajlm-2381	79	41	in	in	ADP
ajlm-2381	79	42	the	the	DET
ajlm-2381	79	43	underestimation	underestimation	NOUN
ajlm-2381	79	44	of	of	ADP
ajlm-2381	79	45	pc	pc	NOUN
ajlm-2381	79	46	infiltration.51	infiltration.51	NOUN
ajlm-2381	79	47	based	base	VERB
ajlm-2381	79	48	on	on	ADP
ajlm-2381	79	49	these	these	DET
ajlm-2381	79	50	results	result	NOUN
ajlm-2381	79	51	,	,	PUNCT
ajlm-2381	79	52	the	the	DET
ajlm-2381	79	53	use	use	NOUN
ajlm-2381	79	54	of	of	ADP
ajlm-2381	79	55	pet	pet	ADJ
ajlm-2381	79	56	/	/	SYM
ajlm-2381	79	57	ct	ct	PROPN
ajlm-2381	79	58	imaging	imaging	NOUN
ajlm-2381	79	59	can	can	AUX
ajlm-2381	79	60	avoid	avoid	VERB
ajlm-2381	79	61	the	the	DET
ajlm-2381	79	62	need	need	NOUN
ajlm-2381	79	63	for	for	ADP
ajlm-2381	79	64	repeated	repeat	VERB
ajlm-2381	79	65	bm	bm	PROPN
ajlm-2381	79	66	biopsies	biopsy	NOUN
ajlm-2381	79	67	in	in	ADP
ajlm-2381	79	68	most	most	ADJ
ajlm-2381	79	69	patients	patient	NOUN
ajlm-2381	79	70	with	with	ADP
ajlm-2381	79	71	diffuse	diffuse	NOUN
ajlm-2381	79	72	and	and	CCONJ
ajlm-2381	79	73	irregular	irregular	ADJ
ajlm-2381	79	74	bm	bm	NOUN
ajlm-2381	79	75	uptake	uptake	NOUN
ajlm-2381	79	76	,	,	PUNCT
ajlm-2381	79	77	but	but	CCONJ
ajlm-2381	79	78	can	can	AUX
ajlm-2381	79	79	not	not	PART
ajlm-2381	79	80	replace	replace	VERB
ajlm-2381	79	81	bm	bm	PROPN
ajlm-2381	79	82	biopsy	biopsy	NOUN
ajlm-2381	79	83	to	to	PART
ajlm-2381	79	84	determine	determine	VERB
ajlm-2381	79	85	bmpc%	bmpc%	PROPN
ajlm-2381	79	86	.	.	PUNCT
ajlm-2381	80	1	imaging	imaging	NOUN
ajlm-2381	80	2	will	will	AUX
ajlm-2381	80	3	continue	continue	VERB
ajlm-2381	80	4	to	to	PART
ajlm-2381	80	5	play	play	VERB
ajlm-2381	80	6	a	a	DET
ajlm-2381	80	7	role	role	NOUN
ajlm-2381	80	8	in	in	ADP
ajlm-2381	80	9	assessing	assess	VERB
ajlm-2381	80	10	myeloma	myeloma	NOUN
ajlm-2381	80	11	-	-	PUNCT
ajlm-2381	80	12	defining	define	VERB
ajlm-2381	80	13	events	event	NOUN
ajlm-2381	80	14	,	,	PUNCT
ajlm-2381	80	15	providing	provide	VERB
ajlm-2381	80	16	prognostic	prognostic	ADJ
ajlm-2381	80	17	information	information	NOUN
ajlm-2381	80	18	,	,	PUNCT
ajlm-2381	80	19	and	and	CCONJ
ajlm-2381	80	20	evaluating	evaluate	VERB
ajlm-2381	80	21	response	response	NOUN
ajlm-2381	80	22	to	to	ADP
ajlm-2381	80	23	treatment	treatment	NOUN
ajlm-2381	80	24	by	by	ADP
ajlm-2381	80	25	providing	provide	VERB
ajlm-2381	80	26	complementary	complementary	ADJ
ajlm-2381	80	27	information.4,39	information.4,39	ADV
ajlm-2381	80	28	emerging	emerge	VERB
ajlm-2381	80	29	technologies	technology	NOUN
ajlm-2381	80	30	and	and	CCONJ
ajlm-2381	80	31	innovations	innovation	NOUN
ajlm-2381	80	32	digital	digital	ADJ
ajlm-2381	80	33	pathology	pathology	NOUN
ajlm-2381	80	34	digital	digital	ADJ
ajlm-2381	80	35	pathology	pathology	NOUN
ajlm-2381	80	36	,	,	PUNCT
ajlm-2381	80	37	with	with	ADP
ajlm-2381	80	38	or	or	CCONJ
ajlm-2381	80	39	without	without	ADP
ajlm-2381	80	40	incorporation	incorporation	NOUN
ajlm-2381	80	41	of	of	ADP
ajlm-2381	80	42	artificial	artificial	ADJ
ajlm-2381	80	43	intelligence	intelligence	NOUN
ajlm-2381	80	44	(	(	PUNCT
ajlm-2381	80	45	ai	ai	NOUN
ajlm-2381	80	46	)	)	PUNCT
ajlm-2381	80	47	,	,	PUNCT
ajlm-2381	80	48	is	be	AUX
ajlm-2381	80	49	growing	grow	VERB
ajlm-2381	80	50	in	in	ADP
ajlm-2381	80	51	popularity	popularity	NOUN
ajlm-2381	80	52	while	while	SCONJ
ajlm-2381	80	53	presenting	present	VERB
ajlm-2381	80	54	both	both	DET
ajlm-2381	80	55	challenges	challenge	NOUN
ajlm-2381	80	56	and	and	CCONJ
ajlm-2381	80	57	opportunities	opportunity	NOUN
ajlm-2381	80	58	for	for	ADP
ajlm-2381	80	59	the	the	DET
ajlm-2381	80	60	future	future	NOUN
ajlm-2381	80	61	.	.	PUNCT
ajlm-2381	81	1	careful	careful	ADJ
ajlm-2381	81	2	consideration	consideration	NOUN
ajlm-2381	81	3	is	be	AUX
ajlm-2381	81	4	required	require	VERB
ajlm-2381	81	5	when	when	SCONJ
ajlm-2381	81	6	introducing	introduce	VERB
ajlm-2381	81	7	this	this	DET
ajlm-2381	81	8	new	new	ADJ
ajlm-2381	81	9	area	area	NOUN
ajlm-2381	81	10	of	of	ADP
ajlm-2381	81	11	medicine	medicine	NOUN
ajlm-2381	81	12	to	to	PART
ajlm-2381	81	13	patient	patient	ADJ
ajlm-2381	81	14	care	care	NOUN
ajlm-2381	81	15	.	.	PUNCT
ajlm-2381	82	1	digitisation	digitisation	NOUN
ajlm-2381	82	2	of	of	ADP
ajlm-2381	82	3	immunostained	immunostaine	VERB
ajlm-2381	82	4	bm	bm	PROPN
ajlm-2381	82	5	biopsy	biopsy	PROPN
ajlm-2381	82	6	sections	section	NOUN
ajlm-2381	82	7	can	can	AUX
ajlm-2381	82	8	be	be	AUX
ajlm-2381	82	9	done	do	VERB
ajlm-2381	82	10	by	by	ADP
ajlm-2381	82	11	taking	take	VERB
ajlm-2381	82	12	still	still	ADV
ajlm-2381	82	13	images	image	NOUN
ajlm-2381	82	14	with	with	ADP
ajlm-2381	82	15	a	a	DET
ajlm-2381	82	16	microscope	microscope	NOUN
ajlm-2381	82	17	camera	camera	NOUN
ajlm-2381	82	18	or	or	CCONJ
ajlm-2381	82	19	dynamic	dynamic	ADJ
ajlm-2381	82	20	images	image	NOUN
ajlm-2381	82	21	with	with	ADP
ajlm-2381	82	22	whole	whole	ADJ
ajlm-2381	82	23	slide	slide	NOUN
ajlm-2381	82	24	imaging	imaging	NOUN
ajlm-2381	82	25	(	(	PUNCT
ajlm-2381	82	26	wsi	wsi	NOUN
ajlm-2381	82	27	)	)	PUNCT
ajlm-2381	82	28	systems	system	NOUN
ajlm-2381	82	29	.	.	PUNCT
ajlm-2381	83	1	images	image	NOUN
ajlm-2381	83	2	can	can	AUX
ajlm-2381	83	3	be	be	AUX
ajlm-2381	83	4	analysed	analyse	VERB
ajlm-2381	83	5	manually	manually	ADV
ajlm-2381	83	6	or	or	CCONJ
ajlm-2381	83	7	using	use	VERB
ajlm-2381	83	8	ai	ai	NOUN
ajlm-2381	83	9	.	.	PROPN
ajlm-2381	83	10	herein	herein	NOUN
ajlm-2381	83	11	,	,	PUNCT
ajlm-2381	83	12	we	we	PRON
ajlm-2381	83	13	review	review	VERB
ajlm-2381	83	14	several	several	ADJ
ajlm-2381	83	15	studies	study	NOUN
ajlm-2381	83	16	that	that	PRON
ajlm-2381	83	17	have	have	AUX
ajlm-2381	83	18	explored	explore	VERB
ajlm-2381	83	19	the	the	DET
ajlm-2381	83	20	use	use	NOUN
ajlm-2381	83	21	of	of	ADP
ajlm-2381	83	22	these	these	DET
ajlm-2381	83	23	innovations	innovation	NOUN
ajlm-2381	83	24	in	in	ADP
ajlm-2381	83	25	estimating	estimate	VERB
ajlm-2381	83	26	bmpc%	bmpc%	PUNCT
ajlm-2381	83	27	.	.	PUNCT
ajlm-2381	84	1	computer	computer	NOUN
ajlm-2381	84	2	-	-	PUNCT
ajlm-2381	84	3	assisted	assist	VERB
ajlm-2381	84	4	image	image	NOUN
ajlm-2381	84	5	analysis	analysis	NOUN
ajlm-2381	84	6	(	(	PUNCT
ajlm-2381	84	7	cia	cia	PROPN
ajlm-2381	84	8	)	)	PUNCT
ajlm-2381	84	9	for	for	ADP
ajlm-2381	84	10	estimating	estimate	VERB
ajlm-2381	84	11	bmpcs	bmpc	NOUN
ajlm-2381	84	12	in	in	ADP
ajlm-2381	84	13	bm	bm	PROPN
ajlm-2381	84	14	biopsies	biopsy	NOUN
ajlm-2381	84	15	dates	date	VERB
ajlm-2381	84	16	to	to	ADP
ajlm-2381	84	17	the	the	DET
ajlm-2381	84	18	early	early	ADJ
ajlm-2381	84	19	2000s	2000s	NUM
ajlm-2381	84	20	.	.	PUNCT
ajlm-2381	85	1	computer	computer	NOUN
ajlm-2381	85	2	-	-	PUNCT
ajlm-2381	85	3	assisted	assist	VERB
ajlm-2381	85	4	image	image	NOUN
ajlm-2381	85	5	analysis	analysis	NOUN
ajlm-2381	85	6	was	be	AUX
ajlm-2381	85	7	shown	show	VERB
ajlm-2381	85	8	to	to	PART
ajlm-2381	85	9	be	be	AUX
ajlm-2381	85	10	superior	superior	ADJ
ajlm-2381	85	11	to	to	ADP
ajlm-2381	85	12	simple	simple	ADJ
ajlm-2381	85	13	visual	visual	ADJ
ajlm-2381	85	14	estimation	estimation	NOUN
ajlm-2381	85	15	of	of	ADP
ajlm-2381	85	16	cd138	cd138	PROPN
ajlm-2381	85	17	immunohistochemistry	immunohistochemistry	PROPN
ajlm-2381	85	18	,	,	PUNCT
ajlm-2381	85	19	due	due	ADP
ajlm-2381	85	20	to	to	ADP
ajlm-2381	85	21	elimination	elimination	NOUN
ajlm-2381	85	22	of	of	ADP
ajlm-2381	85	23	subjectivity	subjectivity	NOUN
ajlm-2381	85	24	.	.	PUNCT
ajlm-2381	86	1	in	in	ADP
ajlm-2381	86	2	a	a	DET
ajlm-2381	86	3	swiss	swiss	ADJ
ajlm-2381	86	4	study	study	NOUN
ajlm-2381	86	5	by	by	ADP
ajlm-2381	86	6	went	go	VERB
ajlm-2381	86	7	et	et	PROPN
ajlm-2381	86	8	al	al	PROPN
ajlm-2381	86	9	.	.	PROPN
ajlm-2381	86	10	in	in	ADP
ajlm-2381	86	11	2006	2006	NUM
ajlm-2381	86	12	,	,	PUNCT
ajlm-2381	86	13	cia	cia	PROPN
ajlm-2381	86	14	was	be	AUX
ajlm-2381	86	15	performed	perform	VERB
ajlm-2381	86	16	using	use	VERB
ajlm-2381	86	17	image	image	NOUN
ajlm-2381	86	18	processing	processing	NOUN
ajlm-2381	86	19	software	software	NOUN
ajlm-2381	86	20	(	(	PUNCT
ajlm-2381	86	21	ks	ks	PROPN
ajlm-2381	86	22	300	300	NUM
ajlm-2381	86	23	,	,	PUNCT
ajlm-2381	86	24	carl	carl	PROPN
ajlm-2381	86	25	zeiss	zeiss	PROPN
ajlm-2381	86	26	ag	ag	PROPN
ajlm-2381	86	27	,	,	PUNCT
ajlm-2381	86	28	feldbach	feldbach	PROPN
ajlm-2381	86	29	,	,	PUNCT
ajlm-2381	86	30	switzerland	switzerland	PROPN
ajlm-2381	86	31	)	)	PUNCT
ajlm-2381	86	32	after	after	ADP
ajlm-2381	86	33	digitising	digitise	VERB
ajlm-2381	86	34	selected	select	VERB
ajlm-2381	86	35	fields	field	NOUN
ajlm-2381	86	36	with	with	ADP
ajlm-2381	86	37	a	a	DET
ajlm-2381	86	38	light	light	ADJ
ajlm-2381	86	39	microscope	microscope	NOUN
ajlm-2381	86	40	and	and	CCONJ
ajlm-2381	86	41	colour	colour	NOUN
ajlm-2381	86	42	video	video	NOUN
ajlm-2381	86	43	camera.52	camera.52	NOUN
ajlm-2381	86	44	this	this	DET
ajlm-2381	86	45	study	study	NOUN
ajlm-2381	86	46	showed	show	VERB
ajlm-2381	86	47	minimal	minimal	ADJ
ajlm-2381	86	48	interobserver	interobserver	NOUN
ajlm-2381	86	49	and	and	CCONJ
ajlm-2381	86	50	intraobserver	intraobserver	ADJ
ajlm-2381	86	51	variability	variability	NOUN
ajlm-2381	86	52	(	(	PUNCT
ajlm-2381	86	53	determined	determine	VERB
ajlm-2381	86	54	by	by	ADP
ajlm-2381	86	55	spearman	spearman	NOUN
ajlm-2381	86	56	’s	’s	PART
ajlm-2381	86	57	rank	rank	NOUN
ajlm-2381	86	58	correlation	correlation	NOUN
ajlm-2381	86	59	coefficient	coefficient	NOUN
ajlm-2381	86	60	)	)	PUNCT
ajlm-2381	86	61	between	between	ADP
ajlm-2381	86	62	two	two	NUM
ajlm-2381	86	63	reviewers	reviewer	NOUN
ajlm-2381	86	64	using	use	VERB
ajlm-2381	86	65	cia.49	cia.49	ADP
ajlm-2381	86	66	a	a	DET
ajlm-2381	86	67	study	study	NOUN
ajlm-2381	86	68	by	by	ADP
ajlm-2381	86	69	stifter	stifter	PROPN
ajlm-2381	86	70	et	et	PROPN
ajlm-2381	86	71	al	al	PROPN
ajlm-2381	86	72	.	.	PROPN
ajlm-2381	87	1	in	in	ADP
ajlm-2381	87	2	croatia	croatia	PROPN
ajlm-2381	87	3	in	in	ADP
ajlm-2381	87	4	2010	2010	NUM
ajlm-2381	87	5	used	use	VERB
ajlm-2381	87	6	similar	similar	ADJ
ajlm-2381	87	7	image	image	NOUN
ajlm-2381	87	8	processing	processing	NOUN
ajlm-2381	87	9	software	software	NOUN
ajlm-2381	87	10	(	(	PUNCT
ajlm-2381	87	11	alphelys	alphelys	NOUN
ajlm-2381	87	12	spot	spot	NOUN
ajlm-2381	87	13	browser	browser	NOUN
ajlm-2381	87	14	2.4.4	2.4.4	NUM
ajlm-2381	87	15	.	.	PROPN
ajlm-2381	87	16	,	,	PUNCT
ajlm-2381	87	17	plaisir	plaisir	PROPN
ajlm-2381	87	18	,	,	PUNCT
ajlm-2381	87	19	france	france	PROPN
ajlm-2381	87	20	)	)	PUNCT
ajlm-2381	87	21	for	for	ADP
ajlm-2381	87	22	cia	cia	PROPN
ajlm-2381	87	23	after	after	ADP
ajlm-2381	87	24	digitisation	digitisation	NOUN
ajlm-2381	87	25	using	use	VERB
ajlm-2381	87	26	a	a	DET
ajlm-2381	87	27	similar	similar	ADJ
ajlm-2381	87	28	method	method	NOUN
ajlm-2381	87	29	showed	show	VERB
ajlm-2381	87	30	high	high	ADJ
ajlm-2381	87	31	reproducibility.24	reproducibility.24	NOUN
ajlm-2381	87	32	the	the	DET
ajlm-2381	87	33	cia	cia	PROPN
ajlm-2381	87	34	evaluated	evaluate	VERB
ajlm-2381	87	35	the	the	DET
ajlm-2381	87	36	relative	relative	ADJ
ajlm-2381	87	37	area	area	NOUN
ajlm-2381	87	38	of	of	ADP
ajlm-2381	87	39	overall	overall	ADJ
ajlm-2381	87	40	positive	positive	ADJ
ajlm-2381	87	41	staining	staining	NOUN
ajlm-2381	87	42	rather	rather	ADV
ajlm-2381	87	43	than	than	ADP
ajlm-2381	87	44	a	a	DET
ajlm-2381	87	45	calculated	calculated	ADJ
ajlm-2381	87	46	percentage	percentage	NOUN
ajlm-2381	87	47	of	of	ADP
ajlm-2381	87	48	individually	individually	ADV
ajlm-2381	87	49	positively	positively	ADV
ajlm-2381	87	50	stained	stain	VERB
ajlm-2381	87	51	cells	cell	NOUN
ajlm-2381	87	52	.	.	PUNCT
ajlm-2381	88	1	computer	computer	NOUN
ajlm-2381	88	2	-	-	PUNCT
ajlm-2381	88	3	assisted	assist	VERB
ajlm-2381	88	4	image	image	NOUN
ajlm-2381	88	5	analysis	analysis	NOUN
ajlm-2381	88	6	is	be	AUX
ajlm-2381	88	7	therefore	therefore	ADV
ajlm-2381	88	8	significantly	significantly	ADV
ajlm-2381	88	9	influenced	influence	VERB
ajlm-2381	88	10	by	by	ADP
ajlm-2381	88	11	background	background	NOUN
ajlm-2381	88	12	staining	stain	VERB
ajlm-2381	88	13	,	,	PUNCT
ajlm-2381	88	14	large	large	ADJ
ajlm-2381	88	15	atypical	atypical	ADJ
ajlm-2381	88	16	pc	pc	NOUN
ajlm-2381	88	17	,	,	PUNCT
ajlm-2381	88	18	and	and	CCONJ
ajlm-2381	88	19	pc	pc	NOUN
ajlm-2381	88	20	clusters.21,49	clusters.21,49	NOUN
ajlm-2381	88	21	technology	technology	NOUN
ajlm-2381	88	22	has	have	AUX
ajlm-2381	88	23	improved	improve	VERB
ajlm-2381	88	24	so	so	SCONJ
ajlm-2381	88	25	that	that	SCONJ
ajlm-2381	88	26	an	an	DET
ajlm-2381	88	27	entire	entire	ADJ
ajlm-2381	88	28	biopsy	biopsy	NOUN
ajlm-2381	88	29	slide	slide	NOUN
ajlm-2381	88	30	can	can	AUX
ajlm-2381	88	31	be	be	AUX
ajlm-2381	88	32	digitised	digitise	VERB
ajlm-2381	88	33	with	with	ADP
ajlm-2381	88	34	wsi	wsi	NOUN
ajlm-2381	88	35	scanners	scanner	NOUN
ajlm-2381	88	36	,	,	PUNCT
ajlm-2381	88	37	and	and	CCONJ
ajlm-2381	88	38	more	more	ADV
ajlm-2381	88	39	advanced	advanced	ADJ
ajlm-2381	88	40	software	software	NOUN
ajlm-2381	88	41	programmes	programme	NOUN
ajlm-2381	88	42	than	than	ADP
ajlm-2381	88	43	those	those	PRON
ajlm-2381	88	44	used	use	VERB
ajlm-2381	88	45	in	in	ADP
ajlm-2381	88	46	cia	cia	PROPN
ajlm-2381	88	47	and	and	CCONJ
ajlm-2381	88	48	ai	ai	NOUN
ajlm-2381	88	49	are	be	AUX
ajlm-2381	88	50	used	use	VERB
ajlm-2381	88	51	to	to	PART
ajlm-2381	88	52	analyse	analyse	VERB
ajlm-2381	88	53	the	the	DET
ajlm-2381	88	54	images.50,51,53	images.50,51,53	DET
ajlm-2381	88	55	the	the	DET
ajlm-2381	88	56	wsi	wsi	NOUN
ajlm-2381	88	57	,	,	PUNCT
ajlm-2381	88	58	used	use	VERB
ajlm-2381	88	59	together	together	ADV
ajlm-2381	88	60	with	with	ADP
ajlm-2381	88	61	an	an	DET
ajlm-2381	88	62	image	image	NOUN
ajlm-2381	88	63	analysis	analysis	NOUN
ajlm-2381	88	64	tool	tool	NOUN
ajlm-2381	88	65	and	and	CCONJ
ajlm-2381	88	66	established	establish	VERB
ajlm-2381	88	67	algorithms	algorithms	NOUN
ajlm-2381	88	68	(	(	PUNCT
ajlm-2381	88	69	asperio	asperio	NOUN
ajlm-2381	88	70	;	;	PUNCT
ajlm-2381	88	71	positive	positive	ADJ
ajlm-2381	88	72	pixel	pixel	NOUN
ajlm-2381	88	73	count	count	PROPN
ajlm-2381	88	74	v9	v9	PROPN
ajlm-2381	88	75	,	,	PUNCT
ajlm-2381	88	76	vista	vista	PROPN
ajlm-2381	88	77	,	,	PUNCT
ajlm-2381	88	78	california	california	PROPN
ajlm-2381	88	79	,	,	PUNCT
ajlm-2381	88	80	united	united	PROPN
ajlm-2381	88	81	states	states	PROPN
ajlm-2381	88	82	)	)	PUNCT
ajlm-2381	88	83	,	,	PUNCT
ajlm-2381	88	84	has	have	AUX
ajlm-2381	88	85	shown	show	VERB
ajlm-2381	88	86	good	good	ADJ
ajlm-2381	88	87	correlation	correlation	NOUN
ajlm-2381	88	88	with	with	ADP
ajlm-2381	88	89	visual	visual	ADJ
ajlm-2381	88	90	estimates	estimate	NOUN
ajlm-2381	88	91	and	and	CCONJ
ajlm-2381	88	92	counts	count	NOUN
ajlm-2381	88	93	by	by	ADP
ajlm-2381	88	94	experienced	experienced	ADJ
ajlm-2381	88	95	pathologists	pathologist	NOUN
ajlm-2381	88	96	.	.	PUNCT
ajlm-2381	89	1	however	however	ADV
ajlm-2381	89	2	,	,	PUNCT
ajlm-2381	89	3	it	it	PRON
ajlm-2381	89	4	is	be	AUX
ajlm-2381	89	5	often	often	ADV
ajlm-2381	89	6	influenced	influence	VERB
ajlm-2381	89	7	by	by	ADP
ajlm-2381	89	8	the	the	DET
ajlm-2381	89	9	intensity	intensity	NOUN
ajlm-2381	89	10	of	of	ADP
ajlm-2381	89	11	the	the	DET
ajlm-2381	89	12	staining	staining	NOUN
ajlm-2381	89	13	,	,	PUNCT
ajlm-2381	89	14	leading	lead	VERB
ajlm-2381	89	15	to	to	ADP
ajlm-2381	89	16	an	an	DET
ajlm-2381	89	17	overestimation	overestimation	NOUN
ajlm-2381	89	18	of	of	ADP
ajlm-2381	89	19	bmpc%.50	bmpc%.50	PROPN
ajlm-2381	89	20	the	the	DET
ajlm-2381	89	21	overestimation	overestimation	NOUN
ajlm-2381	89	22	is	be	AUX
ajlm-2381	89	23	due	due	ADJ
ajlm-2381	89	24	to	to	ADP
ajlm-2381	89	25	a	a	DET
ajlm-2381	89	26	‘	'	PUNCT
ajlm-2381	89	27	halo	halo	NOUN
ajlm-2381	89	28	’	'	PUNCT
ajlm-2381	89	29	effect	effect	NOUN
ajlm-2381	89	30	in	in	ADP
ajlm-2381	89	31	cases	case	NOUN
ajlm-2381	89	32	with	with	ADP
ajlm-2381	89	33	strong	strong	ADJ
ajlm-2381	89	34	positivity	positivity	NOUN
ajlm-2381	89	35	,	,	PUNCT
ajlm-2381	89	36	but	but	CCONJ
ajlm-2381	89	37	in	in	ADP
ajlm-2381	89	38	these	these	DET
ajlm-2381	89	39	cases	case	NOUN
ajlm-2381	89	40	wsi	wsi	VERB
ajlm-2381	89	41	still	still	ADV
ajlm-2381	89	42	showed	show	VERB
ajlm-2381	89	43	good	good	ADJ
ajlm-2381	89	44	correlation	correlation	NOUN
ajlm-2381	89	45	(	(	PUNCT
ajlm-2381	89	46	r	r	NOUN
ajlm-2381	89	47	=	=	NOUN
ajlm-2381	89	48	0.857	0.857	NUM
ajlm-2381	89	49	)	)	PUNCT
ajlm-2381	89	50	with	with	ADP
ajlm-2381	89	51	visual	visual	ADJ
ajlm-2381	89	52	estimates.53	estimates.53	NOUN
ajlm-2381	89	53	another	another	DET
ajlm-2381	89	54	study	study	NOUN
ajlm-2381	89	55	also	also	ADV
ajlm-2381	89	56	claimed	claim	VERB
ajlm-2381	89	57	that	that	SCONJ
ajlm-2381	89	58	automated	automate	VERB
ajlm-2381	89	59	digital	digital	ADJ
ajlm-2381	89	60	enumeration	enumeration	NOUN
ajlm-2381	89	61	of	of	ADP
ajlm-2381	89	62	the	the	DET
ajlm-2381	89	63	entire	entire	ADJ
ajlm-2381	89	64	,	,	PUNCT
ajlm-2381	89	65	immunohistochemically	immunohistochemically	ADV
ajlm-2381	89	66	stained	stain	VERB
ajlm-2381	89	67	(	(	PUNCT
ajlm-2381	89	68	cd138	cd138	NOUN
ajlm-2381	89	69	and	and	CCONJ
ajlm-2381	89	70	mum1	mum1	PROPN
ajlm-2381	89	71	)	)	PUNCT
ajlm-2381	89	72	biopsy	biopsy	NOUN
ajlm-2381	89	73	can	can	AUX
ajlm-2381	89	74	accurately	accurately	ADV
ajlm-2381	89	75	determine	determine	VERB
ajlm-2381	89	76	pc	pc	NOUN
ajlm-2381	89	77	burden	burden	NOUN
ajlm-2381	89	78	,	,	PUNCT
ajlm-2381	89	79	irrespective	irrespective	ADV
ajlm-2381	89	80	of	of	ADP
ajlm-2381	89	81	pattern	pattern	NOUN
ajlm-2381	89	82	or	or	CCONJ
ajlm-2381	89	83	extent	extent	NOUN
ajlm-2381	89	84	of	of	ADP
ajlm-2381	89	85	disease.54	disease.54	NOUN
ajlm-2381	89	86	it	it	PRON
ajlm-2381	89	87	also	also	ADV
ajlm-2381	89	88	showed	show	VERB
ajlm-2381	89	89	that	that	SCONJ
ajlm-2381	89	90	manual	manual	ADJ
ajlm-2381	89	91	visual	visual	ADJ
ajlm-2381	89	92	assessment	assessment	NOUN
ajlm-2381	89	93	(	(	PUNCT
ajlm-2381	89	94	a	a	DET
ajlm-2381	89	95	500	500	NUM
ajlm-2381	89	96	-	-	PUNCT
ajlm-2381	89	97	cell	cell	NOUN
ajlm-2381	89	98	manual	manual	ADJ
ajlm-2381	89	99	count	count	NOUN
ajlm-2381	89	100	in	in	ADP
ajlm-2381	89	101	‘	'	PUNCT
ajlm-2381	89	102	representative	representative	ADJ
ajlm-2381	89	103	regions	region	NOUN
ajlm-2381	89	104	’	'	PUNCT
ajlm-2381	89	105	)	)	PUNCT
ajlm-2381	89	106	tends	tend	VERB
ajlm-2381	89	107	to	to	PART
ajlm-2381	89	108	overestimate	overestimate	VERB
ajlm-2381	89	109	pc	pc	NOUN
ajlm-2381	89	110	burden.54	burden.54	X
ajlm-2381	89	111	the	the	DET
ajlm-2381	89	112	use	use	NOUN
ajlm-2381	89	113	of	of	ADP
ajlm-2381	89	114	an	an	DET
ajlm-2381	89	115	open	open	ADJ
ajlm-2381	89	116	-	-	PUNCT
ajlm-2381	89	117	source	source	NOUN
ajlm-2381	89	118	digital	digital	ADJ
ajlm-2381	89	119	image	image	NOUN
ajlm-2381	89	120	analysis	analysis	NOUN
ajlm-2381	89	121	tool	tool	NOUN
ajlm-2381	89	122	,	,	PUNCT
ajlm-2381	89	123	qupath	qupath	NOUN
ajlm-2381	89	124	,	,	PUNCT
ajlm-2381	89	125	was	be	AUX
ajlm-2381	89	126	validated	validate	VERB
ajlm-2381	89	127	by	by	ADP
ajlm-2381	89	128	baranova	baranova	PROPN
ajlm-2381	89	129	et	et	PROPN
ajlm-2381	89	130	al	al	PROPN
ajlm-2381	89	131	.	.	PROPN
ajlm-2381	89	132	,	,	PUNCT
ajlm-2381	89	133	in	in	ADP
ajlm-2381	89	134	a	a	DET
ajlm-2381	89	135	study	study	NOUN
ajlm-2381	89	136	published	publish	VERB
ajlm-2381	89	137	in	in	ADP
ajlm-2381	89	138	canada	canada	PROPN
ajlm-2381	89	139	in	in	ADP
ajlm-2381	89	140	2021	2021	NUM
ajlm-2381	89	141	,	,	PUNCT
ajlm-2381	89	142	for	for	ADP
ajlm-2381	89	143	the	the	DET
ajlm-2381	89	144	automation	automation	NOUN
ajlm-2381	89	145	of	of	ADP
ajlm-2381	89	146	pc	pc	NOUN
ajlm-2381	89	147	quantification	quantification	NOUN
ajlm-2381	89	148	in	in	ADP
ajlm-2381	89	149	bm	bm	PROPN
ajlm-2381	89	150	biopsies	biopsy	NOUN
ajlm-2381	89	151	from	from	ADP
ajlm-2381	89	152	patients	patient	NOUN
ajlm-2381	89	153	with	with	ADP
ajlm-2381	89	154	mm.55	mm.55	NOUN
ajlm-2381	89	155	they	they	PRON
ajlm-2381	89	156	accurately	accurately	ADV
ajlm-2381	89	157	and	and	CCONJ
ajlm-2381	89	158	reliably	reliably	ADV
ajlm-2381	89	159	estimated	estimate	VERB
ajlm-2381	89	160	bmpc%	bmpc%	PUNCT
ajlm-2381	89	161	on	on	ADP
ajlm-2381	89	162	cd138	cd138	NOUN
ajlm-2381	89	163	-	-	PUNCT
ajlm-2381	89	164	stained	stain	VERB
ajlm-2381	89	165	slides	slide	NOUN
ajlm-2381	89	166	with	with	ADP
ajlm-2381	89	167	good	good	ADJ
ajlm-2381	89	168	correlation	correlation	NOUN
ajlm-2381	89	169	between	between	ADP
ajlm-2381	89	170	manual	manual	ADJ
ajlm-2381	89	171	counting	counting	NOUN
ajlm-2381	89	172	and	and	CCONJ
ajlm-2381	89	173	software	software	NOUN
ajlm-2381	89	174	image	image	NOUN
ajlm-2381	89	175	analysis	analysis	NOUN
ajlm-2381	89	176	(	(	PUNCT
ajlm-2381	89	177	pearson	pearson	PROPN
ajlm-2381	89	178	’s	’s	PART
ajlm-2381	89	179	r	r	NOUN
ajlm-2381	89	180	=	=	SYM
ajlm-2381	89	181	0.96	0.96	NUM
ajlm-2381	89	182	,	,	PUNCT
ajlm-2381	89	183	p	p	X
ajlm-2381	89	184	<	<	X
ajlm-2381	89	185	0.001).56	0.001).56	NUM
ajlm-2381	89	186	the	the	DET
ajlm-2381	89	187	study	study	NOUN
ajlm-2381	89	188	used	use	VERB
ajlm-2381	89	189	an	an	DET
ajlm-2381	89	190	aperio	aperio	PROPN
ajlm-2381	89	191	scanscope	scanscope	NOUN
ajlm-2381	89	192	xt	xt	PROPN
ajlm-2381	89	193	scanner	scanner	NOUN
ajlm-2381	89	194	(	(	PUNCT
ajlm-2381	89	195	aperio	aperio	NOUN
ajlm-2381	89	196	technologies	technologies	PROPN
ajlm-2381	89	197	,	,	PUNCT
ajlm-2381	89	198	california	california	PROPN
ajlm-2381	89	199	,	,	PUNCT
ajlm-2381	89	200	united	united	PROPN
ajlm-2381	89	201	states	states	PROPN
ajlm-2381	89	202	)	)	PUNCT
ajlm-2381	89	203	for	for	ADP
ajlm-2381	89	204	digitisation	digitisation	NOUN
ajlm-2381	89	205	of	of	ADP
ajlm-2381	89	206	the	the	DET
ajlm-2381	89	207	biopsies	biopsy	NOUN
ajlm-2381	89	208	to	to	PART
ajlm-2381	89	209	generate	generate	VERB
ajlm-2381	89	210	wsi	wsi	NOUN
ajlm-2381	89	211	for	for	ADP
ajlm-2381	89	212	analysis.56	analysis.56	NOUN
ajlm-2381	89	213	similar	similar	ADJ
ajlm-2381	89	214	studies	study	NOUN
ajlm-2381	89	215	were	be	AUX
ajlm-2381	89	216	done	do	VERB
ajlm-2381	89	217	by	by	ADP
ajlm-2381	89	218	fu	fu	PROPN
ajlm-2381	89	219	et	et	PROPN
ajlm-2381	89	220	al	al	PROPN
ajlm-2381	89	221	.	.	PROPN
ajlm-2381	90	1	in	in	ADP
ajlm-2381	90	2	canada	canada	PROPN
ajlm-2381	90	3	and	and	CCONJ
ajlm-2381	90	4	the	the	DET
ajlm-2381	90	5	united	united	PROPN
ajlm-2381	90	6	states	states	PROPN
ajlm-2381	90	7	in	in	ADP
ajlm-2381	90	8	2022	2022	NUM
ajlm-2381	90	9	,	,	PUNCT
ajlm-2381	90	10	and	and	CCONJ
ajlm-2381	90	11	by	by	ADP
ajlm-2381	90	12	lomas	lomas	PROPN
ajlm-2381	90	13	et	et	PROPN
ajlm-2381	90	14	al	al	PROPN
ajlm-2381	90	15	.	.	PROPN
ajlm-2381	91	1	in	in	ADP
ajlm-2381	91	2	the	the	DET
ajlm-2381	91	3	united	united	ADJ
ajlm-2381	91	4	kingdom	kingdom	NOUN
ajlm-2381	91	5	in	in	ADP
ajlm-2381	91	6	2022	2022	NUM
ajlm-2381	91	7	,	,	PUNCT
ajlm-2381	91	8	using	use	VERB
ajlm-2381	91	9	wsi.57,58	wsi.57,58	PRON
ajlm-2381	91	10	whole	whole	ADJ
ajlm-2381	91	11	slide	slide	NOUN
ajlm-2381	91	12	imaging	imaging	NOUN
ajlm-2381	91	13	may	may	AUX
ajlm-2381	91	14	be	be	AUX
ajlm-2381	91	15	used	use	VERB
ajlm-2381	91	16	to	to	PART
ajlm-2381	91	17	overcome	overcome	VERB
ajlm-2381	91	18	the	the	DET
ajlm-2381	91	19	considerable	considerable	ADJ
ajlm-2381	91	20	variability	variability	NOUN
ajlm-2381	91	21	in	in	ADP
ajlm-2381	91	22	cellularity	cellularity	NOUN
ajlm-2381	91	23	and	and	CCONJ
ajlm-2381	91	24	distribution	distribution	NOUN
ajlm-2381	91	25	of	of	ADP
ajlm-2381	91	26	plasma	plasma	NOUN
ajlm-2381	91	27	cells	cell	NOUN
ajlm-2381	91	28	in	in	ADP
ajlm-2381	91	29	bm	bm	PROPN
ajlm-2381	91	30	biopsies	biopsy	NOUN
ajlm-2381	91	31	by	by	ADP
ajlm-2381	91	32	providing	provide	VERB
ajlm-2381	91	33	images	image	NOUN
ajlm-2381	91	34	of	of	ADP
ajlm-2381	91	35	the	the	DET
ajlm-2381	91	36	full	full	ADJ
ajlm-2381	91	37	length	length	NOUN
ajlm-2381	91	38	of	of	ADP
ajlm-2381	91	39	the	the	DET
ajlm-2381	91	40	biopsy	biopsy	NOUN
ajlm-2381	91	41	.	.	PUNCT
ajlm-2381	92	1	whole	whole	ADJ
ajlm-2381	92	2	slide	slide	NOUN
ajlm-2381	92	3	imaging	imaging	NOUN
ajlm-2381	92	4	scanners	scanner	NOUN
ajlm-2381	92	5	are	be	AUX
ajlm-2381	92	6	not	not	PART
ajlm-2381	92	7	readily	readily	ADV
ajlm-2381	92	8	available	available	ADJ
ajlm-2381	92	9	in	in	ADP
ajlm-2381	92	10	resource	resource	NOUN
ajlm-2381	92	11	-	-	PUNCT
ajlm-2381	92	12	limited	limit	VERB
ajlm-2381	92	13	settings	setting	NOUN
ajlm-2381	92	14	,	,	PUNCT
ajlm-2381	92	15	hence	hence	ADV
ajlm-2381	92	16	alternative	alternative	ADJ
ajlm-2381	92	17	means	mean	NOUN
ajlm-2381	92	18	of	of	ADP
ajlm-2381	92	19	digitising	digitise	VERB
ajlm-2381	92	20	and	and	CCONJ
ajlm-2381	92	21	analysing	analyse	VERB
ajlm-2381	92	22	biopsies	biopsy	NOUN
ajlm-2381	92	23	are	be	AUX
ajlm-2381	92	24	still	still	ADV
ajlm-2381	92	25	required	require	VERB
ajlm-2381	92	26	.	.	PUNCT
ajlm-2381	93	1	using	use	VERB
ajlm-2381	93	2	the	the	DET
ajlm-2381	93	3	ai	ai	NOUN
ajlm-2381	93	4	of	of	ADP
ajlm-2381	93	5	qupath	qupath	NOUN
ajlm-2381	93	6	,	,	PUNCT
ajlm-2381	93	7	gantana	gantana	PROPN
ajlm-2381	93	8	et	et	PROPN
ajlm-2381	93	9	al	al	PROPN
ajlm-2381	93	10	.	.	PROPN
ajlm-2381	93	11	,	,	PUNCT
ajlm-2381	93	12	in	in	ADP
ajlm-2381	93	13	their	their	PRON
ajlm-2381	93	14	south	south	ADJ
ajlm-2381	93	15	african	african	ADJ
ajlm-2381	93	16	study	study	NOUN
ajlm-2381	93	17	published	publish	VERB
ajlm-2381	93	18	in	in	ADP
ajlm-2381	93	19	2023	2023	NUM
ajlm-2381	93	20	,	,	PUNCT
ajlm-2381	93	21	counted	count	VERB
ajlm-2381	93	22	cd138	cd138	NOUN
ajlm-2381	93	23	-	-	PUNCT
ajlm-2381	93	24	positive	positive	ADJ
ajlm-2381	93	25	pc	pc	NOUN
ajlm-2381	93	26	in	in	ADP
ajlm-2381	93	27	bm	bm	PROPN
ajlm-2381	93	28	biopsies	biopsy	NOUN
ajlm-2381	93	29	and	and	CCONJ
ajlm-2381	93	30	showed	show	VERB
ajlm-2381	93	31	that	that	SCONJ
ajlm-2381	93	32	digital	digital	ADJ
ajlm-2381	93	33	analysis	analysis	NOUN
ajlm-2381	93	34	is	be	AUX
ajlm-2381	93	35	superior	superior	ADJ
ajlm-2381	93	36	to	to	ADP
ajlm-2381	93	37	both	both	CCONJ
ajlm-2381	93	38	a	a	DET
ajlm-2381	93	39	manual	manual	ADJ
ajlm-2381	93	40	counting	counting	NOUN
ajlm-2381	93	41	method	method	NOUN
ajlm-2381	93	42	and	and	CCONJ
ajlm-2381	93	43	a	a	DET
ajlm-2381	93	44	previously	previously	ADV
ajlm-2381	93	45	reported	report	VERB
ajlm-2381	93	46	overview	overview	NOUN
ajlm-2381	93	47	estimation	estimation	NOUN
ajlm-2381	93	48	method	method	NOUN
ajlm-2381	93	49	,	,	PUNCT
ajlm-2381	93	50	regardless	regardless	ADV
ajlm-2381	93	51	of	of	ADP
ajlm-2381	93	52	the	the	DET
ajlm-2381	93	53	tumour	tumour	NOUN
ajlm-2381	93	54	burden	burden	NOUN
ajlm-2381	93	55	of	of	ADP
ajlm-2381	93	56	the	the	DET
ajlm-2381	93	57	sample.59	sample.59	NOUN
ajlm-2381	93	58	in	in	ADP
ajlm-2381	93	59	this	this	DET
ajlm-2381	93	60	study	study	NOUN
ajlm-2381	93	61	,	,	PUNCT
ajlm-2381	93	62	digitisation	digitisation	NOUN
ajlm-2381	93	63	of	of	ADP
ajlm-2381	93	64	representative	representative	ADJ
ajlm-2381	93	65	biopsy	biopsy	NOUN
ajlm-2381	93	66	areas	area	NOUN
ajlm-2381	93	67	with	with	ADP
ajlm-2381	93	68	low	low	ADJ
ajlm-2381	93	69	,	,	PUNCT
ajlm-2381	93	70	intermediate	intermediate	ADJ
ajlm-2381	93	71	and	and	CCONJ
ajlm-2381	93	72	high	high	ADJ
ajlm-2381	93	73	pc	pc	NOUN
ajlm-2381	93	74	densities	density	NOUN
ajlm-2381	93	75	was	be	AUX
ajlm-2381	93	76	done	do	VERB
ajlm-2381	93	77	with	with	ADP
ajlm-2381	93	78	a	a	DET
ajlm-2381	93	79	standard	standard	ADJ
ajlm-2381	93	80	microscope	microscope	NOUN
ajlm-2381	93	81	and	and	CCONJ
ajlm-2381	93	82	camera	camera	NOUN
ajlm-2381	93	83	rather	rather	ADV
ajlm-2381	93	84	than	than	ADP
ajlm-2381	93	85	wsi	wsi	PROPN
ajlm-2381	93	86	.	.	PUNCT
ajlm-2381	93	87	fu	fu	PROPN
ajlm-2381	93	88	et	et	PROPN
ajlm-2381	93	89	al	al	PROPN
ajlm-2381	93	90	.	.	PROPN
ajlm-2381	93	91	developed	develop	VERB
ajlm-2381	93	92	a	a	DET
ajlm-2381	93	93	web	web	NOUN
ajlm-2381	93	94	application	application	NOUN
ajlm-2381	93	95	that	that	PRON
ajlm-2381	93	96	utilises	utilise	VERB
ajlm-2381	93	97	their	their	PRON
ajlm-2381	93	98	developed	develop	VERB
ajlm-2381	93	99	convolutional	convolutional	ADJ
ajlm-2381	93	100	neural	neural	ADJ
ajlm-2381	93	101	network	network	NOUN
ajlm-2381	93	102	,	,	PUNCT
ajlm-2381	93	103	which	which	PRON
ajlm-2381	93	104	allows	allow	VERB
ajlm-2381	93	105	pathologists	pathologist	NOUN
ajlm-2381	93	106	to	to	PART
ajlm-2381	93	107	upload	upload	VERB
ajlm-2381	93	108	single	single	ADJ
ajlm-2381	93	109	images	image	NOUN
ajlm-2381	93	110	from	from	ADP
ajlm-2381	93	111	microscope	microscope	NOUN
ajlm-2381	93	112	cameras	camera	NOUN
ajlm-2381	93	113	to	to	PART
ajlm-2381	93	114	obtain	obtain	VERB
ajlm-2381	93	115	a	a	DET
ajlm-2381	93	116	percentage	percentage	NOUN
ajlm-2381	93	117	of	of	ADP
ajlm-2381	93	118	plasma	plasma	NOUN
ajlm-2381	93	119	cells	cell	NOUN
ajlm-2381	93	120	in	in	ADP
ajlm-2381	93	121	real	real	ADJ
ajlm-2381	93	122	time	time	NOUN
ajlm-2381	93	123	based	base	VERB
ajlm-2381	93	124	on	on	ADP
ajlm-2381	93	125	the	the	DET
ajlm-2381	93	126	cd138	cd138	NOUN
ajlm-2381	93	127	-	-	PUNCT
ajlm-2381	93	128	stained	stain	VERB
ajlm-2381	93	129	plasma	plasma	NOUN
ajlm-2381	93	130	cells	cell	NOUN
ajlm-2381	93	131	on	on	ADP
ajlm-2381	93	132	that	that	DET
ajlm-2381	93	133	image.57	image.57	ADV
ajlm-2381	93	134	these	these	DET
ajlm-2381	93	135	methods	method	NOUN
ajlm-2381	93	136	may	may	AUX
ajlm-2381	93	137	be	be	AUX
ajlm-2381	93	138	more	more	ADV
ajlm-2381	93	139	accessible	accessible	ADJ
ajlm-2381	93	140	to	to	ADP
ajlm-2381	93	141	low	low	ADJ
ajlm-2381	93	142	-	-	PUNCT
ajlm-2381	93	143	resource	resource	NOUN
ajlm-2381	93	144	settings	setting	NOUN
ajlm-2381	93	145	than	than	ADP
ajlm-2381	93	146	using	use	VERB
ajlm-2381	93	147	wsi	wsi	NOUN
ajlm-2381	93	148	.	.	PUNCT
ajlm-2381	94	1	the	the	DET
ajlm-2381	94	2	advantage	advantage	NOUN
ajlm-2381	94	3	of	of	ADP
ajlm-2381	94	4	digital	digital	ADJ
ajlm-2381	94	5	image	image	NOUN
ajlm-2381	94	6	analysis	analysis	NOUN
ajlm-2381	94	7	is	be	AUX
ajlm-2381	94	8	therefore	therefore	ADV
ajlm-2381	94	9	considerable	considerable	ADJ
ajlm-2381	94	10	.	.	PUNCT
ajlm-2381	95	1	it	it	PRON
ajlm-2381	95	2	may	may	AUX
ajlm-2381	95	3	be	be	AUX
ajlm-2381	95	4	incorporated	incorporate	VERB
ajlm-2381	95	5	into	into	ADP
ajlm-2381	95	6	routine	routine	ADJ
ajlm-2381	95	7	use	use	NOUN
ajlm-2381	95	8	,	,	PUNCT
ajlm-2381	95	9	but	but	CCONJ
ajlm-2381	95	10	slides	slide	NOUN
ajlm-2381	95	11	need	need	VERB
ajlm-2381	95	12	to	to	PART
ajlm-2381	95	13	be	be	AUX
ajlm-2381	95	14	of	of	ADP
ajlm-2381	95	15	equal	equal	ADJ
ajlm-2381	95	16	quality	quality	NOUN
ajlm-2381	95	17	.	.	PUNCT
ajlm-2381	96	1	this	this	PRON
ajlm-2381	96	2	requires	require	VERB
ajlm-2381	96	3	standardisation	standardisation	NOUN
ajlm-2381	96	4	of	of	ADP
ajlm-2381	96	5	biopsy	biopsy	NOUN
ajlm-2381	96	6	processing	process	VERB
ajlm-2381	96	7	protocols.52	protocols.52	ADJ
ajlm-2381	96	8	one	one	NUM
ajlm-2381	96	9	study	study	NOUN
ajlm-2381	96	10	showed	show	VERB
ajlm-2381	96	11	that	that	SCONJ
ajlm-2381	96	12	all	all	DET
ajlm-2381	96	13	pre	pre	ADJ
ajlm-2381	96	14	-	-	ADJ
ajlm-2381	96	15	analytical	analytical	ADJ
ajlm-2381	96	16	aspects	aspect	NOUN
ajlm-2381	96	17	affect	affect	VERB
ajlm-2381	96	18	the	the	DET
ajlm-2381	96	19	appearance	appearance	NOUN
ajlm-2381	96	20	of	of	ADP
ajlm-2381	96	21	tissue	tissue	NOUN
ajlm-2381	96	22	sections	section	NOUN
ajlm-2381	96	23	and	and	CCONJ
ajlm-2381	96	24	their	their	PRON
ajlm-2381	96	25	suitability	suitability	NOUN
ajlm-2381	96	26	for	for	ADP
ajlm-2381	96	27	digital	digital	ADJ
ajlm-2381	96	28	pathology	pathology	NOUN
ajlm-2381	96	29	and	and	CCONJ
ajlm-2381	96	30	therefore	therefore	ADV
ajlm-2381	96	31	recommended	recommend	VERB
ajlm-2381	96	32	visually	visually	ADV
ajlm-2381	96	33	checking	check	VERB
ajlm-2381	96	34	the	the	DET
ajlm-2381	96	35	pc	pc	NOUN
ajlm-2381	96	36	estimates	estimate	NOUN
ajlm-2381	96	37	and	and	CCONJ
ajlm-2381	96	38	adjusting	adjust	VERB
ajlm-2381	96	39	both	both	DET
ajlm-2381	96	40	parameters	parameter	NOUN
ajlm-2381	96	41	and	and	CCONJ
ajlm-2381	96	42	thresholds	threshold	VERB
ajlm-2381	96	43	accordingly.60	accordingly.60	PROPN
ajlm-2381	96	44	the	the	DET
ajlm-2381	96	45	college	college	PROPN
ajlm-2381	96	46	of	of	ADP
ajlm-2381	96	47	american	american	ADJ
ajlm-2381	96	48	pathologists	pathologist	NOUN
ajlm-2381	96	49	recently	recently	ADV
ajlm-2381	96	50	released	release	VERB
ajlm-2381	96	51	an	an	DET
ajlm-2381	96	52	updated	update	VERB
ajlm-2381	96	53	guideline	guideline	NOUN
ajlm-2381	96	54	for	for	ADP
ajlm-2381	96	55	the	the	DET
ajlm-2381	96	56	validation	validation	NOUN
ajlm-2381	96	57	of	of	ADP
ajlm-2381	96	58	wsi	wsi	NOUN
ajlm-2381	96	59	for	for	ADP
ajlm-2381	96	60	diagnostic	diagnostic	ADJ
ajlm-2381	96	61	purposes.61	purposes.61	NOUN
ajlm-2381	96	62	artificial	artificial	ADJ
ajlm-2381	96	63	intelligence	intelligence	NOUN
ajlm-2381	96	64	the	the	DET
ajlm-2381	96	65	accurate	accurate	ADJ
ajlm-2381	96	66	determination	determination	NOUN
ajlm-2381	96	67	of	of	ADP
ajlm-2381	96	68	bmpcs	bmpc	NOUN
ajlm-2381	96	69	plays	play	VERB
ajlm-2381	96	70	a	a	DET
ajlm-2381	96	71	central	central	ADJ
ajlm-2381	96	72	role	role	NOUN
ajlm-2381	96	73	in	in	ADP
ajlm-2381	96	74	the	the	DET
ajlm-2381	96	75	diagnosis	diagnosis	NOUN
ajlm-2381	96	76	,	,	PUNCT
ajlm-2381	96	77	prognosis	prognosis	NOUN
ajlm-2381	96	78	,	,	PUNCT
ajlm-2381	96	79	the	the	DET
ajlm-2381	96	80	choice	choice	NOUN
ajlm-2381	96	81	of	of	ADP
ajlm-2381	96	82	therapy	therapy	NOUN
ajlm-2381	96	83	and	and	CCONJ
ajlm-2381	96	84	the	the	DET
ajlm-2381	96	85	monitoring	monitoring	NOUN
ajlm-2381	96	86	of	of	ADP
ajlm-2381	96	87	pc	pc	NOUN
ajlm-2381	96	88	neoplasms	neoplasm	NOUN
ajlm-2381	96	89	and	and	CCONJ
ajlm-2381	96	90	is	be	AUX
ajlm-2381	96	91	therefore	therefore	ADV
ajlm-2381	96	92	essential	essential	ADJ
ajlm-2381	96	93	.	.	PUNCT
ajlm-2381	97	1	artificial	artificial	ADJ
ajlm-2381	97	2	intelligence	intelligence	NOUN
ajlm-2381	97	3	,	,	PUNCT
ajlm-2381	97	4	in	in	ADP
ajlm-2381	97	5	combination	combination	NOUN
ajlm-2381	97	6	with	with	ADP
ajlm-2381	97	7	methods	method	NOUN
ajlm-2381	97	8	such	such	ADJ
ajlm-2381	97	9	as	as	ADP
ajlm-2381	97	10	flow	flow	NOUN
ajlm-2381	97	11	cytometry	cytometry	NOUN
ajlm-2381	97	12	and	and	CCONJ
ajlm-2381	97	13	ngs	ng	NOUN
ajlm-2381	97	14	,	,	PUNCT
ajlm-2381	97	15	can	can	AUX
ajlm-2381	97	16	provide	provide	VERB
ajlm-2381	97	17	information	information	NOUN
ajlm-2381	97	18	to	to	PART
ajlm-2381	97	19	predict	predict	VERB
ajlm-2381	97	20	risk	risk	NOUN
ajlm-2381	97	21	status	status	NOUN
ajlm-2381	97	22	and	and	CCONJ
ajlm-2381	97	23	potentially	potentially	ADV
ajlm-2381	97	24	change	change	VERB
ajlm-2381	97	25	the	the	DET
ajlm-2381	97	26	diagnostic	diagnostic	ADJ
ajlm-2381	97	27	criteria	criterion	NOUN
ajlm-2381	97	28	and	and	CCONJ
ajlm-2381	97	29	risk	risk	NOUN
ajlm-2381	97	30	stratification	stratification	NOUN
ajlm-2381	97	31	for	for	ADP
ajlm-2381	97	32	mm	mm	PROPN
ajlm-2381	97	33	.	.	PUNCT
ajlm-2381	98	1	in	in	ADP
ajlm-2381	98	2	their	their	PRON
ajlm-2381	98	3	2022	2022	NUM
ajlm-2381	98	4	publication	publication	NOUN
ajlm-2381	98	5	in	in	ADP
ajlm-2381	98	6	france	france	PROPN
ajlm-2381	98	7	,	,	PUNCT
ajlm-2381	98	8	clichet	clichet	NOUN
ajlm-2381	98	9	et	et	PROPN
ajlm-2381	98	10	al	al	PROPN
ajlm-2381	98	11	.	.	PROPN
ajlm-2381	98	12	used	use	VERB
ajlm-2381	98	13	an	an	DET
ajlm-2381	98	14	ai	ai	NOUN
ajlm-2381	98	15	-	-	PUNCT
ajlm-2381	98	16	based	base	VERB
ajlm-2381	98	17	gradient	gradient	NOUN
ajlm-2381	98	18	-	-	PUNCT
ajlm-2381	98	19	boosting	boost	VERB
ajlm-2381	98	20	machine	machine	NOUN
ajlm-2381	98	21	algorithm	algorithm	NOUN
ajlm-2381	98	22	to	to	PART
ajlm-2381	98	23	develop	develop	VERB
ajlm-2381	98	24	a	a	DET
ajlm-2381	98	25	decision	decision	NOUN
ajlm-2381	98	26	tree	tree	NOUN
ajlm-2381	98	27	for	for	ADP
ajlm-2381	98	28	determining	determine	VERB
ajlm-2381	98	29	the	the	DET
ajlm-2381	98	30	risk	risk	NOUN
ajlm-2381	98	31	of	of	ADP
ajlm-2381	98	32	mm	mm	PROPN
ajlm-2381	98	33	in	in	ADP
ajlm-2381	98	34	a	a	DET
ajlm-2381	98	35	cohort	cohort	NOUN
ajlm-2381	98	36	of	of	ADP
ajlm-2381	98	37	pc	pc	NOUN
ajlm-2381	98	38	neoplasms	neoplasm	NOUN
ajlm-2381	98	39	.	.	PUNCT
ajlm-2381	99	1	they	they	PRON
ajlm-2381	99	2	used	use	VERB
ajlm-2381	99	3	mfc	mfc	PROPN
ajlm-2381	99	4	(	(	PUNCT
ajlm-2381	99	5	10	10	NUM
ajlm-2381	99	6	-	-	PUNCT
ajlm-2381	99	7	colour	colour	ADJ
ajlm-2381	99	8	single	single	ADJ
ajlm-2381	99	9	tube	tube	NOUN
ajlm-2381	99	10	)	)	PUNCT
ajlm-2381	99	11	parameters	parameter	NOUN
ajlm-2381	99	12	including	include	VERB
ajlm-2381	99	13	pc	pc	NOUN
ajlm-2381	99	14	%	%	NOUN
ajlm-2381	99	15	,	,	PUNCT
ajlm-2381	99	16	pathological	pathological	ADJ
ajlm-2381	99	17	to	to	ADP
ajlm-2381	99	18	normal	normal	ADJ
ajlm-2381	99	19	pc	pc	NOUN
ajlm-2381	99	20	ratio	ratio	NOUN
ajlm-2381	99	21	,	,	PUNCT
ajlm-2381	99	22	total	total	ADJ
ajlm-2381	99	23	pc	pc	NOUN
ajlm-2381	99	24	to	to	ADP
ajlm-2381	99	25	haematogone	haematogone	NOUN
ajlm-2381	99	26	ratio	ratio	NOUN
ajlm-2381	99	27	,	,	PUNCT
ajlm-2381	99	28	total	total	ADJ
ajlm-2381	99	29	pc	pc	NOUN
ajlm-2381	99	30	to	to	PART
ajlm-2381	99	31	progenitor	progenitor	VERB
ajlm-2381	99	32	cd117	cd117	PROPN
ajlm-2381	99	33	+	+	CCONJ
ajlm-2381	99	34	ratio	ratio	NOUN
ajlm-2381	99	35	,	,	PUNCT
ajlm-2381	99	36	mean	mean	VERB
ajlm-2381	99	37	fluorescence	fluorescence	ADJ
ajlm-2381	99	38	intensity	intensity	NOUN
ajlm-2381	99	39	of	of	ADP
ajlm-2381	99	40	cd38	cd38	PROPN
ajlm-2381	99	41	and	and	CCONJ
ajlm-2381	99	42	cd27	cd27	PROPN
ajlm-2381	99	43	from	from	ADP
ajlm-2381	99	44	pathological	pathological	ADJ
ajlm-2381	99	45	pc	pc	NOUN
ajlm-2381	99	46	,	,	PUNCT
ajlm-2381	99	47	and	and	CCONJ
ajlm-2381	99	48	mean	mean	VERB
ajlm-2381	99	49	fluorescence	fluorescence	ADJ
ajlm-2381	99	50	intensity	intensity	NOUN
ajlm-2381	99	51	of	of	ADP
ajlm-2381	99	52	cd27	cd27	PROPN
ajlm-2381	99	53	from	from	ADP
ajlm-2381	99	54	normal	normal	ADJ
ajlm-2381	99	55	cells	cell	NOUN
ajlm-2381	99	56	at	at	ADP
ajlm-2381	99	57	diagnosis	diagnosis	NOUN
ajlm-2381	99	58	.	.	PUNCT
ajlm-2381	100	1	the	the	DET
ajlm-2381	100	2	ai	ai	NOUN
ajlm-2381	100	3	-	-	PUNCT
ajlm-2381	100	4	based	base	VERB
ajlm-2381	100	5	decision	decision	NOUN
ajlm-2381	100	6	tree	tree	NOUN
ajlm-2381	100	7	showed	show	VERB
ajlm-2381	100	8	a	a	DET
ajlm-2381	100	9	sensitivity	sensitivity	NOUN
ajlm-2381	100	10	of	of	ADP
ajlm-2381	100	11	94.2	94.2	NUM
ajlm-2381	100	12	%	%	NOUN
ajlm-2381	100	13	,	,	PUNCT
ajlm-2381	100	14	a	a	DET
ajlm-2381	100	15	specificity	specificity	NOUN
ajlm-2381	100	16	of	of	ADP
ajlm-2381	100	17	93.7	93.7	NUM
ajlm-2381	100	18	%	%	NOUN
ajlm-2381	100	19	and	and	CCONJ
ajlm-2381	100	20	an	an	DET
ajlm-2381	100	21	independent	independent	ADJ
ajlm-2381	100	22	validation	validation	NOUN
ajlm-2381	100	23	success	success	NOUN
ajlm-2381	100	24	rate	rate	NOUN
ajlm-2381	100	25	of	of	ADP
ajlm-2381	100	26	91.0	91.0	NUM
ajlm-2381	100	27	%	%	NOUN
ajlm-2381	100	28	without	without	ADP
ajlm-2381	100	29	misclassification	misclassification	NOUN
ajlm-2381	100	30	between	between	ADP
ajlm-2381	100	31	monoclonal	monoclonal	NOUN
ajlm-2381	100	32	gammopathy	gammopathy	ADJ
ajlm-2381	100	33	of	of	ADP
ajlm-2381	100	34	undetermined	undetermined	ADJ
ajlm-2381	100	35	significance	significance	NOUN
ajlm-2381	100	36	and	and	CCONJ
ajlm-2381	100	37	smouldering	smoulder	VERB
ajlm-2381	100	38	multiple	multiple	ADJ
ajlm-2381	100	39	myeloma.62	myeloma.62	NOUN
ajlm-2381	100	40	this	this	DET
ajlm-2381	100	41	online	online	ADJ
ajlm-2381	100	42	diagnostic	diagnostic	ADJ
ajlm-2381	100	43	tool	tool	NOUN
ajlm-2381	100	44	is	be	AUX
ajlm-2381	100	45	currently	currently	ADV
ajlm-2381	100	46	freely	freely	ADV
ajlm-2381	100	47	available	available	ADJ
ajlm-2381	100	48	and	and	CCONJ
ajlm-2381	100	49	could	could	AUX
ajlm-2381	100	50	be	be	AUX
ajlm-2381	100	51	used	use	VERB
ajlm-2381	100	52	for	for	ADP
ajlm-2381	100	53	cases	case	NOUN
ajlm-2381	100	54	with	with	ADP
ajlm-2381	100	55	diagnostic	diagnostic	ADJ
ajlm-2381	100	56	dilemmas	dilemma	NOUN
ajlm-2381	100	57	in	in	ADP
ajlm-2381	100	58	pc	pc	NOUN
ajlm-2381	100	59	neoplasms	neoplasm	NOUN
ajlm-2381	100	60	.	.	PUNCT
ajlm-2381	101	1	yenamandra	yenamandra	INTJ
ajlm-2381	101	2	et	et	PROPN
ajlm-2381	101	3	al	al	PROPN
ajlm-2381	101	4	.	.	PROPN
ajlm-2381	101	5	,	,	PUNCT
ajlm-2381	101	6	in	in	ADP
ajlm-2381	101	7	their	their	PRON
ajlm-2381	101	8	study	study	NOUN
ajlm-2381	101	9	published	publish	VERB
ajlm-2381	101	10	in	in	ADP
ajlm-2381	101	11	the	the	DET
ajlm-2381	101	12	united	united	PROPN
ajlm-2381	101	13	states	states	PROPN
ajlm-2381	101	14	in	in	ADP
ajlm-2381	101	15	2021	2021	NUM
ajlm-2381	101	16	,	,	PUNCT
ajlm-2381	101	17	used	use	VERB
ajlm-2381	101	18	data	datum	NOUN
ajlm-2381	101	19	at	at	ADP
ajlm-2381	101	20	the	the	DET
ajlm-2381	101	21	time	time	NOUN
ajlm-2381	101	22	of	of	ADP
ajlm-2381	101	23	diagnosis	diagnosis	NOUN
ajlm-2381	101	24	which	which	PRON
ajlm-2381	101	25	included	include	VERB
ajlm-2381	101	26	variables	variable	NOUN
ajlm-2381	101	27	such	such	ADJ
ajlm-2381	101	28	as	as	ADP
ajlm-2381	101	29	patient	patient	ADJ
ajlm-2381	101	30	age	age	NOUN
ajlm-2381	101	31	,	,	PUNCT
ajlm-2381	101	32	white	white	ADJ
ajlm-2381	101	33	blood	blood	NOUN
ajlm-2381	101	34	cell	cell	NOUN
ajlm-2381	101	35	count	count	NOUN
ajlm-2381	101	36	,	,	PUNCT
ajlm-2381	101	37	percentage	percentage	NOUN
ajlm-2381	101	38	of	of	ADP
ajlm-2381	101	39	pc	pc	NOUN
ajlm-2381	101	40	in	in	ADP
ajlm-2381	101	41	the	the	DET
ajlm-2381	101	42	bm	bm	PROPN
ajlm-2381	101	43	on	on	ADP
ajlm-2381	101	44	the	the	DET
ajlm-2381	101	45	myelogram	myelogram	NOUN
ajlm-2381	101	46	,	,	PUNCT
ajlm-2381	101	47	high	high	ADJ
ajlm-2381	101	48	-	-	PUNCT
ajlm-2381	101	49	risk	risk	NOUN
ajlm-2381	101	50	cytogenetic	cytogenetic	ADJ
ajlm-2381	101	51	alterations	alteration	NOUN
ajlm-2381	101	52	,	,	PUNCT
ajlm-2381	101	53	and	and	CCONJ
ajlm-2381	101	54	ngs	ng	NOUN
ajlm-2381	101	55	.	.	PUNCT
ajlm-2381	102	1	these	these	DET
ajlm-2381	102	2	data	datum	NOUN
ajlm-2381	102	3	were	be	AUX
ajlm-2381	102	4	used	use	VERB
ajlm-2381	102	5	to	to	PART
ajlm-2381	102	6	create	create	VERB
ajlm-2381	102	7	neural	neural	ADJ
ajlm-2381	102	8	networks	network	NOUN
ajlm-2381	102	9	with	with	ADP
ajlm-2381	102	10	which	which	PRON
ajlm-2381	102	11	they	they	PRON
ajlm-2381	102	12	developed	develop	VERB
ajlm-2381	102	13	a	a	DET
ajlm-2381	102	14	predictor	predictor	NOUN
ajlm-2381	102	15	for	for	ADP
ajlm-2381	102	16	the	the	DET
ajlm-2381	102	17	risk	risk	NOUN
ajlm-2381	102	18	status	status	NOUN
ajlm-2381	102	19	of	of	ADP
ajlm-2381	102	20	mm	mm	PROPN
ajlm-2381	102	21	,	,	PUNCT
ajlm-2381	102	22	which	which	PRON
ajlm-2381	102	23	has	have	VERB
ajlm-2381	102	24	the	the	DET
ajlm-2381	102	25	potential	potential	NOUN
ajlm-2381	102	26	to	to	PART
ajlm-2381	102	27	predict	predict	VERB
ajlm-2381	102	28	high	high	ADJ
ajlm-2381	102	29	-	-	PUNCT
ajlm-2381	102	30	risk	risk	NOUN
ajlm-2381	102	31	patients.63	patients.63	NOUN
ajlm-2381	102	32	the	the	DET
ajlm-2381	102	33	limitation	limitation	NOUN
ajlm-2381	102	34	is	be	AUX
ajlm-2381	102	35	lack	lack	NOUN
ajlm-2381	102	36	of	of	ADP
ajlm-2381	102	37	estimated	estimate	VERB
ajlm-2381	102	38	bmpc%	bmpc%	PUNCT
ajlm-2381	102	39	in	in	ADP
ajlm-2381	102	40	the	the	DET
ajlm-2381	102	41	bm	bm	PROPN
ajlm-2381	102	42	biopsy	biopsy	PROPN
ajlm-2381	102	43	sections	section	NOUN
ajlm-2381	102	44	.	.	PUNCT
ajlm-2381	103	1	with	with	ADP
ajlm-2381	103	2	picture	picture	NOUN
ajlm-2381	103	3	archiving	archiving	NOUN
ajlm-2381	103	4	and	and	CCONJ
ajlm-2381	103	5	communications	communication	NOUN
ajlm-2381	103	6	systems	system	NOUN
ajlm-2381	103	7	as	as	ADP
ajlm-2381	103	8	the	the	DET
ajlm-2381	103	9	standard	standard	NOUN
ajlm-2381	103	10	in	in	ADP
ajlm-2381	103	11	many	many	ADJ
ajlm-2381	103	12	tertiary	tertiary	ADJ
ajlm-2381	103	13	institutions	institution	NOUN
ajlm-2381	103	14	,	,	PUNCT
ajlm-2381	103	15	radiology	radiology	NOUN
ajlm-2381	103	16	has	have	VERB
ajlm-2381	103	17	a	a	DET
ajlm-2381	103	18	significant	significant	ADJ
ajlm-2381	103	19	potential	potential	NOUN
ajlm-2381	103	20	for	for	ADP
ajlm-2381	103	21	radiomics	radiomic	NOUN
ajlm-2381	103	22	,	,	PUNCT
ajlm-2381	103	23	the	the	DET
ajlm-2381	103	24	use	use	NOUN
ajlm-2381	103	25	of	of	ADP
ajlm-2381	103	26	pattern	pattern	NOUN
ajlm-2381	103	27	recognition	recognition	NOUN
ajlm-2381	103	28	for	for	ADP
ajlm-2381	103	29	the	the	DET
ajlm-2381	103	30	extraction	extraction	NOUN
ajlm-2381	103	31	of	of	ADP
ajlm-2381	103	32	quantitative	quantitative	ADJ
ajlm-2381	103	33	descriptors	descriptor	NOUN
ajlm-2381	103	34	from	from	ADP
ajlm-2381	103	35	imaging	image	VERB
ajlm-2381	103	36	data.64	data.64	PROPN
ajlm-2381	103	37	radiomics	radiomic	NOUN
ajlm-2381	103	38	and	and	CCONJ
ajlm-2381	103	39	computational	computational	ADJ
ajlm-2381	103	40	algorithms	algorithm	NOUN
ajlm-2381	103	41	may	may	AUX
ajlm-2381	103	42	potentially	potentially	ADV
ajlm-2381	103	43	be	be	AUX
ajlm-2381	103	44	used	use	VERB
ajlm-2381	103	45	for	for	ADP
ajlm-2381	103	46	quantitative	quantitative	ADJ
ajlm-2381	103	47	imaging	imaging	NOUN
ajlm-2381	103	48	in	in	ADP
ajlm-2381	103	49	mm	mm	PROPN
ajlm-2381	103	50	patients	patient	NOUN
ajlm-2381	103	51	by	by	ADP
ajlm-2381	103	52	assessing	assess	VERB
ajlm-2381	103	53	different	different	ADJ
ajlm-2381	103	54	bone	bone	NOUN
ajlm-2381	103	55	lesions	lesion	NOUN
ajlm-2381	103	56	in	in	ADP
ajlm-2381	103	57	pet	pet	NOUN
ajlm-2381	103	58	/	/	SYM
ajlm-2381	103	59	ct	ct	PROPN
ajlm-2381	103	60	imaging	imaging	NOUN
ajlm-2381	103	61	and	and	CCONJ
ajlm-2381	103	62	mri.65	mri.65	NOUN
ajlm-2381	103	63	this	this	PRON
ajlm-2381	103	64	is	be	AUX
ajlm-2381	103	65	an	an	DET
ajlm-2381	103	66	interesting	interesting	ADJ
ajlm-2381	103	67	and	and	CCONJ
ajlm-2381	103	68	dynamic	dynamic	ADJ
ajlm-2381	103	69	field	field	NOUN
ajlm-2381	103	70	,	,	PUNCT
ajlm-2381	103	71	in	in	ADP
ajlm-2381	103	72	early	early	ADJ
ajlm-2381	103	73	phase	phase	NOUN
ajlm-2381	103	74	of	of	ADP
ajlm-2381	103	75	development.65,66	development.65,66	NOUN
ajlm-2381	103	76	however	however	ADV
ajlm-2381	103	77	,	,	PUNCT
ajlm-2381	103	78	this	this	PRON
ajlm-2381	103	79	depends	depend	VERB
ajlm-2381	103	80	on	on	ADP
ajlm-2381	103	81	the	the	DET
ajlm-2381	103	82	availability	availability	NOUN
ajlm-2381	103	83	of	of	ADP
ajlm-2381	103	84	technology	technology	NOUN
ajlm-2381	103	85	in	in	ADP
ajlm-2381	103	86	some	some	DET
ajlm-2381	103	87	tertiary	tertiary	ADJ
ajlm-2381	103	88	facilities	facility	NOUN
ajlm-2381	103	89	with	with	ADP
ajlm-2381	103	90	pet	pet	NOUN
ajlm-2381	103	91	/	/	SYM
ajlm-2381	103	92	ct	ct	PROPN
ajlm-2381	103	93	and	and	CCONJ
ajlm-2381	103	94	mri	mri	NOUN
ajlm-2381	103	95	technologies	technology	NOUN
ajlm-2381	103	96	.	.	PUNCT
ajlm-2381	104	1	estimation	estimation	NOUN
ajlm-2381	104	2	of	of	ADP
ajlm-2381	104	3	plasma	plasma	NOUN
ajlm-2381	104	4	cells	cell	NOUN
ajlm-2381	104	5	in	in	ADP
ajlm-2381	104	6	bone	bone	NOUN
ajlm-2381	104	7	marrow	marrow	NOUN
ajlm-2381	104	8	for	for	ADP
ajlm-2381	104	9	measurable	measurable	ADJ
ajlm-2381	104	10	residual	residual	ADJ
ajlm-2381	104	11	disease	disease	NOUN
ajlm-2381	104	12	there	there	PRON
ajlm-2381	104	13	are	be	VERB
ajlm-2381	104	14	several	several	ADJ
ajlm-2381	104	15	strategies	strategy	NOUN
ajlm-2381	104	16	for	for	ADP
ajlm-2381	104	17	mrd	mrd	ADJ
ajlm-2381	104	18	detection	detection	NOUN
ajlm-2381	104	19	in	in	ADP
ajlm-2381	104	20	myeloma	myeloma	NOUN
ajlm-2381	104	21	,	,	PUNCT
ajlm-2381	104	22	including	include	VERB
ajlm-2381	104	23	mfc	mfc	PROPN
ajlm-2381	104	24	,	,	PUNCT
ajlm-2381	104	25	qpcr	qpcr	ADJ
ajlm-2381	104	26	,	,	PUNCT
ajlm-2381	104	27	and	and	CCONJ
ajlm-2381	104	28	high	high	ADJ
ajlm-2381	104	29	-	-	PUNCT
ajlm-2381	104	30	throughput	throughput	NOUN
ajlm-2381	104	31	sequencing	sequencing	NOUN
ajlm-2381	104	32	.	.	PUNCT
ajlm-2381	105	1	the	the	DET
ajlm-2381	105	2	two	two	NUM
ajlm-2381	105	3	currently	currently	ADV
ajlm-2381	105	4	validated	validate	VERB
ajlm-2381	105	5	mrd	mrd	ADJ
ajlm-2381	105	6	methods	method	NOUN
ajlm-2381	105	7	recommended	recommend	VERB
ajlm-2381	105	8	by	by	ADP
ajlm-2381	105	9	the	the	DET
ajlm-2381	105	10	imwg	imwg	NOUN
ajlm-2381	105	11	are	be	AUX
ajlm-2381	105	12	next	next	ADJ
ajlm-2381	105	13	-	-	PUNCT
ajlm-2381	105	14	generation	generation	NOUN
ajlm-2381	105	15	flow	flow	NOUN
ajlm-2381	105	16	cytometry	cytometry	NOUN
ajlm-2381	105	17	and	and	CCONJ
ajlm-2381	105	18	ngs	ng	NOUN
ajlm-2381	105	19	.	.	PUNCT
ajlm-2381	106	1	next	next	ADJ
ajlm-2381	106	2	-	-	PUNCT
ajlm-2381	106	3	generation	generation	NOUN
ajlm-2381	106	4	flow	flow	NOUN
ajlm-2381	106	5	refers	refer	VERB
ajlm-2381	106	6	to	to	ADP
ajlm-2381	106	7	the	the	DET
ajlm-2381	106	8	8	8	NUM
ajlm-2381	106	9	-	-	PUNCT
ajlm-2381	106	10	colour	colour	ADJ
ajlm-2381	106	11	2	2	NUM
ajlm-2381	106	12	-	-	PUNCT
ajlm-2381	106	13	tube	tube	NOUN
ajlm-2381	106	14	flow	flow	NOUN
ajlm-2381	106	15	cytometry	cytometry	NOUN
ajlm-2381	106	16	method	method	NOUN
ajlm-2381	106	17	developed	develop	VERB
ajlm-2381	106	18	by	by	ADP
ajlm-2381	106	19	the	the	DET
ajlm-2381	106	20	euroflow	euroflow	PROPN
ajlm-2381	106	21	consortium	consortium	NOUN
ajlm-2381	106	22	,	,	PUNCT
ajlm-2381	106	23	which	which	PRON
ajlm-2381	106	24	uses	use	VERB
ajlm-2381	106	25	specific	specific	ADJ
ajlm-2381	106	26	combinations	combination	NOUN
ajlm-2381	106	27	of	of	ADP
ajlm-2381	106	28	antibodies	antibody	NOUN
ajlm-2381	106	29	to	to	PART
ajlm-2381	106	30	identify	identify	VERB
ajlm-2381	106	31	and	and	CCONJ
ajlm-2381	106	32	cross	cross	ADJ
ajlm-2381	106	33	-	-	ADJ
ajlm-2381	106	34	reference	reference	ADJ
ajlm-2381	106	35	neoplastic	neoplastic	ADJ
ajlm-2381	106	36	pc	pc	NOUN
ajlm-2381	106	37	.	.	PUNCT
ajlm-2381	107	1	it	it	PRON
ajlm-2381	107	2	has	have	VERB
ajlm-2381	107	3	a	a	DET
ajlm-2381	107	4	sensitivity	sensitivity	NOUN
ajlm-2381	107	5	of	of	ADP
ajlm-2381	107	6	10	10	NUM
ajlm-2381	107	7	-	-	SYM
ajlm-2381	107	8	6	6	NUM
ajlm-2381	107	9	.	.	PUNCT
ajlm-2381	108	1	in	in	ADP
ajlm-2381	108	2	contrast	contrast	NOUN
ajlm-2381	108	3	,	,	PUNCT
ajlm-2381	108	4	conventional	conventional	ADJ
ajlm-2381	108	5	4–8	4–8	NUM
ajlm-2381	108	6	colour	colour	NOUN
ajlm-2381	108	7	flow	flow	NOUN
ajlm-2381	108	8	cytometry	cytometry	NOUN
ajlm-2381	108	9	methods	method	NOUN
ajlm-2381	108	10	can	can	AUX
ajlm-2381	108	11	only	only	ADV
ajlm-2381	108	12	detect	detect	VERB
ajlm-2381	108	13	neoplastic	neoplastic	ADJ
ajlm-2381	108	14	pc	pc	NOUN
ajlm-2381	108	15	with	with	ADP
ajlm-2381	108	16	a	a	DET
ajlm-2381	108	17	sensitivity	sensitivity	NOUN
ajlm-2381	108	18	of	of	ADP
ajlm-2381	108	19	10	10	NUM
ajlm-2381	108	20	-	-	PUNCT
ajlm-2381	108	21	4.67,68	4.67,68	NUM
ajlm-2381	108	22	next	next	ADJ
ajlm-2381	108	23	-	-	PUNCT
ajlm-2381	108	24	generation	generation	NOUN
ajlm-2381	108	25	flow	flow	NOUN
ajlm-2381	108	26	cytometry	cytometry	NOUN
ajlm-2381	108	27	multiparameter	multiparameter	NOUN
ajlm-2381	108	28	flow	flow	NOUN
ajlm-2381	108	29	cytometry	cytometry	NOUN
ajlm-2381	108	30	is	be	AUX
ajlm-2381	108	31	a	a	DET
ajlm-2381	108	32	sensitive	sensitive	ADJ
ajlm-2381	108	33	and	and	CCONJ
ajlm-2381	108	34	rapid	rapid	ADJ
ajlm-2381	108	35	approach	approach	NOUN
ajlm-2381	108	36	to	to	ADP
ajlm-2381	108	37	assessing	assess	VERB
ajlm-2381	108	38	treatment	treatment	NOUN
ajlm-2381	108	39	efficacy	efficacy	NOUN
ajlm-2381	108	40	with	with	ADP
ajlm-2381	108	41	confirmed	confirm	VERB
ajlm-2381	108	42	prognostic	prognostic	ADJ
ajlm-2381	108	43	value	value	NOUN
ajlm-2381	108	44	that	that	PRON
ajlm-2381	108	45	predicts	predict	VERB
ajlm-2381	108	46	progression	progression	NOUN
ajlm-2381	108	47	-	-	PUNCT
ajlm-2381	108	48	free	free	ADJ
ajlm-2381	108	49	and	and	CCONJ
ajlm-2381	108	50	overall	overall	ADJ
ajlm-2381	108	51	survival	survival	NOUN
ajlm-2381	108	52	independent	independent	ADJ
ajlm-2381	108	53	of	of	ADP
ajlm-2381	108	54	categorical	categorical	ADJ
ajlm-2381	108	55	response	response	NOUN
ajlm-2381	108	56	assessment	assessment	NOUN
ajlm-2381	108	57	and	and	CCONJ
ajlm-2381	108	58	patient	patient	ADJ
ajlm-2381	108	59	biology.4,37,68,69,70	biology.4,37,68,69,70	PROPN
ajlm-2381	108	60	the	the	DET
ajlm-2381	108	61	imwg	imwg	NOUN
ajlm-2381	108	62	defined	define	VERB
ajlm-2381	108	63	‘	'	PUNCT
ajlm-2381	108	64	flow	flow	NOUN
ajlm-2381	108	65	mrd	mrd	ADJ
ajlm-2381	108	66	negative	negative	NOUN
ajlm-2381	108	67	’	'	PUNCT
ajlm-2381	108	68	as	as	ADP
ajlm-2381	108	69	the	the	DET
ajlm-2381	108	70	absence	absence	NOUN
ajlm-2381	108	71	of	of	ADP
ajlm-2381	108	72	phenotypically	phenotypically	ADV
ajlm-2381	108	73	aberrant	aberrant	ADJ
ajlm-2381	108	74	clonal	clonal	ADJ
ajlm-2381	108	75	pc	pc	NOUN
ajlm-2381	108	76	detected	detect	VERB
ajlm-2381	108	77	by	by	ADP
ajlm-2381	108	78	bm	bm	PROPN
ajlm-2381	108	79	next	next	ADJ
ajlm-2381	108	80	-	-	PUNCT
ajlm-2381	108	81	generation	generation	NOUN
ajlm-2381	108	82	flow	flow	NOUN
ajlm-2381	108	83	cytometry	cytometry	NOUN
ajlm-2381	108	84	with	with	ADP
ajlm-2381	108	85	a	a	DET
ajlm-2381	108	86	minimum	minimum	ADJ
ajlm-2381	108	87	sensitivity	sensitivity	NOUN
ajlm-2381	108	88	of	of	ADP
ajlm-2381	108	89	1	1	NUM
ajlm-2381	108	90	in	in	ADP
ajlm-2381	108	91	105	105	NUM
ajlm-2381	108	92	nucleated	nucleated	ADJ
ajlm-2381	108	93	cells	cell	NOUN
ajlm-2381	108	94	.	.	PUNCT
ajlm-2381	109	1	the	the	DET
ajlm-2381	109	2	same	same	ADJ
ajlm-2381	109	3	minimum	minimum	ADJ
ajlm-2381	109	4	sensitivity	sensitivity	NOUN
ajlm-2381	109	5	is	be	AUX
ajlm-2381	109	6	proposed	propose	VERB
ajlm-2381	109	7	for	for	SCONJ
ajlm-2381	109	8	the	the	DET
ajlm-2381	109	9	‘	'	PUNCT
ajlm-2381	109	10	sequencing	sequence	VERB
ajlm-2381	109	11	mrd	mrd	ADJ
ajlm-2381	109	12	negative	negative	ADJ
ajlm-2381	109	13	’	'	PUNCT
ajlm-2381	109	14	state	state	NOUN
ajlm-2381	109	15	detected	detect	VERB
ajlm-2381	109	16	by	by	ADP
ajlm-2381	109	17	ngs.4	ngs.4	PROPN
ajlm-2381	109	18	the	the	DET
ajlm-2381	109	19	threshold	threshold	NOUN
ajlm-2381	109	20	used	use	VERB
ajlm-2381	109	21	to	to	PART
ajlm-2381	109	22	distinguish	distinguish	VERB
ajlm-2381	109	23	between	between	ADP
ajlm-2381	109	24	mrd	mrd	PROPN
ajlm-2381	109	25	positive	positive	ADJ
ajlm-2381	109	26	and	and	CCONJ
ajlm-2381	109	27	mrd	mrd	ADJ
ajlm-2381	109	28	negative	negative	NOUN
ajlm-2381	109	29	may	may	AUX
ajlm-2381	109	30	vary	vary	VERB
ajlm-2381	109	31	from	from	ADP
ajlm-2381	109	32	sample	sample	NOUN
ajlm-2381	109	33	to	to	ADP
ajlm-2381	109	34	sample	sample	NOUN
ajlm-2381	109	35	,	,	PUNCT
ajlm-2381	109	36	and	and	CCONJ
ajlm-2381	109	37	may	may	AUX
ajlm-2381	109	38	change	change	VERB
ajlm-2381	109	39	as	as	SCONJ
ajlm-2381	109	40	both	both	DET
ajlm-2381	109	41	technologies	technology	NOUN
ajlm-2381	109	42	and	and	CCONJ
ajlm-2381	109	43	treatments	treatment	NOUN
ajlm-2381	109	44	improve	improve	VERB
ajlm-2381	109	45	.	.	PUNCT
ajlm-2381	110	1	the	the	DET
ajlm-2381	110	2	international	international	ADJ
ajlm-2381	110	3	clinical	clinical	ADJ
ajlm-2381	110	4	cytometry	cytometry	PROPN
ajlm-2381	110	5	society	society	NOUN
ajlm-2381	110	6	proposed	propose	VERB
ajlm-2381	110	7	a	a	DET
ajlm-2381	110	8	consensus	consensus	NOUN
ajlm-2381	110	9	guideline	guideline	NOUN
ajlm-2381	110	10	for	for	ADP
ajlm-2381	110	11	the	the	DET
ajlm-2381	110	12	use	use	NOUN
ajlm-2381	110	13	of	of	ADP
ajlm-2381	110	14	flow	flow	NOUN
ajlm-2381	110	15	cytometry	cytometry	NOUN
ajlm-2381	110	16	for	for	ADP
ajlm-2381	110	17	mrd	mrd	PROPN
ajlm-2381	110	18	.	.	PUNCT
ajlm-2381	111	1	the	the	DET
ajlm-2381	111	2	international	international	ADJ
ajlm-2381	111	3	clinical	clinical	ADJ
ajlm-2381	111	4	cytometry	cytometry	NOUN
ajlm-2381	111	5	society	society	NOUN
ajlm-2381	111	6	recommends	recommend	VERB
ajlm-2381	111	7	the	the	DET
ajlm-2381	111	8	use	use	NOUN
ajlm-2381	111	9	of	of	ADP
ajlm-2381	111	10	at	at	ADV
ajlm-2381	111	11	least	least	ADV
ajlm-2381	111	12	five	five	NUM
ajlm-2381	111	13	initial	initial	ADJ
ajlm-2381	111	14	gating	gate	VERB
ajlm-2381	111	15	parameters	parameter	NOUN
ajlm-2381	111	16	(	(	PUNCT
ajlm-2381	111	17	cd38	cd38	PROPN
ajlm-2381	111	18	,	,	PUNCT
ajlm-2381	111	19	cd138	cd138	PROPN
ajlm-2381	111	20	,	,	PUNCT
ajlm-2381	111	21	cd45	cd45	PROPN
ajlm-2381	111	22	,	,	PUNCT
ajlm-2381	111	23	forward	forward	ADV
ajlm-2381	111	24	scatter	scatter	NOUN
ajlm-2381	111	25	and	and	CCONJ
ajlm-2381	111	26	side	side	NOUN
ajlm-2381	111	27	scatter	scatter	NOUN
ajlm-2381	111	28	)	)	PUNCT
ajlm-2381	111	29	within	within	ADP
ajlm-2381	111	30	the	the	DET
ajlm-2381	111	31	same	same	ADJ
ajlm-2381	111	32	aliquot	aliquot	NOUN
ajlm-2381	111	33	to	to	PART
ajlm-2381	111	34	accurately	accurately	ADV
ajlm-2381	111	35	identify	identify	VERB
ajlm-2381	111	36	the	the	DET
ajlm-2381	111	37	total	total	ADJ
ajlm-2381	111	38	pc	pc	NOUN
ajlm-2381	111	39	compartment	compartment	NOUN
ajlm-2381	111	40	and	and	CCONJ
ajlm-2381	111	41	to	to	PART
ajlm-2381	111	42	specify	specify	VERB
ajlm-2381	111	43	the	the	DET
ajlm-2381	111	44	limit	limit	NOUN
ajlm-2381	111	45	of	of	ADP
ajlm-2381	111	46	detection	detection	NOUN
ajlm-2381	111	47	,	,	PUNCT
ajlm-2381	111	48	with	with	ADP
ajlm-2381	111	49	a	a	DET
ajlm-2381	111	50	limit	limit	NOUN
ajlm-2381	111	51	of	of	ADP
ajlm-2381	111	52	detection	detection	NOUN
ajlm-2381	111	53	of	of	ADP
ajlm-2381	111	54	0.001	0.001	NUM
ajlm-2381	111	55	%	%	NOUN
ajlm-2381	111	56	(	(	PUNCT
ajlm-2381	111	57	requiring	require	VERB
ajlm-2381	111	58	a	a	DET
ajlm-2381	111	59	total	total	ADJ
ajlm-2381	111	60	number	number	NOUN
ajlm-2381	111	61	of	of	ADP
ajlm-2381	111	62	3	3	NUM
ajlm-2381	111	63	×	×	NOUN
ajlm-2381	111	64	106	106	NUM
ajlm-2381	111	65	cells	cell	NOUN
ajlm-2381	111	66	for	for	ADP
ajlm-2381	111	67	analysis	analysis	NOUN
ajlm-2381	111	68	)	)	PUNCT
ajlm-2381	111	69	and	and	CCONJ
ajlm-2381	111	70	ideally	ideally	ADV
ajlm-2381	111	71	a	a	DET
ajlm-2381	111	72	limit	limit	NOUN
ajlm-2381	111	73	of	of	ADP
ajlm-2381	111	74	quantification	quantification	NOUN
ajlm-2381	111	75	of	of	ADP
ajlm-2381	111	76	0.001	0.001	NUM
ajlm-2381	111	77	%	%	NOUN
ajlm-2381	111	78	(	(	PUNCT
ajlm-2381	111	79	requiring	require	VERB
ajlm-2381	111	80	a	a	DET
ajlm-2381	111	81	total	total	ADJ
ajlm-2381	111	82	number	number	NOUN
ajlm-2381	111	83	of	of	ADP
ajlm-2381	111	84	5	5	NUM
ajlm-2381	111	85	×	×	NOUN
ajlm-2381	111	86	106	106	NUM
ajlm-2381	111	87	cells	cell	NOUN
ajlm-2381	111	88	for	for	ADP
ajlm-2381	111	89	analysis).67	analysis).67	PROPN
ajlm-2381	111	90	the	the	DET
ajlm-2381	111	91	international	international	ADJ
ajlm-2381	111	92	clinical	clinical	ADJ
ajlm-2381	111	93	cytometry	cytometry	PROPN
ajlm-2381	111	94	society	society	NOUN
ajlm-2381	111	95	recommendation	recommendation	NOUN
ajlm-2381	111	96	is	be	AUX
ajlm-2381	111	97	to	to	PART
ajlm-2381	111	98	report	report	VERB
ajlm-2381	111	99	limit	limit	NOUN
ajlm-2381	111	100	of	of	ADP
ajlm-2381	111	101	detection	detection	NOUN
ajlm-2381	111	102	and	and	CCONJ
ajlm-2381	111	103	limit	limit	NOUN
ajlm-2381	111	104	of	of	ADP
ajlm-2381	111	105	quantification	quantification	NOUN
ajlm-2381	111	106	for	for	ADP
ajlm-2381	111	107	each	each	DET
ajlm-2381	111	108	case	case	NOUN
ajlm-2381	111	109	based	base	VERB
ajlm-2381	111	110	on	on	ADP
ajlm-2381	111	111	the	the	DET
ajlm-2381	111	112	number	number	NOUN
ajlm-2381	111	113	of	of	ADP
ajlm-2381	111	114	events	event	NOUN
ajlm-2381	111	115	below	below	ADP
ajlm-2381	111	116	the	the	DET
ajlm-2381	111	117	detection	detection	NOUN
ajlm-2381	111	118	limit	limit	NOUN
ajlm-2381	111	119	and	and	CCONJ
ajlm-2381	111	120	the	the	DET
ajlm-2381	111	121	number	number	NOUN
ajlm-2381	111	122	of	of	ADP
ajlm-2381	111	123	events.71	events.71	PROPN
ajlm-2381	111	124	furthermore	furthermore	ADV
ajlm-2381	111	125	,	,	PUNCT
ajlm-2381	111	126	cd9	cd9	PROPN
ajlm-2381	111	127	,	,	PUNCT
ajlm-2381	111	128	cd56	cd56	PROPN
ajlm-2381	111	129	,	,	PUNCT
ajlm-2381	111	130	cd27	cd27	PROPN
ajlm-2381	111	131	,	,	PUNCT
ajlm-2381	111	132	cd81	cd81	PROPN
ajlm-2381	111	133	and	and	CCONJ
ajlm-2381	111	134	cd117	cd117	PROPN
ajlm-2381	111	135	should	should	AUX
ajlm-2381	111	136	be	be	AUX
ajlm-2381	111	137	analysed	analyse	VERB
ajlm-2381	111	138	in	in	ADP
ajlm-2381	111	139	combination	combination	NOUN
ajlm-2381	111	140	with	with	ADP
ajlm-2381	111	141	the	the	DET
ajlm-2381	111	142	initial	initial	ADJ
ajlm-2381	111	143	gating	gate	VERB
ajlm-2381	111	144	parameters	parameter	NOUN
ajlm-2381	111	145	for	for	ADP
ajlm-2381	111	146	detection	detection	NOUN
ajlm-2381	111	147	of	of	ADP
ajlm-2381	111	148	mrd	mrd	PROPN
ajlm-2381	111	149	in	in	ADP
ajlm-2381	111	150	mm.72	mm.72	NOUN
ajlm-2381	111	151	another	another	DET
ajlm-2381	111	152	method	method	NOUN
ajlm-2381	111	153	,	,	PUNCT
ajlm-2381	111	154	the	the	DET
ajlm-2381	111	155	memorial	memorial	ADJ
ajlm-2381	111	156	sloan	sloan	PROPN
ajlm-2381	111	157	kettering	kettering	PROPN
ajlm-2381	111	158	cancer	cancer	PROPN
ajlm-2381	111	159	centre	centre	PROPN
ajlm-2381	111	160	10	10	NUM
ajlm-2381	111	161	-	-	PUNCT
ajlm-2381	111	162	colour	colour	ADJ
ajlm-2381	111	163	single	single	ADJ
ajlm-2381	111	164	tube	tube	NOUN
ajlm-2381	111	165	method	method	NOUN
ajlm-2381	111	166	,	,	PUNCT
ajlm-2381	111	167	was	be	AUX
ajlm-2381	111	168	compared	compare	VERB
ajlm-2381	111	169	with	with	ADP
ajlm-2381	111	170	the	the	DET
ajlm-2381	111	171	imwg	imwg	NOUN
ajlm-2381	111	172	-	-	PUNCT
ajlm-2381	111	173	recommended	recommend	VERB
ajlm-2381	111	174	euroflow	euroflow	NOUN
ajlm-2381	111	175	8	8	NUM
ajlm-2381	111	176	-	-	PUNCT
ajlm-2381	111	177	colour	colour	ADJ
ajlm-2381	111	178	2	2	NUM
ajlm-2381	111	179	-	-	PUNCT
ajlm-2381	111	180	tube	tube	NOUN
ajlm-2381	111	181	method	method	NOUN
ajlm-2381	111	182	and	and	CCONJ
ajlm-2381	111	183	showed	show	VERB
ajlm-2381	111	184	a	a	DET
ajlm-2381	111	185	high	high	ADJ
ajlm-2381	111	186	degree	degree	NOUN
ajlm-2381	111	187	of	of	ADP
ajlm-2381	111	188	agreement	agreement	NOUN
ajlm-2381	111	189	(	(	PUNCT
ajlm-2381	111	190	r2	r2	NOUN
ajlm-2381	111	191	=	=	NOUN
ajlm-2381	111	192	0.97	0.97	NUM
ajlm-2381	111	193	)	)	PUNCT
ajlm-2381	111	194	with	with	ADP
ajlm-2381	111	195	the	the	DET
ajlm-2381	111	196	residual	residual	ADJ
ajlm-2381	111	197	disease	disease	NOUN
ajlm-2381	111	198	burden	burden	NOUN
ajlm-2381	111	199	detected	detect	VERB
ajlm-2381	111	200	with	with	ADP
ajlm-2381	111	201	abnormal	abnormal	ADJ
ajlm-2381	111	202	pc.73	pc.73	NOUN
ajlm-2381	111	203	it	it	PRON
ajlm-2381	111	204	is	be	AUX
ajlm-2381	111	205	noteworthy	noteworthy	ADJ
ajlm-2381	111	206	that	that	SCONJ
ajlm-2381	111	207	a	a	DET
ajlm-2381	111	208	bm	bm	PROPN
ajlm-2381	111	209	aspirate	aspirate	NOUN
ajlm-2381	111	210	sample	sample	NOUN
ajlm-2381	111	211	containing	contain	VERB
ajlm-2381	111	212	10	10	NUM
ajlm-2381	111	213	x	x	SYM
ajlm-2381	111	214	106	106	NUM
ajlm-2381	111	215	cells	cell	NOUN
ajlm-2381	111	216	is	be	AUX
ajlm-2381	111	217	required	require	VERB
ajlm-2381	111	218	for	for	ADP
ajlm-2381	111	219	consistent	consistent	ADJ
ajlm-2381	111	220	disease	disease	NOUN
ajlm-2381	111	221	detection	detection	NOUN
ajlm-2381	111	222	,	,	PUNCT
ajlm-2381	111	223	rapid	rapid	ADJ
ajlm-2381	111	224	processing	processing	NOUN
ajlm-2381	111	225	avoids	avoid	VERB
ajlm-2381	111	226	cell	cell	NOUN
ajlm-2381	111	227	degeneration	degeneration	NOUN
ajlm-2381	111	228	,	,	PUNCT
ajlm-2381	111	229	and	and	CCONJ
ajlm-2381	111	230	the	the	DET
ajlm-2381	111	231	use	use	NOUN
ajlm-2381	111	232	of	of	ADP
ajlm-2381	111	233	therapeutic	therapeutic	ADJ
ajlm-2381	111	234	monoclonal	monoclonal	NOUN
ajlm-2381	111	235	antibodies	antibody	NOUN
ajlm-2381	111	236	such	such	ADJ
ajlm-2381	111	237	as	as	ADP
ajlm-2381	111	238	daratumumab	daratumumab	NOUN
ajlm-2381	111	239	can	can	AUX
ajlm-2381	111	240	lead	lead	VERB
ajlm-2381	111	241	to	to	ADP
ajlm-2381	111	242	false	false	ADJ
ajlm-2381	111	243	-	-	PUNCT
ajlm-2381	111	244	negative	negative	ADJ
ajlm-2381	111	245	mrd	mrd	ADJ
ajlm-2381	111	246	results	result	NOUN
ajlm-2381	111	247	.	.	PUNCT
ajlm-2381	112	1	in	in	ADP
ajlm-2381	112	2	addition	addition	NOUN
ajlm-2381	112	3	to	to	ADP
ajlm-2381	112	4	sample	sample	NOUN
ajlm-2381	112	5	processing	processing	NOUN
ajlm-2381	112	6	problems	problem	NOUN
ajlm-2381	112	7	,	,	PUNCT
ajlm-2381	112	8	immunophenotype	immunophenotype	NOUN
ajlm-2381	112	9	in	in	ADP
ajlm-2381	112	10	mm	mm	PROPN
ajlm-2381	112	11	has	have	AUX
ajlm-2381	112	12	been	be	AUX
ajlm-2381	112	13	shown	show	VERB
ajlm-2381	112	14	to	to	PART
ajlm-2381	112	15	be	be	AUX
ajlm-2381	112	16	unstable	unstable	ADJ
ajlm-2381	112	17	,	,	PUNCT
ajlm-2381	112	18	and	and	CCONJ
ajlm-2381	112	19	many	many	ADJ
ajlm-2381	112	20	patients	patient	NOUN
ajlm-2381	112	21	(	(	PUNCT
ajlm-2381	112	22	41	41	NUM
ajlm-2381	112	23	%	%	NOUN
ajlm-2381	112	24	)	)	PUNCT
ajlm-2381	112	25	change	change	NOUN
ajlm-2381	112	26	immunophenotype	immunophenotype	NOUN
ajlm-2381	112	27	,	,	PUNCT
ajlm-2381	112	28	which	which	PRON
ajlm-2381	112	29	can	can	AUX
ajlm-2381	112	30	complicate	complicate	VERB
ajlm-2381	112	31	interpretation.74	interpretation.74	ADJ
ajlm-2381	112	32	in	in	ADP
ajlm-2381	112	33	an	an	DET
ajlm-2381	112	34	attempt	attempt	NOUN
ajlm-2381	112	35	to	to	PART
ajlm-2381	112	36	overcome	overcome	VERB
ajlm-2381	112	37	the	the	DET
ajlm-2381	112	38	potential	potential	ADJ
ajlm-2381	112	39	loss	loss	NOUN
ajlm-2381	112	40	of	of	ADP
ajlm-2381	112	41	typical	typical	ADJ
ajlm-2381	112	42	gating	gate	VERB
ajlm-2381	112	43	markers	marker	NOUN
ajlm-2381	112	44	(	(	PUNCT
ajlm-2381	112	45	e.g.	e.g.	ADV
ajlm-2381	112	46	,	,	PUNCT
ajlm-2381	112	47	cd38	cd38	PROPN
ajlm-2381	112	48	and	and	CCONJ
ajlm-2381	112	49	cd138	cd138	PROPN
ajlm-2381	112	50	)	)	PUNCT
ajlm-2381	112	51	after	after	ADP
ajlm-2381	112	52	treatment	treatment	NOUN
ajlm-2381	112	53	with	with	ADP
ajlm-2381	112	54	monoclonal	monoclonal	NOUN
ajlm-2381	112	55	antibodies	antibody	NOUN
ajlm-2381	112	56	,	,	PUNCT
ajlm-2381	112	57	the	the	DET
ajlm-2381	112	58	members	member	NOUN
ajlm-2381	112	59	of	of	ADP
ajlm-2381	112	60	the	the	DET
ajlm-2381	112	61	signalling	signal	VERB
ajlm-2381	112	62	lymphocyte	lymphocyte	ADJ
ajlm-2381	112	63	activation	activation	NOUN
ajlm-2381	112	64	molecules	molecule	NOUN
ajlm-2381	112	65	family	family	NOUN
ajlm-2381	112	66	,	,	PUNCT
ajlm-2381	112	67	cd229	cd229	PROPN
ajlm-2381	112	68	and	and	CCONJ
ajlm-2381	112	69	cd319	cd319	PROPN
ajlm-2381	112	70	,	,	PUNCT
ajlm-2381	112	71	have	have	AUX
ajlm-2381	112	72	been	be	AUX
ajlm-2381	112	73	identified	identify	VERB
ajlm-2381	112	74	as	as	ADP
ajlm-2381	112	75	new	new	ADJ
ajlm-2381	112	76	gating	gating	NOUN
ajlm-2381	112	77	markers	marker	NOUN
ajlm-2381	112	78	for	for	ADP
ajlm-2381	112	79	pc	pc	NOUN
ajlm-2381	112	80	in	in	ADP
ajlm-2381	112	81	flow	flow	NOUN
ajlm-2381	112	82	cytometric	cytometric	ADJ
ajlm-2381	112	83	immunophenotyping	immunophenotyping	NOUN
ajlm-2381	112	84	,	,	PUNCT
ajlm-2381	112	85	particularly	particularly	ADV
ajlm-2381	112	86	in	in	ADP
ajlm-2381	112	87	relapsed	relapse	VERB
ajlm-2381	112	88	or	or	CCONJ
ajlm-2381	112	89	resistant	resistant	ADJ
ajlm-2381	112	90	cases	case	NOUN
ajlm-2381	112	91	of	of	ADP
ajlm-2381	112	92	mm.75,76,77	mm.75,76,77	PROPN
ajlm-2381	112	93	the	the	DET
ajlm-2381	112	94	cd229	cd229	PROPN
ajlm-2381	112	95	marker	marker	NOUN
ajlm-2381	112	96	has	have	VERB
ajlm-2381	112	97	a	a	DET
ajlm-2381	112	98	strong	strong	ADJ
ajlm-2381	112	99	and	and	CCONJ
ajlm-2381	112	100	homogenous	homogenous	ADJ
ajlm-2381	112	101	expression	expression	NOUN
ajlm-2381	112	102	in	in	ADP
ajlm-2381	112	103	pc	pc	NOUN
ajlm-2381	112	104	while	while	SCONJ
ajlm-2381	112	105	cd138	cd138	NOUN
ajlm-2381	112	106	expression	expression	NOUN
ajlm-2381	112	107	showed	show	VERB
ajlm-2381	112	108	significant	significant	ADJ
ajlm-2381	112	109	variability.75,76	variability.75,76	NOUN
ajlm-2381	112	110	the	the	DET
ajlm-2381	112	111	new	new	ADJ
ajlm-2381	112	112	markers	marker	NOUN
ajlm-2381	112	113	may	may	AUX
ajlm-2381	112	114	prove	prove	VERB
ajlm-2381	112	115	to	to	PART
ajlm-2381	112	116	be	be	AUX
ajlm-2381	112	117	useful	useful	ADJ
ajlm-2381	112	118	additions	addition	NOUN
ajlm-2381	112	119	for	for	ADP
ajlm-2381	112	120	gating	gate	VERB
ajlm-2381	112	121	clonal	clonal	ADJ
ajlm-2381	112	122	pc	pc	NOUN
ajlm-2381	112	123	,	,	PUNCT
ajlm-2381	112	124	estimating	estimate	VERB
ajlm-2381	112	125	pc	pc	NOUN
ajlm-2381	112	126	in	in	ADP
ajlm-2381	112	127	bm	bm	PROPN
ajlm-2381	112	128	and	and	CCONJ
ajlm-2381	112	129	assessing	assess	VERB
ajlm-2381	112	130	mrd	mrd	PROPN
ajlm-2381	112	131	in	in	ADP
ajlm-2381	112	132	relapsed	relapse	VERB
ajlm-2381	112	133	and	and	CCONJ
ajlm-2381	112	134	resistant	resistant	ADJ
ajlm-2381	112	135	mm	mm	NOUN
ajlm-2381	112	136	.	.	PUNCT
ajlm-2381	113	1	it	it	PRON
ajlm-2381	113	2	makes	make	VERB
ajlm-2381	113	3	sense	sense	NOUN
ajlm-2381	113	4	for	for	SCONJ
ajlm-2381	113	5	pathologists	pathologist	NOUN
ajlm-2381	113	6	to	to	PART
ajlm-2381	113	7	familiarise	familiarise	VERB
ajlm-2381	113	8	themselves	themselves	PRON
ajlm-2381	113	9	with	with	ADP
ajlm-2381	113	10	these	these	DET
ajlm-2381	113	11	novel	novel	ADJ
ajlm-2381	113	12	markers	marker	NOUN
ajlm-2381	113	13	and	and	CCONJ
ajlm-2381	113	14	mrd	mrd	ADJ
ajlm-2381	113	15	methods	method	NOUN
ajlm-2381	113	16	as	as	ADP
ajlm-2381	113	17	monoclonal	monoclonal	NOUN
ajlm-2381	113	18	antibody	antibody	NOUN
ajlm-2381	113	19	therapies	therapy	NOUN
ajlm-2381	113	20	such	such	ADJ
ajlm-2381	113	21	as	as	ADP
ajlm-2381	113	22	anti	anti	ADJ
ajlm-2381	113	23	-	-	NOUN
ajlm-2381	113	24	cd38	cd38	PROPN
ajlm-2381	113	25	become	become	VERB
ajlm-2381	113	26	more	more	ADV
ajlm-2381	113	27	readily	readily	ADV
ajlm-2381	113	28	available	available	ADJ
ajlm-2381	113	29	in	in	ADP
ajlm-2381	113	30	resource	resource	NOUN
ajlm-2381	113	31	-	-	PUNCT
ajlm-2381	113	32	limited	limit	VERB
ajlm-2381	113	33	settings	setting	NOUN
ajlm-2381	113	34	.	.	PUNCT
ajlm-2381	114	1	next	next	ADJ
ajlm-2381	114	2	-	-	PUNCT
ajlm-2381	114	3	generation	generation	NOUN
ajlm-2381	114	4	sequencing	sequence	VERB
ajlm-2381	114	5	the	the	DET
ajlm-2381	114	6	use	use	NOUN
ajlm-2381	114	7	of	of	ADP
ajlm-2381	114	8	ngs	ng	NOUN
ajlm-2381	114	9	,	,	PUNCT
ajlm-2381	114	10	as	as	ADP
ajlm-2381	114	11	with	with	ADP
ajlm-2381	114	12	aso	aso	NOUN
ajlm-2381	114	13	-	-	PUNCT
ajlm-2381	114	14	qpcr	qpcr	ADJ
ajlm-2381	114	15	,	,	PUNCT
ajlm-2381	114	16	is	be	AUX
ajlm-2381	114	17	based	base	VERB
ajlm-2381	114	18	on	on	ADP
ajlm-2381	114	19	the	the	DET
ajlm-2381	114	20	identification	identification	NOUN
ajlm-2381	114	21	and	and	CCONJ
ajlm-2381	114	22	amplification	amplification	NOUN
ajlm-2381	114	23	of	of	ADP
ajlm-2381	114	24	the	the	DET
ajlm-2381	114	25	sequence	sequence	NOUN
ajlm-2381	114	26	of	of	ADP
ajlm-2381	114	27	interest	interest	NOUN
ajlm-2381	114	28	,	,	PUNCT
ajlm-2381	114	29	usually	usually	ADV
ajlm-2381	114	30	in	in	ADP
ajlm-2381	114	31	the	the	DET
ajlm-2381	114	32	variable	variable	ADJ
ajlm-2381	114	33	regions	region	NOUN
ajlm-2381	114	34	of	of	ADP
ajlm-2381	114	35	the	the	DET
ajlm-2381	114	36	igh	igh	PROPN
ajlm-2381	114	37	gene	gene	NOUN
ajlm-2381	114	38	on	on	ADP
ajlm-2381	114	39	chromosome	chromosome	NOUN
ajlm-2381	114	40	14	14	NUM
ajlm-2381	114	41	.	.	PUNCT
ajlm-2381	115	1	however	however	ADV
ajlm-2381	115	2	,	,	PUNCT
ajlm-2381	115	3	for	for	ADP
ajlm-2381	115	4	the	the	DET
ajlm-2381	115	5	follow	follow	NOUN
ajlm-2381	115	6	-	-	PUNCT
ajlm-2381	115	7	up	up	NOUN
ajlm-2381	115	8	of	of	ADP
ajlm-2381	115	9	patients	patient	NOUN
ajlm-2381	115	10	using	use	VERB
ajlm-2381	115	11	pcr	pcr	NOUN
ajlm-2381	115	12	-	-	PUNCT
ajlm-2381	115	13	based	base	VERB
ajlm-2381	115	14	methods	method	NOUN
ajlm-2381	115	15	,	,	PUNCT
ajlm-2381	115	16	a	a	DET
ajlm-2381	115	17	patient	patient	NOUN
ajlm-2381	115	18	-	-	PUNCT
ajlm-2381	115	19	specific	specific	ADJ
ajlm-2381	115	20	primer	primer	NOUN
ajlm-2381	115	21	must	must	AUX
ajlm-2381	115	22	be	be	AUX
ajlm-2381	115	23	developed	develop	VERB
ajlm-2381	115	24	from	from	ADP
ajlm-2381	115	25	the	the	DET
ajlm-2381	115	26	diagnostic	diagnostic	ADJ
ajlm-2381	115	27	sequence	sequence	NOUN
ajlm-2381	115	28	.	.	PUNCT
ajlm-2381	116	1	with	with	ADP
ajlm-2381	116	2	ngs	ng	NOUN
ajlm-2381	116	3	,	,	PUNCT
ajlm-2381	116	4	these	these	DET
ajlm-2381	116	5	regions	region	NOUN
ajlm-2381	116	6	are	be	AUX
ajlm-2381	116	7	amplified	amplify	VERB
ajlm-2381	116	8	and	and	CCONJ
ajlm-2381	116	9	sequenced	sequence	VERB
ajlm-2381	116	10	with	with	ADP
ajlm-2381	116	11	specific	specific	ADJ
ajlm-2381	116	12	primers	primer	NOUN
ajlm-2381	116	13	that	that	PRON
ajlm-2381	116	14	are	be	AUX
ajlm-2381	116	15	not	not	PART
ajlm-2381	116	16	patient	patient	ADJ
ajlm-2381	116	17	specific.36	specific.36	NOUN
ajlm-2381	116	18	for	for	ADP
ajlm-2381	116	19	this	this	DET
ajlm-2381	116	20	reason	reason	NOUN
ajlm-2381	116	21	,	,	PUNCT
ajlm-2381	116	22	among	among	ADP
ajlm-2381	116	23	others	other	NOUN
ajlm-2381	116	24	,	,	PUNCT
ajlm-2381	116	25	aso	aso	NOUN
ajlm-2381	116	26	-	-	PUNCT
ajlm-2381	116	27	pcr	pcr	PROPN
ajlm-2381	116	28	has	have	AUX
ajlm-2381	116	29	been	be	AUX
ajlm-2381	116	30	largely	largely	ADV
ajlm-2381	116	31	replaced	replace	VERB
ajlm-2381	116	32	by	by	ADP
ajlm-2381	116	33	ngs	ng	NOUN
ajlm-2381	116	34	methods	method	NOUN
ajlm-2381	116	35	because	because	SCONJ
ajlm-2381	116	36	patient	patient	ADJ
ajlm-2381	116	37	specific	specific	ADJ
ajlm-2381	116	38	probes	probe	NOUN
ajlm-2381	116	39	are	be	AUX
ajlm-2381	116	40	not	not	PART
ajlm-2381	116	41	as	as	ADV
ajlm-2381	116	42	reliable	reliable	ADJ
ajlm-2381	116	43	in	in	ADP
ajlm-2381	116	44	identifying	identify	VERB
ajlm-2381	116	45	clonal	clonal	ADJ
ajlm-2381	116	46	igh	igh	PROPN
ajlm-2381	116	47	after	after	ADP
ajlm-2381	116	48	somatic	somatic	ADJ
ajlm-2381	116	49	hypermutation	hypermutation	NOUN
ajlm-2381	116	50	compared	compare	VERB
ajlm-2381	116	51	to	to	ADP
ajlm-2381	116	52	ngs	ng	NOUN
ajlm-2381	116	53	during	during	ADP
ajlm-2381	116	54	follow	follow	NOUN
ajlm-2381	116	55	-	-	PUNCT
ajlm-2381	116	56	up.36,37,78,79	up.36,37,78,79	NOUN
ajlm-2381	116	57	this	this	PRON
ajlm-2381	116	58	is	be	AUX
ajlm-2381	116	59	an	an	DET
ajlm-2381	116	60	indication	indication	NOUN
ajlm-2381	116	61	of	of	ADP
ajlm-2381	116	62	the	the	DET
ajlm-2381	116	63	superior	superior	ADJ
ajlm-2381	116	64	applicability	applicability	NOUN
ajlm-2381	116	65	of	of	ADP
ajlm-2381	116	66	ngs	ng	NOUN
ajlm-2381	116	67	over	over	ADP
ajlm-2381	116	68	the	the	DET
ajlm-2381	116	69	need	need	NOUN
ajlm-2381	116	70	to	to	PART
ajlm-2381	116	71	develop	develop	VERB
ajlm-2381	116	72	patient	patient	NOUN
ajlm-2381	116	73	-	-	PUNCT
ajlm-2381	116	74	specific	specific	ADJ
ajlm-2381	116	75	primers	primer	NOUN
ajlm-2381	116	76	.	.	PUNCT
ajlm-2381	117	1	next	next	ADJ
ajlm-2381	117	2	-	-	PUNCT
ajlm-2381	117	3	generation	generation	NOUN
ajlm-2381	117	4	sequencing	sequencing	NOUN
ajlm-2381	117	5	is	be	AUX
ajlm-2381	117	6	not	not	PART
ajlm-2381	117	7	entirely	entirely	ADV
ajlm-2381	117	8	free	free	ADJ
ajlm-2381	117	9	from	from	ADP
ajlm-2381	117	10	the	the	DET
ajlm-2381	117	11	effects	effect	NOUN
ajlm-2381	117	12	of	of	ADP
ajlm-2381	117	13	somatic	somatic	ADJ
ajlm-2381	117	14	hypermutation	hypermutation	NOUN
ajlm-2381	117	15	as	as	SCONJ
ajlm-2381	117	16	it	it	PRON
ajlm-2381	117	17	uses	use	VERB
ajlm-2381	117	18	consensus	consensus	NOUN
ajlm-2381	117	19	primers	primer	NOUN
ajlm-2381	117	20	for	for	ADP
ajlm-2381	117	21	clonality	clonality	NOUN
ajlm-2381	117	22	detection	detection	NOUN
ajlm-2381	117	23	and	and	CCONJ
ajlm-2381	117	24	subsequent	subsequent	ADJ
ajlm-2381	117	25	mrd	mrd	ADJ
ajlm-2381	117	26	analysis	analysis	NOUN
ajlm-2381	117	27	.	.	PUNCT
ajlm-2381	118	1	cost	cost	NOUN
ajlm-2381	118	2	and	and	CCONJ
ajlm-2381	118	3	poor	poor	ADJ
ajlm-2381	118	4	availability	availability	NOUN
ajlm-2381	118	5	are	be	AUX
ajlm-2381	118	6	disadvantages	disadvantage	NOUN
ajlm-2381	118	7	of	of	ADP
ajlm-2381	118	8	ngs	ng	NOUN
ajlm-2381	118	9	,	,	PUNCT
ajlm-2381	118	10	especially	especially	ADV
ajlm-2381	118	11	in	in	ADP
ajlm-2381	118	12	resource	resource	NOUN
ajlm-2381	118	13	-	-	PUNCT
ajlm-2381	118	14	limited	limit	VERB
ajlm-2381	118	15	settings	setting	NOUN
ajlm-2381	118	16	.	.	PUNCT
ajlm-2381	119	1	in	in	ADP
ajlm-2381	119	2	addition	addition	NOUN
ajlm-2381	119	3	,	,	PUNCT
ajlm-2381	119	4	due	due	ADP
ajlm-2381	119	5	to	to	ADP
ajlm-2381	119	6	the	the	DET
ajlm-2381	119	7	labour	labour	NOUN
ajlm-2381	119	8	-	-	PUNCT
ajlm-2381	119	9	intensive	intensive	ADJ
ajlm-2381	119	10	nature	nature	NOUN
ajlm-2381	119	11	and	and	CCONJ
ajlm-2381	119	12	difficulties	difficulty	NOUN
ajlm-2381	119	13	in	in	ADP
ajlm-2381	119	14	interpreting	interpret	VERB
ajlm-2381	119	15	the	the	DET
ajlm-2381	119	16	results	result	NOUN
ajlm-2381	119	17	of	of	ADP
ajlm-2381	119	18	ngs	ng	NOUN
ajlm-2381	119	19	,	,	PUNCT
ajlm-2381	119	20	a	a	DET
ajlm-2381	119	21	high	high	ADJ
ajlm-2381	119	22	level	level	NOUN
ajlm-2381	119	23	of	of	ADP
ajlm-2381	119	24	expertise	expertise	NOUN
ajlm-2381	119	25	is	be	AUX
ajlm-2381	119	26	required	require	VERB
ajlm-2381	119	27	.	.	PUNCT
ajlm-2381	120	1	but	but	CCONJ
ajlm-2381	120	2	it	it	PRON
ajlm-2381	120	3	remains	remain	VERB
ajlm-2381	120	4	a	a	DET
ajlm-2381	120	5	useful	useful	ADJ
ajlm-2381	120	6	instrument	instrument	NOUN
ajlm-2381	120	7	because	because	SCONJ
ajlm-2381	120	8	it	it	PRON
ajlm-2381	120	9	is	be	AUX
ajlm-2381	120	10	very	very	ADV
ajlm-2381	120	11	sensitive	sensitive	ADJ
ajlm-2381	120	12	and	and	CCONJ
ajlm-2381	120	13	has	have	AUX
ajlm-2381	120	14	been	be	AUX
ajlm-2381	120	15	sufficiently	sufficiently	ADV
ajlm-2381	120	16	standardised	standardise	VERB
ajlm-2381	120	17	for	for	ADP
ajlm-2381	120	18	general	general	ADJ
ajlm-2381	120	19	use	use	NOUN
ajlm-2381	120	20	.	.	PUNCT
ajlm-2381	121	1	summary	summary	NOUN
ajlm-2381	121	2	of	of	ADP
ajlm-2381	121	3	reviewed	review	VERB
ajlm-2381	121	4	methods	method	NOUN
ajlm-2381	121	5	for	for	ADP
ajlm-2381	121	6	plasma	plasma	NOUN
ajlm-2381	121	7	cell	cell	NOUN
ajlm-2381	121	8	estimation	estimation	NOUN
ajlm-2381	121	9	the	the	DET
ajlm-2381	121	10	quantitation	quantitation	NOUN
ajlm-2381	121	11	of	of	ADP
ajlm-2381	121	12	bmpc%	bmpc%	PUNCT
ajlm-2381	121	13	on	on	ADP
ajlm-2381	121	14	romanowsky	romanowsky	NOUN
ajlm-2381	121	15	-	-	PUNCT
ajlm-2381	121	16	stained	stain	VERB
ajlm-2381	121	17	bma	bma	PROPN
ajlm-2381	121	18	alone	alone	ADV
ajlm-2381	121	19	may	may	AUX
ajlm-2381	121	20	misrepresent	misrepresent	VERB
ajlm-2381	121	21	the	the	DET
ajlm-2381	121	22	accurate	accurate	ADJ
ajlm-2381	121	23	count	count	NOUN
ajlm-2381	121	24	of	of	ADP
ajlm-2381	121	25	pc	pc	NOUN
ajlm-2381	121	26	due	due	ADP
ajlm-2381	121	27	to	to	ADP
ajlm-2381	121	28	the	the	DET
ajlm-2381	121	29	patchy	patchy	ADJ
ajlm-2381	121	30	nature	nature	NOUN
ajlm-2381	121	31	of	of	ADP
ajlm-2381	121	32	infiltration	infiltration	NOUN
ajlm-2381	121	33	and	and	CCONJ
ajlm-2381	121	34	sample	sample	NOUN
ajlm-2381	121	35	haemodilution	haemodilution	NOUN
ajlm-2381	121	36	.	.	PUNCT
ajlm-2381	122	1	bone	bone	NOUN
ajlm-2381	122	2	marrow	marrow	PROPN
ajlm-2381	122	3	pc	pc	NOUN
ajlm-2381	122	4	percentage	percentage	NOUN
ajlm-2381	122	5	is	be	AUX
ajlm-2381	122	6	consistently	consistently	ADV
ajlm-2381	122	7	lower	low	ADJ
ajlm-2381	122	8	on	on	ADP
ajlm-2381	122	9	bma	bma	PROPN
ajlm-2381	122	10	as	as	SCONJ
ajlm-2381	122	11	compared	compare	VERB
ajlm-2381	122	12	to	to	ADP
ajlm-2381	122	13	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	122	14	-	-	PUNCT
ajlm-2381	122	15	stained	stain	VERB
ajlm-2381	122	16	bm	bm	PROPN
ajlm-2381	122	17	biopsies	biopsy	NOUN
ajlm-2381	122	18	.	.	PUNCT
ajlm-2381	123	1	flow	flow	NOUN
ajlm-2381	123	2	cytometry	cytometry	PROPN
ajlm-2381	123	3	alone	alone	ADV
ajlm-2381	123	4	yields	yield	NOUN
ajlm-2381	123	5	consistently	consistently	ADV
ajlm-2381	123	6	lower	low	ADJ
ajlm-2381	123	7	results	result	NOUN
ajlm-2381	123	8	compared	compare	VERB
ajlm-2381	123	9	to	to	ADP
ajlm-2381	123	10	bma	bma	PROPN
ajlm-2381	123	11	myelograms	myelogram	NOUN
ajlm-2381	123	12	and	and	CCONJ
ajlm-2381	123	13	are	be	AUX
ajlm-2381	123	14	not	not	PART
ajlm-2381	123	15	readily	readily	ADV
ajlm-2381	123	16	available	available	ADJ
ajlm-2381	123	17	in	in	ADP
ajlm-2381	123	18	resource	resource	NOUN
ajlm-2381	123	19	-	-	PUNCT
ajlm-2381	123	20	constrained	constrain	VERB
ajlm-2381	123	21	settings	setting	NOUN
ajlm-2381	123	22	.	.	PUNCT
ajlm-2381	124	1	flow	flow	NOUN
ajlm-2381	124	2	cytometry	cytometry	PROPN
ajlm-2381	124	3	is	be	AUX
ajlm-2381	124	4	,	,	PUNCT
ajlm-2381	124	5	however	however	ADV
ajlm-2381	124	6	,	,	PUNCT
ajlm-2381	124	7	useful	useful	ADJ
ajlm-2381	124	8	for	for	ADP
ajlm-2381	124	9	determination	determination	NOUN
ajlm-2381	124	10	of	of	ADP
ajlm-2381	124	11	pc	pc	NOUN
ajlm-2381	124	12	clonality	clonality	NOUN
ajlm-2381	124	13	,	,	PUNCT
ajlm-2381	124	14	mrd	mrd	NOUN
ajlm-2381	124	15	,	,	PUNCT
ajlm-2381	124	16	and	and	CCONJ
ajlm-2381	124	17	risk	risk	NOUN
ajlm-2381	124	18	stratification	stratification	NOUN
ajlm-2381	124	19	of	of	ADP
ajlm-2381	124	20	mm	mm	PROPN
ajlm-2381	124	21	.	.	PUNCT
ajlm-2381	125	1	a	a	DET
ajlm-2381	125	2	combination	combination	NOUN
ajlm-2381	125	3	of	of	ADP
ajlm-2381	125	4	bma	bma	PROPN
ajlm-2381	125	5	,	,	PUNCT
ajlm-2381	125	6	bm	bm	PROPN
ajlm-2381	125	7	biopsy	biopsy	PROPN
ajlm-2381	125	8	,	,	PUNCT
ajlm-2381	125	9	and	and	CCONJ
ajlm-2381	125	10	flow	flow	VERB
ajlm-2381	125	11	cytometry	cytometry	NOUN
ajlm-2381	125	12	assessment	assessment	NOUN
ajlm-2381	125	13	of	of	ADP
ajlm-2381	125	14	pc	pc	NOUN
ajlm-2381	125	15	yield	yield	NOUN
ajlm-2381	125	16	superior	superior	ADJ
ajlm-2381	125	17	results	result	NOUN
ajlm-2381	125	18	compared	compare	VERB
ajlm-2381	125	19	to	to	ADP
ajlm-2381	125	20	using	use	VERB
ajlm-2381	125	21	each	each	DET
ajlm-2381	125	22	sample	sample	NOUN
ajlm-2381	125	23	on	on	ADP
ajlm-2381	125	24	its	its	PRON
ajlm-2381	125	25	own	own	ADJ
ajlm-2381	125	26	.	.	PUNCT
ajlm-2381	126	1	cd138	cd138	NOUN
ajlm-2381	126	2	or	or	CCONJ
ajlm-2381	126	3	mum1	mum1	PROPN
ajlm-2381	126	4	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	126	5	improves	improve	VERB
ajlm-2381	126	6	pc	pc	NOUN
ajlm-2381	126	7	identification	identification	NOUN
ajlm-2381	126	8	compared	compare	VERB
ajlm-2381	126	9	to	to	ADP
ajlm-2381	126	10	haematoxylin	haematoxylin	NOUN
ajlm-2381	126	11	and	and	CCONJ
ajlm-2381	126	12	eosin	eosin	NOUN
ajlm-2381	126	13	and	and	CCONJ
ajlm-2381	126	14	other	other	ADJ
ajlm-2381	126	15	stains	stain	NOUN
ajlm-2381	126	16	.	.	PUNCT
ajlm-2381	127	1	manual	manual	ADJ
ajlm-2381	127	2	counting	counting	NOUN
ajlm-2381	127	3	in	in	ADP
ajlm-2381	127	4	representative	representative	ADJ
ajlm-2381	127	5	areas	area	NOUN
ajlm-2381	127	6	of	of	ADP
ajlm-2381	127	7	cd138	cd138	NOUN
ajlm-2381	127	8	-	-	PUNCT
ajlm-2381	127	9	stained	stain	VERB
ajlm-2381	127	10	biopsies	biopsy	NOUN
ajlm-2381	127	11	has	have	AUX
ajlm-2381	127	12	been	be	AUX
ajlm-2381	127	13	shown	show	VERB
ajlm-2381	127	14	to	to	PART
ajlm-2381	127	15	improve	improve	VERB
ajlm-2381	127	16	reproducibility	reproducibility	NOUN
ajlm-2381	127	17	,	,	PUNCT
ajlm-2381	127	18	compared	compare	VERB
ajlm-2381	127	19	to	to	AUX
ajlm-2381	127	20	overview	overview	VERB
ajlm-2381	127	21	estimation	estimation	NOUN
ajlm-2381	127	22	.	.	PUNCT
ajlm-2381	128	1	use	use	NOUN
ajlm-2381	128	2	of	of	ADP
ajlm-2381	128	3	ai	ai	ADJ
ajlm-2381	128	4	image	image	NOUN
ajlm-2381	128	5	analysis	analysis	NOUN
ajlm-2381	128	6	on	on	ADP
ajlm-2381	128	7	wsi	wsi	NOUN
ajlm-2381	128	8	or	or	CCONJ
ajlm-2381	128	9	static	static	ADJ
ajlm-2381	128	10	images	image	NOUN
ajlm-2381	128	11	may	may	AUX
ajlm-2381	128	12	currently	currently	ADV
ajlm-2381	128	13	be	be	AUX
ajlm-2381	128	14	the	the	DET
ajlm-2381	128	15	best	good	ADJ
ajlm-2381	128	16	method	method	NOUN
ajlm-2381	128	17	for	for	ADP
ajlm-2381	128	18	bmpc	bmpc	NOUN
ajlm-2381	128	19	estimation	estimation	NOUN
ajlm-2381	128	20	.	.	PUNCT
ajlm-2381	129	1	guidelines	guideline	NOUN
ajlm-2381	129	2	for	for	ADP
ajlm-2381	129	3	the	the	DET
ajlm-2381	129	4	standardisation	standardisation	NOUN
ajlm-2381	129	5	and	and	CCONJ
ajlm-2381	129	6	validation	validation	NOUN
ajlm-2381	129	7	of	of	ADP
ajlm-2381	129	8	digital	digital	ADJ
ajlm-2381	129	9	techniques	technique	NOUN
ajlm-2381	129	10	have	have	AUX
ajlm-2381	129	11	been	be	AUX
ajlm-2381	129	12	published	publish	VERB
ajlm-2381	129	13	and	and	CCONJ
ajlm-2381	129	14	using	use	VERB
ajlm-2381	129	15	static	static	ADJ
ajlm-2381	129	16	images	image	NOUN
ajlm-2381	129	17	in	in	ADP
ajlm-2381	129	18	combination	combination	NOUN
ajlm-2381	129	19	with	with	ADP
ajlm-2381	129	20	open	open	ADJ
ajlm-2381	129	21	-	-	PUNCT
ajlm-2381	129	22	source	source	NOUN
ajlm-2381	129	23	software	software	NOUN
ajlm-2381	129	24	for	for	ADP
ajlm-2381	129	25	image	image	NOUN
ajlm-2381	129	26	analysis	analysis	NOUN
ajlm-2381	129	27	will	will	AUX
ajlm-2381	129	28	be	be	AUX
ajlm-2381	129	29	possible	possible	ADJ
ajlm-2381	129	30	in	in	ADP
ajlm-2381	129	31	situations	situation	NOUN
ajlm-2381	129	32	with	with	ADP
ajlm-2381	129	33	limited	limited	ADJ
ajlm-2381	129	34	resources	resource	NOUN
ajlm-2381	129	35	.	.	PUNCT
ajlm-2381	130	1	radiological	radiological	ADJ
ajlm-2381	130	2	imaging	imaging	NOUN
ajlm-2381	130	3	is	be	AUX
ajlm-2381	130	4	crucial	crucial	ADJ
ajlm-2381	130	5	for	for	ADP
ajlm-2381	130	6	the	the	DET
ajlm-2381	130	7	diagnosis	diagnosis	NOUN
ajlm-2381	130	8	and	and	CCONJ
ajlm-2381	130	9	treatment	treatment	NOUN
ajlm-2381	130	10	of	of	ADP
ajlm-2381	130	11	mm	mm	PROPN
ajlm-2381	130	12	.	.	PUNCT
ajlm-2381	131	1	introduction	introduction	NOUN
ajlm-2381	131	2	of	of	ADP
ajlm-2381	131	3	new	new	ADJ
ajlm-2381	131	4	technologies	technology	NOUN
ajlm-2381	131	5	such	such	ADJ
ajlm-2381	131	6	as	as	ADP
ajlm-2381	131	7	double	double	ADJ
ajlm-2381	131	8	-	-	PUNCT
ajlm-2381	131	9	energy	energy	NOUN
ajlm-2381	131	10	ct	ct	NOUN
ajlm-2381	131	11	and	and	CCONJ
ajlm-2381	131	12	radiomics	radiomic	NOUN
ajlm-2381	131	13	as	as	ADP
ajlm-2381	131	14	standard	standard	ADJ
ajlm-2381	131	15	practice	practice	NOUN
ajlm-2381	131	16	may	may	AUX
ajlm-2381	131	17	necessitate	necessitate	ADJ
ajlm-2381	131	18	changes	change	NOUN
ajlm-2381	131	19	to	to	ADP
ajlm-2381	131	20	imwg	imwg	NOUN
ajlm-2381	131	21	guidelines	guideline	NOUN
ajlm-2381	131	22	.	.	PUNCT
ajlm-2381	132	1	these	these	DET
ajlm-2381	132	2	techniques	technique	NOUN
ajlm-2381	132	3	are	be	AUX
ajlm-2381	132	4	still	still	ADV
ajlm-2381	132	5	in	in	ADP
ajlm-2381	132	6	the	the	DET
ajlm-2381	132	7	early	early	ADJ
ajlm-2381	132	8	stages	stage	NOUN
ajlm-2381	132	9	of	of	ADP
ajlm-2381	132	10	development	development	NOUN
ajlm-2381	132	11	for	for	ADP
ajlm-2381	132	12	the	the	DET
ajlm-2381	132	13	assessment	assessment	NOUN
ajlm-2381	132	14	of	of	ADP
ajlm-2381	132	15	patients	patient	NOUN
ajlm-2381	132	16	with	with	ADP
ajlm-2381	132	17	mm	mm	PROPN
ajlm-2381	132	18	and	and	CCONJ
ajlm-2381	132	19	are	be	AUX
ajlm-2381	132	20	an	an	DET
ajlm-2381	132	21	exciting	exciting	ADJ
ajlm-2381	132	22	and	and	CCONJ
ajlm-2381	132	23	rapidly	rapidly	ADV
ajlm-2381	132	24	evolving	evolve	VERB
ajlm-2381	132	25	field	field	NOUN
ajlm-2381	132	26	.	.	PUNCT
ajlm-2381	133	1	further	further	ADJ
ajlm-2381	133	2	development	development	NOUN
ajlm-2381	133	3	will	will	AUX
ajlm-2381	133	4	be	be	AUX
ajlm-2381	133	5	required	require	VERB
ajlm-2381	133	6	before	before	SCONJ
ajlm-2381	133	7	radiological	radiological	ADJ
ajlm-2381	133	8	imaging	imaging	NOUN
ajlm-2381	133	9	can	can	AUX
ajlm-2381	133	10	replace	replace	VERB
ajlm-2381	133	11	bm	bm	PROPN
ajlm-2381	133	12	biopsy	biopsy	NOUN
ajlm-2381	133	13	for	for	ADP
ajlm-2381	133	14	bmpc	bmpc	NOUN
ajlm-2381	133	15	quantitation	quantitation	NOUN
ajlm-2381	133	16	.	.	PUNCT
ajlm-2381	134	1	allele	allele	NOUN
ajlm-2381	134	2	-	-	PUNCT
ajlm-2381	134	3	specific	specific	ADJ
ajlm-2381	134	4	oligonucleotide	oligonucleotide	NOUN
ajlm-2381	134	5	-	-	PUNCT
ajlm-2381	134	6	qpcr	qpcr	ADV
ajlm-2381	134	7	and	and	CCONJ
ajlm-2381	134	8	ngs	ng	NOUN
ajlm-2381	134	9	are	be	AUX
ajlm-2381	134	10	commonly	commonly	ADV
ajlm-2381	134	11	used	use	VERB
ajlm-2381	134	12	to	to	PART
ajlm-2381	134	13	quantify	quantify	VERB
ajlm-2381	134	14	clonal	clonal	ADJ
ajlm-2381	134	15	pc	pc	NOUN
ajlm-2381	134	16	in	in	ADP
ajlm-2381	134	17	the	the	DET
ajlm-2381	134	18	follow	follow	NOUN
ajlm-2381	134	19	-	-	PUNCT
ajlm-2381	134	20	up	up	NOUN
ajlm-2381	134	21	of	of	ADP
ajlm-2381	134	22	treatment	treatment	NOUN
ajlm-2381	134	23	response	response	NOUN
ajlm-2381	134	24	and	and	CCONJ
ajlm-2381	134	25	detection	detection	NOUN
ajlm-2381	134	26	of	of	ADP
ajlm-2381	134	27	mrd	mrd	PROPN
ajlm-2381	134	28	.	.	PUNCT
ajlm-2381	135	1	allele	allele	NOUN
ajlm-2381	135	2	-	-	PUNCT
ajlm-2381	135	3	specific	specific	ADJ
ajlm-2381	135	4	oligonucleotide	oligonucleotide	NOUN
ajlm-2381	135	5	-	-	PUNCT
ajlm-2381	135	6	qpcr	qpcr	ADV
ajlm-2381	135	7	correlates	correlate	VERB
ajlm-2381	135	8	well	well	ADV
ajlm-2381	135	9	with	with	ADP
ajlm-2381	135	10	mfc	mfc	PROPN
ajlm-2381	135	11	for	for	ADP
ajlm-2381	135	12	mrd	mrd	ADJ
ajlm-2381	135	13	quantification	quantification	NOUN
ajlm-2381	135	14	,	,	PUNCT
ajlm-2381	135	15	but	but	CCONJ
ajlm-2381	135	16	has	have	VERB
ajlm-2381	135	17	limitations	limitation	NOUN
ajlm-2381	135	18	in	in	ADP
ajlm-2381	135	19	clonality	clonality	NOUN
ajlm-2381	135	20	detection	detection	NOUN
ajlm-2381	135	21	and	and	CCONJ
ajlm-2381	135	22	sequencing	sequencing	NOUN
ajlm-2381	135	23	,	,	PUNCT
ajlm-2381	135	24	which	which	PRON
ajlm-2381	135	25	affects	affect	VERB
ajlm-2381	135	26	its	its	PRON
ajlm-2381	135	27	applicability	applicability	NOUN
ajlm-2381	135	28	.	.	PUNCT
ajlm-2381	136	1	next	next	ADJ
ajlm-2381	136	2	-	-	PUNCT
ajlm-2381	136	3	generation	generation	NOUN
ajlm-2381	136	4	sequencing	sequencing	NOUN
ajlm-2381	136	5	has	have	AUX
ajlm-2381	136	6	replaced	replace	VERB
ajlm-2381	136	7	aso	aso	NOUN
ajlm-2381	136	8	-	-	PUNCT
ajlm-2381	136	9	qpcr	qpcr	ADV
ajlm-2381	136	10	because	because	SCONJ
ajlm-2381	136	11	it	it	PRON
ajlm-2381	136	12	is	be	AUX
ajlm-2381	136	13	more	more	ADV
ajlm-2381	136	14	sensitive	sensitive	ADJ
ajlm-2381	136	15	and	and	CCONJ
ajlm-2381	136	16	does	do	AUX
ajlm-2381	136	17	not	not	PART
ajlm-2381	136	18	require	require	VERB
ajlm-2381	136	19	patient	patient	NOUN
ajlm-2381	136	20	-	-	PUNCT
ajlm-2381	136	21	specific	specific	ADJ
ajlm-2381	136	22	primers	primer	NOUN
ajlm-2381	136	23	for	for	ADP
ajlm-2381	136	24	mrd	mrd	ADJ
ajlm-2381	136	25	monitoring	monitoring	NOUN
ajlm-2381	136	26	,	,	PUNCT
ajlm-2381	136	27	but	but	CCONJ
ajlm-2381	136	28	using	use	VERB
ajlm-2381	136	29	either	either	CCONJ
ajlm-2381	136	30	molecular	molecular	ADJ
ajlm-2381	136	31	technique	technique	NOUN
ajlm-2381	136	32	for	for	ADP
ajlm-2381	136	33	this	this	DET
ajlm-2381	136	34	purpose	purpose	NOUN
ajlm-2381	136	35	can	can	AUX
ajlm-2381	136	36	be	be	AUX
ajlm-2381	136	37	challenging	challenge	VERB
ajlm-2381	136	38	.	.	PUNCT
ajlm-2381	137	1	conclusion	conclusion	NOUN
ajlm-2381	137	2	diagnosis	diagnosis	NOUN
ajlm-2381	137	3	and	and	CCONJ
ajlm-2381	137	4	classification	classification	NOUN
ajlm-2381	137	5	of	of	ADP
ajlm-2381	137	6	pc	pc	NOUN
ajlm-2381	137	7	neoplasms	neoplasm	NOUN
ajlm-2381	137	8	depends	depend	VERB
ajlm-2381	137	9	on	on	ADP
ajlm-2381	137	10	accurate	accurate	ADJ
ajlm-2381	137	11	quantification	quantification	NOUN
ajlm-2381	137	12	of	of	ADP
ajlm-2381	137	13	pc	pc	NOUN
ajlm-2381	137	14	in	in	ADP
ajlm-2381	137	15	bm	bm	PROPN
ajlm-2381	137	16	biopsy	biopsy	PROPN
ajlm-2381	137	17	.	.	PUNCT
ajlm-2381	138	1	although	although	SCONJ
ajlm-2381	138	2	there	there	PRON
ajlm-2381	138	3	is	be	VERB
ajlm-2381	138	4	no	no	DET
ajlm-2381	138	5	consensus	consensus	NOUN
ajlm-2381	138	6	on	on	ADP
ajlm-2381	138	7	the	the	DET
ajlm-2381	138	8	optimal	optimal	ADJ
ajlm-2381	138	9	method	method	NOUN
ajlm-2381	138	10	for	for	ADP
ajlm-2381	138	11	estimating	estimate	VERB
ajlm-2381	138	12	pc	pc	NOUN
ajlm-2381	138	13	in	in	ADP
ajlm-2381	138	14	bm	bm	PROPN
ajlm-2381	138	15	,	,	PUNCT
ajlm-2381	138	16	cd138	cd138	NOUN
ajlm-2381	138	17	-	-	PUNCT
ajlm-2381	138	18	stained	stain	VERB
ajlm-2381	138	19	biopsies	biopsy	NOUN
ajlm-2381	138	20	are	be	AUX
ajlm-2381	138	21	the	the	DET
ajlm-2381	138	22	preferred	preferred	ADJ
ajlm-2381	138	23	sample	sample	NOUN
ajlm-2381	138	24	for	for	ADP
ajlm-2381	138	25	this	this	DET
ajlm-2381	138	26	estimation	estimation	NOUN
ajlm-2381	138	27	and	and	CCONJ
ajlm-2381	138	28	remain	remain	VERB
ajlm-2381	138	29	invaluable	invaluable	ADJ
ajlm-2381	138	30	for	for	ADP
ajlm-2381	138	31	diagnosis	diagnosis	NOUN
ajlm-2381	138	32	and	and	CCONJ
ajlm-2381	138	33	assessment	assessment	NOUN
ajlm-2381	138	34	of	of	ADP
ajlm-2381	138	35	response	response	NOUN
ajlm-2381	138	36	.	.	PUNCT
ajlm-2381	139	1	no	no	DET
ajlm-2381	139	2	sample	sample	NOUN
ajlm-2381	139	3	or	or	CCONJ
ajlm-2381	139	4	method	method	NOUN
ajlm-2381	139	5	should	should	AUX
ajlm-2381	139	6	be	be	AUX
ajlm-2381	139	7	used	use	VERB
ajlm-2381	139	8	in	in	ADP
ajlm-2381	139	9	isolation	isolation	NOUN
ajlm-2381	139	10	,	,	PUNCT
ajlm-2381	139	11	as	as	SCONJ
ajlm-2381	139	12	they	they	PRON
ajlm-2381	139	13	are	be	AUX
ajlm-2381	139	14	better	well	ADV
ajlm-2381	139	15	used	use	VERB
ajlm-2381	139	16	in	in	ADP
ajlm-2381	139	17	combination	combination	NOUN
ajlm-2381	139	18	for	for	ADP
ajlm-2381	139	19	this	this	DET
ajlm-2381	139	20	estimation	estimation	NOUN
ajlm-2381	139	21	,	,	PUNCT
ajlm-2381	139	22	and	and	CCONJ
ajlm-2381	139	23	laboratories	laboratory	NOUN
ajlm-2381	139	24	without	without	ADP
ajlm-2381	139	25	advanced	advanced	ADJ
ajlm-2381	139	26	techniques	technique	NOUN
ajlm-2381	139	27	should	should	AUX
ajlm-2381	139	28	continue	continue	VERB
ajlm-2381	139	29	to	to	PART
ajlm-2381	139	30	use	use	VERB
ajlm-2381	139	31	the	the	DET
ajlm-2381	139	32	best	good	ADJ
ajlm-2381	139	33	methods	method	NOUN
ajlm-2381	139	34	available	available	ADJ
ajlm-2381	139	35	to	to	ADP
ajlm-2381	139	36	them	they	PRON
ajlm-2381	139	37	.	.	PUNCT
ajlm-2381	140	1	in	in	ADP
ajlm-2381	140	2	our	our	PRON
ajlm-2381	140	3	quest	quest	NOUN
ajlm-2381	140	4	for	for	ADP
ajlm-2381	140	5	a	a	DET
ajlm-2381	140	6	gold	gold	ADJ
ajlm-2381	140	7	standard	standard	ADJ
ajlm-2381	140	8	method	method	NOUN
ajlm-2381	140	9	,	,	PUNCT
ajlm-2381	140	10	this	this	PRON
ajlm-2381	140	11	will	will	AUX
ajlm-2381	140	12	require	require	VERB
ajlm-2381	140	13	continued	continued	ADJ
ajlm-2381	140	14	research	research	NOUN
ajlm-2381	140	15	and	and	CCONJ
ajlm-2381	140	16	collaboration	collaboration	NOUN
ajlm-2381	140	17	to	to	PART
ajlm-2381	140	18	expand	expand	VERB
ajlm-2381	140	19	and	and	CCONJ
ajlm-2381	140	20	improve	improve	VERB
ajlm-2381	140	21	the	the	DET
ajlm-2381	140	22	currently	currently	ADV
ajlm-2381	140	23	published	publish	VERB
ajlm-2381	140	24	methods	method	NOUN
ajlm-2381	140	25	.	.	PUNCT
ajlm-2381	141	1	finally	finally	ADV
ajlm-2381	141	2	,	,	PUNCT
ajlm-2381	141	3	digital	digital	ADJ
ajlm-2381	141	4	pathology	pathology	NOUN
ajlm-2381	141	5	is	be	AUX
ajlm-2381	141	6	likely	likely	ADJ
ajlm-2381	141	7	to	to	PART
ajlm-2381	141	8	redefine	redefine	VERB
ajlm-2381	141	9	the	the	DET
ajlm-2381	141	10	way	way	NOUN
ajlm-2381	141	11	we	we	PRON
ajlm-2381	141	12	practise	practise	VERB
ajlm-2381	141	13	laboratory	laboratory	NOUN
ajlm-2381	141	14	medicine	medicine	NOUN
ajlm-2381	141	15	and	and	CCONJ
ajlm-2381	141	16	the	the	DET
ajlm-2381	141	17	role	role	NOUN
ajlm-2381	141	18	of	of	ADP
ajlm-2381	141	19	the	the	DET
ajlm-2381	141	20	pathologist	pathologist	NOUN
ajlm-2381	141	21	in	in	ADP
ajlm-2381	141	22	this	this	DET
ajlm-2381	141	23	new	new	ADJ
ajlm-2381	141	24	digital	digital	ADJ
ajlm-2381	141	25	age	age	NOUN
ajlm-2381	141	26	,	,	PUNCT
ajlm-2381	141	27	and	and	CCONJ
ajlm-2381	141	28	limited	limited	ADJ
ajlm-2381	141	29	resources	resource	NOUN
ajlm-2381	141	30	need	need	AUX
ajlm-2381	141	31	not	not	PART
ajlm-2381	141	32	necessarily	necessarily	ADV
ajlm-2381	141	33	be	be	AUX
ajlm-2381	141	34	a	a	DET
ajlm-2381	141	35	limiting	limit	VERB
ajlm-2381	141	36	factor	factor	NOUN
ajlm-2381	141	37	.	.	PUNCT
ajlm-2381	142	1	acknowledgements	acknowledgement	NOUN
ajlm-2381	142	2	competing	compete	VERB
ajlm-2381	142	3	interests	interest	NOUN
ajlm-2381	142	4	the	the	DET
ajlm-2381	142	5	authors	author	NOUN
ajlm-2381	142	6	declare	declare	VERB
ajlm-2381	142	7	that	that	SCONJ
ajlm-2381	142	8	they	they	PRON
ajlm-2381	142	9	have	have	VERB
ajlm-2381	142	10	no	no	DET
ajlm-2381	142	11	financial	financial	ADJ
ajlm-2381	142	12	or	or	CCONJ
ajlm-2381	142	13	personal	personal	ADJ
ajlm-2381	142	14	relationships	relationship	NOUN
ajlm-2381	142	15	that	that	PRON
ajlm-2381	142	16	may	may	AUX
ajlm-2381	142	17	have	have	AUX
ajlm-2381	142	18	inappropriately	inappropriately	ADV
ajlm-2381	142	19	influenced	influence	VERB
ajlm-2381	142	20	them	they	PRON
ajlm-2381	142	21	in	in	ADP
ajlm-2381	142	22	writing	write	VERB
ajlm-2381	142	23	this	this	DET
ajlm-2381	142	24	article	article	NOUN
ajlm-2381	142	25	.	.	PUNCT
ajlm-2381	143	1	authors	author	NOUN
ajlm-2381	143	2	’	’	PART
ajlm-2381	143	3	contributions	contribution	NOUN
ajlm-2381	143	4	e.j.g	e.j.g	PROPN
ajlm-2381	143	5	.	.	PUNCT
ajlm-2381	143	6	conceptualised	conceptualise	VERB
ajlm-2381	143	7	the	the	DET
ajlm-2381	143	8	manuscript	manuscript	NOUN
ajlm-2381	143	9	,	,	PUNCT
ajlm-2381	143	10	wrote	write	VERB
ajlm-2381	143	11	the	the	DET
ajlm-2381	143	12	original	original	ADJ
ajlm-2381	143	13	draft	draft	NOUN
ajlm-2381	143	14	and	and	CCONJ
ajlm-2381	143	15	participated	participate	VERB
ajlm-2381	143	16	in	in	ADP
ajlm-2381	143	17	the	the	DET
ajlm-2381	143	18	review	review	NOUN
ajlm-2381	143	19	and	and	CCONJ
ajlm-2381	143	20	editing	editing	NOUN
ajlm-2381	143	21	.	.	PUNCT
ajlm-2381	144	1	z.c.c	z.c.c	NOUN
ajlm-2381	144	2	.	.	PUNCT
ajlm-2381	145	1	and	and	CCONJ
ajlm-2381	145	2	e.m	e.m	PROPN
ajlm-2381	145	3	.	.	PROPN
ajlm-2381	145	4	were	be	AUX
ajlm-2381	145	5	involved	involve	VERB
ajlm-2381	145	6	in	in	ADP
ajlm-2381	145	7	the	the	DET
ajlm-2381	145	8	preparation	preparation	NOUN
ajlm-2381	145	9	of	of	ADP
ajlm-2381	145	10	subsequent	subsequent	ADJ
ajlm-2381	145	11	drafts	draft	NOUN
ajlm-2381	145	12	and	and	CCONJ
ajlm-2381	145	13	in	in	ADP
ajlm-2381	145	14	the	the	DET
ajlm-2381	145	15	review	review	NOUN
ajlm-2381	145	16	and	and	CCONJ
ajlm-2381	145	17	editing	editing	NOUN
ajlm-2381	145	18	of	of	ADP
ajlm-2381	145	19	the	the	DET
ajlm-2381	145	20	manuscript	manuscript	NOUN
ajlm-2381	145	21	.	.	PUNCT
ajlm-2381	146	1	ethical	ethical	ADJ
ajlm-2381	146	2	considerations	consideration	NOUN
ajlm-2381	146	3	this	this	DET
ajlm-2381	146	4	article	article	NOUN
ajlm-2381	146	5	followed	follow	VERB
ajlm-2381	146	6	all	all	DET
ajlm-2381	146	7	ethical	ethical	ADJ
ajlm-2381	146	8	standards	standard	NOUN
ajlm-2381	146	9	for	for	ADP
ajlm-2381	146	10	research	research	NOUN
ajlm-2381	146	11	without	without	ADP
ajlm-2381	146	12	direct	direct	ADJ
ajlm-2381	146	13	contact	contact	NOUN
ajlm-2381	146	14	with	with	ADP
ajlm-2381	146	15	human	human	ADJ
ajlm-2381	146	16	or	or	CCONJ
ajlm-2381	146	17	animal	animal	NOUN
ajlm-2381	146	18	subjects	subject	NOUN
ajlm-2381	146	19	.	.	PUNCT
ajlm-2381	147	1	sources	source	NOUN
ajlm-2381	147	2	of	of	ADP
ajlm-2381	147	3	support	support	NOUN
ajlm-2381	147	4	this	this	DET
ajlm-2381	147	5	research	research	NOUN
ajlm-2381	147	6	received	receive	VERB
ajlm-2381	147	7	no	no	DET
ajlm-2381	147	8	specific	specific	ADJ
ajlm-2381	147	9	grant	grant	NOUN
ajlm-2381	147	10	from	from	ADP
ajlm-2381	147	11	any	any	DET
ajlm-2381	147	12	funding	funding	NOUN
ajlm-2381	147	13	agency	agency	NOUN
ajlm-2381	147	14	in	in	ADP
ajlm-2381	147	15	the	the	DET
ajlm-2381	147	16	public	public	ADJ
ajlm-2381	147	17	,	,	PUNCT
ajlm-2381	147	18	commercial	commercial	ADJ
ajlm-2381	147	19	,	,	PUNCT
ajlm-2381	147	20	or	or	CCONJ
ajlm-2381	147	21	not	not	PART
ajlm-2381	147	22	-	-	PUNCT
ajlm-2381	147	23	for	for	ADP
ajlm-2381	147	24	-	-	PUNCT
ajlm-2381	147	25	profit	profit	NOUN
ajlm-2381	147	26	sectors	sector	NOUN
ajlm-2381	147	27	.	.	PUNCT
ajlm-2381	148	1	data	datum	NOUN
ajlm-2381	148	2	availability	availability	NOUN
ajlm-2381	148	3	data	datum	NOUN
ajlm-2381	148	4	sharing	sharing	NOUN
ajlm-2381	148	5	is	be	AUX
ajlm-2381	148	6	not	not	PART
ajlm-2381	148	7	applicable	applicable	ADJ
ajlm-2381	148	8	to	to	ADP
ajlm-2381	148	9	this	this	DET
ajlm-2381	148	10	article	article	NOUN
ajlm-2381	148	11	as	as	SCONJ
ajlm-2381	148	12	no	no	DET
ajlm-2381	148	13	new	new	ADJ
ajlm-2381	148	14	data	datum	NOUN
ajlm-2381	148	15	were	be	AUX
ajlm-2381	148	16	created	create	VERB
ajlm-2381	148	17	or	or	CCONJ
ajlm-2381	148	18	analysed	analyse	VERB
ajlm-2381	148	19	in	in	ADP
ajlm-2381	148	20	this	this	DET
ajlm-2381	148	21	study	study	NOUN
ajlm-2381	148	22	.	.	PUNCT
ajlm-2381	149	1	disclaimer	disclaimer	VERB
ajlm-2381	149	2	the	the	DET
ajlm-2381	149	3	views	view	NOUN
ajlm-2381	149	4	and	and	CCONJ
ajlm-2381	149	5	opinions	opinion	NOUN
ajlm-2381	149	6	expressed	express	VERB
ajlm-2381	149	7	in	in	ADP
ajlm-2381	149	8	this	this	DET
ajlm-2381	149	9	article	article	NOUN
ajlm-2381	149	10	are	be	AUX
ajlm-2381	149	11	those	those	PRON
ajlm-2381	149	12	of	of	ADP
ajlm-2381	149	13	the	the	DET
ajlm-2381	149	14	authors	author	NOUN
ajlm-2381	149	15	and	and	CCONJ
ajlm-2381	149	16	are	be	AUX
ajlm-2381	149	17	the	the	DET
ajlm-2381	149	18	product	product	NOUN
ajlm-2381	149	19	of	of	ADP
ajlm-2381	149	20	professional	professional	ADJ
ajlm-2381	149	21	research	research	NOUN
ajlm-2381	149	22	.	.	PUNCT
ajlm-2381	150	1	it	it	PRON
ajlm-2381	150	2	does	do	AUX
ajlm-2381	150	3	not	not	PART
ajlm-2381	150	4	necessarily	necessarily	ADV
ajlm-2381	150	5	reflect	reflect	VERB
ajlm-2381	150	6	the	the	DET
ajlm-2381	150	7	official	official	ADJ
ajlm-2381	150	8	policy	policy	NOUN
ajlm-2381	150	9	or	or	CCONJ
ajlm-2381	150	10	position	position	NOUN
ajlm-2381	150	11	of	of	ADP
ajlm-2381	150	12	any	any	DET
ajlm-2381	150	13	affiliated	affiliated	ADJ
ajlm-2381	150	14	institution	institution	NOUN
ajlm-2381	150	15	,	,	PUNCT
ajlm-2381	150	16	funder	funder	NOUN
ajlm-2381	150	17	,	,	PUNCT
ajlm-2381	150	18	agency	agency	NOUN
ajlm-2381	150	19	,	,	PUNCT
ajlm-2381	150	20	or	or	CCONJ
ajlm-2381	150	21	that	that	PRON
ajlm-2381	150	22	of	of	ADP
ajlm-2381	150	23	the	the	DET
ajlm-2381	150	24	publisher	publisher	NOUN
ajlm-2381	150	25	.	.	PUNCT
ajlm-2381	151	1	the	the	DET
ajlm-2381	151	2	authors	author	NOUN
ajlm-2381	151	3	are	be	AUX
ajlm-2381	151	4	responsible	responsible	ADJ
ajlm-2381	151	5	for	for	ADP
ajlm-2381	151	6	this	this	DET
ajlm-2381	151	7	article	article	NOUN
ajlm-2381	151	8	’s	’s	PART
ajlm-2381	151	9	results	result	NOUN
ajlm-2381	151	10	,	,	PUNCT
ajlm-2381	151	11	findings	finding	NOUN
ajlm-2381	151	12	,	,	PUNCT
ajlm-2381	151	13	and	and	CCONJ
ajlm-2381	151	14	content	content	NOUN
ajlm-2381	151	15	.	.	PUNCT
ajlm-2381	152	1	references	reference	NOUN
ajlm-2381	152	2	swerdlow	swerdlow	VERB
ajlm-2381	152	3	sh	sh	PROPN
ajlm-2381	152	4	,	,	PUNCT
ajlm-2381	152	5	campo	campo	PROPN
ajlm-2381	152	6	e	e	PROPN
ajlm-2381	152	7	,	,	PUNCT
ajlm-2381	152	8	pileri	pileri	PROPN
ajlm-2381	152	9	sa	sa	PROPN
ajlm-2381	152	10	,	,	PUNCT
ajlm-2381	152	11	et	et	PROPN
ajlm-2381	152	12	al	al	PROPN
ajlm-2381	152	13	.	.	PUNCT
ajlm-2381	153	1	who	who	PRON
ajlm-2381	153	2	classification	classification	NOUN
ajlm-2381	153	3	of	of	ADP
ajlm-2381	153	4	tumours	tumour	NOUN
ajlm-2381	153	5	of	of	ADP
ajlm-2381	153	6	the	the	DET
ajlm-2381	153	7	haematopoietic	haematopoietic	ADJ
ajlm-2381	153	8	and	and	CCONJ
ajlm-2381	153	9	lymphoid	lymphoid	ADJ
ajlm-2381	153	10	tissues	tissue	NOUN
ajlm-2381	153	11	the	the	DET
ajlm-2381	153	12	2016	2016	NUM
ajlm-2381	153	13	revision	revision	NOUN
ajlm-2381	153	14	of	of	ADP
ajlm-2381	153	15	the	the	DET
ajlm-2381	153	16	world	world	PROPN
ajlm-2381	153	17	health	health	PROPN
ajlm-2381	153	18	organization	organization	NOUN
ajlm-2381	153	19	classification	classification	NOUN
ajlm-2381	153	20	of	of	ADP
ajlm-2381	153	21	lymphoid	lymphoid	ADJ
ajlm-2381	153	22	neoplasms	neoplasm	NOUN
ajlm-2381	153	23	.	.	PUNCT
ajlm-2381	154	1	blood	blood	NOUN
ajlm-2381	154	2	.	.	PUNCT
ajlm-2381	155	1	2016;127(20):2375–2390	2016;127(20):2375–2390	X
ajlm-2381	155	2	.	.	PUNCT
ajlm-2381	156	1	https://doi.org/10.1182/blood-2016-01-643569	https://doi.org/10.1182/blood-2016-01-643569	PROPN
ajlm-2381	156	2	alaggio	alaggio	PROPN
ajlm-2381	156	3	r	r	PROPN
ajlm-2381	156	4	,	,	PUNCT
ajlm-2381	156	5	amador	amador	PROPN
ajlm-2381	156	6	c	c	PROPN
ajlm-2381	156	7	,	,	PUNCT
ajlm-2381	156	8	anagnostopoulos	anagnostopoulos	PROPN
ajlm-2381	156	9	i	i	PROPN
ajlm-2381	156	10	,	,	PUNCT
ajlm-2381	156	11	et	et	PROPN
ajlm-2381	156	12	al	al	PROPN
ajlm-2381	156	13	.	.	PUNCT
ajlm-2381	157	1	the	the	DET
ajlm-2381	157	2	5th	5th	ADJ
ajlm-2381	157	3	edition	edition	NOUN
ajlm-2381	157	4	of	of	ADP
ajlm-2381	157	5	the	the	DET
ajlm-2381	157	6	world	world	PROPN
ajlm-2381	157	7	health	health	PROPN
ajlm-2381	157	8	organization	organization	NOUN
ajlm-2381	157	9	classification	classification	NOUN
ajlm-2381	157	10	of	of	ADP
ajlm-2381	157	11	haematolymphoid	haematolymphoid	ADJ
ajlm-2381	157	12	tumours	tumours	NOUN
ajlm-2381	157	13	:	:	PUNCT
ajlm-2381	157	14	lymphoid	lymphoid	ADJ
ajlm-2381	157	15	neoplasms	neoplasm	NOUN
ajlm-2381	157	16	.	.	PUNCT
ajlm-2381	158	1	leukemia	leukemia	NOUN
ajlm-2381	158	2	.	.	PUNCT
ajlm-2381	159	1	2022;36:2750	2022;36:2750	X
ajlm-2381	159	2	.	.	PUNCT
ajlm-2381	160	1	https://doi.org/10.1038/s41375-022-01694-y	https://doi.org/10.1038/s41375-022-01694-y	PROPN
ajlm-2381	160	2	rajkumar	rajkumar	PROPN
ajlm-2381	160	3	sv	sv	PROPN
ajlm-2381	160	4	.	.	PUNCT
ajlm-2381	160	5	multiple	multiple	ADJ
ajlm-2381	160	6	myeloma	myeloma	NOUN
ajlm-2381	160	7	:	:	PUNCT
ajlm-2381	160	8	2022	2022	NUM
ajlm-2381	160	9	update	update	NOUN
ajlm-2381	160	10	on	on	ADP
ajlm-2381	160	11	diagnosis	diagnosis	NOUN
ajlm-2381	160	12	,	,	PUNCT
ajlm-2381	160	13	risk	risk	NOUN
ajlm-2381	160	14	stratification	stratification	NOUN
ajlm-2381	160	15	,	,	PUNCT
ajlm-2381	160	16	and	and	CCONJ
ajlm-2381	160	17	management	management	NOUN
ajlm-2381	160	18	.	.	PUNCT
ajlm-2381	160	19	am	be	AUX
ajlm-2381	160	20	j	j	PROPN
ajlm-2381	160	21	hematol	hematol	NOUN
ajlm-2381	160	22	.	.	PUNCT
ajlm-2381	161	1	2022;97(8):1086–1107	2022;97(8):1086–1107	NOUN
ajlm-2381	161	2	.	.	PUNCT
ajlm-2381	162	1	https://doi.org/10.1002/ajh.26590	https://doi.org/10.1002/ajh.26590	PROPN
ajlm-2381	162	2	kumar	kumar	PROPN
ajlm-2381	162	3	s	s	PROPN
ajlm-2381	162	4	,	,	PUNCT
ajlm-2381	162	5	paiva	paiva	PROPN
ajlm-2381	162	6	b	b	PROPN
ajlm-2381	162	7	,	,	PUNCT
ajlm-2381	162	8	anderson	anderson	PROPN
ajlm-2381	162	9	kc	kc	PROPN
ajlm-2381	162	10	,	,	PUNCT
ajlm-2381	162	11	et	et	PROPN
ajlm-2381	162	12	al	al	PROPN
ajlm-2381	162	13	.	.	PUNCT
ajlm-2381	163	1	international	international	ADJ
ajlm-2381	163	2	myeloma	myeloma	PROPN
ajlm-2381	163	3	working	working	PROPN
ajlm-2381	163	4	group	group	PROPN
ajlm-2381	163	5	consensus	consensus	NOUN
ajlm-2381	163	6	criteria	criterion	NOUN
ajlm-2381	163	7	for	for	ADP
ajlm-2381	163	8	response	response	NOUN
ajlm-2381	163	9	and	and	CCONJ
ajlm-2381	163	10	minimal	minimal	ADJ
ajlm-2381	163	11	residual	residual	ADJ
ajlm-2381	163	12	disease	disease	NOUN
ajlm-2381	163	13	assessment	assessment	NOUN
ajlm-2381	163	14	in	in	ADP
ajlm-2381	163	15	multiple	multiple	ADJ
ajlm-2381	163	16	myeloma	myeloma	NOUN
ajlm-2381	163	17	.	.	PUNCT
ajlm-2381	164	1	lancet	lancet	PROPN
ajlm-2381	164	2	oncol	oncol	PROPN
ajlm-2381	164	3	.	.	PUNCT
ajlm-2381	165	1	2016;17	2016;17	X
ajlm-2381	165	2	.	.	PUNCT
ajlm-2381	166	1	o’connell	o’connell	PROPN
ajlm-2381	166	2	fp	fp	NOUN
ajlm-2381	166	3	,	,	PUNCT
ajlm-2381	166	4	pinkus	pinku	NOUN
ajlm-2381	166	5	jl	jl	PROPN
ajlm-2381	166	6	,	,	PUNCT
ajlm-2381	166	7	pinkus	pinku	NOUN
ajlm-2381	166	8	gs	gs	PROPN
ajlm-2381	166	9	.	.	PUNCT
ajlm-2381	167	1	cd138	cd138	PROPN
ajlm-2381	167	2	(	(	PUNCT
ajlm-2381	167	3	syndecan-1	syndecan-1	PROPN
ajlm-2381	167	4	)	)	PUNCT
ajlm-2381	167	5	,	,	PUNCT
ajlm-2381	167	6	a	a	DET
ajlm-2381	167	7	plasma	plasma	NOUN
ajlm-2381	167	8	cell	cell	NOUN
ajlm-2381	167	9	marker	marker	NOUN
ajlm-2381	167	10	:	:	PUNCT
ajlm-2381	167	11	immunohistochemical	immunohistochemical	ADJ
ajlm-2381	167	12	profile	profile	NOUN
ajlm-2381	167	13	in	in	ADP
ajlm-2381	167	14	hematopoietic	hematopoietic	ADJ
ajlm-2381	167	15	and	and	CCONJ
ajlm-2381	167	16	nonhematopoietic	nonhematopoietic	ADJ
ajlm-2381	167	17	neoplasms	neoplasm	NOUN
ajlm-2381	167	18	.	.	PUNCT
ajlm-2381	168	1	am	be	AUX
ajlm-2381	168	2	j	j	PROPN
ajlm-2381	168	3	clin	clin	PROPN
ajlm-2381	168	4	pathol	pathol	NOUN
ajlm-2381	168	5	.	.	PUNCT
ajlm-2381	169	1	2004;121(2):254–263	2004;121(2):254–263	NUM
ajlm-2381	169	2	.	.	PUNCT
ajlm-2381	169	3	https://doi.org/10.1309/617dwb5gnfwxhw4l	https://doi.org/10.1309/617dwb5gnfwxhw4l	VERB
ajlm-2381	169	4	chilosi	chilosi	PROPN
ajlm-2381	169	5	m	m	PROPN
ajlm-2381	169	6	,	,	PUNCT
ajlm-2381	169	7	adami	adami	PROPN
ajlm-2381	169	8	f	f	AUX
ajlm-2381	169	9	,	,	PUNCT
ajlm-2381	169	10	lestani	lestani	X
ajlm-2381	169	11	m	m	PROPN
ajlm-2381	169	12	,	,	PUNCT
ajlm-2381	169	13	et	et	PROPN
ajlm-2381	169	14	al	al	PROPN
ajlm-2381	169	15	.	.	PUNCT
ajlm-2381	170	1	cd138	cd138	PROPN
ajlm-2381	170	2	/	/	SYM
ajlm-2381	170	3	syndecan-1	syndecan-1	PROPN
ajlm-2381	170	4	:	:	PUNCT
ajlm-2381	170	5	a	a	DET
ajlm-2381	170	6	useful	useful	ADJ
ajlm-2381	170	7	immunohistochemical	immunohistochemical	ADJ
ajlm-2381	170	8	marker	marker	NOUN
ajlm-2381	170	9	of	of	ADP
ajlm-2381	170	10	normal	normal	ADJ
ajlm-2381	170	11	and	and	CCONJ
ajlm-2381	170	12	neoplastic	neoplastic	ADJ
ajlm-2381	170	13	plasma	plasma	NOUN
ajlm-2381	170	14	cells	cell	NOUN
ajlm-2381	170	15	on	on	ADP
ajlm-2381	170	16	routine	routine	ADJ
ajlm-2381	170	17	trephine	trephine	ADJ
ajlm-2381	170	18	bone	bone	NOUN
ajlm-2381	170	19	marrow	marrow	NOUN
ajlm-2381	170	20	biopsies	biopsy	NOUN
ajlm-2381	170	21	.	.	PUNCT
ajlm-2381	171	1	modern	modern	ADJ
ajlm-2381	171	2	pathol	pathol	NOUN
ajlm-2381	171	3	.	.	PUNCT
ajlm-2381	172	1	1999;12(12	1999;12(12	NUM
ajlm-2381	172	2	):	):	PUNCT
ajlm-2381	172	3	1101–1106	1101–1106	NUM
ajlm-2381	172	4	.	.	PUNCT
ajlm-2381	173	1	colquhoun	colquhoun	ADJ
ajlm-2381	173	2	hl	hl	NOUN
ajlm-2381	173	3	,	,	PUNCT
ajlm-2381	173	4	levac	levac	NOUN
ajlm-2381	173	5	d	d	PROPN
ajlm-2381	173	6	,	,	PUNCT
ajlm-2381	173	7	o’brien	o’brien	PROPN
ajlm-2381	173	8	kk	kk	PROPN
ajlm-2381	173	9	,	,	PUNCT
ajlm-2381	173	10	et	et	PROPN
ajlm-2381	173	11	al	al	PROPN
ajlm-2381	173	12	.	.	PUNCT
ajlm-2381	174	1	scoping	scope	VERB
ajlm-2381	174	2	reviews	review	NOUN
ajlm-2381	174	3	:	:	PUNCT
ajlm-2381	174	4	time	time	NOUN
ajlm-2381	174	5	for	for	ADP
ajlm-2381	174	6	clarity	clarity	NOUN
ajlm-2381	174	7	in	in	ADP
ajlm-2381	174	8	definition	definition	NOUN
ajlm-2381	174	9	,	,	PUNCT
ajlm-2381	174	10	methods	method	NOUN
ajlm-2381	174	11	,	,	PUNCT
ajlm-2381	174	12	and	and	CCONJ
ajlm-2381	174	13	reporting	report	VERB
ajlm-2381	174	14	.	.	PUNCT
ajlm-2381	175	1	j	j	PROPN
ajlm-2381	175	2	clin	clin	PROPN
ajlm-2381	175	3	epidemiol	epidemiol	PROPN
ajlm-2381	175	4	.	.	PUNCT
ajlm-2381	176	1	2014;67(12):1291–1294	2014;67(12):1291–1294	NOUN
ajlm-2381	176	2	.	.	PUNCT
ajlm-2381	177	1	https://doi.org/10.1016/j.jclinepi.2014.03.013	https://doi.org/10.1016/j.jclinepi.2014.03.013	NUM
ajlm-2381	177	2	arksey	arksey	PROPN
ajlm-2381	177	3	h	h	NOUN
ajlm-2381	177	4	,	,	PUNCT
ajlm-2381	177	5	o’malley	o’malley	VERB
ajlm-2381	177	6	l.	l.	NOUN
ajlm-2381	177	7	scoping	scope	VERB
ajlm-2381	177	8	studies	study	NOUN
ajlm-2381	177	9	:	:	PUNCT
ajlm-2381	177	10	towards	towards	ADP
ajlm-2381	177	11	a	a	DET
ajlm-2381	177	12	methodological	methodological	ADJ
ajlm-2381	177	13	framework	framework	NOUN
ajlm-2381	177	14	.	.	PUNCT
ajlm-2381	178	1	int	int	NOUN
ajlm-2381	178	2	j	j	PROPN
ajlm-2381	178	3	soc	soc	PROPN
ajlm-2381	178	4	res	re	VERB
ajlm-2381	178	5	methodol	methodol	NOUN
ajlm-2381	178	6	.	.	PUNCT
ajlm-2381	179	1	2005;8(1):19–32	2005;8(1):19–32	NUM
ajlm-2381	179	2	.	.	PUNCT
ajlm-2381	179	3	https://doi.org/10.1080/1364557032000119616	https://doi.org/10.1080/1364557032000119616	X
ajlm-2381	179	4	levac	levac	NOUN
ajlm-2381	179	5	d	d	NOUN
ajlm-2381	179	6	,	,	PUNCT
ajlm-2381	179	7	colquhoun	colquhoun	ADJ
ajlm-2381	179	8	h	h	NOUN
ajlm-2381	179	9	,	,	PUNCT
ajlm-2381	179	10	o’brien	o’brien	PROPN
ajlm-2381	179	11	kk	kk	AUX
ajlm-2381	179	12	.	.	PUNCT
ajlm-2381	179	13	scoping	scope	VERB
ajlm-2381	179	14	studies	study	NOUN
ajlm-2381	179	15	:	:	PUNCT
ajlm-2381	179	16	advancing	advance	VERB
ajlm-2381	179	17	the	the	DET
ajlm-2381	179	18	methodology	methodology	NOUN
ajlm-2381	179	19	.	.	PUNCT
ajlm-2381	180	1	implement	implement	VERB
ajlm-2381	180	2	sci	sci	PROPN
ajlm-2381	180	3	.	.	PUNCT
ajlm-2381	181	1	2010;5(1):69	2010;5(1):69	NUM
ajlm-2381	181	2	.	.	PUNCT
ajlm-2381	181	3	https://doi.org/10.1186/1748-5908-5-69	https://doi.org/10.1186/1748-5908-5-69	PROPN
ajlm-2381	181	4	batinić	batinić	PROPN
ajlm-2381	181	5	d	d	PROPN
ajlm-2381	181	6	,	,	PUNCT
ajlm-2381	181	7	marusić	marusić	PROPN
ajlm-2381	181	8	m	m	PROPN
ajlm-2381	181	9	,	,	PUNCT
ajlm-2381	181	10	pavletić	pavletić	NOUN
ajlm-2381	181	11	z	z	NOUN
ajlm-2381	181	12	,	,	PUNCT
ajlm-2381	181	13	et	et	PROPN
ajlm-2381	181	14	al	al	PROPN
ajlm-2381	181	15	.	.	PROPN
ajlm-2381	181	16	relationship	relationship	NOUN
ajlm-2381	181	17	between	between	ADP
ajlm-2381	181	18	differing	differ	VERB
ajlm-2381	181	19	volumes	volume	NOUN
ajlm-2381	181	20	of	of	ADP
ajlm-2381	181	21	bone	bone	NOUN
ajlm-2381	181	22	marrow	marrow	NOUN
ajlm-2381	181	23	aspirates	aspirate	NOUN
ajlm-2381	181	24	and	and	CCONJ
ajlm-2381	181	25	their	their	PRON
ajlm-2381	181	26	cellular	cellular	ADJ
ajlm-2381	181	27	composition	composition	NOUN
ajlm-2381	181	28	.	.	PUNCT
ajlm-2381	182	1	bone	bone	NOUN
ajlm-2381	182	2	marrow	marrow	PROPN
ajlm-2381	182	3	transplant	transplant	NOUN
ajlm-2381	182	4	.	.	PUNCT
ajlm-2381	183	1	1990;6(2):103–107	1990;6(2):103–107	X
ajlm-2381	183	2	.	.	PUNCT
ajlm-2381	183	3	bain	bain	PROPN
ajlm-2381	183	4	bj	bj	PROPN
ajlm-2381	183	5	,	,	PUNCT
ajlm-2381	183	6	bates	bates	PROPN
ajlm-2381	183	7	i	i	PROPN
ajlm-2381	183	8	,	,	PUNCT
ajlm-2381	183	9	laffan	laffan	PROPN
ajlm-2381	183	10	ma	ma	PROPN
ajlm-2381	183	11	,	,	PUNCT
ajlm-2381	183	12	lewis	lewis	PROPN
ajlm-2381	183	13	sm	sm	PROPN
ajlm-2381	183	14	.	.	PROPN
ajlm-2381	183	15	dacie	dacie	PROPN
ajlm-2381	183	16	and	and	CCONJ
ajlm-2381	183	17	lewis	lewis	PROPN
ajlm-2381	183	18	practical	practical	ADJ
ajlm-2381	183	19	haematology	haematology	NOUN
ajlm-2381	183	20	:	:	PUNCT
ajlm-2381	183	21	twelfth	twelfth	ADJ
ajlm-2381	183	22	edition	edition	NOUN
ajlm-2381	183	23	.	.	PUNCT
ajlm-2381	184	1	elsevier	elsevier	PROPN
ajlm-2381	184	2	,	,	PUNCT
ajlm-2381	184	3	london	london	PROPN
ajlm-2381	184	4	,	,	PUNCT
ajlm-2381	184	5	2017	2017	NUM
ajlm-2381	184	6	.	.	PUNCT
ajlm-2381	185	1	chapter	chapter	NOUN
ajlm-2381	185	2	7	7	NUM
ajlm-2381	185	3	,	,	PUNCT
ajlm-2381	185	4	bone	bone	NOUN
ajlm-2381	185	5	marrow	marrow	NOUN
ajlm-2381	185	6	biopsy	biopsy	NOUN
ajlm-2381	185	7	;	;	PUNCT
ajlm-2381	185	8	p.	p.	NOUN
ajlm-2381	185	9	112–125	112–125	NUM
ajlm-2381	185	10	.	.	PUNCT
ajlm-2381	186	1	jain	jain	PROPN
ajlm-2381	186	2	g	g	PROPN
ajlm-2381	186	3	,	,	PUNCT
ajlm-2381	186	4	das	das	PROPN
ajlm-2381	186	5	n	n	PRON
ajlm-2381	186	6	,	,	PUNCT
ajlm-2381	186	7	gajendra	gajendra	PROPN
ajlm-2381	186	8	s	s	PROPN
ajlm-2381	186	9	,	,	PUNCT
ajlm-2381	186	10	et	et	PROPN
ajlm-2381	186	11	al	al	PROPN
ajlm-2381	186	12	.	.	PROPN
ajlm-2381	186	13	effect	effect	NOUN
ajlm-2381	186	14	of	of	ADP
ajlm-2381	186	15	the	the	DET
ajlm-2381	186	16	sequence	sequence	NOUN
ajlm-2381	186	17	of	of	ADP
ajlm-2381	186	18	pull	pull	NOUN
ajlm-2381	186	19	of	of	ADP
ajlm-2381	186	20	bone	bone	NOUN
ajlm-2381	186	21	marrow	marrow	NOUN
ajlm-2381	186	22	aspirates	aspirate	NOUN
ajlm-2381	186	23	on	on	ADP
ajlm-2381	186	24	plasma	plasma	NOUN
ajlm-2381	186	25	cell	cell	NOUN
ajlm-2381	186	26	quantification	quantification	NOUN
ajlm-2381	186	27	in	in	ADP
ajlm-2381	186	28	plasma	plasma	NOUN
ajlm-2381	186	29	cell	cell	NOUN
ajlm-2381	186	30	proliferative	proliferative	ADJ
ajlm-2381	186	31	disorders	disorder	NOUN
ajlm-2381	186	32	.	.	PUNCT
ajlm-2381	187	1	int	int	NOUN
ajlm-2381	187	2	j	j	PROPN
ajlm-2381	187	3	lab	lab	NOUN
ajlm-2381	187	4	hematol	hematol	NOUN
ajlm-2381	187	5	.	.	PUNCT
ajlm-2381	188	1	2022;44(5):837–845	2022;44(5):837–845	X
ajlm-2381	188	2	.	.	PUNCT
ajlm-2381	188	3	https://doi.org/10.1111/ijlh.13887	https://doi.org/10.1111/ijlh.13887	PROPN
ajlm-2381	188	4	nadav	nadav	PROPN
ajlm-2381	188	5	l	l	PROPN
ajlm-2381	188	6	,	,	PUNCT
ajlm-2381	188	7	katz	katz	PROPN
ajlm-2381	188	8	bz	bz	PROPN
ajlm-2381	188	9	,	,	PUNCT
ajlm-2381	188	10	baron	baron	PROPN
ajlm-2381	188	11	s	s	PROPN
ajlm-2381	188	12	,	,	PUNCT
ajlm-2381	188	13	et	et	PROPN
ajlm-2381	188	14	al	al	PROPN
ajlm-2381	188	15	.	.	PUNCT
ajlm-2381	189	1	diverse	diverse	ADJ
ajlm-2381	189	2	niches	niche	NOUN
ajlm-2381	189	3	within	within	ADP
ajlm-2381	189	4	multiple	multiple	ADJ
ajlm-2381	189	5	myeloma	myeloma	NOUN
ajlm-2381	189	6	bone	bone	NOUN
ajlm-2381	189	7	marrow	marrow	PROPN
ajlm-2381	189	8	aspirates	aspirate	NOUN
ajlm-2381	189	9	affect	affect	VERB
ajlm-2381	189	10	plasma	plasma	NOUN
ajlm-2381	189	11	cell	cell	NOUN
ajlm-2381	189	12	enumeration	enumeration	NOUN
ajlm-2381	189	13	.	.	PUNCT
ajlm-2381	190	1	br	br	PROPN
ajlm-2381	190	2	j	j	PROPN
ajlm-2381	190	3	haematol	haematol	NOUN
ajlm-2381	190	4	.	.	PUNCT
ajlm-2381	191	1	2006;133(5):530–532	2006;133(5):530–532	X
ajlm-2381	191	2	.	.	PUNCT
ajlm-2381	191	3	https://doi.org/10.1111/j.1365-2141.2006.06068.x	https://doi.org/10.1111/j.1365-2141.2006.06068.x	ADJ
ajlm-2381	191	4	bain	bain	PROPN
ajlm-2381	191	5	bj	bj	PROPN
ajlm-2381	191	6	,	,	PUNCT
ajlm-2381	191	7	clark	clark	PROPN
ajlm-2381	191	8	dm	dm	PROPN
ajlm-2381	191	9	,	,	PUNCT
ajlm-2381	191	10	wilkins	wilkins	PROPN
ajlm-2381	191	11	bs	bs	PROPN
ajlm-2381	191	12	.	.	PUNCT
ajlm-2381	191	13	bone	bone	PROPN
ajlm-2381	191	14	marrow	marrow	PROPN
ajlm-2381	191	15	pathology	pathology	PROPN
ajlm-2381	191	16	.	.	PUNCT
ajlm-2381	192	1	john	john	PROPN
ajlm-2381	192	2	wiley	wiley	PROPN
ajlm-2381	192	3	&	&	CCONJ
ajlm-2381	192	4	sons	sons	PROPN
ajlm-2381	192	5	,	,	PUNCT
ajlm-2381	192	6	chichester	chichester	PROPN
ajlm-2381	192	7	,	,	PUNCT
ajlm-2381	192	8	2019	2019	NUM
ajlm-2381	192	9	,	,	PUNCT
ajlm-2381	192	10	chapter	chapter	NOUN
ajlm-2381	192	11	1	1	NUM
ajlm-2381	192	12	,	,	PUNCT
ajlm-2381	192	13	the	the	DET
ajlm-2381	192	14	normal	normal	ADJ
ajlm-2381	192	15	bone	bone	NOUN
ajlm-2381	192	16	marrow	marrow	NOUN
ajlm-2381	192	17	;	;	PUNCT
ajlm-2381	192	18	p.	p.	PROPN
ajlm-2381	192	19	1–53	1–53	PROPN
ajlm-2381	192	20	.	.	PUNCT
ajlm-2381	193	1	islam	islam	PROPN
ajlm-2381	193	2	a.	a.	NOUN
ajlm-2381	193	3	bone	bone	PROPN
ajlm-2381	193	4	marrow	marrow	PROPN
ajlm-2381	193	5	aspiration	aspiration	NOUN
ajlm-2381	193	6	before	before	ADP
ajlm-2381	193	7	bone	bone	NOUN
ajlm-2381	193	8	marrow	marrow	PROPN
ajlm-2381	193	9	core	core	NOUN
ajlm-2381	193	10	biopsy	biopsy	NOUN
ajlm-2381	193	11	using	use	VERB
ajlm-2381	193	12	the	the	DET
ajlm-2381	193	13	same	same	ADJ
ajlm-2381	193	14	bone	bone	NOUN
ajlm-2381	193	15	marrow	marrow	NOUN
ajlm-2381	193	16	biopsy	biopsy	PROPN
ajlm-2381	193	17	needle	needle	PROPN
ajlm-2381	193	18	:	:	PUNCT
ajlm-2381	193	19	a	a	DET
ajlm-2381	193	20	good	good	ADJ
ajlm-2381	193	21	or	or	CCONJ
ajlm-2381	193	22	bad	bad	ADJ
ajlm-2381	193	23	practice	practice	NOUN
ajlm-2381	193	24	?	?	PUNCT
ajlm-2381	194	1	j	j	PROPN
ajlm-2381	194	2	clin	clin	PROPN
ajlm-2381	194	3	pathol	pathol	PROPN
ajlm-2381	194	4	.	.	PUNCT
ajlm-2381	195	1	2007;60(2):212–215	2007;60(2):212–215	X
ajlm-2381	195	2	.	.	PUNCT
ajlm-2381	195	3	https://doi.org/10.1136/jcp.2006.037341	https://doi.org/10.1136/jcp.2006.037341	PROPN
ajlm-2381	195	4	nunez	nunez	PROPN
ajlm-2381	195	5	al	al	PROPN
ajlm-2381	195	6	,	,	PUNCT
ajlm-2381	195	7	siegal	siegal	PROPN
ajlm-2381	195	8	gp	gp	PROPN
ajlm-2381	195	9	,	,	PUNCT
ajlm-2381	195	10	reddy	reddy	PROPN
ajlm-2381	195	11	vvb	vvb	PROPN
ajlm-2381	195	12	,	,	PUNCT
ajlm-2381	195	13	wei	wei	PROPN
ajlm-2381	195	14	s.	s.	PROPN
ajlm-2381	195	15	cd138	cd138	PROPN
ajlm-2381	195	16	(	(	PUNCT
ajlm-2381	195	17	syndecan-1	syndecan-1	PROPN
ajlm-2381	195	18	)	)	PUNCT
ajlm-2381	195	19	expression	expression	NOUN
ajlm-2381	195	20	in	in	ADP
ajlm-2381	195	21	bone	bone	NOUN
ajlm-2381	195	22	-	-	PUNCT
ajlm-2381	195	23	forming	form	VERB
ajlm-2381	195	24	tumors	tumor	NOUN
ajlm-2381	195	25	.	.	PUNCT
ajlm-2381	195	26	am	be	AUX
ajlm-2381	195	27	j	j	PROPN
ajlm-2381	195	28	clin	clin	PROPN
ajlm-2381	195	29	pathol	pathol	NOUN
ajlm-2381	195	30	.	.	PUNCT
ajlm-2381	196	1	2012;137(3):423–428	2012;137(3):423–428	X
ajlm-2381	196	2	.	.	PUNCT
ajlm-2381	197	1	https://doi.org/10.1309/ajcp6v4ypfbocyxg	https://doi.org/10.1309/ajcp6v4ypfbocyxg	PROPN
ajlm-2381	197	2	terpstra	terpstra	PROPN
ajlm-2381	197	3	we	we	PRON
ajlm-2381	197	4	,	,	PUNCT
ajlm-2381	197	5	lokhorst	lokhorst	VERB
ajlm-2381	197	6	hm	hm	INTJ
ajlm-2381	197	7	,	,	PUNCT
ajlm-2381	197	8	blomjous	blomjous	ADJ
ajlm-2381	197	9	f	f	PROPN
ajlm-2381	197	10	,	,	PUNCT
ajlm-2381	197	11	th	th	PROPN
ajlm-2381	197	12	.	.	PUNCT
ajlm-2381	197	13	meuwissen	meuwissen	PROPN
ajlm-2381	197	14	oja	oja	PROPN
ajlm-2381	197	15	,	,	PUNCT
ajlm-2381	197	16	dekker	dekker	PROPN
ajlm-2381	197	17	aw	aw	INTJ
ajlm-2381	197	18	.	.	PROPN
ajlm-2381	197	19	comparison	comparison	NOUN
ajlm-2381	197	20	of	of	ADP
ajlm-2381	197	21	plasma	plasma	NOUN
ajlm-2381	197	22	cell	cell	NOUN
ajlm-2381	197	23	infiltration	infiltration	NOUN
ajlm-2381	197	24	in	in	ADP
ajlm-2381	197	25	bone	bone	NOUN
ajlm-2381	197	26	marrow	marrow	NOUN
ajlm-2381	197	27	biopsies	biopsy	NOUN
ajlm-2381	197	28	and	and	CCONJ
ajlm-2381	197	29	aspirates	aspirate	NOUN
ajlm-2381	197	30	in	in	ADP
ajlm-2381	197	31	patients	patient	NOUN
ajlm-2381	197	32	with	with	ADP
ajlm-2381	197	33	multiple	multiple	ADJ
ajlm-2381	197	34	myeloma	myeloma	NOUN
ajlm-2381	197	35	.	.	PUNCT
ajlm-2381	198	1	br	br	PROPN
ajlm-2381	198	2	j	j	PROPN
ajlm-2381	198	3	haematol	haematol	NOUN
ajlm-2381	198	4	.	.	PUNCT
ajlm-2381	199	1	1992;82(1):46–49	1992;82(1):46–49	X
ajlm-2381	199	2	.	.	PUNCT
ajlm-2381	200	1	https://doi.org/10.1111/j.1365-2141.1992.tb04592.x	https://doi.org/10.1111/j.1365-2141.1992.tb04592.x	PROPN
ajlm-2381	200	2	smith	smith	PROPN
ajlm-2381	200	3	fb	fb	PROPN
ajlm-2381	200	4	,	,	PUNCT
ajlm-2381	200	5	elnawawi	elnawawi	PROPN
ajlm-2381	200	6	a.	a.	PROPN
ajlm-2381	200	7	technical	technical	PROPN
ajlm-2381	200	8	note	note	PROPN
ajlm-2381	200	9	:	:	PUNCT
ajlm-2381	200	10	a	a	DET
ajlm-2381	200	11	counting	counting	NOUN
ajlm-2381	200	12	strategy	strategy	NOUN
ajlm-2381	200	13	for	for	ADP
ajlm-2381	200	14	estimating	estimate	VERB
ajlm-2381	200	15	plasma	plasma	NOUN
ajlm-2381	200	16	cell	cell	NOUN
ajlm-2381	200	17	number	number	NOUN
ajlm-2381	200	18	in	in	ADP
ajlm-2381	200	19	cd138	cd138	NOUN
ajlm-2381	200	20	-	-	PUNCT
ajlm-2381	200	21	stained	stain	VERB
ajlm-2381	200	22	bone	bone	NOUN
ajlm-2381	200	23	marrow	marrow	NOUN
ajlm-2381	200	24	core	core	PROPN
ajlm-2381	200	25	biopsy	biopsy	NOUN
ajlm-2381	200	26	sections	section	NOUN
ajlm-2381	200	27	.	.	PUNCT
ajlm-2381	201	1	ann	ann	PROPN
ajlm-2381	201	2	clin	clin	PROPN
ajlm-2381	201	3	lab	lab	PROPN
ajlm-2381	201	4	sci	sci	PROPN
ajlm-2381	201	5	.	.	PUNCT
ajlm-2381	202	1	2008;38(2):138–142	2008;38(2):138–142	NUM
ajlm-2381	202	2	.	.	PUNCT
ajlm-2381	203	1	al	al	PROPN
ajlm-2381	203	2	-	-	PUNCT
ajlm-2381	203	3	quran	quran	PROPN
ajlm-2381	203	4	sz	sz	PROPN
ajlm-2381	203	5	,	,	PUNCT
ajlm-2381	203	6	yang	yang	PROPN
ajlm-2381	203	7	l	l	PROPN
ajlm-2381	203	8	,	,	PUNCT
ajlm-2381	203	9	magill	magill	PROPN
ajlm-2381	203	10	jm	jm	PROPN
ajlm-2381	203	11	,	,	PUNCT
ajlm-2381	203	12	braylan	braylan	PROPN
ajlm-2381	203	13	rc	rc	PROPN
ajlm-2381	203	14	,	,	PUNCT
ajlm-2381	203	15	douglas	douglas	PROPN
ajlm-2381	203	16	-	-	PUNCT
ajlm-2381	203	17	nikitin	nikitin	PROPN
ajlm-2381	203	18	vk	vk	PROPN
ajlm-2381	203	19	.	.	PUNCT
ajlm-2381	204	1	assessment	assessment	NOUN
ajlm-2381	204	2	of	of	ADP
ajlm-2381	204	3	bone	bone	NOUN
ajlm-2381	204	4	marrow	marrow	NOUN
ajlm-2381	204	5	plasma	plasma	NOUN
ajlm-2381	204	6	cell	cell	NOUN
ajlm-2381	204	7	infiltrates	infiltrate	NOUN
ajlm-2381	204	8	in	in	ADP
ajlm-2381	204	9	multiple	multiple	ADJ
ajlm-2381	204	10	myeloma	myeloma	NOUN
ajlm-2381	204	11	:	:	PUNCT
ajlm-2381	204	12	the	the	DET
ajlm-2381	204	13	added	add	VERB
ajlm-2381	204	14	value	value	NOUN
ajlm-2381	204	15	of	of	ADP
ajlm-2381	204	16	cd138	cd138	PROPN
ajlm-2381	204	17	immunohistochemistry	immunohistochemistry	PROPN
ajlm-2381	204	18	.	.	PUNCT
ajlm-2381	205	1	hum	hum	PROPN
ajlm-2381	205	2	pathol	pathol	PROPN
ajlm-2381	205	3	.	.	PUNCT
ajlm-2381	206	1	2007;38(12):1779–1787	2007;38(12):1779–1787	X
ajlm-2381	206	2	.	.	PUNCT
ajlm-2381	206	3	https://doi.org/10.1016/j.humpath.2007.04.010	https://doi.org/10.1016/j.humpath.2007.04.010	NOUN
ajlm-2381	206	4	joshi	joshi	PROPN
ajlm-2381	206	5	r	r	PROPN
ajlm-2381	206	6	,	,	PUNCT
ajlm-2381	206	7	horncastle	horncastle	ADJ
ajlm-2381	206	8	d	d	NOUN
ajlm-2381	206	9	,	,	PUNCT
ajlm-2381	206	10	elderfield	elderfield	NOUN
ajlm-2381	206	11	k	k	PROPN
ajlm-2381	206	12	,	,	PUNCT
ajlm-2381	206	13	lampert	lampert	PROPN
ajlm-2381	206	14	i	i	PROPN
ajlm-2381	206	15	,	,	PUNCT
ajlm-2381	206	16	rahemtulla	rahemtulla	NOUN
ajlm-2381	206	17	a	a	PRON
ajlm-2381	206	18	,	,	PUNCT
ajlm-2381	206	19	naresh	naresh	PROPN
ajlm-2381	206	20	kn	kn	PROPN
ajlm-2381	206	21	.	.	PUNCT
ajlm-2381	206	22	bone	bone	PROPN
ajlm-2381	206	23	marrow	marrow	PROPN
ajlm-2381	206	24	trephine	trephine	NOUN
ajlm-2381	206	25	combined	combine	VERB
ajlm-2381	206	26	with	with	ADP
ajlm-2381	206	27	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	206	28	is	be	AUX
ajlm-2381	206	29	superior	superior	ADJ
ajlm-2381	206	30	to	to	ADP
ajlm-2381	206	31	bone	bone	NOUN
ajlm-2381	206	32	marrow	marrow	NOUN
ajlm-2381	206	33	aspirate	aspirate	NOUN
ajlm-2381	206	34	in	in	ADP
ajlm-2381	206	35	follow	follow	NOUN
ajlm-2381	206	36	-	-	PUNCT
ajlm-2381	206	37	up	up	NOUN
ajlm-2381	206	38	of	of	ADP
ajlm-2381	206	39	myeloma	myeloma	NOUN
ajlm-2381	206	40	patients	patient	NOUN
ajlm-2381	206	41	.	.	PUNCT
ajlm-2381	207	1	j	j	PROPN
ajlm-2381	207	2	clin	clin	PROPN
ajlm-2381	207	3	pathol	pathol	PROPN
ajlm-2381	207	4	.	.	PUNCT
ajlm-2381	208	1	2008;61(2):213–216	2008;61(2):213–216	X
ajlm-2381	208	2	.	.	NOUN
ajlm-2381	208	3	https://doi.org/10.1136/jcp.2007.049130	https://doi.org/10.1136/jcp.2007.049130	PROPN
ajlm-2381	208	4	ng	ng	PROPN
ajlm-2381	208	5	ap	ap	PROPN
ajlm-2381	208	6	,	,	PUNCT
ajlm-2381	208	7	wei	wei	PROPN
ajlm-2381	208	8	a	a	PROPN
ajlm-2381	208	9	,	,	PUNCT
ajlm-2381	208	10	bhurani	bhurani	PROPN
ajlm-2381	208	11	d	d	PROPN
ajlm-2381	208	12	,	,	PUNCT
ajlm-2381	208	13	chapple	chapple	PROPN
ajlm-2381	208	14	p	p	NOUN
ajlm-2381	208	15	,	,	PUNCT
ajlm-2381	208	16	feleppa	feleppa	NOUN
ajlm-2381	208	17	f	f	PROPN
ajlm-2381	208	18	,	,	PUNCT
ajlm-2381	208	19	juneja	juneja	PROPN
ajlm-2381	208	20	s.	s.	PROPN
ajlm-2381	208	21	the	the	DET
ajlm-2381	208	22	sensitivity	sensitivity	NOUN
ajlm-2381	208	23	of	of	ADP
ajlm-2381	208	24	cd138	cd138	PROPN
ajlm-2381	208	25	immunostaining	immunostaining	NOUN
ajlm-2381	208	26	of	of	ADP
ajlm-2381	208	27	bone	bone	NOUN
ajlm-2381	208	28	marrow	marrow	PROPN
ajlm-2381	208	29	trephine	trephine	NOUN
ajlm-2381	208	30	specimens	specimen	NOUN
ajlm-2381	208	31	for	for	ADP
ajlm-2381	208	32	quantifying	quantify	VERB
ajlm-2381	208	33	marrow	marrow	PROPN
ajlm-2381	208	34	involvement	involvement	NOUN
ajlm-2381	208	35	in	in	ADP
ajlm-2381	208	36	mgus	mgus	ADJ
ajlm-2381	208	37	and	and	CCONJ
ajlm-2381	208	38	myeloma	myeloma	PROPN
ajlm-2381	208	39	,	,	PUNCT
ajlm-2381	208	40	including	include	VERB
ajlm-2381	208	41	samples	sample	NOUN
ajlm-2381	208	42	with	with	ADP
ajlm-2381	208	43	a	a	DET
ajlm-2381	208	44	low	low	ADJ
ajlm-2381	208	45	percentage	percentage	NOUN
ajlm-2381	208	46	of	of	ADP
ajlm-2381	208	47	plasma	plasma	NOUN
ajlm-2381	208	48	cells	cell	NOUN
ajlm-2381	208	49	.	.	PUNCT
ajlm-2381	209	1	haematologica	haematologica	PROPN
ajlm-2381	209	2	.	.	PUNCT
ajlm-2381	210	1	2006;91(7	2006;91(7	NUM
ajlm-2381	210	2	):	):	PUNCT
ajlm-2381	210	3	972–975	972–975	NUM
ajlm-2381	210	4	.	.	PUNCT
ajlm-2381	211	1	ng	ng	PROPN
ajlm-2381	211	2	ap	ap	PROPN
ajlm-2381	211	3	,	,	PUNCT
ajlm-2381	211	4	wei	wei	PROPN
ajlm-2381	211	5	a	a	PROPN
ajlm-2381	211	6	,	,	PUNCT
ajlm-2381	211	7	bhurani	bhurani	PROPN
ajlm-2381	211	8	d	d	NOUN
ajlm-2381	211	9	,	,	PUNCT
ajlm-2381	211	10	chappell	chappell	NOUN
ajlm-2381	211	11	p	p	NOUN
ajlm-2381	211	12	,	,	PUNCT
ajlm-2381	211	13	feleppa	feleppa	NOUN
ajlm-2381	211	14	f	f	PROPN
ajlm-2381	211	15	,	,	PUNCT
ajlm-2381	211	16	juneja	juneja	ADJ
ajlm-2381	211	17	s.	s.	PROPN
ajlm-2381	211	18	cd	cd	PROPN
ajlm-2381	211	19	138	138	NUM
ajlm-2381	211	20	immunostaining	immunostaining	NOUN
ajlm-2381	211	21	of	of	ADP
ajlm-2381	211	22	bone	bone	NOUN
ajlm-2381	211	23	marrow	marrow	PROPN
ajlm-2381	211	24	trephine	trephine	PROPN
ajlm-2381	211	25	specimens	specimen	NOUN
ajlm-2381	211	26	is	be	AUX
ajlm-2381	211	27	the	the	DET
ajlm-2381	211	28	most	most	ADV
ajlm-2381	211	29	sensitive	sensitive	ADJ
ajlm-2381	211	30	method	method	NOUN
ajlm-2381	211	31	for	for	ADP
ajlm-2381	211	32	quantifying	quantify	VERB
ajlm-2381	211	33	marrow	marrow	NOUN
ajlm-2381	211	34	involvement	involvement	NOUN
ajlm-2381	211	35	in	in	ADP
ajlm-2381	211	36	patients	patient	NOUN
ajlm-2381	211	37	with	with	ADP
ajlm-2381	211	38	plasma	plasma	NOUN
ajlm-2381	211	39	cell	cell	NOUN
ajlm-2381	211	40	dyscrasias	dyscrasia	NOUN
ajlm-2381	211	41	.	.	PUNCT
ajlm-2381	212	1	blood	blood	NOUN
ajlm-2381	212	2	.	.	PUNCT
ajlm-2381	213	1	2005;106(11):5071	2005;106(11):5071	X
ajlm-2381	213	2	.	.	PUNCT
ajlm-2381	213	3	https://doi.org/10.1182/blood.v106.11.5071.5071	https://doi.org/10.1182/blood.v106.11.5071.5071	PROPN
ajlm-2381	213	4	vijayanarayanan	vijayanarayanan	NOUN
ajlm-2381	213	5	a	a	DET
ajlm-2381	213	6	,	,	PUNCT
ajlm-2381	213	7	inamdar	inamdar	PROPN
ajlm-2381	213	8	k	k	NOUN
ajlm-2381	213	9	,	,	PUNCT
ajlm-2381	213	10	menon	menon	PROPN
ajlm-2381	213	11	m	m	PROPN
ajlm-2381	213	12	,	,	PUNCT
ajlm-2381	213	13	kuriakose	kuriakose	ADJ
ajlm-2381	213	14	p.	p.	PROPN
ajlm-2381	213	15	should	should	AUX
ajlm-2381	213	16	cd138	cd138	PROPN
ajlm-2381	213	17	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	213	18	be	be	AUX
ajlm-2381	213	19	standard	standard	ADJ
ajlm-2381	213	20	recommended	recommend	VERB
ajlm-2381	213	21	practice	practice	NOUN
ajlm-2381	213	22	for	for	ADP
ajlm-2381	213	23	bone	bone	NOUN
ajlm-2381	213	24	marrow	marrow	NOUN
ajlm-2381	213	25	evaluation	evaluation	NOUN
ajlm-2381	213	26	of	of	ADP
ajlm-2381	213	27	plasma	plasma	NOUN
ajlm-2381	213	28	cell	cell	NOUN
ajlm-2381	213	29	neoplasms	neoplasm	NOUN
ajlm-2381	213	30	?	?	PUNCT
ajlm-2381	214	1	am	be	AUX
ajlm-2381	214	2	j	j	PROPN
ajlm-2381	214	3	clin	clin	PROPN
ajlm-2381	214	4	pathol	pathol	PROPN
ajlm-2381	214	5	.	.	PUNCT
ajlm-2381	215	1	2020;154(supplement_1):s110	2020;154(supplement_1):s110	X
ajlm-2381	215	2	.	.	PUNCT
ajlm-2381	216	1	https://doi.org/10.1093/ajcp/aqaa161.241	https://doi.org/10.1093/ajcp/aqaa161.241	X
ajlm-2381	216	2	štifter	štifter	PRON
ajlm-2381	216	3	s	s	PROPN
ajlm-2381	216	4	,	,	PUNCT
ajlm-2381	216	5	babarović	babarović	NOUN
ajlm-2381	216	6	e	e	NOUN
ajlm-2381	216	7	,	,	PUNCT
ajlm-2381	216	8	valković	valković	PROPN
ajlm-2381	216	9	t	t	PROPN
ajlm-2381	216	10	,	,	PUNCT
ajlm-2381	216	11	et	et	PROPN
ajlm-2381	216	12	al	al	PROPN
ajlm-2381	216	13	.	.	PROPN
ajlm-2381	216	14	combined	combined	ADJ
ajlm-2381	216	15	evaluation	evaluation	NOUN
ajlm-2381	216	16	of	of	ADP
ajlm-2381	216	17	bone	bone	NOUN
ajlm-2381	216	18	marrow	marrow	NOUN
ajlm-2381	216	19	aspirate	aspirate	NOUN
ajlm-2381	216	20	and	and	CCONJ
ajlm-2381	216	21	biopsy	biopsy	NOUN
ajlm-2381	216	22	is	be	AUX
ajlm-2381	216	23	superior	superior	ADJ
ajlm-2381	216	24	in	in	ADP
ajlm-2381	216	25	the	the	DET
ajlm-2381	216	26	prognosis	prognosis	NOUN
ajlm-2381	216	27	of	of	ADP
ajlm-2381	216	28	multiple	multiple	ADJ
ajlm-2381	216	29	myeloma	myeloma	NOUN
ajlm-2381	216	30	.	.	PUNCT
ajlm-2381	217	1	diagn	diagn	NOUN
ajlm-2381	217	2	pathol	pathol	NOUN
ajlm-2381	217	3	.	.	PUNCT
ajlm-2381	218	1	2010;5(1):30	2010;5(1):30	X
ajlm-2381	218	2	.	.	PUNCT
ajlm-2381	218	3	https://doi.org/10.1186/1746-1596-5-30	https://doi.org/10.1186/1746-1596-5-30	PROPN
ajlm-2381	218	4	paiva	paiva	PROPN
ajlm-2381	218	5	b	b	PROPN
ajlm-2381	218	6	,	,	PUNCT
ajlm-2381	218	7	vidriales	vidriale	NOUN
ajlm-2381	218	8	mb	mb	NOUN
ajlm-2381	218	9	,	,	PUNCT
ajlm-2381	218	10	pérez	pérez	PROPN
ajlm-2381	218	11	jj	jj	PROPN
ajlm-2381	218	12	,	,	PUNCT
ajlm-2381	218	13	et	et	PROPN
ajlm-2381	218	14	al	al	PROPN
ajlm-2381	218	15	.	.	PROPN
ajlm-2381	218	16	multiparameter	multiparameter	AUX
ajlm-2381	218	17	flow	flow	VERB
ajlm-2381	218	18	cytometry	cytometry	ADJ
ajlm-2381	218	19	quantification	quantification	NOUN
ajlm-2381	218	20	of	of	ADP
ajlm-2381	218	21	bone	bone	NOUN
ajlm-2381	218	22	marrow	marrow	NOUN
ajlm-2381	218	23	plasma	plasma	NOUN
ajlm-2381	218	24	cells	cell	NOUN
ajlm-2381	218	25	at	at	ADP
ajlm-2381	218	26	diagnosis	diagnosis	NOUN
ajlm-2381	218	27	provides	provide	VERB
ajlm-2381	218	28	more	more	ADJ
ajlm-2381	218	29	prognostic	prognostic	ADJ
ajlm-2381	218	30	information	information	NOUN
ajlm-2381	218	31	than	than	ADP
ajlm-2381	218	32	morphological	morphological	ADJ
ajlm-2381	218	33	assessment	assessment	NOUN
ajlm-2381	218	34	in	in	ADP
ajlm-2381	218	35	myeloma	myeloma	NOUN
ajlm-2381	218	36	patients	patient	NOUN
ajlm-2381	218	37	.	.	PUNCT
ajlm-2381	219	1	haematologica	haematologica	PROPN
ajlm-2381	219	2	.	.	PUNCT
ajlm-2381	220	1	2009;94(11):1599–1602	2009;94(11):1599–1602	NUM
ajlm-2381	220	2	.	.	PUNCT
ajlm-2381	221	1	https://doi.org/10.3324/haematol.2009.009100	https://doi.org/10.3324/haematol.2009.009100	PROPN
ajlm-2381	221	2	spears	spears	PROPN
ajlm-2381	221	3	md	md	PROPN
ajlm-2381	221	4	,	,	PUNCT
ajlm-2381	221	5	olteanu	olteanu	VERB
ajlm-2381	221	6	h	h	NOUN
ajlm-2381	221	7	,	,	PUNCT
ajlm-2381	221	8	kroft	kroft	PROPN
ajlm-2381	221	9	sh	sh	PROPN
ajlm-2381	221	10	,	,	PUNCT
ajlm-2381	221	11	harrington	harrington	PROPN
ajlm-2381	221	12	am	be	AUX
ajlm-2381	221	13	.	.	PUNCT
ajlm-2381	222	1	the	the	DET
ajlm-2381	222	2	immunophenotypic	immunophenotypic	ADJ
ajlm-2381	222	3	stability	stability	NOUN
ajlm-2381	222	4	of	of	ADP
ajlm-2381	222	5	plasma	plasma	NOUN
ajlm-2381	222	6	cell	cell	NOUN
ajlm-2381	222	7	myeloma	myeloma	NOUN
ajlm-2381	222	8	by	by	ADP
ajlm-2381	222	9	flow	flow	NOUN
ajlm-2381	222	10	cytometry	cytometry	NOUN
ajlm-2381	222	11	.	.	PUNCT
ajlm-2381	223	1	int	int	PROPN
ajlm-2381	223	2	j	j	PROPN
ajlm-2381	223	3	lab	lab	NOUN
ajlm-2381	223	4	hematol	hematol	NOUN
ajlm-2381	223	5	.	.	PUNCT
ajlm-2381	224	1	2011;33(5):483–491	2011;33(5):483–491	X
ajlm-2381	224	2	.	.	PUNCT
ajlm-2381	225	1	https://doi.org/10.1111/j.1751-553x.2011.01317.x	https://doi.org/10.1111/j.1751-553x.2011.01317.x	PROPN
ajlm-2381	225	2	ajise	ajise	PROPN
ajlm-2381	225	3	oe	oe	PROPN
ajlm-2381	225	4	,	,	PUNCT
ajlm-2381	225	5	roshal	roshal	NOUN
ajlm-2381	225	6	m	m	PROPN
ajlm-2381	225	7	,	,	PUNCT
ajlm-2381	225	8	wang	wang	PROPN
ajlm-2381	225	9	l	l	PROPN
ajlm-2381	225	10	,	,	PUNCT
ajlm-2381	225	11	et	et	PROPN
ajlm-2381	225	12	al	al	PROPN
ajlm-2381	225	13	.	.	PROPN
ajlm-2381	226	1	clinical	clinical	ADJ
ajlm-2381	226	2	utility	utility	NOUN
ajlm-2381	226	3	of	of	ADP
ajlm-2381	226	4	morphology	morphology	NOUN
ajlm-2381	226	5	,	,	PUNCT
ajlm-2381	226	6	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2381	226	7	,	,	PUNCT
ajlm-2381	226	8	flow	flow	NOUN
ajlm-2381	226	9	cytometry	cytometry	NOUN
ajlm-2381	226	10	,	,	PUNCT
ajlm-2381	226	11	and	and	CCONJ
ajlm-2381	226	12	fish	fish	VERB
ajlm-2381	226	13	analysis	analysis	NOUN
ajlm-2381	226	14	in	in	ADP
ajlm-2381	226	15	monitoring	monitoring	NOUN
ajlm-2381	226	16	of	of	ADP
ajlm-2381	226	17	plasma	plasma	NOUN
ajlm-2381	226	18	cell	cell	NOUN
ajlm-2381	226	19	neoplasms	neoplasm	NOUN
ajlm-2381	226	20	in	in	ADP
ajlm-2381	226	21	the	the	DET
ajlm-2381	226	22	bone	bone	NOUN
ajlm-2381	226	23	marrow	marrow	NOUN
ajlm-2381	226	24	.	.	PUNCT
ajlm-2381	227	1	j	j	PROPN
ajlm-2381	227	2	hematop	hematop	NOUN
ajlm-2381	227	3	.	.	PUNCT
ajlm-2381	228	1	2016;9(1):9–18	2016;9(1):9–18	NUM
ajlm-2381	228	2	.	.	PROPN
ajlm-2381	228	3	https://doi.org/10.1007/s12308-015-0264-1	https://doi.org/10.1007/s12308-015-0264-1	NUM
ajlm-2381	228	4	smock	smock	PROPN
ajlm-2381	228	5	kj	kj	PROPN
ajlm-2381	228	6	,	,	PUNCT
ajlm-2381	228	7	perkins	perkins	PROPN
ajlm-2381	228	8	sl	sl	PROPN
ajlm-2381	228	9	,	,	PUNCT
ajlm-2381	228	10	bahler	bahler	NOUN
ajlm-2381	228	11	dw	dw	PROPN
ajlm-2381	228	12	.	.	PROPN
ajlm-2381	228	13	quantitation	quantitation	NOUN
ajlm-2381	228	14	of	of	ADP
ajlm-2381	228	15	plasma	plasma	NOUN
ajlm-2381	228	16	cells	cell	NOUN
ajlm-2381	228	17	in	in	ADP
ajlm-2381	228	18	bone	bone	NOUN
ajlm-2381	228	19	marrow	marrow	NOUN
ajlm-2381	228	20	aspirates	aspirate	NOUN
ajlm-2381	228	21	by	by	ADP
ajlm-2381	228	22	flow	flow	NOUN
ajlm-2381	228	23	cytometric	cytometric	ADJ
ajlm-2381	228	24	analysis	analysis	NOUN
ajlm-2381	228	25	compared	compare	VERB
ajlm-2381	228	26	with	with	ADP
ajlm-2381	228	27	morphologic	morphologic	ADJ
ajlm-2381	228	28	assessment	assessment	NOUN
ajlm-2381	228	29	.	.	PUNCT
ajlm-2381	229	1	arch	arch	ADJ
ajlm-2381	229	2	pathol	pathol	NOUN
ajlm-2381	229	3	lab	lab	NOUN
ajlm-2381	229	4	med	me	VERB
ajlm-2381	229	5	.	.	PUNCT
ajlm-2381	230	1	2007;131(6):951–955	2007;131(6):951–955	NUM
ajlm-2381	230	2	.	.	PUNCT
ajlm-2381	230	3	https://doi.org/10.5858/2007-131-951-qopcib	https://doi.org/10.5858/2007-131-951-qopcib	PROPN
ajlm-2381	230	4	frébet	frébet	PROPN
ajlm-2381	230	5	e	e	PROPN
ajlm-2381	230	6	,	,	PUNCT
ajlm-2381	230	7	abraham	abraham	PROPN
ajlm-2381	230	8	j	j	PROPN
ajlm-2381	230	9	,	,	PUNCT
ajlm-2381	230	10	geneviève	geneviève	PROPN
ajlm-2381	230	11	f	f	PROPN
ajlm-2381	230	12	,	,	PUNCT
ajlm-2381	230	13	et	et	PROPN
ajlm-2381	230	14	al	al	PROPN
ajlm-2381	230	15	.	.	PUNCT
ajlm-2381	231	1	a	a	DET
ajlm-2381	231	2	geil	geil	NOUN
ajlm-2381	231	3	flow	flow	NOUN
ajlm-2381	231	4	cytometry	cytometry	NOUN
ajlm-2381	231	5	consensus	consensus	NOUN
ajlm-2381	231	6	proposal	proposal	NOUN
ajlm-2381	231	7	for	for	ADP
ajlm-2381	231	8	quantification	quantification	NOUN
ajlm-2381	231	9	of	of	ADP
ajlm-2381	231	10	plasma	plasma	NOUN
ajlm-2381	231	11	cells	cell	NOUN
ajlm-2381	231	12	:	:	PUNCT
ajlm-2381	231	13	application	application	NOUN
ajlm-2381	231	14	to	to	PART
ajlm-2381	231	15	differential	differential	VERB
ajlm-2381	231	16	diagnosis	diagnosis	NOUN
ajlm-2381	231	17	between	between	ADP
ajlm-2381	231	18	mgus	mgus	ADJ
ajlm-2381	231	19	and	and	CCONJ
ajlm-2381	231	20	myeloma	myeloma	NOUN
ajlm-2381	231	21	.	.	PUNCT
ajlm-2381	232	1	cytometry	cytometry	PROPN
ajlm-2381	232	2	b	b	PROPN
ajlm-2381	232	3	clin	clin	PROPN
ajlm-2381	232	4	cytom	cytom	NOUN
ajlm-2381	232	5	.	.	PUNCT
ajlm-2381	233	1	2011;80(3):176–185	2011;80(3):176–185	NUM
ajlm-2381	233	2	.	.	PUNCT
ajlm-2381	233	3	https://doi.org/10.1002/cyto.b.20581	https://doi.org/10.1002/cyto.b.20581	X
ajlm-2381	234	1	matsue	matsue	PROPN
ajlm-2381	234	2	k	k	PROPN
ajlm-2381	234	3	,	,	PUNCT
ajlm-2381	234	4	matsue	matsue	NOUN
ajlm-2381	234	5	y	y	PROPN
ajlm-2381	234	6	,	,	PUNCT
ajlm-2381	234	7	kumata	kumata	PROPN
ajlm-2381	234	8	k	k	PROPN
ajlm-2381	234	9	,	,	PUNCT
ajlm-2381	234	10	et	et	PROPN
ajlm-2381	234	11	al	al	PROPN
ajlm-2381	234	12	.	.	PUNCT
ajlm-2381	235	1	quantification	quantification	NOUN
ajlm-2381	235	2	of	of	ADP
ajlm-2381	235	3	bone	bone	NOUN
ajlm-2381	235	4	marrow	marrow	NOUN
ajlm-2381	235	5	plasma	plasma	NOUN
ajlm-2381	235	6	cell	cell	NOUN
ajlm-2381	235	7	infiltration	infiltration	NOUN
ajlm-2381	235	8	in	in	ADP
ajlm-2381	235	9	multiple	multiple	ADJ
ajlm-2381	235	10	myeloma	myeloma	NOUN
ajlm-2381	235	11	:	:	PUNCT
ajlm-2381	235	12	usefulness	usefulness	NOUN
ajlm-2381	235	13	of	of	ADP
ajlm-2381	235	14	bone	bone	NOUN
ajlm-2381	235	15	marrow	marrow	NOUN
ajlm-2381	235	16	aspirate	aspirate	VERB
ajlm-2381	235	17	clot	clot	NOUN
ajlm-2381	235	18	with	with	ADP
ajlm-2381	235	19	cd138	cd138	PROPN
ajlm-2381	235	20	immunohistochemistry	immunohistochemistry	PROPN
ajlm-2381	235	21	.	.	PUNCT
ajlm-2381	236	1	hematol	hematol	PROPN
ajlm-2381	236	2	oncol	oncol	ADJ
ajlm-2381	236	3	.	.	PUNCT
ajlm-2381	237	1	2017;35(3):176–185	2017;35(3):176–185	X
ajlm-2381	237	2	.	.	PUNCT
ajlm-2381	238	1	https://doi.org/10.1002/hon.2300	https://doi.org/10.1002/hon.2300	VERB
ajlm-2381	238	2	gantana	gantana	PROPN
ajlm-2381	238	3	e	e	PROPN
ajlm-2381	238	4	,	,	PUNCT
ajlm-2381	238	5	mashigo	mashigo	VERB
ajlm-2381	238	6	n	n	CCONJ
ajlm-2381	238	7	,	,	PUNCT
ajlm-2381	238	8	abdullah	abdullah	PROPN
ajlm-2381	238	9	i	i	PROPN
ajlm-2381	238	10	,	,	PUNCT
ajlm-2381	238	11	et	et	PROPN
ajlm-2381	238	12	al	al	PROPN
ajlm-2381	238	13	.	.	PUNCT
ajlm-2381	239	1	evaluation	evaluation	NOUN
ajlm-2381	239	2	of	of	ADP
ajlm-2381	239	3	an	an	DET
ajlm-2381	239	4	innovative	innovative	ADJ
ajlm-2381	239	5	new	new	ADJ
ajlm-2381	239	6	method	method	NOUN
ajlm-2381	239	7	for	for	ADP
ajlm-2381	239	8	quantitation	quantitation	NOUN
ajlm-2381	239	9	of	of	ADP
ajlm-2381	239	10	plasma	plasma	NOUN
ajlm-2381	239	11	cells	cell	NOUN
ajlm-2381	239	12	on	on	ADP
ajlm-2381	239	13	cd138	cd138	PROPN
ajlm-2381	239	14	immunohistochemistry	immunohistochemistry	PROPN
ajlm-2381	239	15	.	.	PUNCT
ajlm-2381	240	1	j	j	PROPN
ajlm-2381	240	2	clin	clin	PROPN
ajlm-2381	240	3	pathol	pathol	PROPN
ajlm-2381	240	4	.	.	PUNCT
ajlm-2381	241	1	2023;76(4):261–265	2023;76(4):261–265	X
ajlm-2381	241	2	.	.	PUNCT
ajlm-2381	241	3	https://doi.org/10.1097/01.hs9.0000850660.08752.99	https://doi.org/10.1097/01.hs9.0000850660.08752.99	PROPN
ajlm-2381	241	4	owen	owen	PROPN
ajlm-2381	241	5	rg	rg	PROPN
ajlm-2381	241	6	,	,	PUNCT
ajlm-2381	241	7	johnson	johnson	PROPN
ajlm-2381	241	8	rj	rj	PROPN
ajlm-2381	241	9	,	,	PUNCT
ajlm-2381	241	10	rawstron	rawstron	PROPN
ajlm-2381	241	11	ac	ac	PROPN
ajlm-2381	241	12	,	,	PUNCT
ajlm-2381	241	13	et	et	PROPN
ajlm-2381	241	14	al	al	PROPN
ajlm-2381	241	15	.	.	PROPN
ajlm-2381	241	16	assessment	assessment	NOUN
ajlm-2381	241	17	of	of	ADP
ajlm-2381	241	18	igh	igh	PROPN
ajlm-2381	241	19	pcr	pcr	NOUN
ajlm-2381	241	20	strategies	strategy	NOUN
ajlm-2381	241	21	in	in	ADP
ajlm-2381	241	22	multiple	multiple	ADJ
ajlm-2381	241	23	myeloma	myeloma	NOUN
ajlm-2381	241	24	.	.	PUNCT
ajlm-2381	242	1	j	j	PROPN
ajlm-2381	242	2	clin	clin	PROPN
ajlm-2381	242	3	pathol	pathol	PROPN
ajlm-2381	242	4	.	.	PUNCT
ajlm-2381	243	1	1996;49(8):672–675	1996;49(8):672–675	X
ajlm-2381	243	2	.	.	PUNCT
ajlm-2381	244	1	https://doi.org/10.1136/jcp.49.8.672	https://doi.org/10.1136/jcp.49.8.672	PROPN
ajlm-2381	244	2	ladetto	ladetto	PROPN
ajlm-2381	244	3	m	m	PROPN
ajlm-2381	244	4	,	,	PUNCT
ajlm-2381	244	5	donovan	donovan	PROPN
ajlm-2381	244	6	jw	jw	PROPN
ajlm-2381	244	7	,	,	PUNCT
ajlm-2381	244	8	harig	harig	PROPN
ajlm-2381	244	9	s	s	PROPN
ajlm-2381	244	10	,	,	PUNCT
ajlm-2381	244	11	et	et	PROPN
ajlm-2381	244	12	al	al	PROPN
ajlm-2381	244	13	.	.	PUNCT
ajlm-2381	245	1	real	real	ADJ
ajlm-2381	245	2	-	-	PUNCT
ajlm-2381	245	3	time	time	NOUN
ajlm-2381	245	4	polymerase	polymerase	NOUN
ajlm-2381	245	5	chain	chain	NOUN
ajlm-2381	245	6	reaction	reaction	NOUN
ajlm-2381	245	7	of	of	ADP
ajlm-2381	245	8	immunoglobulin	immunoglobulin	NOUN
ajlm-2381	245	9	rearrangements	rearrangement	NOUN
ajlm-2381	245	10	for	for	ADP
ajlm-2381	245	11	quantitative	quantitative	ADJ
ajlm-2381	245	12	evaluation	evaluation	NOUN
ajlm-2381	245	13	of	of	ADP
ajlm-2381	245	14	minimal	minimal	ADJ
ajlm-2381	245	15	residual	residual	ADJ
ajlm-2381	245	16	disease	disease	NOUN
ajlm-2381	245	17	in	in	ADP
ajlm-2381	245	18	multiple	multiple	ADJ
ajlm-2381	245	19	myeloma	myeloma	NOUN
ajlm-2381	245	20	.	.	PUNCT
ajlm-2381	246	1	biol	biol	PROPN
ajlm-2381	246	2	blood	blood	NOUN
ajlm-2381	246	3	marrow	marrow	PROPN
ajlm-2381	246	4	transplant	transplant	NOUN
ajlm-2381	246	5	.	.	PUNCT
ajlm-2381	247	1	2000;6(3):241–253	2000;6(3):241–253	X
ajlm-2381	247	2	.	.	PUNCT
ajlm-2381	248	1	https://doi.org/10.1016/s1083-8791(00)70006-1	https://doi.org/10.1016/s1083-8791(00)70006-1	PROPN
ajlm-2381	248	2	ladetto	ladetto	PROPN
ajlm-2381	248	3	m	m	PROPN
ajlm-2381	248	4	,	,	PUNCT
ajlm-2381	248	5	omedè	omedè	PROPN
ajlm-2381	248	6	p	p	PROPN
ajlm-2381	248	7	,	,	PUNCT
ajlm-2381	248	8	sametti	sametti	PROPN
ajlm-2381	248	9	s	s	PROPN
ajlm-2381	248	10	,	,	PUNCT
ajlm-2381	248	11	et	et	PROPN
ajlm-2381	248	12	al	al	PROPN
ajlm-2381	248	13	.	.	PUNCT
ajlm-2381	249	1	real	real	ADJ
ajlm-2381	249	2	-	-	PUNCT
ajlm-2381	249	3	time	time	NOUN
ajlm-2381	249	4	polymerase	polymerase	NOUN
ajlm-2381	249	5	chain	chain	NOUN
ajlm-2381	249	6	reaction	reaction	NOUN
ajlm-2381	249	7	in	in	ADP
ajlm-2381	249	8	multiple	multiple	ADJ
ajlm-2381	249	9	myeloma	myeloma	NOUN
ajlm-2381	249	10	:	:	PUNCT
ajlm-2381	249	11	quantitative	quantitative	ADJ
ajlm-2381	249	12	analysis	analysis	NOUN
ajlm-2381	249	13	of	of	ADP
ajlm-2381	249	14	tumor	tumor	NOUN
ajlm-2381	249	15	contamination	contamination	NOUN
ajlm-2381	249	16	of	of	ADP
ajlm-2381	249	17	stem	stem	NOUN
ajlm-2381	249	18	cell	cell	NOUN
ajlm-2381	249	19	harvests	harvest	NOUN
ajlm-2381	249	20	.	.	PUNCT
ajlm-2381	250	1	exp	exp	NOUN
ajlm-2381	250	2	hematol	hematol	NOUN
ajlm-2381	250	3	.	.	PUNCT
ajlm-2381	251	1	2002;30(6):529–536	2002;30(6):529–536	X
ajlm-2381	251	2	.	.	PUNCT
ajlm-2381	252	1	https://doi.org/10.1016/s0301-472x(02)00794-4	https://doi.org/10.1016/s0301-472x(02)00794-4	PROPN
ajlm-2381	252	2	rustad	rustad	PROPN
ajlm-2381	252	3	eh	eh	INTJ
ajlm-2381	252	4	,	,	PUNCT
ajlm-2381	252	5	misund	misund	ADJ
ajlm-2381	252	6	k	k	PROPN
ajlm-2381	252	7	,	,	PUNCT
ajlm-2381	252	8	bernard	bernard	PROPN
ajlm-2381	252	9	e	e	PROPN
ajlm-2381	252	10	,	,	PUNCT
ajlm-2381	252	11	et	et	PROPN
ajlm-2381	252	12	al	al	PROPN
ajlm-2381	252	13	.	.	PROPN
ajlm-2381	252	14	stability	stability	NOUN
ajlm-2381	252	15	and	and	CCONJ
ajlm-2381	252	16	uniqueness	uniqueness	NOUN
ajlm-2381	252	17	of	of	ADP
ajlm-2381	252	18	clonal	clonal	ADJ
ajlm-2381	252	19	immunoglobulin	immunoglobulin	PROPN
ajlm-2381	252	20	cdr3	cdr3	PROPN
ajlm-2381	252	21	sequences	sequence	NOUN
ajlm-2381	252	22	for	for	ADP
ajlm-2381	252	23	mrd	mrd	ADJ
ajlm-2381	252	24	tracking	tracking	NOUN
ajlm-2381	252	25	in	in	ADP
ajlm-2381	252	26	multiple	multiple	ADJ
ajlm-2381	252	27	myeloma	myeloma	NOUN
ajlm-2381	252	28	.	.	PUNCT
ajlm-2381	252	29	am	be	AUX
ajlm-2381	252	30	j	j	PROPN
ajlm-2381	252	31	hematol	hematol	NOUN
ajlm-2381	252	32	.	.	PUNCT
ajlm-2381	253	1	2019;94(12):1364–1373	2019;94(12):1364–1373	X
ajlm-2381	253	2	.	.	PUNCT
ajlm-2381	254	1	https://doi.org/10.1002/ajh.25641	https://doi.org/10.1002/ajh.25641	PROPN
ajlm-2381	254	2	ho	ho	PROPN
ajlm-2381	255	1	c	c	PROPN
ajlm-2381	255	2	,	,	PUNCT
ajlm-2381	255	3	arcila	arcila	VERB
ajlm-2381	255	4	me	i	PRON
ajlm-2381	255	5	.	.	PUNCT
ajlm-2381	256	1	minimal	minimal	ADJ
ajlm-2381	256	2	residual	residual	ADJ
ajlm-2381	256	3	disease	disease	NOUN
ajlm-2381	256	4	detection	detection	NOUN
ajlm-2381	256	5	of	of	ADP
ajlm-2381	256	6	myeloma	myeloma	NOUN
ajlm-2381	256	7	using	use	VERB
ajlm-2381	256	8	sequencing	sequencing	NOUN
ajlm-2381	256	9	of	of	ADP
ajlm-2381	256	10	immunoglobulin	immunoglobulin	NOUN
ajlm-2381	256	11	heavy	heavy	ADJ
ajlm-2381	256	12	chain	chain	NOUN
ajlm-2381	256	13	gene	gene	NOUN
ajlm-2381	256	14	vdj	vdj	PROPN
ajlm-2381	256	15	regions	region	NOUN
ajlm-2381	256	16	.	.	PUNCT
ajlm-2381	257	1	semin	semin	PROPN
ajlm-2381	257	2	hematol	hematol	PROPN
ajlm-2381	257	3	.	.	PUNCT
ajlm-2381	258	1	2018;55(1):13–18	2018;55(1):13–18	X
ajlm-2381	258	2	.	.	PUNCT
ajlm-2381	258	3	https://doi.org/10.1053/j.seminhematol.2018.02.007	https://doi.org/10.1053/j.seminhematol.2018.02.007	PROPN
ajlm-2381	258	4	puig	puig	PROPN
ajlm-2381	258	5	n	n	CCONJ
ajlm-2381	258	6	,	,	PUNCT
ajlm-2381	258	7	sarasquete	sarasquete	PROPN
ajlm-2381	258	8	me	i	PRON
ajlm-2381	258	9	,	,	PUNCT
ajlm-2381	258	10	balanzategui	balanzategui	NOUN
ajlm-2381	258	11	a	a	PROPN
ajlm-2381	258	12	,	,	PUNCT
ajlm-2381	258	13	et	et	PROPN
ajlm-2381	258	14	al	al	PROPN
ajlm-2381	258	15	.	.	PROPN
ajlm-2381	259	1	critical	critical	ADJ
ajlm-2381	259	2	evaluation	evaluation	NOUN
ajlm-2381	259	3	of	of	ADP
ajlm-2381	259	4	aso	aso	PROPN
ajlm-2381	259	5	rq	rq	PROPN
ajlm-2381	259	6	-	-	PUNCT
ajlm-2381	259	7	pcr	pcr	NOUN
ajlm-2381	259	8	for	for	ADP
ajlm-2381	259	9	minimal	minimal	ADJ
ajlm-2381	259	10	residual	residual	ADJ
ajlm-2381	259	11	disease	disease	NOUN
ajlm-2381	259	12	evaluation	evaluation	NOUN
ajlm-2381	259	13	in	in	ADP
ajlm-2381	259	14	multiple	multiple	ADJ
ajlm-2381	259	15	myeloma	myeloma	NOUN
ajlm-2381	259	16	.	.	PUNCT
ajlm-2381	260	1	a	a	DET
ajlm-2381	260	2	comparative	comparative	ADJ
ajlm-2381	260	3	analysis	analysis	NOUN
ajlm-2381	260	4	with	with	ADP
ajlm-2381	260	5	flow	flow	NOUN
ajlm-2381	260	6	cytometry	cytometry	NOUN
ajlm-2381	260	7	.	.	PUNCT
ajlm-2381	261	1	leukemia	leukemia	NOUN
ajlm-2381	261	2	.	.	PUNCT
ajlm-2381	262	1	2014;28(2):391–397	2014;28(2):391–397	X
ajlm-2381	262	2	.	.	PROPN
ajlm-2381	262	3	https://doi.org/10.1038/leu.2013.217	https://doi.org/10.1038/leu.2013.217	PROPN
ajlm-2381	262	4	kyle	kyle	PROPN
ajlm-2381	262	5	ra	ra	PROPN
ajlm-2381	262	6	,	,	PUNCT
ajlm-2381	262	7	gertz	gertz	PROPN
ajlm-2381	262	8	ma	ma	PROPN
ajlm-2381	262	9	,	,	PUNCT
ajlm-2381	262	10	witzig	witzig	PROPN
ajlm-2381	262	11	te	te	PROPN
ajlm-2381	262	12	,	,	PUNCT
ajlm-2381	262	13	et	et	PROPN
ajlm-2381	262	14	al	al	PROPN
ajlm-2381	262	15	.	.	PROPN
ajlm-2381	263	1	review	review	PROPN
ajlm-2381	263	2	of	of	ADP
ajlm-2381	263	3	1027	1027	NUM
ajlm-2381	263	4	patients	patient	NOUN
ajlm-2381	263	5	with	with	ADP
ajlm-2381	263	6	newly	newly	ADV
ajlm-2381	263	7	diagnosed	diagnose	VERB
ajlm-2381	263	8	multiple	multiple	ADJ
ajlm-2381	263	9	myeloma	myeloma	NOUN
ajlm-2381	263	10	.	.	PUNCT
ajlm-2381	264	1	mayo	mayo	PROPN
ajlm-2381	264	2	clin	clin	PROPN
ajlm-2381	264	3	proc	proc	PROPN
ajlm-2381	264	4	.	.	PUNCT
ajlm-2381	265	1	2003;78(1):21–33	2003;78(1):21–33	X
ajlm-2381	265	2	.	.	PUNCT
ajlm-2381	266	1	https://doi.org/10.4065/78.1.21	https://doi.org/10.4065/78.1.21	PROPN
ajlm-2381	266	2	hillengass	hillengass	PROPN
ajlm-2381	266	3	j	j	PROPN
ajlm-2381	266	4	,	,	PUNCT
ajlm-2381	266	5	usmani	usmani	PROPN
ajlm-2381	266	6	s	s	PROPN
ajlm-2381	266	7	,	,	PUNCT
ajlm-2381	266	8	rajkumar	rajkumar	PROPN
ajlm-2381	266	9	sv	sv	PROPN
ajlm-2381	266	10	,	,	PUNCT
ajlm-2381	266	11	et	et	PROPN
ajlm-2381	266	12	al	al	PROPN
ajlm-2381	266	13	.	.	PUNCT
ajlm-2381	267	1	international	international	ADJ
ajlm-2381	267	2	myeloma	myeloma	PROPN
ajlm-2381	267	3	working	working	PROPN
ajlm-2381	267	4	group	group	NOUN
ajlm-2381	267	5	consensus	consensus	NOUN
ajlm-2381	267	6	recommendations	recommendation	NOUN
ajlm-2381	267	7	on	on	ADP
ajlm-2381	267	8	imaging	imaging	NOUN
ajlm-2381	267	9	in	in	ADP
ajlm-2381	267	10	monoclonal	monoclonal	NOUN
ajlm-2381	267	11	plasma	plasma	NOUN
ajlm-2381	267	12	cell	cell	NOUN
ajlm-2381	267	13	disorders	disorder	NOUN
ajlm-2381	267	14	.	.	PUNCT
ajlm-2381	268	1	lancet	lancet	PROPN
ajlm-2381	268	2	oncol	oncol	PROPN
ajlm-2381	268	3	.	.	PUNCT
ajlm-2381	269	1	2019;20(6):e302	2019;20(6):e302	PROPN
ajlm-2381	269	2	–	–	PUNCT
ajlm-2381	269	3	e312	e312	PROPN
ajlm-2381	269	4	.	.	PUNCT
ajlm-2381	270	1	https://doi.org/10.1016/s1470-2045(19)30309-2	https://doi.org/10.1016/s1470-2045(19)30309-2	PROPN
ajlm-2381	270	2	hillengass	hillengass	PROPN
ajlm-2381	270	3	j	j	PROPN
ajlm-2381	270	4	,	,	PUNCT
ajlm-2381	270	5	moulopoulos	moulopoulos	PROPN
ajlm-2381	270	6	la	la	PROPN
ajlm-2381	270	7	,	,	PUNCT
ajlm-2381	270	8	delorme	delorme	PROPN
ajlm-2381	270	9	s	s	PROPN
ajlm-2381	270	10	,	,	PUNCT
ajlm-2381	270	11	et	et	PROPN
ajlm-2381	270	12	al	al	PROPN
ajlm-2381	270	13	.	.	PROPN
ajlm-2381	270	14	findings	finding	NOUN
ajlm-2381	270	15	of	of	ADP
ajlm-2381	270	16	whole	whole	ADJ
ajlm-2381	270	17	body	body	NOUN
ajlm-2381	270	18	computed	compute	VERB
ajlm-2381	270	19	tomography	tomography	NOUN
ajlm-2381	270	20	compared	compare	VERB
ajlm-2381	270	21	to	to	ADP
ajlm-2381	270	22	conventional	conventional	ADJ
ajlm-2381	270	23	skeletal	skeletal	ADJ
ajlm-2381	270	24	survey	survey	NOUN
ajlm-2381	270	25	in	in	ADP
ajlm-2381	270	26	patients	patient	NOUN
ajlm-2381	270	27	with	with	ADP
ajlm-2381	270	28	monoclonal	monoclonal	NOUN
ajlm-2381	270	29	plasma	plasma	NOUN
ajlm-2381	270	30	cell	cell	NOUN
ajlm-2381	270	31	disorders	disorder	NOUN
ajlm-2381	270	32	–	–	PUNCT
ajlm-2381	270	33	a	a	DET
ajlm-2381	270	34	study	study	NOUN
ajlm-2381	270	35	of	of	ADP
ajlm-2381	270	36	the	the	DET
ajlm-2381	270	37	international	international	ADJ
ajlm-2381	270	38	myeloma	myeloma	PROPN
ajlm-2381	270	39	working	working	NOUN
ajlm-2381	270	40	group	group	NOUN
ajlm-2381	270	41	.	.	PUNCT
ajlm-2381	271	1	blood	blood	NOUN
ajlm-2381	271	2	.	.	PUNCT
ajlm-2381	272	1	2016;128(22):4468	2016;128(22):4468	X
ajlm-2381	272	2	.	.	PUNCT
ajlm-2381	272	3	https://doi.org/10.1182/blood.v128.22.4468.4468	https://doi.org/10.1182/blood.v128.22.4468.4468	NOUN
ajlm-2381	272	4	wolf	wolf	PROPN
ajlm-2381	272	5	mb	mb	PROPN
ajlm-2381	272	6	,	,	PUNCT
ajlm-2381	272	7	murray	murray	PROPN
ajlm-2381	272	8	f	f	PROPN
ajlm-2381	272	9	,	,	PUNCT
ajlm-2381	272	10	kilk	kilk	PROPN
ajlm-2381	272	11	k	k	PROPN
ajlm-2381	272	12	,	,	PUNCT
ajlm-2381	272	13	et	et	PROPN
ajlm-2381	272	14	al	al	PROPN
ajlm-2381	272	15	.	.	PROPN
ajlm-2381	272	16	sensitivity	sensitivity	NOUN
ajlm-2381	272	17	of	of	ADP
ajlm-2381	272	18	whole	whole	ADJ
ajlm-2381	272	19	-	-	PUNCT
ajlm-2381	272	20	body	body	NOUN
ajlm-2381	272	21	ct	ct	NOUN
ajlm-2381	272	22	and	and	CCONJ
ajlm-2381	272	23	mri	mri	NOUN
ajlm-2381	272	24	versus	versus	ADP
ajlm-2381	272	25	projection	projection	NOUN
ajlm-2381	272	26	radiography	radiography	NOUN
ajlm-2381	272	27	in	in	ADP
ajlm-2381	272	28	the	the	DET
ajlm-2381	272	29	detection	detection	NOUN
ajlm-2381	272	30	of	of	ADP
ajlm-2381	272	31	osteolyses	osteolyse	NOUN
ajlm-2381	272	32	in	in	ADP
ajlm-2381	272	33	patients	patient	NOUN
ajlm-2381	272	34	with	with	ADP
ajlm-2381	272	35	monoclonal	monoclonal	NOUN
ajlm-2381	272	36	plasma	plasma	NOUN
ajlm-2381	272	37	cell	cell	NOUN
ajlm-2381	272	38	disease	disease	NOUN
ajlm-2381	272	39	.	.	PUNCT
ajlm-2381	273	1	eur	eur	PROPN
ajlm-2381	273	2	j	j	PROPN
ajlm-2381	273	3	radiol	radiol	NOUN
ajlm-2381	273	4	.	.	PUNCT
ajlm-2381	274	1	2014;83(7):1222–1230	2014;83(7):1222–1230	NUM
ajlm-2381	274	2	.	.	PUNCT
ajlm-2381	275	1	https://doi.org/10.1016/j.ejrad.2014.02.008	https://doi.org/10.1016/j.ejrad.2014.02.008	PROPN
ajlm-2381	275	2	kröpil	kröpil	PROPN
ajlm-2381	275	3	p	p	X
ajlm-2381	275	4	,	,	PUNCT
ajlm-2381	275	5	fenk	fenk	PROPN
ajlm-2381	275	6	r	r	NOUN
ajlm-2381	275	7	,	,	PUNCT
ajlm-2381	275	8	fritz	fritz	PROPN
ajlm-2381	275	9	lb	lb	PROPN
ajlm-2381	275	10	,	,	PUNCT
ajlm-2381	275	11	et	et	PROPN
ajlm-2381	275	12	al	al	PROPN
ajlm-2381	275	13	.	.	PROPN
ajlm-2381	275	14	comparison	comparison	NOUN
ajlm-2381	275	15	of	of	ADP
ajlm-2381	275	16	whole	whole	ADJ
ajlm-2381	275	17	-	-	PUNCT
ajlm-2381	275	18	body	body	NOUN
ajlm-2381	275	19	64	64	NUM
ajlm-2381	275	20	-	-	PUNCT
ajlm-2381	275	21	slice	slice	NOUN
ajlm-2381	275	22	multidetector	multidetector	NOUN
ajlm-2381	275	23	computed	compute	VERB
ajlm-2381	275	24	tomography	tomography	NOUN
ajlm-2381	275	25	and	and	CCONJ
ajlm-2381	275	26	conventional	conventional	ADJ
ajlm-2381	275	27	radiography	radiography	NOUN
ajlm-2381	275	28	in	in	ADP
ajlm-2381	275	29	staging	staging	NOUN
ajlm-2381	275	30	of	of	ADP
ajlm-2381	275	31	multiple	multiple	ADJ
ajlm-2381	275	32	myeloma	myeloma	NOUN
ajlm-2381	275	33	.	.	PUNCT
ajlm-2381	276	1	eur	eur	NOUN
ajlm-2381	276	2	radiol	radiol	NOUN
ajlm-2381	276	3	.	.	PUNCT
ajlm-2381	277	1	2008;18(1):51–58	2008;18(1):51–58	X
ajlm-2381	277	2	.	.	PUNCT
ajlm-2381	278	1	https://doi.org/10.1007/s00330-007-0738-3	https://doi.org/10.1007/s00330-007-0738-3	NUM
ajlm-2381	278	2	hinge	hinge	PROPN
ajlm-2381	278	3	m	m	PROPN
ajlm-2381	278	4	,	,	PUNCT
ajlm-2381	278	5	andersen	andersen	PROPN
ajlm-2381	278	6	kt	kt	PROPN
ajlm-2381	278	7	,	,	PUNCT
ajlm-2381	278	8	lund	lund	PROPN
ajlm-2381	278	9	t	t	PROPN
ajlm-2381	278	10	,	,	PUNCT
ajlm-2381	278	11	et	et	PROPN
ajlm-2381	278	12	al	al	PROPN
ajlm-2381	278	13	.	.	PROPN
ajlm-2381	278	14	baseline	baseline	PROPN
ajlm-2381	278	15	bone	bone	NOUN
ajlm-2381	278	16	involvement	involvement	NOUN
ajlm-2381	278	17	in	in	ADP
ajlm-2381	278	18	multiple	multiple	ADJ
ajlm-2381	278	19	myeloma	myeloma	NOUN
ajlm-2381	278	20	–	–	PUNCT
ajlm-2381	278	21	a	a	DET
ajlm-2381	278	22	prospective	prospective	ADJ
ajlm-2381	278	23	comparison	comparison	NOUN
ajlm-2381	278	24	of	of	ADP
ajlm-2381	278	25	conventional	conventional	ADJ
ajlm-2381	278	26	x	x	NOUN
ajlm-2381	278	27	-	-	NOUN
ajlm-2381	278	28	ray	ray	ADJ
ajlm-2381	278	29	,	,	PUNCT
ajlm-2381	278	30	low	low	ADJ
ajlm-2381	278	31	-	-	PUNCT
ajlm-2381	278	32	dose	dose	NOUN
ajlm-2381	278	33	computed	compute	VERB
ajlm-2381	278	34	tomography	tomography	NOUN
ajlm-2381	278	35	,	,	PUNCT
ajlm-2381	278	36	and	and	CCONJ
ajlm-2381	278	37	18flourodeoxyglucose	18flourodeoxyglucose	NUM
ajlm-2381	278	38	positron	positron	NOUN
ajlm-2381	278	39	emission	emission	NOUN
ajlm-2381	278	40	tomography	tomography	NOUN
ajlm-2381	278	41	in	in	ADP
ajlm-2381	278	42	previously	previously	ADV
ajlm-2381	278	43	untreated	untreated	ADJ
ajlm-2381	278	44	patients	patient	NOUN
ajlm-2381	278	45	.	.	PUNCT
ajlm-2381	279	1	haematologica	haematologica	PROPN
ajlm-2381	279	2	.	.	PUNCT
ajlm-2381	280	1	2016;101	2016;101	NUM
ajlm-2381	280	2	:	:	PUNCT
ajlm-2381	281	1	e415–418	e415–418	PROPN
ajlm-2381	281	2	.	.	PUNCT
ajlm-2381	282	1	https://doi.org/10.3324/haematol.2016.146092	https://doi.org/10.3324/haematol.2016.146092	PROPN
ajlm-2381	282	2	zamagni	zamagni	NOUN
ajlm-2381	282	3	e	e	NOUN
ajlm-2381	282	4	,	,	PUNCT
ajlm-2381	282	5	nanni	nanni	PROPN
ajlm-2381	282	6	c	c	PROPN
ajlm-2381	282	7	,	,	PUNCT
ajlm-2381	282	8	patriarca	patriarca	NOUN
ajlm-2381	282	9	f	f	X
ajlm-2381	282	10	,	,	PUNCT
ajlm-2381	282	11	et	et	PROPN
ajlm-2381	282	12	al	al	PROPN
ajlm-2381	282	13	.	.	PUNCT
ajlm-2381	283	1	a	a	DET
ajlm-2381	283	2	prospective	prospective	ADJ
ajlm-2381	283	3	comparison	comparison	NOUN
ajlm-2381	283	4	of	of	ADP
ajlm-2381	283	5	18f	18f	PROPN
ajlm-2381	283	6	-	-	PUNCT
ajlm-2381	283	7	fluorodeoxyglucose	fluorodeoxyglucose	PROPN
ajlm-2381	283	8	positron	positron	NOUN
ajlm-2381	283	9	emission	emission	NOUN
ajlm-2381	283	10	tomography	tomography	NOUN
ajlm-2381	283	11	-	-	PUNCT
ajlm-2381	283	12	computed	compute	VERB
ajlm-2381	283	13	tomography	tomography	NOUN
ajlm-2381	283	14	,	,	PUNCT
ajlm-2381	283	15	magnetic	magnetic	ADJ
ajlm-2381	283	16	resonance	resonance	NOUN
ajlm-2381	283	17	imaging	imaging	NOUN
ajlm-2381	283	18	and	and	CCONJ
ajlm-2381	283	19	whole	whole	ADJ
ajlm-2381	283	20	-	-	PUNCT
ajlm-2381	283	21	body	body	NOUN
ajlm-2381	283	22	planar	planar	ADJ
ajlm-2381	283	23	radiographs	radiograph	NOUN
ajlm-2381	283	24	in	in	ADP
ajlm-2381	283	25	the	the	DET
ajlm-2381	283	26	assessment	assessment	NOUN
ajlm-2381	283	27	of	of	ADP
ajlm-2381	283	28	bone	bone	NOUN
ajlm-2381	283	29	disease	disease	NOUN
ajlm-2381	283	30	in	in	ADP
ajlm-2381	283	31	newly	newly	ADV
ajlm-2381	283	32	diagnosed	diagnose	VERB
ajlm-2381	283	33	multiple	multiple	ADJ
ajlm-2381	283	34	myeloma	myeloma	NOUN
ajlm-2381	283	35	.	.	PUNCT
ajlm-2381	284	1	haematologica	haematologica	PROPN
ajlm-2381	284	2	.	.	PUNCT
ajlm-2381	285	1	2007;92(1):50–55	2007;92(1):50–55	X
ajlm-2381	285	2	.	.	PUNCT
ajlm-2381	286	1	https://doi.org/10.3324/haematol.10554	https://doi.org/10.3324/haematol.10554	X
ajlm-2381	286	2	charalampous	charalampous	ADJ
ajlm-2381	286	3	c	c	PROPN
ajlm-2381	286	4	,	,	PUNCT
ajlm-2381	286	5	goel	goel	PROPN
ajlm-2381	286	6	u	u	PROPN
ajlm-2381	286	7	,	,	PUNCT
ajlm-2381	286	8	broski	broski	PROPN
ajlm-2381	286	9	sm	sm	PROPN
ajlm-2381	286	10	,	,	PUNCT
ajlm-2381	286	11	et	et	PROPN
ajlm-2381	286	12	al	al	PROPN
ajlm-2381	286	13	.	.	PUNCT
ajlm-2381	286	14	utility	utility	NOUN
ajlm-2381	286	15	of	of	ADP
ajlm-2381	286	16	pet	pet	NOUN
ajlm-2381	286	17	/	/	SYM
ajlm-2381	286	18	ct	ct	NOUN
ajlm-2381	286	19	in	in	ADP
ajlm-2381	286	20	assessing	assess	VERB
ajlm-2381	286	21	early	early	ADJ
ajlm-2381	286	22	treatment	treatment	NOUN
ajlm-2381	286	23	response	response	NOUN
ajlm-2381	286	24	in	in	ADP
ajlm-2381	286	25	patients	patient	NOUN
ajlm-2381	286	26	with	with	ADP
ajlm-2381	286	27	newly	newly	ADV
ajlm-2381	286	28	diagnosed	diagnose	VERB
ajlm-2381	286	29	multiple	multiple	ADJ
ajlm-2381	286	30	myeloma	myeloma	NOUN
ajlm-2381	286	31	.	.	PUNCT
ajlm-2381	287	1	blood	blood	NOUN
ajlm-2381	287	2	adv	adv	PROPN
ajlm-2381	287	3	.	.	PUNCT
ajlm-2381	288	1	2022;6(9):2763–2772	2022;6(9):2763–2772	PROPN
ajlm-2381	288	2	.	.	PUNCT
ajlm-2381	289	1	https://doi.org/10.1182/bloodadvances.2022007052	https://doi.org/10.1182/bloodadvances.2022007052	PROPN
ajlm-2381	289	2	zamagni	zamagni	PROPN
ajlm-2381	289	3	e	e	PROPN
ajlm-2381	289	4	,	,	PUNCT
ajlm-2381	289	5	tacchetti	tacchetti	PROPN
ajlm-2381	289	6	p	p	X
ajlm-2381	289	7	,	,	PUNCT
ajlm-2381	289	8	cavo	cavo	X
ajlm-2381	289	9	m.	m.	NOUN
ajlm-2381	289	10	imaging	imaging	NOUN
ajlm-2381	289	11	in	in	ADP
ajlm-2381	289	12	multiple	multiple	ADJ
ajlm-2381	289	13	myeloma	myeloma	NOUN
ajlm-2381	289	14	:	:	PUNCT
ajlm-2381	289	15	how	how	SCONJ
ajlm-2381	289	16	?	?	PUNCT
ajlm-2381	290	1	when	when	SCONJ
ajlm-2381	290	2	?	?	PUNCT
ajlm-2381	291	1	blood	blood	NOUN
ajlm-2381	291	2	.	.	PUNCT
ajlm-2381	292	1	2019;133(7):644–651	2019;133(7):644–651	X
ajlm-2381	292	2	.	.	PROPN
ajlm-2381	292	3	https://doi.org/10.1182/blood-2018-08-825356	https://doi.org/10.1182/blood-2018-08-825356	NUM
ajlm-2381	292	4	usmani	usmani	PROPN
ajlm-2381	292	5	sz	sz	PROPN
ajlm-2381	292	6	,	,	PUNCT
ajlm-2381	292	7	mitchell	mitchell	PROPN
ajlm-2381	292	8	a	a	PROPN
ajlm-2381	292	9	,	,	PUNCT
ajlm-2381	292	10	waheed	waheed	PROPN
ajlm-2381	292	11	s	s	PROPN
ajlm-2381	292	12	,	,	PUNCT
ajlm-2381	292	13	et	et	PROPN
ajlm-2381	292	14	al	al	PROPN
ajlm-2381	292	15	.	.	PUNCT
ajlm-2381	292	16	prognostic	prognostic	ADJ
ajlm-2381	292	17	implications	implication	NOUN
ajlm-2381	292	18	of	of	ADP
ajlm-2381	292	19	serial	serial	ADJ
ajlm-2381	292	20	18	18	NUM
ajlm-2381	292	21	-	-	PUNCT
ajlm-2381	292	22	fluoro	fluoro	NOUN
ajlm-2381	292	23	-	-	PUNCT
ajlm-2381	292	24	deoxyglucose	deoxyglucose	NOUN
ajlm-2381	292	25	emission	emission	NOUN
ajlm-2381	292	26	tomography	tomography	NOUN
ajlm-2381	292	27	in	in	ADP
ajlm-2381	292	28	multiple	multiple	ADJ
ajlm-2381	292	29	myeloma	myeloma	NOUN
ajlm-2381	292	30	treated	treat	VERB
ajlm-2381	292	31	with	with	ADP
ajlm-2381	292	32	total	total	ADJ
ajlm-2381	292	33	therapy	therapy	NOUN
ajlm-2381	292	34	3	3	NUM
ajlm-2381	292	35	.	.	PUNCT
ajlm-2381	292	36	blood	blood	NOUN
ajlm-2381	292	37	.	.	PUNCT
ajlm-2381	293	1	2013;121(10):1819–1823	2013;121(10):1819–1823	NUM
ajlm-2381	293	2	.	.	X
ajlm-2381	293	3	https://doi.org/10.1182/blood-2012-08-451690	https://doi.org/10.1182/blood-2012-08-451690	NUM
ajlm-2381	293	4	davies	davy	NOUN
ajlm-2381	293	5	fe	fe	PROPN
ajlm-2381	293	6	,	,	PUNCT
ajlm-2381	293	7	rosenthal	rosenthal	PROPN
ajlm-2381	293	8	a	a	PROPN
ajlm-2381	293	9	,	,	PUNCT
ajlm-2381	293	10	rasche	rasche	PROPN
ajlm-2381	293	11	l	l	NOUN
ajlm-2381	293	12	,	,	PUNCT
ajlm-2381	293	13	et	et	PROPN
ajlm-2381	293	14	al	al	PROPN
ajlm-2381	293	15	.	.	PUNCT
ajlm-2381	293	16	treatment	treatment	NOUN
ajlm-2381	293	17	to	to	ADP
ajlm-2381	293	18	suppression	suppression	NOUN
ajlm-2381	293	19	of	of	ADP
ajlm-2381	293	20	focal	focal	ADJ
ajlm-2381	293	21	lesions	lesion	NOUN
ajlm-2381	293	22	on	on	ADP
ajlm-2381	293	23	positron	positron	NOUN
ajlm-2381	293	24	emission	emission	NOUN
ajlm-2381	293	25	tomography	tomography	NOUN
ajlm-2381	293	26	-	-	PUNCT
ajlm-2381	293	27	computed	compute	VERB
ajlm-2381	293	28	tomography	tomography	NOUN
ajlm-2381	293	29	is	be	AUX
ajlm-2381	293	30	a	a	DET
ajlm-2381	293	31	therapeutic	therapeutic	ADJ
ajlm-2381	293	32	goal	goal	NOUN
ajlm-2381	293	33	in	in	ADP
ajlm-2381	293	34	newly	newly	ADV
ajlm-2381	293	35	diagnosed	diagnose	VERB
ajlm-2381	293	36	multiple	multiple	ADJ
ajlm-2381	293	37	myeloma	myeloma	NOUN
ajlm-2381	293	38	.	.	PUNCT
ajlm-2381	294	1	haematologica	haematologica	PROPN
ajlm-2381	294	2	.	.	PUNCT
ajlm-2381	295	1	2018;103(6):1047–1053	2018;103(6):1047–1053	NUM
ajlm-2381	295	2	.	.	PUNCT
ajlm-2381	296	1	https://doi.org/10.3324/haematol.2017.177139	https://doi.org/10.3324/haematol.2017.177139	PROPN
ajlm-2381	296	2	walker	walker	PROPN
ajlm-2381	296	3	r	r	PROPN
ajlm-2381	296	4	,	,	PUNCT
ajlm-2381	296	5	barlogie	barlogie	NOUN
ajlm-2381	296	6	b	b	NOUN
ajlm-2381	296	7	,	,	PUNCT
ajlm-2381	296	8	haessler	haessler	PROPN
ajlm-2381	296	9	j	j	PROPN
ajlm-2381	296	10	,	,	PUNCT
ajlm-2381	296	11	et	et	PROPN
ajlm-2381	296	12	al	al	PROPN
ajlm-2381	296	13	.	.	PUNCT
ajlm-2381	296	14	magnetic	magnetic	ADJ
ajlm-2381	296	15	resonance	resonance	NOUN
ajlm-2381	296	16	imaging	imaging	NOUN
ajlm-2381	296	17	in	in	ADP
ajlm-2381	296	18	multiple	multiple	ADJ
ajlm-2381	296	19	myeloma	myeloma	NOUN
ajlm-2381	296	20	:	:	PUNCT
ajlm-2381	296	21	diagnostic	diagnostic	ADJ
ajlm-2381	296	22	and	and	CCONJ
ajlm-2381	296	23	clinical	clinical	ADJ
ajlm-2381	296	24	implications	implication	NOUN
ajlm-2381	296	25	.	.	PUNCT
ajlm-2381	297	1	j	j	PROPN
ajlm-2381	297	2	clin	clin	PROPN
ajlm-2381	297	3	oncol	oncol	PROPN
ajlm-2381	297	4	.	.	PUNCT
ajlm-2381	298	1	2007;25(9):1121–1128	2007;25(9):1121–1128	PROPN
ajlm-2381	298	2	.	.	PUNCT
ajlm-2381	299	1	https://doi.org/10.1200/jco.2006.08.5803	https://doi.org/10.1200/jco.2006.08.5803	PROPN
ajlm-2381	299	2	bartel	bartel	PROPN
ajlm-2381	299	3	tb	tb	PROPN
ajlm-2381	299	4	,	,	PUNCT
ajlm-2381	299	5	haessler	haessler	PROPN
ajlm-2381	299	6	j	j	PROPN
ajlm-2381	299	7	,	,	PUNCT
ajlm-2381	299	8	brown	brown	ADJ
ajlm-2381	299	9	tly	tly	ADV
ajlm-2381	299	10	,	,	PUNCT
ajlm-2381	299	11	et	et	PROPN
ajlm-2381	299	12	al	al	PROPN
ajlm-2381	299	13	.	.	PROPN
ajlm-2381	299	14	f18	f18	PROPN
ajlm-2381	299	15	-	-	PUNCT
ajlm-2381	299	16	fluorodeoxyglucose	fluorodeoxyglucose	NOUN
ajlm-2381	299	17	positron	positron	NOUN
ajlm-2381	299	18	emission	emission	NOUN
ajlm-2381	299	19	tomography	tomography	NOUN
ajlm-2381	299	20	in	in	ADP
ajlm-2381	299	21	the	the	DET
ajlm-2381	299	22	context	context	NOUN
ajlm-2381	299	23	of	of	ADP
ajlm-2381	299	24	other	other	ADJ
ajlm-2381	299	25	imaging	imaging	NOUN
ajlm-2381	299	26	techniques	technique	NOUN
ajlm-2381	299	27	and	and	CCONJ
ajlm-2381	299	28	prognostic	prognostic	ADJ
ajlm-2381	299	29	factors	factor	NOUN
ajlm-2381	299	30	in	in	ADP
ajlm-2381	299	31	multiple	multiple	ADJ
ajlm-2381	299	32	myeloma	myeloma	NOUN
ajlm-2381	299	33	.	.	PUNCT
ajlm-2381	300	1	blood	blood	NOUN
ajlm-2381	300	2	.	.	PUNCT
ajlm-2381	301	1	2009;114(10):2068–2076	2009;114(10):2068–2076	NUM
ajlm-2381	301	2	.	.	PUNCT
ajlm-2381	301	3	https://doi.org/10.1182/blood-2009-03-213280	https://doi.org/10.1182/blood-2009-03-213280	PROPN
ajlm-2381	301	4	gebreslassie	gebreslassie	PROPN
ajlm-2381	301	5	ks	ks	PROPN
ajlm-2381	301	6	,	,	PUNCT
ajlm-2381	301	7	bassa	bassa	PROPN
ajlm-2381	301	8	fc	fc	PROPN
ajlm-2381	301	9	,	,	PUNCT
ajlm-2381	301	10	chapanduka	chapanduka	PROPN
ajlm-2381	301	11	zc	zc	PROPN
ajlm-2381	301	12	,	,	PUNCT
ajlm-2381	301	13	warwick	warwick	PROPN
ajlm-2381	301	14	jm	jm	PROPN
ajlm-2381	301	15	.	.	PUNCT
ajlm-2381	302	1	the	the	DET
ajlm-2381	302	2	relationship	relationship	NOUN
ajlm-2381	302	3	between	between	ADP
ajlm-2381	302	4	bone	bone	NOUN
ajlm-2381	302	5	marrow	marrow	NOUN
ajlm-2381	302	6	involvement	involvement	NOUN
ajlm-2381	302	7	on	on	ADP
ajlm-2381	302	8	18f	18f	PROPN
ajlm-2381	302	9	-	-	PUNCT
ajlm-2381	302	10	fdg	fdg	PROPN
ajlm-2381	302	11	pet	pet	PROPN
ajlm-2381	302	12	/	/	SYM
ajlm-2381	302	13	ct	ct	PROPN
ajlm-2381	302	14	and	and	CCONJ
ajlm-2381	302	15	bone	bone	NOUN
ajlm-2381	302	16	marrow	marrow	NOUN
ajlm-2381	302	17	biopsy	biopsy	NOUN
ajlm-2381	302	18	in	in	ADP
ajlm-2381	302	19	patients	patient	NOUN
ajlm-2381	302	20	with	with	ADP
ajlm-2381	302	21	multiple	multiple	ADJ
ajlm-2381	302	22	myeloma	myeloma	NOUN
ajlm-2381	302	23	and	and	CCONJ
ajlm-2381	302	24	other	other	ADJ
ajlm-2381	302	25	plasma	plasma	NOUN
ajlm-2381	302	26	cell	cell	NOUN
ajlm-2381	302	27	neoplasms	neoplasm	NOUN
ajlm-2381	302	28	.	.	PUNCT
ajlm-2381	303	1	s	s	PROPN
ajlm-2381	303	2	afr	afr	PROPN
ajlm-2381	303	3	j	j	PROPN
ajlm-2381	303	4	oncol	oncol	PROPN
ajlm-2381	303	5	.	.	PUNCT
ajlm-2381	304	1	2022;6:197	2022;6:197	X
ajlm-2381	304	2	.	.	PROPN
ajlm-2381	304	3	https://doi.org/10.4102/sajo.v6i0.197	https://doi.org/10.4102/sajo.v6i0.197	NOUN
ajlm-2381	304	4	went	go	VERB
ajlm-2381	304	5	p	p	X
ajlm-2381	304	6	,	,	PUNCT
ajlm-2381	304	7	mayer	mayer	PROPN
ajlm-2381	304	8	s	s	PROPN
ajlm-2381	304	9	,	,	PUNCT
ajlm-2381	304	10	oberholzer	oberholzer	NOUN
ajlm-2381	304	11	n	n	CCONJ
ajlm-2381	304	12	,	,	PUNCT
ajlm-2381	304	13	dirnhofer	dirnhofer	VERB
ajlm-2381	304	14	s.	s.	PROPN
ajlm-2381	304	15	plasma	plasma	PROPN
ajlm-2381	304	16	cell	cell	NOUN
ajlm-2381	304	17	quantification	quantification	NOUN
ajlm-2381	304	18	in	in	ADP
ajlm-2381	304	19	bone	bone	NOUN
ajlm-2381	304	20	marrow	marrow	NOUN
ajlm-2381	304	21	by	by	ADP
ajlm-2381	304	22	computer	computer	NOUN
ajlm-2381	304	23	-	-	PUNCT
ajlm-2381	304	24	assisted	assist	VERB
ajlm-2381	304	25	image	image	NOUN
ajlm-2381	304	26	analysis	analysis	NOUN
ajlm-2381	304	27	.	.	PUNCT
ajlm-2381	305	1	histol	histol	ADJ
ajlm-2381	305	2	histopathol	histopathol	NOUN
ajlm-2381	305	3	.	.	PUNCT
ajlm-2381	306	1	2006	2006	NUM
ajlm-2381	306	2	;	;	PUNCT
ajlm-2381	306	3	21(9):951–956	21(9):951–956	NUM
ajlm-2381	306	4	.	.	PUNCT
ajlm-2381	307	1	https://doi.org/10.14670/hh-21.951	https://doi.org/10.14670/hh-21.951	PROPN
ajlm-2381	307	2	keller	keller	PROPN
ajlm-2381	307	3	a	a	PRON
ajlm-2381	307	4	,	,	PUNCT
ajlm-2381	307	5	laziuk	laziuk	PROPN
ajlm-2381	307	6	k	k	NOUN
ajlm-2381	307	7	,	,	PUNCT
ajlm-2381	307	8	hammer	hammer	NOUN
ajlm-2381	307	9	r	r	NOUN
ajlm-2381	307	10	,	,	PUNCT
ajlm-2381	307	11	kovalenko	kovalenko	ADJ
ajlm-2381	307	12	m.	m.	NOUN
ajlm-2381	307	13	estimation	estimation	NOUN
ajlm-2381	307	14	of	of	ADP
ajlm-2381	307	15	plasma	plasma	NOUN
ajlm-2381	307	16	cells	cell	NOUN
ajlm-2381	307	17	by	by	ADP
ajlm-2381	307	18	cd138	cd138	PROPN
ajlm-2381	307	19	-	-	PUNCT
ajlm-2381	307	20	labeled	label	VERB
ajlm-2381	307	21	tissue	tissue	NOUN
ajlm-2381	307	22	sections	section	NOUN
ajlm-2381	307	23	is	be	AUX
ajlm-2381	307	24	superior	superior	ADJ
ajlm-2381	307	25	to	to	ADP
ajlm-2381	307	26	standard	standard	ADJ
ajlm-2381	307	27	bone	bone	NOUN
ajlm-2381	307	28	marrow	marrow	NOUN
ajlm-2381	307	29	differential	differential	ADJ
ajlm-2381	307	30	aspirate	aspirate	NOUN
ajlm-2381	307	31	smears	smear	NOUN
ajlm-2381	307	32	and	and	CCONJ
ajlm-2381	307	33	whole	whole	ADJ
ajlm-2381	307	34	slide	slide	NOUN
ajlm-2381	307	35	image	image	NOUN
ajlm-2381	307	36	analysis	analysis	NOUN
ajlm-2381	307	37	.	.	PUNCT
ajlm-2381	308	1	am	be	AUX
ajlm-2381	308	2	j	j	PROPN
ajlm-2381	308	3	clin	clin	PROPN
ajlm-2381	308	4	pathol	pathol	NOUN
ajlm-2381	308	5	.	.	PUNCT
ajlm-2381	309	1	2016;146(suppl_1):164	2016;146(suppl_1):164	NUM
ajlm-2381	309	2	.	.	PUNCT
ajlm-2381	310	1	https://doi.org/10.1093/ajcp/aqw151.025	https://doi.org/10.1093/ajcp/aqw151.025	PROPN
ajlm-2381	310	2	malherbe	malherbe	PROPN
ajlm-2381	310	3	jaj	jaj	PROPN
ajlm-2381	310	4	,	,	PUNCT
ajlm-2381	310	5	fuller	full	ADJ
ajlm-2381	310	6	ka	ka	PROPN
ajlm-2381	310	7	,	,	PUNCT
ajlm-2381	310	8	mirzai	mirzai	NOUN
ajlm-2381	310	9	b	b	NOUN
ajlm-2381	310	10	,	,	PUNCT
ajlm-2381	310	11	augustson	augustson	PROPN
ajlm-2381	310	12	bm	bm	PROPN
ajlm-2381	310	13	,	,	PUNCT
ajlm-2381	310	14	erber	erber	PROPN
ajlm-2381	310	15	wn	wn	PROPN
ajlm-2381	310	16	.	.	PROPN
ajlm-2381	310	17	automated	automate	VERB
ajlm-2381	310	18	digital	digital	ADJ
ajlm-2381	310	19	enumeration	enumeration	NOUN
ajlm-2381	310	20	of	of	ADP
ajlm-2381	310	21	plasma	plasma	NOUN
ajlm-2381	310	22	cells	cell	NOUN
ajlm-2381	310	23	in	in	ADP
ajlm-2381	310	24	bone	bone	NOUN
ajlm-2381	310	25	marrow	marrow	NOUN
ajlm-2381	310	26	trephine	trephine	NOUN
ajlm-2381	310	27	biopsies	biopsy	NOUN
ajlm-2381	310	28	of	of	ADP
ajlm-2381	310	29	multiple	multiple	ADJ
ajlm-2381	310	30	myeloma	myeloma	NOUN
ajlm-2381	310	31	.	.	PUNCT
ajlm-2381	311	1	j	j	PROPN
ajlm-2381	311	2	clin	clin	PROPN
ajlm-2381	311	3	pathol	pathol	PROPN
ajlm-2381	311	4	.	.	PUNCT
ajlm-2381	312	1	2022;75(1):50–57	2022;75(1):50–57	X
ajlm-2381	312	2	.	.	PUNCT
ajlm-2381	313	1	https://doi.org/10.1136/jclinpath-2020-207066	https://doi.org/10.1136/jclinpath-2020-207066	PROPN
ajlm-2381	313	2	bankhead	bankhead	PROPN
ajlm-2381	313	3	p	p	PROPN
ajlm-2381	313	4	,	,	PUNCT
ajlm-2381	313	5	loughrey	loughrey	PROPN
ajlm-2381	313	6	mb	mb	PROPN
ajlm-2381	313	7	,	,	PUNCT
ajlm-2381	313	8	fernández	fernández	PROPN
ajlm-2381	313	9	ja	ja	PROPN
ajlm-2381	313	10	,	,	PUNCT
ajlm-2381	313	11	et	et	PROPN
ajlm-2381	313	12	al	al	PROPN
ajlm-2381	313	13	.	.	PROPN
ajlm-2381	313	14	qupath	qupath	PROPN
ajlm-2381	313	15	:	:	PUNCT
ajlm-2381	313	16	open	open	ADJ
ajlm-2381	313	17	source	source	NOUN
ajlm-2381	313	18	software	software	NOUN
ajlm-2381	313	19	for	for	ADP
ajlm-2381	313	20	digital	digital	ADJ
ajlm-2381	313	21	pathology	pathology	NOUN
ajlm-2381	313	22	image	image	NOUN
ajlm-2381	313	23	analysis	analysis	NOUN
ajlm-2381	313	24	.	.	PUNCT
ajlm-2381	314	1	sci	sci	PROPN
ajlm-2381	314	2	rep	rep	PROPN
ajlm-2381	314	3	.	.	PROPN
ajlm-2381	314	4	2017;7(1):16878	2017;7(1):16878	NUM
ajlm-2381	314	5	.	.	PUNCT
ajlm-2381	315	1	https://doi.org/10.1101/099796	https://doi.org/10.1101/099796	PROPN
ajlm-2381	315	2	baranova	baranova	X
ajlm-2381	316	1	k	k	X
ajlm-2381	316	2	,	,	PUNCT
ajlm-2381	316	3	tran	tran	PROPN
ajlm-2381	316	4	c	c	AUX
ajlm-2381	316	5	,	,	PUNCT
ajlm-2381	316	6	plantinga	plantinga	ADV
ajlm-2381	316	7	p	p	NOUN
ajlm-2381	316	8	,	,	PUNCT
ajlm-2381	316	9	sangle	sangle	NOUN
ajlm-2381	316	10	n.	n.	NOUN
ajlm-2381	316	11	evaluation	evaluation	NOUN
ajlm-2381	316	12	of	of	ADP
ajlm-2381	316	13	an	an	DET
ajlm-2381	316	14	open	open	ADJ
ajlm-2381	316	15	-	-	PUNCT
ajlm-2381	316	16	source	source	NOUN
ajlm-2381	316	17	machine	machine	NOUN
ajlm-2381	316	18	-	-	PUNCT
ajlm-2381	316	19	learning	learn	VERB
ajlm-2381	316	20	tool	tool	NOUN
ajlm-2381	316	21	to	to	PART
ajlm-2381	316	22	quantify	quantify	VERB
ajlm-2381	316	23	bone	bone	NOUN
ajlm-2381	316	24	marrow	marrow	NOUN
ajlm-2381	316	25	plasma	plasma	NOUN
ajlm-2381	316	26	cells	cell	NOUN
ajlm-2381	316	27	.	.	PUNCT
ajlm-2381	317	1	j	j	PROPN
ajlm-2381	317	2	clin	clin	PROPN
ajlm-2381	317	3	pathol	pathol	PROPN
ajlm-2381	317	4	.	.	PUNCT
ajlm-2381	318	1	2021;74(7):462–468	2021;74(7):462–468	X
ajlm-2381	318	2	.	.	PUNCT
ajlm-2381	318	3	https://doi.org/10.1136/jclinpath-2021-207524	https://doi.org/10.1136/jclinpath-2021-207524	PROPN
ajlm-2381	318	4	fu	fu	PROPN
ajlm-2381	319	1	f	f	PROPN
ajlm-2381	319	2	,	,	PUNCT
ajlm-2381	319	3	guenther	guenther	PROPN
ajlm-2381	319	4	a	a	X
ajlm-2381	319	5	,	,	PUNCT
ajlm-2381	319	6	sakhdari	sakhdari	PROPN
ajlm-2381	319	7	a	a	PRON
ajlm-2381	319	8	,	,	PUNCT
ajlm-2381	319	9	mckee	mckee	PROPN
ajlm-2381	319	10	td	td	PROPN
ajlm-2381	319	11	,	,	PUNCT
ajlm-2381	319	12	xia	xia	PROPN
ajlm-2381	319	13	d.	d.	PROPN
ajlm-2381	319	14	deep	deep	PROPN
ajlm-2381	319	15	learning	learn	VERB
ajlm-2381	319	16	accurately	accurately	ADV
ajlm-2381	319	17	quantifies	quantify	VERB
ajlm-2381	319	18	plasma	plasma	NOUN
ajlm-2381	319	19	cell	cell	NOUN
ajlm-2381	319	20	percentages	percentage	NOUN
ajlm-2381	319	21	on	on	ADP
ajlm-2381	319	22	cd138	cd138	NOUN
ajlm-2381	319	23	-	-	PUNCT
ajlm-2381	319	24	stained	stain	VERB
ajlm-2381	319	25	bone	bone	NOUN
ajlm-2381	319	26	marrow	marrow	NOUN
ajlm-2381	319	27	samples	sample	NOUN
ajlm-2381	319	28	.	.	PUNCT
ajlm-2381	320	1	j	j	NOUN
ajlm-2381	320	2	pathol	pathol	NOUN
ajlm-2381	320	3	inform	inform	NOUN
ajlm-2381	320	4	.	.	PUNCT
ajlm-2381	321	1	2022;13:100011	2022;13:100011	NUM
ajlm-2381	321	2	.	.	PUNCT
ajlm-2381	322	1	https://doi.org/10.1016/j.jpi.2022.100011	https://doi.org/10.1016/j.jpi.2022.100011	PROPN
ajlm-2381	322	2	lomas	lomas	PROPN
ajlm-2381	322	3	oc	oc	PROPN
ajlm-2381	322	4	,	,	PUNCT
ajlm-2381	322	5	royston	royston	PROPN
ajlm-2381	322	6	d	d	PROPN
ajlm-2381	322	7	,	,	PUNCT
ajlm-2381	322	8	ryou	ryou	PROPN
ajlm-2381	322	9	h	h	NOUN
ajlm-2381	322	10	,	,	PUNCT
ajlm-2381	322	11	et	et	PROPN
ajlm-2381	322	12	al	al	PROPN
ajlm-2381	322	13	.	.	PUNCT
ajlm-2381	323	1	artificial	artificial	ADJ
ajlm-2381	323	2	intelligence	intelligence	NOUN
ajlm-2381	323	3	-	-	PUNCT
ajlm-2381	323	4	based	base	VERB
ajlm-2381	323	5	quantitative	quantitative	ADJ
ajlm-2381	323	6	and	and	CCONJ
ajlm-2381	323	7	topological	topological	ADJ
ajlm-2381	323	8	analysis	analysis	NOUN
ajlm-2381	323	9	of	of	ADP
ajlm-2381	323	10	plasma	plasma	NOUN
ajlm-2381	323	11	cell	cell	NOUN
ajlm-2381	323	12	burden	burden	NOUN
ajlm-2381	323	13	:	:	PUNCT
ajlm-2381	323	14	a	a	DET
ajlm-2381	323	15	new	new	ADJ
ajlm-2381	323	16	tool	tool	NOUN
ajlm-2381	323	17	for	for	ADP
ajlm-2381	323	18	the	the	DET
ajlm-2381	323	19	assessment	assessment	NOUN
ajlm-2381	323	20	of	of	ADP
ajlm-2381	323	21	myeloma	myeloma	NOUN
ajlm-2381	323	22	.	.	PUNCT
ajlm-2381	324	1	blood	blood	NOUN
ajlm-2381	324	2	.	.	PUNCT
ajlm-2381	325	1	2022;140(supplement	2022;140(supplement	NUM
ajlm-2381	326	1	1):12603–12604	1):12603–12604	NUM
ajlm-2381	326	2	.	.	PUNCT
ajlm-2381	327	1	https://doi.org/10.1182/blood-2022-158525	https://doi.org/10.1182/blood-2022-158525	PROPN
ajlm-2381	327	2	gantana	gantana	PROPN
ajlm-2381	327	3	ej	ej	PROPN
ajlm-2381	327	4	,	,	PUNCT
ajlm-2381	327	5	nell	nell	PROPN
ajlm-2381	327	6	e	e	PROPN
ajlm-2381	327	7	,	,	PUNCT
ajlm-2381	327	8	musekwa	musekwa	NOUN
ajlm-2381	327	9	e	e	NOUN
ajlm-2381	327	10	,	,	PUNCT
ajlm-2381	327	11	et	et	PROPN
ajlm-2381	327	12	al	al	PROPN
ajlm-2381	327	13	.	.	PUNCT
ajlm-2381	327	14	evaluation	evaluation	NOUN
ajlm-2381	327	15	of	of	ADP
ajlm-2381	327	16	a	a	DET
ajlm-2381	327	17	new	new	ADJ
ajlm-2381	327	18	technique	technique	NOUN
ajlm-2381	327	19	using	use	VERB
ajlm-2381	327	20	artificial	artificial	ADJ
ajlm-2381	327	21	intelligence	intelligence	NOUN
ajlm-2381	327	22	for	for	ADP
ajlm-2381	327	23	quantification	quantification	NOUN
ajlm-2381	327	24	of	of	ADP
ajlm-2381	327	25	plasma	plasma	NOUN
ajlm-2381	327	26	cells	cell	NOUN
ajlm-2381	327	27	on	on	ADP
ajlm-2381	327	28	cd138	cd138	PROPN
ajlm-2381	327	29	immunohistochemistry	immunohistochemistry	PROPN
ajlm-2381	327	30	.	.	PUNCT
ajlm-2381	328	1	int	int	PROPN
ajlm-2381	328	2	j	j	PROPN
ajlm-2381	328	3	lab	lab	NOUN
ajlm-2381	328	4	hematol	hematol	NOUN
ajlm-2381	328	5	.	.	PUNCT
ajlm-2381	329	1	2023;46(1):50–57	2023;46(1):50–57	NUM
ajlm-2381	329	2	.	.	PUNCT
ajlm-2381	329	3	https://doi.org/10.1111/ijlh.14161	https://doi.org/10.1111/ijlh.14161	ADJ
ajlm-2381	329	4	chlipala	chlipala	PROPN
ajlm-2381	329	5	ea	ea	NOUN
ajlm-2381	329	6	,	,	PUNCT
ajlm-2381	329	7	butters	butters	PROPN
ajlm-2381	329	8	m	m	PROPN
ajlm-2381	329	9	,	,	PUNCT
ajlm-2381	329	10	brous	brous	ADJ
ajlm-2381	329	11	m	m	PROPN
ajlm-2381	329	12	,	,	PUNCT
ajlm-2381	329	13	et	et	PROPN
ajlm-2381	329	14	al	al	PROPN
ajlm-2381	329	15	.	.	PROPN
ajlm-2381	329	16	impact	impact	NOUN
ajlm-2381	329	17	of	of	ADP
ajlm-2381	329	18	preanalytical	preanalytical	ADJ
ajlm-2381	329	19	factors	factor	NOUN
ajlm-2381	329	20	during	during	ADP
ajlm-2381	329	21	histology	histology	NOUN
ajlm-2381	329	22	processing	processing	NOUN
ajlm-2381	329	23	on	on	ADP
ajlm-2381	329	24	section	section	NOUN
ajlm-2381	329	25	suitability	suitability	NOUN
ajlm-2381	329	26	for	for	ADP
ajlm-2381	329	27	digital	digital	ADJ
ajlm-2381	329	28	image	image	NOUN
ajlm-2381	329	29	analysis	analysis	NOUN
ajlm-2381	329	30	.	.	PUNCT
ajlm-2381	330	1	toxicol	toxicol	PROPN
ajlm-2381	330	2	pathol	pathol	NOUN
ajlm-2381	330	3	.	.	PUNCT
ajlm-2381	330	4	2021	2021	NUM
ajlm-2381	330	5	;	;	PUNCT
ajlm-2381	330	6	49(4):755–772	49(4):755–772	NUM
ajlm-2381	330	7	.	.	PUNCT
ajlm-2381	331	1	https://doi.org/10.1177/0192623320970534	https://doi.org/10.1177/0192623320970534	VERB
ajlm-2381	331	2	evans	evans	PROPN
ajlm-2381	331	3	aj	aj	PROPN
ajlm-2381	331	4	,	,	PUNCT
ajlm-2381	331	5	brown	brown	ADJ
ajlm-2381	331	6	rw	rw	NOUN
ajlm-2381	331	7	,	,	PUNCT
ajlm-2381	331	8	bui	bui	PROPN
ajlm-2381	331	9	mm	mm	PROPN
ajlm-2381	331	10	,	,	PUNCT
ajlm-2381	331	11	et	et	PROPN
ajlm-2381	331	12	al	al	PROPN
ajlm-2381	331	13	.	.	PUNCT
ajlm-2381	332	1	validating	validate	VERB
ajlm-2381	332	2	whole	whole	ADJ
ajlm-2381	332	3	slide	slide	NOUN
ajlm-2381	332	4	imaging	imaging	NOUN
ajlm-2381	332	5	systems	system	NOUN
ajlm-2381	332	6	for	for	ADP
ajlm-2381	332	7	diagnostic	diagnostic	ADJ
ajlm-2381	332	8	purposes	purpose	NOUN
ajlm-2381	332	9	in	in	ADP
ajlm-2381	332	10	pathology	pathology	PROPN
ajlm-2381	332	11	.	.	PUNCT
ajlm-2381	333	1	arch	arch	ADJ
ajlm-2381	333	2	pathol	pathol	PROPN
ajlm-2381	333	3	lab	lab	NOUN
ajlm-2381	333	4	med	me	VERB
ajlm-2381	333	5	.	.	PUNCT
ajlm-2381	334	1	2022;146(4):440–450	2022;146(4):440–450	NUM
ajlm-2381	334	2	.	.	PUNCT
ajlm-2381	334	3	https://doi.org/10.5858/arpa.2020-0723-cp	https://doi.org/10.5858/arpa.2020-0723-cp	NUM
ajlm-2381	334	4	clichet	clichet	NOUN
ajlm-2381	334	5	v	v	NOUN
ajlm-2381	334	6	,	,	PUNCT
ajlm-2381	334	7	harrivel	harrivel	NOUN
ajlm-2381	334	8	v	v	NOUN
ajlm-2381	334	9	,	,	PUNCT
ajlm-2381	334	10	delette	delette	VERB
ajlm-2381	334	11	c	c	NOUN
ajlm-2381	334	12	,	,	PUNCT
ajlm-2381	334	13	et	et	PROPN
ajlm-2381	334	14	al	al	PROPN
ajlm-2381	334	15	.	.	PROPN
ajlm-2381	334	16	accurate	accurate	ADJ
ajlm-2381	334	17	classification	classification	NOUN
ajlm-2381	334	18	of	of	ADP
ajlm-2381	334	19	plasma	plasma	NOUN
ajlm-2381	334	20	cell	cell	NOUN
ajlm-2381	334	21	dyscrasias	dyscrasia	NOUN
ajlm-2381	334	22	is	be	AUX
ajlm-2381	334	23	achieved	achieve	VERB
ajlm-2381	334	24	by	by	ADP
ajlm-2381	334	25	combining	combine	VERB
ajlm-2381	334	26	artificial	artificial	ADJ
ajlm-2381	334	27	intelligence	intelligence	NOUN
ajlm-2381	334	28	and	and	CCONJ
ajlm-2381	334	29	flow	flow	NOUN
ajlm-2381	334	30	cytometry	cytometry	NOUN
ajlm-2381	334	31	.	.	PUNCT
ajlm-2381	335	1	br	br	PROPN
ajlm-2381	335	2	j	j	PROPN
ajlm-2381	335	3	haematol	haematol	NOUN
ajlm-2381	335	4	.	.	PUNCT
ajlm-2381	336	1	2022;196(5):1175–1183	2022;196(5):1175–1183	NUM
ajlm-2381	336	2	.	.	PUNCT
ajlm-2381	337	1	https://doi.org/10.1111/bjh.17933	https://doi.org/10.1111/bjh.17933	PROPN
ajlm-2381	337	2	yenamandra	yenamandra	VERB
ajlm-2381	337	3	a	a	PROPN
ajlm-2381	337	4	,	,	PUNCT
ajlm-2381	337	5	hughes	hughes	PROPN
ajlm-2381	337	6	c	c	PROPN
ajlm-2381	337	7	,	,	PUNCT
ajlm-2381	337	8	maris	maris	PROPN
ajlm-2381	337	9	as	as	ADP
ajlm-2381	337	10	.	.	PUNCT
ajlm-2381	337	11	artificial	artificial	ADJ
ajlm-2381	337	12	intelligence	intelligence	NOUN
ajlm-2381	337	13	in	in	ADP
ajlm-2381	337	14	plasma	plasma	NOUN
ajlm-2381	337	15	cell	cell	NOUN
ajlm-2381	337	16	myeloma	myeloma	NOUN
ajlm-2381	337	17	:	:	PUNCT
ajlm-2381	337	18	neural	neural	ADJ
ajlm-2381	337	19	networks	network	NOUN
ajlm-2381	337	20	and	and	CCONJ
ajlm-2381	337	21	support	support	VERB
ajlm-2381	337	22	vector	vector	NOUN
ajlm-2381	337	23	machines	machine	NOUN
ajlm-2381	337	24	in	in	ADP
ajlm-2381	337	25	the	the	DET
ajlm-2381	337	26	classification	classification	NOUN
ajlm-2381	337	27	of	of	ADP
ajlm-2381	337	28	plasma	plasma	NOUN
ajlm-2381	337	29	cell	cell	NOUN
ajlm-2381	337	30	myeloma	myeloma	NOUN
ajlm-2381	337	31	data	datum	NOUN
ajlm-2381	337	32	at	at	ADP
ajlm-2381	337	33	diagnosis	diagnosis	NOUN
ajlm-2381	337	34	.	.	PUNCT
ajlm-2381	338	1	j	j	PROPN
ajlm-2381	338	2	pathol	pathol	NOUN
ajlm-2381	338	3	inform	inform	NOUN
ajlm-2381	338	4	.	.	PUNCT
ajlm-2381	339	1	2021;12(1):35	2021;12(1):35	X
ajlm-2381	339	2	.	.	PUNCT
ajlm-2381	340	1	https://doi.org/10.4103/jpi.jpi_26_21	https://doi.org/10.4103/jpi.jpi_26_21	PROPN
ajlm-2381	340	2	kaplan	kaplan	PROPN
ajlm-2381	340	3	kj	kj	PROPN
ajlm-2381	340	4	,	,	PUNCT
ajlm-2381	340	5	rao	rao	PROPN
ajlm-2381	340	6	lkf	lkf	PROPN
ajlm-2381	340	7	.	.	PUNCT
ajlm-2381	341	1	digital	digital	PROPN
ajlm-2381	341	2	pathology	pathology	PROPN
ajlm-2381	341	3	:	:	PUNCT
ajlm-2381	341	4	historical	historical	ADJ
ajlm-2381	341	5	perspectives	perspective	NOUN
ajlm-2381	341	6	,	,	PUNCT
ajlm-2381	341	7	current	current	ADJ
ajlm-2381	341	8	concepts	concept	NOUN
ajlm-2381	341	9	and	and	CCONJ
ajlm-2381	341	10	future	future	ADJ
ajlm-2381	341	11	applications	application	NOUN
ajlm-2381	341	12	.	.	PUNCT
ajlm-2381	342	1	springer	springer	PROPN
ajlm-2381	342	2	,	,	PUNCT
ajlm-2381	342	3	london	london	PROPN
ajlm-2381	342	4	,	,	PUNCT
ajlm-2381	342	5	2016	2016	NUM
ajlm-2381	342	6	,	,	PUNCT
ajlm-2381	342	7	chapter	chapter	NOUN
ajlm-2381	342	8	1	1	NUM
ajlm-2381	342	9	,	,	PUNCT
ajlm-2381	342	10	introduction	introduction	NOUN
ajlm-2381	342	11	;	;	PUNCT
ajlm-2381	342	12	p.	p.	NOUN
ajlm-2381	342	13	1–3	1–3	NUM
ajlm-2381	342	14	tagliafico	tagliafico	NOUN
ajlm-2381	342	15	as	as	ADP
ajlm-2381	342	16	,	,	PUNCT
ajlm-2381	342	17	dominietto	dominietto	ADJ
ajlm-2381	342	18	a	a	DET
ajlm-2381	342	19	,	,	PUNCT
ajlm-2381	342	20	belgioia	belgioia	PROPN
ajlm-2381	342	21	l	l	NOUN
ajlm-2381	342	22	,	,	PUNCT
ajlm-2381	342	23	campi	campi	VERB
ajlm-2381	342	24	c	c	NOUN
ajlm-2381	342	25	,	,	PUNCT
ajlm-2381	342	26	schenone	schenone	PROPN
ajlm-2381	342	27	d	d	PROPN
ajlm-2381	342	28	,	,	PUNCT
ajlm-2381	342	29	piana	piana	PROPN
ajlm-2381	342	30	m.	m.	PROPN
ajlm-2381	342	31	quantitative	quantitative	ADJ
ajlm-2381	342	32	imaging	imaging	NOUN
ajlm-2381	342	33	and	and	CCONJ
ajlm-2381	342	34	radiomics	radiomic	NOUN
ajlm-2381	342	35	in	in	ADP
ajlm-2381	342	36	multiple	multiple	ADJ
ajlm-2381	342	37	myeloma	myeloma	NOUN
ajlm-2381	342	38	:	:	PUNCT
ajlm-2381	342	39	a	a	DET
ajlm-2381	342	40	potential	potential	ADJ
ajlm-2381	342	41	opportunity	opportunity	NOUN
ajlm-2381	342	42	?	?	PUNCT
ajlm-2381	343	1	medicina	medicina	PROPN
ajlm-2381	343	2	(	(	PUNCT
ajlm-2381	343	3	lithuania	lithuania	PROPN
ajlm-2381	343	4	)	)	PUNCT
ajlm-2381	343	5	.	.	PUNCT
ajlm-2381	344	1	2021;57(2):94	2021;57(2):94	NUM
ajlm-2381	344	2	.	.	NOUN
ajlm-2381	344	3	https://doi.org/10.3390/medicina57020094	https://doi.org/10.3390/medicina57020094	PROPN
ajlm-2381	344	4	wennmann	wennmann	PROPN
ajlm-2381	344	5	m	m	PROPN
ajlm-2381	344	6	,	,	PUNCT
ajlm-2381	344	7	murray	murray	PROPN
ajlm-2381	344	8	jm	jm	PROPN
ajlm-2381	344	9	.	.	PROPN
ajlm-2381	344	10	potential	potential	PROPN
ajlm-2381	344	11	of	of	ADP
ajlm-2381	344	12	radiomics	radiomic	NOUN
ajlm-2381	344	13	and	and	CCONJ
ajlm-2381	344	14	artificial	artificial	ADJ
ajlm-2381	344	15	intelligence	intelligence	NOUN
ajlm-2381	344	16	in	in	ADP
ajlm-2381	344	17	myeloma	myeloma	PROPN
ajlm-2381	344	18	imaging	imaging	PROPN
ajlm-2381	344	19	:	:	PUNCT
ajlm-2381	344	20	development	development	NOUN
ajlm-2381	344	21	of	of	ADP
ajlm-2381	344	22	automatic	automatic	ADJ
ajlm-2381	344	23	,	,	PUNCT
ajlm-2381	344	24	comprehensive	comprehensive	ADJ
ajlm-2381	344	25	,	,	PUNCT
ajlm-2381	344	26	objective	objective	ADJ
ajlm-2381	344	27	skeletal	skeletal	ADJ
ajlm-2381	344	28	analyses	analysis	NOUN
ajlm-2381	344	29	from	from	ADP
ajlm-2381	344	30	whole	whole	ADJ
ajlm-2381	344	31	-	-	PUNCT
ajlm-2381	344	32	body	body	NOUN
ajlm-2381	344	33	imaging	imaging	NOUN
ajlm-2381	344	34	data	datum	NOUN
ajlm-2381	344	35	.	.	PUNCT
ajlm-2381	345	1	radiologe	radiologe	PROPN
ajlm-2381	345	2	.	.	PUNCT
ajlm-2381	346	1	2022;62:44–50	2022;62:44–50	NUM
ajlm-2381	346	2	.	.	PUNCT
ajlm-2381	347	1	https://doi.org/10.1007/s00117-021-00940-1	https://doi.org/10.1007/s00117-021-00940-1	PROPN
ajlm-2381	347	2	arroz	arroz	PROPN
ajlm-2381	347	3	m	m	PROPN
ajlm-2381	347	4	,	,	PUNCT
ajlm-2381	347	5	came	come	VERB
ajlm-2381	347	6	n	n	PRON
ajlm-2381	347	7	,	,	PUNCT
ajlm-2381	347	8	lin	lin	PROPN
ajlm-2381	347	9	p	p	PROPN
ajlm-2381	347	10	,	,	PUNCT
ajlm-2381	347	11	et	et	PROPN
ajlm-2381	347	12	al	al	PROPN
ajlm-2381	347	13	.	.	PUNCT
ajlm-2381	348	1	consensus	consensus	NOUN
ajlm-2381	348	2	guidelines	guideline	NOUN
ajlm-2381	348	3	on	on	ADP
ajlm-2381	348	4	plasma	plasma	NOUN
ajlm-2381	348	5	cell	cell	NOUN
ajlm-2381	348	6	myeloma	myeloma	NOUN
ajlm-2381	348	7	minimal	minimal	ADJ
ajlm-2381	348	8	residual	residual	ADJ
ajlm-2381	348	9	disease	disease	NOUN
ajlm-2381	348	10	analysis	analysis	NOUN
ajlm-2381	348	11	and	and	CCONJ
ajlm-2381	348	12	reporting	reporting	NOUN
ajlm-2381	348	13	.	.	PUNCT
ajlm-2381	349	1	cytometry	cytometry	PROPN
ajlm-2381	349	2	b	b	PROPN
ajlm-2381	349	3	clin	clin	PROPN
ajlm-2381	349	4	cytom	cytom	NOUN
ajlm-2381	349	5	.	.	PUNCT
ajlm-2381	350	1	2016;90(1):31–39	2016;90(1):31–39	NUM
ajlm-2381	350	2	.	.	PUNCT
ajlm-2381	351	1	https://doi.org/10.1002/cyto.b.21228	https://doi.org/10.1002/cyto.b.21228	PROPN
ajlm-2381	351	2	flores	flores	PROPN
ajlm-2381	351	3	-	-	PUNCT
ajlm-2381	351	4	montero	montero	PROPN
ajlm-2381	351	5	j	j	PROPN
ajlm-2381	351	6	,	,	PUNCT
ajlm-2381	351	7	sanoja	sanoja	NOUN
ajlm-2381	351	8	-	-	PUNCT
ajlm-2381	351	9	flores	flores	PROPN
ajlm-2381	351	10	l	l	PROPN
ajlm-2381	351	11	,	,	PUNCT
ajlm-2381	351	12	et	et	PROPN
ajlm-2381	351	13	al	al	PROPN
ajlm-2381	351	14	.	.	PUNCT
ajlm-2381	352	1	next	next	ADJ
ajlm-2381	352	2	generation	generation	NOUN
ajlm-2381	352	3	flow	flow	NOUN
ajlm-2381	352	4	for	for	ADP
ajlm-2381	352	5	highly	highly	ADV
ajlm-2381	352	6	sensitive	sensitive	ADJ
ajlm-2381	352	7	and	and	CCONJ
ajlm-2381	352	8	standardized	standardized	ADJ
ajlm-2381	352	9	detection	detection	NOUN
ajlm-2381	352	10	of	of	ADP
ajlm-2381	352	11	minimal	minimal	ADJ
ajlm-2381	352	12	residual	residual	ADJ
ajlm-2381	352	13	disease	disease	NOUN
ajlm-2381	352	14	in	in	ADP
ajlm-2381	352	15	multiple	multiple	ADJ
ajlm-2381	352	16	myeloma	myeloma	NOUN
ajlm-2381	352	17	.	.	PUNCT
ajlm-2381	353	1	leukemia	leukemia	NOUN
ajlm-2381	353	2	.	.	PUNCT
ajlm-2381	354	1	2017;31(10):2094–2103	2017;31(10):2094–2103	NUM
ajlm-2381	354	2	.	.	PUNCT
ajlm-2381	354	3	https://doi.org/10.1038/leu.2017.29	https://doi.org/10.1038/leu.2017.29	PROPN
ajlm-2381	354	4	paiva	paiva	PROPN
ajlm-2381	354	5	b	b	PROPN
ajlm-2381	354	6	,	,	PUNCT
ajlm-2381	354	7	gutiérrez	gutiérrez	PROPN
ajlm-2381	354	8	nc	nc	PROPN
ajlm-2381	354	9	,	,	PUNCT
ajlm-2381	354	10	rosiñol	rosiñol	PROPN
ajlm-2381	354	11	l	l	PROPN
ajlm-2381	354	12	,	,	PUNCT
ajlm-2381	354	13	et	et	PROPN
ajlm-2381	354	14	al	al	PROPN
ajlm-2381	354	15	.	.	PROPN
ajlm-2381	354	16	high	high	ADJ
ajlm-2381	354	17	-	-	PUNCT
ajlm-2381	354	18	risk	risk	NOUN
ajlm-2381	354	19	cytogenetics	cytogenetic	NOUN
ajlm-2381	354	20	and	and	CCONJ
ajlm-2381	354	21	persistent	persistent	ADJ
ajlm-2381	354	22	minimal	minimal	ADJ
ajlm-2381	354	23	residual	residual	ADJ
ajlm-2381	354	24	disease	disease	NOUN
ajlm-2381	354	25	by	by	ADP
ajlm-2381	354	26	multiparameter	multiparameter	NOUN
ajlm-2381	354	27	flow	flow	NOUN
ajlm-2381	354	28	cytometry	cytometry	PROPN
ajlm-2381	354	29	predict	predict	VERB
ajlm-2381	354	30	unsustained	unsustained	ADJ
ajlm-2381	354	31	complete	complete	ADJ
ajlm-2381	354	32	response	response	NOUN
ajlm-2381	354	33	after	after	ADP
ajlm-2381	354	34	autologous	autologous	ADJ
ajlm-2381	354	35	stem	stem	NOUN
ajlm-2381	354	36	cell	cell	NOUN
ajlm-2381	354	37	transplantation	transplantation	NOUN
ajlm-2381	354	38	in	in	ADP
ajlm-2381	354	39	multiple	multiple	ADJ
ajlm-2381	354	40	myeloma	myeloma	NOUN
ajlm-2381	354	41	.	.	PUNCT
ajlm-2381	355	1	blood	blood	NOUN
ajlm-2381	355	2	.	.	PUNCT
ajlm-2381	356	1	2012;119(3):687–691	2012;119(3):687–691	NUM
ajlm-2381	356	2	.	.	PUNCT
ajlm-2381	357	1	https://doi.org/10.1182/blood-2011-07-370460	https://doi.org/10.1182/blood-2011-07-370460	X
ajlm-2381	357	2	lahuerta	lahuerta	PROPN
ajlm-2381	357	3	jj	jj	PROPN
ajlm-2381	357	4	,	,	PUNCT
ajlm-2381	357	5	paiva	paiva	PROPN
ajlm-2381	357	6	b	b	PROPN
ajlm-2381	357	7	,	,	PUNCT
ajlm-2381	357	8	vidriales	vidriale	NOUN
ajlm-2381	357	9	mb	mb	NOUN
ajlm-2381	357	10	,	,	PUNCT
ajlm-2381	357	11	et	et	PROPN
ajlm-2381	357	12	al	al	PROPN
ajlm-2381	357	13	.	.	PUNCT
ajlm-2381	358	1	depth	depth	NOUN
ajlm-2381	358	2	of	of	ADP
ajlm-2381	358	3	response	response	NOUN
ajlm-2381	358	4	in	in	ADP
ajlm-2381	358	5	multiple	multiple	ADJ
ajlm-2381	358	6	myeloma	myeloma	NOUN
ajlm-2381	358	7	:	:	PUNCT
ajlm-2381	358	8	a	a	DET
ajlm-2381	358	9	pooled	pooled	ADJ
ajlm-2381	358	10	analysis	analysis	NOUN
ajlm-2381	358	11	of	of	ADP
ajlm-2381	358	12	three	three	NUM
ajlm-2381	358	13	pethema	pethema	NOUN
ajlm-2381	358	14	/	/	SYM
ajlm-2381	358	15	gem	gem	NOUN
ajlm-2381	358	16	clinical	clinical	ADJ
ajlm-2381	358	17	trials	trial	NOUN
ajlm-2381	358	18	.	.	PUNCT
ajlm-2381	359	1	j	j	PROPN
ajlm-2381	359	2	clin	clin	PROPN
ajlm-2381	359	3	oncol	oncol	PROPN
ajlm-2381	359	4	.	.	PUNCT
ajlm-2381	360	1	2017;35(25):2900–2912	2017;35(25):2900–2912	NUM
ajlm-2381	360	2	.	.	PUNCT
ajlm-2381	361	1	https://doi.org/10.1200/jco.2016.69.2517	https://doi.org/10.1200/jco.2016.69.2517	PROPN
ajlm-2381	361	2	rawstron	rawstron	PROPN
ajlm-2381	361	3	ac	ac	PROPN
ajlm-2381	361	4	,	,	PUNCT
ajlm-2381	361	5	böttcher	böttcher	PROPN
ajlm-2381	361	6	s	s	NOUN
ajlm-2381	361	7	,	,	PUNCT
ajlm-2381	361	8	letestu	letestu	ADJ
ajlm-2381	361	9	r	r	NOUN
ajlm-2381	361	10	,	,	PUNCT
ajlm-2381	361	11	et	et	PROPN
ajlm-2381	361	12	al	al	PROPN
ajlm-2381	361	13	.	.	PUNCT
ajlm-2381	362	1	improving	improve	VERB
ajlm-2381	362	2	efficiency	efficiency	NOUN
ajlm-2381	362	3	and	and	CCONJ
ajlm-2381	362	4	sensitivity	sensitivity	NOUN
ajlm-2381	362	5	:	:	PUNCT
ajlm-2381	362	6	european	european	ADJ
ajlm-2381	362	7	research	research	NOUN
ajlm-2381	362	8	initiative	initiative	NOUN
ajlm-2381	362	9	in	in	ADP
ajlm-2381	362	10	cll	cll	PROPN
ajlm-2381	362	11	(	(	PUNCT
ajlm-2381	362	12	eric	eric	PROPN
ajlm-2381	362	13	)	)	PUNCT
ajlm-2381	362	14	update	update	NOUN
ajlm-2381	362	15	on	on	ADP
ajlm-2381	362	16	the	the	DET
ajlm-2381	362	17	international	international	ADJ
ajlm-2381	362	18	harmonised	harmonise	VERB
ajlm-2381	362	19	approach	approach	NOUN
ajlm-2381	362	20	for	for	ADP
ajlm-2381	362	21	flow	flow	NOUN
ajlm-2381	362	22	cytometric	cytometric	ADJ
ajlm-2381	362	23	residual	residual	ADJ
ajlm-2381	362	24	disease	disease	NOUN
ajlm-2381	362	25	monitoring	monitor	VERB
ajlm-2381	362	26	in	in	ADP
ajlm-2381	362	27	cll	cll	PROPN
ajlm-2381	362	28	.	.	PUNCT
ajlm-2381	363	1	leukemia	leukemia	NOUN
ajlm-2381	363	2	.	.	PUNCT
ajlm-2381	364	1	2013;27(1):142–149	2013;27(1):142–149	X
ajlm-2381	364	2	.	.	PUNCT
ajlm-2381	364	3	https://doi.org/10.1038/leu.2012.216	https://doi.org/10.1038/leu.2012.216	VERB
ajlm-2381	364	4	stetler	stetler	NOUN
ajlm-2381	364	5	-	-	PUNCT
ajlm-2381	364	6	stevenson	stevenson	PROPN
ajlm-2381	364	7	m	m	PROPN
ajlm-2381	364	8	,	,	PUNCT
ajlm-2381	364	9	paiva	paiva	PROPN
ajlm-2381	364	10	b	b	PROPN
ajlm-2381	364	11	,	,	PUNCT
ajlm-2381	364	12	stoolman	stoolman	PROPN
ajlm-2381	364	13	l	l	PROPN
ajlm-2381	364	14	,	,	PUNCT
ajlm-2381	364	15	et	et	PROPN
ajlm-2381	364	16	al	al	PROPN
ajlm-2381	364	17	.	.	PUNCT
ajlm-2381	365	1	consensus	consensus	NOUN
ajlm-2381	365	2	guidelines	guideline	NOUN
ajlm-2381	365	3	for	for	ADP
ajlm-2381	365	4	myeloma	myeloma	NOUN
ajlm-2381	365	5	minimal	minimal	ADJ
ajlm-2381	365	6	residual	residual	ADJ
ajlm-2381	365	7	disease	disease	NOUN
ajlm-2381	365	8	sample	sample	NOUN
ajlm-2381	365	9	staining	stain	VERB
ajlm-2381	365	10	and	and	CCONJ
ajlm-2381	365	11	data	datum	NOUN
ajlm-2381	365	12	acquisition	acquisition	NOUN
ajlm-2381	365	13	.	.	PUNCT
ajlm-2381	366	1	cytometry	cytometry	PROPN
ajlm-2381	366	2	b	b	PROPN
ajlm-2381	366	3	clin	clin	PROPN
ajlm-2381	366	4	cytom	cytom	PROPN
ajlm-2381	366	5	.	.	PUNCT
ajlm-2381	367	1	2016;90(1):26–30	2016;90(1):26–30	X
ajlm-2381	367	2	.	.	PUNCT
ajlm-2381	368	1	https://doi.org/10.1002/cyto.b.21249	https://doi.org/10.1002/cyto.b.21249	X
ajlm-2381	368	2	roshal	roshal	PROPN
ajlm-2381	368	3	m	m	PROPN
ajlm-2381	368	4	,	,	PUNCT
ajlm-2381	368	5	flores	flores	PROPN
ajlm-2381	368	6	-	-	PUNCT
ajlm-2381	368	7	montero	montero	PROPN
ajlm-2381	368	8	ja	ja	PROPN
ajlm-2381	368	9	,	,	PUNCT
ajlm-2381	368	10	gao	gao	PROPN
ajlm-2381	368	11	q	q	PROPN
ajlm-2381	368	12	,	,	PUNCT
ajlm-2381	368	13	et	et	PROPN
ajlm-2381	368	14	al	al	PROPN
ajlm-2381	368	15	.	.	PUNCT
ajlm-2381	368	16	mrd	mrd	PROPN
ajlm-2381	368	17	detection	detection	NOUN
ajlm-2381	368	18	in	in	ADP
ajlm-2381	368	19	multiple	multiple	ADJ
ajlm-2381	368	20	myeloma	myeloma	NOUN
ajlm-2381	368	21	:	:	PUNCT
ajlm-2381	368	22	comparison	comparison	NOUN
ajlm-2381	368	23	between	between	ADP
ajlm-2381	368	24	mskcc	mskcc	PROPN
ajlm-2381	368	25	10	10	NUM
ajlm-2381	368	26	-	-	PUNCT
ajlm-2381	368	27	color	color	NOUN
ajlm-2381	368	28	single	single	ADJ
ajlm-2381	368	29	-	-	PUNCT
ajlm-2381	368	30	tube	tube	NOUN
ajlm-2381	368	31	and	and	CCONJ
ajlm-2381	368	32	euroflow	euroflow	VERB
ajlm-2381	368	33	8	8	NUM
ajlm-2381	368	34	-	-	PUNCT
ajlm-2381	368	35	color	color	ADJ
ajlm-2381	368	36	2	2	NUM
ajlm-2381	368	37	-	-	PUNCT
ajlm-2381	368	38	tube	tube	NOUN
ajlm-2381	368	39	methods	method	NOUN
ajlm-2381	368	40	.	.	PUNCT
ajlm-2381	369	1	blood	blood	NOUN
ajlm-2381	369	2	adv	adv	PROPN
ajlm-2381	369	3	.	.	PUNCT
ajlm-2381	370	1	2017;1(12):728–732	2017;1(12):728–732	NUM
ajlm-2381	370	2	.	.	PUNCT
ajlm-2381	371	1	https://doi.org/10.1182/bloodadvances.2016003715	https://doi.org/10.1182/bloodadvances.2016003715	NOUN
ajlm-2381	371	2	cao	cao	PROPN
ajlm-2381	371	3	w	w	PROPN
ajlm-2381	371	4	,	,	PUNCT
ajlm-2381	371	5	goolsby	goolsby	ADJ
ajlm-2381	371	6	cl	cl	NOUN
ajlm-2381	371	7	,	,	PUNCT
ajlm-2381	371	8	nelson	nelson	PROPN
ajlm-2381	371	9	bp	bp	PROPN
ajlm-2381	371	10	,	,	PUNCT
ajlm-2381	371	11	singhal	singhal	PROPN
ajlm-2381	371	12	s	s	PROPN
ajlm-2381	371	13	,	,	PUNCT
ajlm-2381	371	14	mehta	mehta	PROPN
ajlm-2381	371	15	j	j	PROPN
ajlm-2381	371	16	,	,	PUNCT
ajlm-2381	371	17	peterson	peterson	PROPN
ajlm-2381	371	18	lac	lac	PROPN
ajlm-2381	371	19	.	.	PUNCT
ajlm-2381	371	20	instability	instability	NOUN
ajlm-2381	371	21	of	of	ADP
ajlm-2381	371	22	immunophenotype	immunophenotype	NOUN
ajlm-2381	371	23	in	in	ADP
ajlm-2381	371	24	plasma	plasma	NOUN
ajlm-2381	371	25	cell	cell	NOUN
ajlm-2381	371	26	myeloma	myeloma	NOUN
ajlm-2381	371	27	.	.	PUNCT
ajlm-2381	372	1	am	be	AUX
ajlm-2381	372	2	j	j	PROPN
ajlm-2381	372	3	clin	clin	PROPN
ajlm-2381	372	4	pathol	pathol	NOUN
ajlm-2381	372	5	.	.	PUNCT
ajlm-2381	373	1	2008;129(6):926–933	2008;129(6):926–933	NUM
ajlm-2381	373	2	.	.	PUNCT
ajlm-2381	373	3	https://doi.org/10.1309/8uvf7yq1d4d4etqv	https://doi.org/10.1309/8uvf7yq1d4d4etqv	PROPN
ajlm-2381	373	4	ghogale	ghogale	PROPN
ajlm-2381	373	5	s	s	PROPN
ajlm-2381	373	6	,	,	PUNCT
ajlm-2381	373	7	tauro	tauro	PROPN
ajlm-2381	373	8	w	w	PROPN
ajlm-2381	373	9	,	,	PUNCT
ajlm-2381	373	10	priyadarshini	priyadarshini	VERB
ajlm-2381	373	11	a	a	PRON
ajlm-2381	373	12	,	,	PUNCT
ajlm-2381	373	13	et	et	PROPN
ajlm-2381	373	14	al	al	PROPN
ajlm-2381	373	15	.	.	PROPN
ajlm-2381	374	1	slam	slam	PROPN
ajlm-2381	374	2	family	family	NOUN
ajlm-2381	374	3	member	member	NOUN
ajlm-2381	374	4	‘	'	PUNCT
ajlm-2381	374	5	cd229	cd229	PROPN
ajlm-2381	374	6	’	'	PUNCT
ajlm-2381	374	7	:	:	PUNCT
ajlm-2381	374	8	a	a	DET
ajlm-2381	374	9	novel	novel	ADJ
ajlm-2381	374	10	gating	gating	NOUN
ajlm-2381	374	11	marker	marker	NOUN
ajlm-2381	374	12	for	for	ADP
ajlm-2381	374	13	plasma	plasma	NOUN
ajlm-2381	374	14	cells	cell	NOUN
ajlm-2381	374	15	in	in	ADP
ajlm-2381	374	16	flow	flow	NOUN
ajlm-2381	374	17	cytometric	cytometric	ADJ
ajlm-2381	374	18	immunophenotyping	immunophenotyping	NOUN
ajlm-2381	374	19	(	(	PUNCT
ajlm-2381	374	20	fci	fci	NOUN
ajlm-2381	374	21	)	)	PUNCT
ajlm-2381	374	22	of	of	ADP
ajlm-2381	374	23	multiple	multiple	ADJ
ajlm-2381	374	24	myeloma	myeloma	NOUN
ajlm-2381	374	25	(	(	PUNCT
ajlm-2381	374	26	mm	mm	PROPN
ajlm-2381	374	27	)	)	PUNCT
ajlm-2381	374	28	.	.	PUNCT
ajlm-2381	375	1	clin	clin	PROPN
ajlm-2381	375	2	lymphoma	lymphoma	PROPN
ajlm-2381	375	3	myeloma	myeloma	PROPN
ajlm-2381	375	4	leuk	leuk	NOUN
ajlm-2381	375	5	.	.	PUNCT
ajlm-2381	376	1	2017;17(1):e19	2017;17(1):e19	X
ajlm-2381	376	2	.	.	PUNCT
ajlm-2381	377	1	https://doi.org/10.1016/j.clml.2017.03.032	https://doi.org/10.1016/j.clml.2017.03.032	PROPN
ajlm-2381	377	2	tembhare	tembhare	PROPN
ajlm-2381	377	3	pr	pr	PROPN
ajlm-2381	377	4	,	,	PUNCT
ajlm-2381	377	5	ghogale	ghogale	PROPN
ajlm-2381	377	6	s	s	PROPN
ajlm-2381	377	7	,	,	PUNCT
ajlm-2381	377	8	tauro	tauro	PROPN
ajlm-2381	377	9	w	w	PROPN
ajlm-2381	377	10	,	,	PUNCT
ajlm-2381	377	11	et	et	PROPN
ajlm-2381	377	12	al	al	PROPN
ajlm-2381	377	13	.	.	PUNCT
ajlm-2381	377	14	evaluation	evaluation	NOUN
ajlm-2381	377	15	of	of	ADP
ajlm-2381	377	16	cd229	cd229	PROPN
ajlm-2381	377	17	as	as	ADP
ajlm-2381	377	18	a	a	DET
ajlm-2381	377	19	new	new	ADJ
ajlm-2381	377	20	alternative	alternative	ADJ
ajlm-2381	377	21	plasma	plasma	NOUN
ajlm-2381	377	22	cell	cell	NOUN
ajlm-2381	377	23	gating	gating	NOUN
ajlm-2381	377	24	marker	marker	NOUN
ajlm-2381	377	25	in	in	ADP
ajlm-2381	377	26	the	the	DET
ajlm-2381	377	27	flow	flow	NOUN
ajlm-2381	377	28	cytometric	cytometric	ADJ
ajlm-2381	377	29	immunophenotyping	immunophenotyping	NOUN
ajlm-2381	377	30	of	of	ADP
ajlm-2381	377	31	monoclonal	monoclonal	NOUN
ajlm-2381	377	32	gammopathies	gammopathy	NOUN
ajlm-2381	377	33	.	.	PUNCT
ajlm-2381	378	1	cytometry	cytometry	PROPN
ajlm-2381	378	2	b	b	PROPN
ajlm-2381	378	3	clin	clin	PROPN
ajlm-2381	378	4	cytom	cytom	NOUN
ajlm-2381	378	5	.	.	PUNCT
ajlm-2381	379	1	2018;94(3):509–519	2018;94(3):509–519	NUM
ajlm-2381	379	2	.	.	PUNCT
ajlm-2381	379	3	https://doi.org/10.1002/cyto.b.21619	https://doi.org/10.1002/cyto.b.21619	X
ajlm-2381	380	1	sriram	sriram	PROPN
ajlm-2381	380	2	h	h	PROPN
ajlm-2381	380	3	,	,	PUNCT
ajlm-2381	380	4	ghogale	ghogale	PROPN
ajlm-2381	380	5	s	s	PROPN
ajlm-2381	380	6	,	,	PUNCT
ajlm-2381	380	7	subramanian	subramanian	PROPN
ajlm-2381	380	8	pg	pg	PROPN
ajlm-2381	380	9	,	,	PUNCT
ajlm-2381	380	10	et	et	PROPN
ajlm-2381	380	11	al	al	PROPN
ajlm-2381	380	12	.	.	PUNCT
ajlm-2381	380	13	evaluation	evaluation	NOUN
ajlm-2381	380	14	of	of	ADP
ajlm-2381	380	15	cd319	cd319	PROPN
ajlm-2381	380	16	(	(	PUNCT
ajlm-2381	380	17	slamf7	slamf7	NOUN
ajlm-2381	380	18	)	)	PUNCT
ajlm-2381	380	19	as	as	ADP
ajlm-2381	380	20	a	a	DET
ajlm-2381	380	21	novel	novel	ADJ
ajlm-2381	380	22	gating	gating	NOUN
ajlm-2381	380	23	marker	marker	NOUN
ajlm-2381	380	24	for	for	ADP
ajlm-2381	380	25	plasma	plasma	NOUN
ajlm-2381	380	26	cells	cell	NOUN
ajlm-2381	380	27	in	in	ADP
ajlm-2381	380	28	flow	flow	NOUN
ajlm-2381	380	29	cytometric	cytometric	ADJ
ajlm-2381	380	30	immunophenotyping	immunophenotyping	NOUN
ajlm-2381	380	31	of	of	ADP
ajlm-2381	380	32	multiple	multiple	ADJ
ajlm-2381	380	33	myeloma	myeloma	NOUN
ajlm-2381	380	34	.	.	PUNCT
ajlm-2381	381	1	clin	clin	PROPN
ajlm-2381	381	2	lymphoma	lymphoma	PROPN
ajlm-2381	381	3	myeloma	myeloma	PROPN
ajlm-2381	381	4	leuk	leuk	PROPN
ajlm-2381	381	5	.	.	PUNCT
ajlm-2381	382	1	2019;19(10):e153	2019;19(10):e153	X
ajlm-2381	382	2	.	.	PUNCT
ajlm-2381	383	1	https://doi.org/10.1016/j.clml.2019.09.255	https://doi.org/10.1016/j.clml.2019.09.255	ADJ
ajlm-2381	383	2	bakkus	bakkus	PROPN
ajlm-2381	383	3	mhc	mhc	PROPN
ajlm-2381	383	4	,	,	PUNCT
ajlm-2381	383	5	bouko	bouko	PROPN
ajlm-2381	383	6	y	y	PROPN
ajlm-2381	383	7	,	,	PUNCT
ajlm-2381	383	8	samson	samson	PROPN
ajlm-2381	383	9	d	d	PROPN
ajlm-2381	383	10	,	,	PUNCT
ajlm-2381	383	11	et	et	PROPN
ajlm-2381	383	12	al	al	PROPN
ajlm-2381	383	13	.	.	PUNCT
ajlm-2381	384	1	post	post	ADJ
ajlm-2381	384	2	-	-	ADJ
ajlm-2381	384	3	transplantation	transplantation	ADJ
ajlm-2381	384	4	tumour	tumour	NOUN
ajlm-2381	384	5	load	load	NOUN
ajlm-2381	384	6	in	in	ADP
ajlm-2381	384	7	bone	bone	NOUN
ajlm-2381	384	8	marrow	marrow	NOUN
ajlm-2381	384	9	,	,	PUNCT
ajlm-2381	384	10	as	as	SCONJ
ajlm-2381	384	11	assessed	assess	VERB
ajlm-2381	384	12	by	by	ADP
ajlm-2381	384	13	quantitative	quantitative	ADJ
ajlm-2381	384	14	aso	aso	PROPN
ajlm-2381	384	15	-	-	PUNCT
ajlm-2381	384	16	pcr	pcr	NOUN
ajlm-2381	384	17	,	,	PUNCT
ajlm-2381	384	18	is	be	AUX
ajlm-2381	384	19	a	a	DET
ajlm-2381	384	20	prognostic	prognostic	ADJ
ajlm-2381	384	21	parameter	parameter	NOUN
ajlm-2381	384	22	in	in	ADP
ajlm-2381	384	23	multiple	multiple	ADJ
ajlm-2381	384	24	myeloma	myeloma	NOUN
ajlm-2381	384	25	.	.	PUNCT
ajlm-2381	385	1	br	br	PROPN
ajlm-2381	385	2	j	j	PROPN
ajlm-2381	385	3	haematol	haematol	NOUN
ajlm-2381	385	4	.	.	PUNCT
ajlm-2381	386	1	2004;126(5):665–674	2004;126(5):665–674	NUM
ajlm-2381	386	2	.	.	PUNCT
ajlm-2381	387	1	https://doi.org/10.1111/j.1365-2141.2004.05120.x	https://doi.org/10.1111/j.1365-2141.2004.05120.x	NOUN
ajlm-2381	387	2	ladetto	ladetto	PROPN
ajlm-2381	387	3	m	m	PROPN
ajlm-2381	387	4	,	,	PUNCT
ajlm-2381	387	5	brüggemann	brüggemann	PROPN
ajlm-2381	387	6	m	m	PROPN
ajlm-2381	387	7	,	,	PUNCT
ajlm-2381	387	8	monitillo	monitillo	PROPN
ajlm-2381	387	9	l	l	PROPN
ajlm-2381	387	10	,	,	PUNCT
ajlm-2381	387	11	et	et	PROPN
ajlm-2381	387	12	al	al	PROPN
ajlm-2381	387	13	.	.	PROPN
ajlm-2381	388	1	next	next	ADJ
ajlm-2381	388	2	-	-	PUNCT
ajlm-2381	388	3	generation	generation	NOUN
ajlm-2381	388	4	sequencing	sequencing	NOUN
ajlm-2381	388	5	and	and	CCONJ
ajlm-2381	388	6	real	real	ADJ
ajlm-2381	388	7	-	-	PUNCT
ajlm-2381	388	8	time	time	NOUN
ajlm-2381	388	9	quantitative	quantitative	ADJ
ajlm-2381	388	10	pcr	pcr	NOUN
ajlm-2381	388	11	for	for	ADP
ajlm-2381	388	12	minimal	minimal	ADJ
ajlm-2381	388	13	residual	residual	ADJ
ajlm-2381	388	14	disease	disease	NOUN
ajlm-2381	388	15	detection	detection	NOUN
ajlm-2381	388	16	in	in	ADP
ajlm-2381	388	17	b	b	NOUN
ajlm-2381	388	18	-	-	PUNCT
ajlm-2381	388	19	cell	cell	NOUN
ajlm-2381	388	20	disorders	disorder	NOUN
ajlm-2381	388	21	.	.	PUNCT
ajlm-2381	389	1	leukemia	leukemia	NOUN
ajlm-2381	389	2	.	.	PUNCT
ajlm-2381	390	1	2014;28(6):1299–1307	2014;28(6):1299–1307	NUM
ajlm-2381	390	2	.	.	PUNCT
ajlm-2381	391	1	https://doi.org/10.1038/leu.2013.375	https://doi.org/10.1038/leu.2013.375	PROPN